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Summary 
This thesis investigates the RNA-binding protein Roquin-1 and its paralog Roquin-2 and their 
crucial role in T cell-mediated immune responses. Roquin-1 was first identified in a screen for 
autoimmune regulators. Here, a single point mutation in the ROQ-domain of Roquin causes a 
severe systemic lupus erythematosus-like phenotype in the so-called sanroque mice. 
Conditional deletion of Roquin paralogs in T cells partially resembles the phenotype, highly 
emphasizing the essential role for Roquin in the prevention of autoimmunity.  
The first part presented in this thesis contributed to the discovery of a cooperative type of gene 
regulation by multiple Roquin proteins. The present state of knowledge is that Roquin binds 
stem loop cis-elements in the 3'-untranslated region (UTR) of mRNAs that encode important 
factors for T cell differentiation and induces mRNA decay thereof. I identified a novel way of 
gene regulation, which requires multiple Roquin proteins interacting with essential and non-
essential stem loops in the 3'-UTRs of Nfkbid and Ox40 thereby inducing mRNA degradation. 
Interestingly, the Nfkbid transcript was controlled by Roquin not only via mRNA decay, but also 
by inhibition of translation. These analyses were the first evidence that multiple Roquin proteins 
confer a robust post-transcriptional mRNA gene regulation.  
The second part of this thesis investigated another layer of the cooperative function of Roquin: 
its physical and functional cooperation with the endonuclease Regnase-1. Regnase-1 and 
Roquin share overlapping target mRNAs and ablation of Regnase-1 in T cells resembles the 
phenotype of sanroque mice and mice lacking Roquin in T cells. In addition, TCR activation in 
T cells triggers cleavage of Roquin as well as Regnase-1 via the MALT1 paracaspase, thereby 
releasing target mRNAs from repression. We therefore addressed the questions: Why do 
Roquin and Regnase-1 have the same functions and are equally regulated in T cells? We 
hypothesized that Roquin and Regnase-1 cooperatively repressed their target mRNAs in 
T cells and thus prevented autoimmunity. By comparing the phenotypes of mice conditionally 
deleted for the Roquin paralogs, Regnase-1 and all three proteins in T cells, we identified a 
new cooperative function in directing regulatory T cell development in the thymus and 
preventing autoimmunity especially by controlling TH17 and TFH differentiation. Global gene 
expression analysis of CD4 T cells lacking Roquin and Regnase-1 uncovered different types 
of post-transcriptional gene regulation by Roquin and Regnase-1, whereas most genes 
depended on the presence of Roquin as well as Regnase-1. Identifying a direct interaction of 
Regnase-1 with Roquin finally proved the concept of cooperativity. In conclusion, this thesis 
provides evidence that cooperative gene regulation by Roquin and Regnase-1 is a safeguard 
mechanism to prevent overshooting immune responses that potentially cause autoimmunity. 
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Zusammenfassung 
Diese Dissertation untersucht das RNS-bindende Protein Roquin-1 sowie dessen Paralog 
Roquin-2 und deren essentielle Funktion in T-Zell-gesteuerten Immunantworten. Roquin-1 
wurde zum ersten Mal in einem Screen für Autoimmunregulatoren beschrieben. Hierbei wurde 
die sogenannte sanroque Maus entdeckt, die durch eine einzige Punktmutation in der ROQ-
Domäne von Roquin-1 eine starke Lupus-ähnliche Autoimmunerkrankung entwickelt. Mäuse 
mit einer T-Zell-spezifischen Deletion beider Roquin Paraloge weisen eine ähnliche 
Autoimmunerkrankung auf. Dies unterstreicht die zentrale Rolle von Roquin-1 und Roquin-2 
in der Prävention von Autoimmunität. 
Der erste Teil dieser Arbeit konnte zur Entdeckung einer kooperativen Genregulation durch 
mehrere Roquin-Proteine beitragen. Nach aktuellem Wissensstand erkennt Roquin 
Haarnadelstrukturen sogenannter cis-Elemente in der 3'-untranslatierten Region (UTR) von 
mRNS und induziert dadurch deren Abbau. Diese mRNS kodieren für wichtige Faktoren der 
T-Zellaktivierung. Wir konnten eine neue Art der Regulation durch Roquin identifizieren, bei 
welcher mehrere Roquin-Proteine benötigt werden, um essentielle und nicht-essentielle 
Haarnadelstrukturen in den 3'-UTRs von Nfkbid und Ox40 zu erkennen und somit deren mRNS 
Abbau einzuleiten. Interessanterweise konnte Roquin nicht nur den mRNS Abbau von Nfkbid 
induzieren, sondern führte auch zur Inhibition der Translation der mRNS. Diese Erkenntnisse 
sind erste Beweise dafür, dass mehrere Roquin-Proteine zusammenwirken, um eine robuste 
post-transkriptionelle Genregulation zu ermöglichen.  
Im zweiten Teil dieser Arbeit wird eine weitere Ebene der Funktionsweise von Roquin 
untersucht: seine physische und funktionelle Kooperation mit der Endonuklease Regnase-1. 
Roquin und Regnase-1 teilen sich ein gemeinsames Set von Ziel-RNS und die Phänotypen 
von Mäusen mit konditionellen Deletionen von Regnase-1 in T-Zellen ähneln dem Phänotypen 
der sanroque Mäuse sowie Mäusen mit einer T-Zell-spezifischen Deletion von Roquin. 
Zusätzlich werden die Proteinmengen sowohl von Roquin als auch Regnase-1 in T-Zellen in 
gleicher Art und Weise kontrolliert, da die Paracaspase MALT1 beide Proteine abhängig von 
der T-Zellrezeptorstimulation spaltet. Wir adressierten daher experimentell die folgenden 
Fragen: Warum haben Roquin und Regnase-1 die gleichen Funktionen in T-Zellen und warum 
wird ihre Expression auf gleiche Weise kontrolliert? Wir stellten die Hypothese auf, dass 
Roquin und Regnase-1 kooperative Funktionen in T-Zellen ausüben, indem sie zusammen 
ihre Ziel-mRNS reprimieren, um damit gemeinsam Autoimmunität vorzubeugen. Ein Vergleich 
der Phänotypen von Mäusen mit T-Zell-spezifischen Deletionen der Roquin Paraloge, 
Regnase-1 und allen drei Genen zeigte eine neue kooperative Funktion in der Entwicklung 
Zusammenfassung 
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von regulatorischen T-Zellen im Thymus. Zusätzlich konnten wir beweisen, dass Roquin und 
Regnase-1 zusammen Autoimmunität vorbeugen, insbesondere durch die Kontrolle der 
Aktivierung von naiven CD4 T-Zellen und ihrer Differenzierung zu follikulären T-Helferzellen 
sowie IL-17-produzierenden T-Helferzellen (TH17 Zellen). Globale Genexpressionsanalysen 
von CD4 T-Zellen, die kein Roquin und/oder Regnase-1 exprimierten, konnten dazu beitragen, 
verschiedene Arten von Genregulationen durch Roquin und Regnase-1 zu identifizieren. Diese 
Analyse zeigte eine Abhängigkeit der meisten Gene von beiden Faktoren. Die Tatsache, dass 
Roquin und Regnase-1 direkt miteinander interagierten, stärkte das Modell einer kooperativen 
Funktionsweise.  
Zusammengefasst zeigt diese Arbeit, dass die kooperative Genregulation durch Roquin und 
Regnase-1 einen Schutzmechanismus zur Verhinderung einer übermäßigen Immunantwort 
darstellt, die potentiell Autoimmunität auslösen kann. 
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Human genes and proteins are written in capital letters. 
Mouse genes and proteins are written in lowercase.  
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b beta 
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% percent 
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D aspartic acid (Asp) 
DC dendritic cell 
DKO double knockout 
DMEM Dulbecco’s Modified Eagle Medium 
DMSO dimethyl sulfoxide 
DN double negative 
DNA desoxyribonucleic acid 
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dox doxycycline 
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DTT dithiothreitol 
ECL enhanced chemiluminescence 
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FC fold-change 
FCS fetal calf serum 
fl full length 
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GO gene ontology 
Gy gray 
h hour 
H2O water 
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HEK human embryonic kidney cells 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HEPN higher eukaryotes and prokaryotes nucleotide-binding domain 
HITS-CLIP high-throughput sequencing of RNA isolated by crosslinking immunoprecipitation 
HRP horseradish peroxidase 
Icos inducible T cell co-stimulator 
IFN interferon 
Ig immunoglobulin 
IL interleukin 
iono ionomycin 
IP immunoprecipitation 
IRES internal ribosome entry site 
Irf interferon regulatory factor 
K lysine (Lys) 
kb kilo base pair 
kd knockdown 
kDa kilodalton 
KO knockout 
L Leucine (Leu) 
LB lysogeny broth 
LBE linear binding element 
LE loop exchange mutation 
LM loop mutation 
LN lymph node 
m milli 
M molar 
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M methionine (Met) 
MCPIP monocyte chemotactic protein-induced protein 
MEF mouse embryonic fibroblast 
MFI median fluorescent intensity 
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min minutes 
Mio million 
mRNA messenger RNA 
n nano 
N asparagine (Asn) 
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NaCl sodium chloride 
NKT natural killer T cell 
nm nanometer 
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nt nucleotide  
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PAGE polyacrylamide gel electrophoresis 
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PBS phosphate buffer saline 
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PTM post translational modification 
pu purine base 
PVDF polyvinylidene difluoride 
py pyrimidine base 
R arginine (Arg) 
RA rheumatoid arthritis 
rad radiation absorbed dose 
RBP RNA-binding protein 
RIP RNA Immunoprecipitation 
RNA ribonucleic acid 
RPF ribosome-protected fragment 
rpm rounds per minute 
RSM reversed stem mutation 
RT room temperature 
S serine (Ser) 
san sanroque mutation (M199R) 
SDS sodium dodecyl sulfate 
sec second 
seq sequencing 
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T threonine (Thr) 
tam tamoxifen 
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1 Introduction 
1.1 The immune system 
Our body is exposed to pathogens, toxins, and environmental cues throughout its lifetime. To 
ensure health and survival, the immune system has evolved and found ways to defend against 
foreign microorganisms including viruses, bacteria, fungi, and parasites. Anatomic and 
chemical barriers like the skin epithelium or the complement system are the most primitive 
ways of protection against harmful organisms. Since pathogens have evolved to evade these 
relatively simple barriers, vertebrates developed a more specialized host defense: the innate 
and the adaptive immune system.  
1.1.1 The innate and adaptive immunity 
All immune cells derive from pluripotent hematopoietic stem cells of the bone marrow that 
diverge into two types of stem cell lineages: Stem cells either give rise to a common lymphoid 
progenitor that comprises the lymphoid lineage of leukocytes formed by T and B lymphocytes, 
natural killer cells (NK) and innate lymphoid cells (ILC) or a common myeloid progenitor that 
gives rise to cells of the innate immune system such as macrophages, granulocytes, mast cells 
and dendritic cells. The innate immune cells exhibit protective function by recognizing 
infections, sensing foreign pathogens and directly mediating clearance of pathogens or 
recruiting cells of the adaptive immune response. These processes are based on the 
recognition of pathogen-associated molecular patterns (PAMPs) via pattern recognition 
receptors (PRRs) for example the toll-like receptors (TLRs) on the cell surface of innate 
immune cells. (Janeway and Medzhitov, 2002). Activation of PRRs on macrophages or 
neutrophils directly induces phagocytosis of bacteria but can in turn cause inflammation via 
secretion of cytokines and chemokines. However, the innate immune cells are only capable of 
recognizing invariant molecules, that are shared by multiple pathogens, but are incapable of 
recognizing pathogen-specific structures and defending the host from reinfections (Murphy and 
Weaver, 2017). 
The lymphoid lineage is composed of T and B lymphocytes as well as NK cells and ILCs, 
whereas the latter have been described as more “innate” lymphocytes. NK cells are large 
lymphoid-like cells that directly eliminate infected target cells. Besides a lymphoid morphology, 
ILCs are described for their protective role in early immune responses especially at epithelial 
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barriers (Neill and Flynn, 2018). In contrast to cells of the innate immune response, T and B 
lymphocytes have evolved ways to fight pathogens in a more specialized and sensitive 
manner: Different from NK and ILCs, T and B lymphocytes carry a highly variable clonal 
antigen-receptor that facilitates recognition of a unique foreign antigen. Therefore, 
lymphocytes can detect a multiplicity of pathogens and are capable to generate memory to 
rapidly respond to reinfections with the same pathogen.  
B cells mature in the bone marrow and express the B-cell receptor (BCR). As soon as the BCR 
encounters antigen, naïve B-lymphocytes differentiate towards plasma cells that are 
specialized to produce their antigen receptor in two forms: soluble antibodies 
(immunoglobulins) or membrane-bound BCRs. Besides antibodies, also BCRs directly engage 
with the epitope of the respective antigen in the extracellular fluids including interstitial and 
intravascular compartments.  
In turn, T lymphocytes arise and mature in the thymus and carry the T cell receptor (TCR), 
which recognizes protein-antigens only if presented on MHC-molecules (major 
histocompatibility complex) on the surface of various cell types including antigen-presenting 
cells (APCs). Receptors of the adaptive immune system (BCR and TCR) are encoded by gene 
segments that undergo somatic rearrangement, which is termed V(D)J-recombination. Gene 
rearrangement of variable (V), diversity (D) and joining (J) regions during cell maturation is 
mediated by RAG proteins (recombination-activating gene) (Grawunder et al., 1998). This 
somatic recombination occurs independently in individual lymphocytes and results in a 
polyclonal receptor repertoire of 1013-1018 (Nikolich-Zugich et al., 2004). As soon as the 
receptor on a naïve mature lymphocyte encounters its cognate foreign antigen, the cell is 
activated and starts to divide, thereby serving as a “clone” for identical progeny with the same 
receptor-antigen-specificity. The model of clonal selection was first proposed in the 1950s by 
Macfarlane Burnet, who set a milestone for the understanding of T cell immunity (Burnet, 
1962).  
1.1.2 Central T cell tolerance 
Removing thymi from young mice (thymectomy) results in a drastic immunodeficiency, 
emphasizing the importance of this lymphoid organ in maintaining a functional immune 
response (Metcalf, 1960). Common lymphoid progenitors from the bone marrow enter the 
thymus where they become mature T lymphocytes (T cells). T cells characteristically express 
either CD4 or CD8 co-receptors, which classifies them as T helper cells (CD4+) or cytotoxic T 
cells (CD8+). CD4 interacts with MHC II (class 2) expressed on antigen-presenting cells like 
macrophages, dendritic cells and B cells, whereas CD8 recognizes MHC I (class 1) that is 
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expressed on all cells and recruits its ligands from endogenous polypeptide degradation 
products thereby displaying antigens derived from endogenous or viral peptides.  
The process of T cell maturation can last up to 7 days and starts with immature T cells that 
neither express CD4 or CD8 nor the TCR and accessory molecules (CD3). Within this double 
negative (DN) stage, cells are sub-divided into DN1, DN2, DN3 and DN4 stages defined by 
their characteristic surface expression of CD44, CD25 and CD117 (cKit). The pre-TCR 
development during DN3 and DN4 and successful rearrangement of TCR b and a chains 
further induces the expression of both CD4 and CD8 resulting in double-positive thymocytes 
(DP). During subsequent maturation steps, the expression of one co-receptor is lost, resulting 
in CD4 and CD8 single positive (SP) T cells (Murphy and Weaver, 2017).  
To prevent reactivity of the TCR to self-antigens, T cells go through several selection 
processes termed clonal selection. The widely-accepted affinity hypothesis proposes that 
positive and negative selection of thymocytes depend on the affinity of the TCR to self-
peptide:MHC complexes (p:MHC) presented by thymic epithelial cells (Klein et al., 2014). 
Studies in TCR-transgenic mice have emphasized that positive selection in the thymic cortex 
is induced by low-affinity p:MHC interaction, whereas negative selection in the medulla is 
favored by high-affinity agonists leading to clonal deletion by apoptosis to prevent self-
reactivity (Daniels et al., 2006). In contrast, no or very low affinity interactions of lymphocytes 
with p:MHC causes death by neglect. Interestingly, a subgroup of CD4 T helper cells termed 
regulatory T cells (Treg) derive from T cells that encounter stronger TCR p:MHC interaction than 
positively selected T cells, but still show less affinity than those dying by negative selection 
(Jordan et al., 2001). These specialized T cells function to dampen an overshooting immune 
response and prevent autoimmunity. However, the concept of selection in the thymus is highly 
controversial, since some studies propose that most of the clonal deletion occurs at the DP 
stage in the thymic cortex independent from processes in the medulla (McCaughtry et al., 
2008; Stritesky et al., 2013). These controversial findings may arise primarily due to the use of 
different model systems such as TCR transgenic mice that express their TCR early at DN 
stages and therefore do not represent physiological TCR expression or models with 
endogenous superantigens that fail to copy Ag-specific clonal deletion. 
1.1.3 The role of CD4 and CD8 T cells in the immune system 
After maturation in the thymus, mature naïve, self-tolerant CD4 and CD8 T cells migrate to 
secondary lymphoid organs (spleen and lymph nodes) constantly searching for dendritic cells 
that carry the cognate peptide ligand to their TCR, the recognition of which by the naïve T cell 
is called the priming step. After establishing the contact of APC and naïve T cell by adhesion 
molecules, the T cell scans the APCs for its cognate p:MHC ligand. In order to fully activate 
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the T cell and cause differentiation and proliferation, it is obligatory for the T cell to receive 
three major signals: 1. Binding of the TCR and CD4 or CD8 co-receptor to p:MHC II or I (Chen 
and Flies, 2013). 2. Stimulation of a co-stimulatory receptor like CD28 or Icos on the T cell by 
B7 or IcosL molecules from the same APC (Gonzalo et al., 2001). 3. Sensing of cytokines in 
the environment. These three signals convey activation, survival and differentiation of T cells 
by translating signals from outside the cells into intracellular signaling pathways. The combined 
downstream activation of AP-1, NFAT (nuclear factor of activated T cells) and NF-kB (nuclear 
factor kB) signaling pathways is essential for the production of the hallmark cytokine IL-2 which 
drives T cell proliferation and activation (Hoefig and Heissmeyer, 2018). 
Antigen-specific CD8 T cells recognize virus-infected cells, clear those cells and form memory. 
Prior to developing this function, naïve CD8 T cells get their first contact to foreign cognate 
antigen loaded on MHC class I on DCs in the subcapsular sinus region or the interfollicular 
region of the draining lymph node (Hickman et al., 2008; John et al., 2009). Additional co-
stimulation and inflammatory cytokines in the microenvironment contribute to full activation of 
cytotoxic CD8 T cells. Through re-entering in the lymphatic system and blood stream, activated 
CD8 T cells reach the site of infection and, upon antigenic stimulation, destroy infected cells 
via the secretion of granzymes or perforin subsequently inducing apoptosis of the target cell 
(Barber et al., 2003). Interestingly, viruses have evolved strategies to downregulate MHC class 
I molecules, which allows escape from CD8-mediated clearance (Halenius et al., 2015). Very 
recently, non-recirculating tissue-resident memory CD8 T cells (TRM) that lack molecules 
necessary for migration (such as Klf2, S1PR1, Ccr7) but express residency markers (such as 
CD103 or CD69) have been identified to derive from T cells that enter tissues during a primary 
immune response and then reside at the site of a cleared infection in skin, lung and gut. 
Interestingly, CD103+ TRM cells are highly abundant at solid tumor sites and their proportion is 
positively correlating with tumor clearance and good prognosis, making this cell type a 
promising tool for anti-tumor immunity (Amsen et al., 2018).  
Besides CD8 T cells, CD4 T helper cells are an essential component of the adaptive immune 
system. They specifically contribute to clear bacterial or viral infections by providing help to 
other immune and non-immune cells and form memory to be re-activated upon a secondary 
infection. CD4 T cells can comprise different T helper cell (TH) subsets amongst them TH1, 
TH2, TH17, follicular T helper cells (TFH) and induced regulatory T cells (iTreg) which can be 
distinguished by their characteristic expression of subset-specifying transcription factors and 
hallmark cytokine secretion (Sallusto, 2016) (Figure 1). The differentiation into these subsets 
results from integrating TCR and co-stimulatory receptor signaling with signal transduction 
from cytokine receptors. The latter causes phosphorylation of cytoplasmic signal transducer 
and activator of transcription (Stat) proteins, followed by nuclear translocation of homodimers 
that further induce expression of the subset-specific master transcription factors (O'Shea et 
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al., 2011). Besides a complex network of transcription factors, post-transcriptional regulators 
such as micro RNAs (miRNAs) and RNA-binding proteins (RBPs) function in cell fate decisions 
of T cells. Here, the turnover of mRNAs encoding for important factors that drive fate decisions 
of T cells during stimulation (through cytokine or co-stimulatory receptors) are controlled, thus 
providing a mechanism to rapidly respond to environmental changes. The miRNA cluster miR-
17-92 and individual miRNAs thereof have been demonstrated to function in T cell 
differentiation (Baumjohann, 2018).  
 
 
Figure 1 ç Schematic representation of CD4 T cell differentiation into T helper cell subsets. 
Differentiation of naïve CD4 T cells into TH1, TH2, TH17, TFH and iTreg results from incorporating TCR 
stimulation by peptide-loaded MHC II and co-stimulation by an antigen-presenting cell in the presence 
of a specific cytokine milieu (shown by arrows). Cytokine receptor signaling on CD4 T cells results in 
phosphorylation, activation and nuclear translocation of Stat proteins that then further induce the 
expression of the hallmark transcription factors of the different T helper cell subsets (shown in the 
nucleus). These specific signaling cascades result in a unique expression of receptors and secretion of 
pro- (TH1, TH2, TH17 and TFH) or anti-inflammatory (iTreg) cytokines. 
 
Additionally, lineage commitment is strictly connected to epigenetic changes at lineage-specific 
gene loci, since transcriptional changes are fixed epigenetically by altered chromatin states, 
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unique enhancer landscapes and a complex network of transcriptional activators and 
repressors (Kanno et al., 2012). 
TH1 cells provide pro-inflammatory help in case of intracellular infections with microorganisms 
including viruses, protozoa and bacteria. The differentiation of naïve T cells to TH1 cells is 
caused through an initial IL-12 and subsequent IFN-g receptor signaling thereby activating 
Stat4 and Stat1 proteins. These Stat proteins together function in the transcriptional activation 
of Tbet, which is the hallmark transcription factor of TH1 cells. Tbet itself induces gene 
expression of IFN-g, thus acting as a positive feedback loop for further TH1 differentiation 
(Amsen et al., 2009; Mosmann et al., 1986). Moreover, TH1 cells are an important source of 
IL-2, which augments CD4 and CD8 effector T cell functions and proliferation. Additionally, 
IFN-g production helps to clear intracellular infections by induction and activation of 
macrophages. 
The TH2 subset is involved in clearing infections with parasites, especially helminths by 
secretion of the cytokines IL-4, IL-5 and IL-13 and moreover contributes to allergic 
immunopathology. The production of IL-5 causes recruitment of eosinophils which then 
produce major basic protein to directly kill parasites, whereas IL-4 and IL-13 secretion recruit 
macrophages that enhance tissue repair at sites of infections (Kouro and Takatsu, 2009). The 
development of TH2 cells is driven by the cytokine IL-4, whereas IL-4 receptor signaling further 
causes activation of Stat6, which in turn translocates to the nucleus and stimulates the 
expression of the TH2-specific transcription factor Gata3 (Zheng and Flavell, 1997). Gata3 
provides a positive feedback loop by inducing its own transcription as well as IL-4 and 
promoting transcription of IL-13 (Ouyang et al., 2000).  
Upon infection with extracellular bacteria and fungi, the secretion of IL-6 and TGF-b by innate 
immune cells induces the differentiation of the TH17 subset. Engagement of IL-6 with its 
receptor induces downstream activation of the transcription factor Stat3, which further causes 
expression of the master regulator RORgt that directly acts on the transcription of the signature 
cytokine IL-17 (Ghoreschi et al., 2010). The release of the IL-17 family members IL-17A and 
IL-17F leads to the recruitment of neutrophils to sites of infection and causes stimulation of 
fibroblasts and epithelial cells carrying IL-17 receptors to produce IL-6 which further amplifies 
the TH17 response. The expansion of TH17 cells additionally requires the cytokine IL-23 
(Ouyang et al., 2008). Interestingly, the propagation of autoimmune diseases such as 
experimental autoimmune encephalomyelitis (EAE) in mice is attributed to TH17 cells, since 
neutralization of IL-17 secretion with a monoclonal antibody prevents the onset of disease 
(Hofstetter et al., 2005; Komiyama et al., 2006). Therefore, it is proposed that an imbalance of 
these T cell subsets may lead to tissue inflammation. 
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Intriguingly, an additional subset of T helper cells is induced by TGF-b, which is termed induced 
regulatory T cells (iTreg). Unlike the previously described T helper cell subsets, regulatory T 
cells have immune-repressive activity and thereby prevent autoimmunity. The plasticity of Treg 
and TH17 cells is critical to keep immune homeostasis (Knochelmann et al., 2018). Disruption 
of regulatory T cell function or removal contributes to a vast number of autoimmune and 
inflammatory pathologies (Sakaguchi et al., 1995; Shevach, 2000), whereas dominance of 
TH17 responses have been associated to autoimmunity in humans. Different from TH17 cells, 
regulatory T cells are not induced by the pro-inflammatory cytokines IL-6 and IL-23. Unlike, the 
development of thymic Treg (tTreg) cells, which has been described previously (chapter 1.1.2), 
a smaller proportion of Treg cells is induced in the periphery (iTreg) promoted by high doses of 
TGF-b and IL-2, which induces the expression of the hallmark transcription factor Foxp3 and 
the IL-2 receptor CD25 (Sakaguchi et al., 2008). The expression of the inhibitory co-stimulatory 
receptor Ctla-4 allows iTreg cells to compete with naïve CD4 T cells for their interaction with 
CD28 on APCs, since Ctla-4 and CD28 share the costimulatory ligands CD80 and CD86 on 
APCs. Thus, regulatory T cells prevent signals for activation of naïve T cells (Yamaguchi et 
al., 2013). Additionally, Ctla-4 controls the expression of CD28-ligands on APCs cell-
extrinsically by trans-endocytosis thereof into Ctla-4-expressing cells (Qureshi et al., 2011). 
The suppressive capacity of regulatory T cells is further maintained by production of anti-
inflammatory cytokines like TGF-b and IL-10. TGF-b secretion acts as a positive feedback loop 
for Treg induction and TH17 differentiation, whereas IL-10 has inhibitory function on TH1 cells. 
In contrast to the previously described T helper cell subsets, follicular T helper cell (TFH) 
differentiation is a two-step process. Their capability of providing help to B cells in germinal 
centers (GC) of secondary lymphoid organs during an infection, makes them a central 
component of the humoral immune response. Upon T cell activation and co-stimulation in the 
presence of the cytokines IL-6, IL-21 and TGF-b, a pre-TFH stage is formed in the T-cell zone 
of the follicle characterized by high levels of PD-1 (programmed cell death protein 1) and Icos, 
which is complemented by increased expression of the hallmark transcription factor Bcl-6. By 
elevated abundance of Cxcr5, the cells migrate to the T-B-cell border within the B cell follicle, 
where T and B cells interact by offering signals required to induce GC reaction of both cell 
types. The B cell provides the TFH cell with antigenic stimulation and stimulatory and inhibitory 
signals (CD80, CD86, IcosL, Ox40L, PD-L1/2), whereas secretion of IL-21 and IL-4 as well as 
expression of CD40L by the TFH cell prompts B cell entry in the follicle. Here, B cells proliferate 
and differentiate into memory B cells or antibody-secreting plasma cells by undergoing somatic 
hypermutation thus shaping the humoral immune response (Webb and Linterman, 2017). In 
mouse models for systemic lupus erythematosus such as the Bxd2 mice, autoimmunity is 
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caused by aberrant frequencies of follicular T helper cells that directly correlate with the 
abundance of autoreactive GC B cells and production of autoantibodies (Kim et al., 2015).  
Recently, thymic-derived Foxp3-expressing T cells in the GC were characterized as follicular 
regulatory T cells (TFR). They share TFH-hallmarks like PD-1, Cxcr5 and Bcl6 expression and 
additionally express Foxp3, but are distinct from both T cell subtypes. TFR cells have regulatory 
function thereby restraining the GC response and controlling TFH development, but the distinct 
purpose of this T cell subset has not been completely solved yet (Linterman et al., 2011).  
T helper cell differentiation is a highly complex process. Differentiation into one T helper cell 
lineage is often accompanied by inhibitory signals for reciprocally developing CD4 T cell 
subsets. For example, TH2-promoting IL-2/Stat5 signaling blocks differentiation of TH17 
differentiation (Yamane and Paul, 2013). Recent research has provided several examples of 
T cell differentiation with a high degree of plasticity, indicating that the process is far more 
complex than hypothesized and differentiation into the one or the other lineage is not as definite 
as initially thought. 
1.1.4 Co-stimulation of T cells and downstream signaling 
The T cell receptor (TCR) is a multiprotein complex that intracellularly comprises 
immunoreceptor tyrosine-based activation motifs (ITAMS). After cognate antigen binding to 
the TCR and stabilization by CD4 or CD8 co-receptors, Src-family kinases phosphorylate 
tyrosine residues on ITAMs, which initiates complex signaling cascades by recruiting scaffold 
proteins and activating multiple downstream signaling pathways. This signaling cascade 
ultimately results in the activation of three major transcription factors (AP-1, NFAT and NF-kB) 
crucial for expression of the cytokine IL-2, which is essential for T cell proliferation and survival. 
However, signal from the TCR requires additional signals from co-stimulatory receptors to 
achieve full activation. The classical “two-signal model” first proposed in 1970 that full 
activation of T cells requires engagement of the TCR with peptide-loaded MHC as well as co-
stimulatory signals (Bretscher and Cohn, 1970). Since then, co-stimulatory receptors have 
been identified that can, together with TCR signaling, transduce extracellular stimulation either 
into positive or negative signals inside the T cells by further triggering signaling cascades that 
induce differentiation and peripheral T cell homeostasis (Chen and Flies, 2013). Most co-
stimulatory molecules belong to either the tumor necrosis factor receptor superfamily (Tnfrsf) 
or the immunoglobulin superfamily (IgSF) and both inhibitory and stimulatory receptors are 
dynamically expressed dependent on the activation status of the T cell (Zhu et al., 2011).  
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1.1.4.1 The CD28 receptor family 
The best studied IgSF co-stimulatory receptors are the CD28 gene family proteins. CD28, 
cytotoxic T lymphocyte antigen 4 (Ctla-4) and inducible co-stimulator (Icos) are expressed from 
a gene cluster on the mouse chromosome 1, proposing that these genes derived from gene 
duplication (Ling et al., 2001). CD28 and Ctla-4 ligate with B7-1 (CD80) and B7-2 (CD86) on 
APCs and additionally interact with B7-H2 (IcosL), the ligand for Icos. Consequently, Icos, 
CD28 and Ctla-4 can compete for their ligand association (Yao et al., 2011). In contrast to Icos 
and CD28, Ctla-4 has inhibitory function on T cell activation by directly competing for positive 
signals via CD28 by sequestering CD80 and CD86 (Parry et al., 2005). Mice deficient for Ctla-
4 exhibit fatal lymphoproliferation of CD4 T cells and injection of Ctla-4-ligand into mice 
deficient for Ctla-4 rescued the phenotype by blocking binding sites for CD28 on CD80/CD86, 
suggesting a role for Ctla-4 in controlling T cell proliferation (Chambers et al., 1997). Another 
inhibitory molecule of the CD28 family is PD-1 (programmed death 1), which interacts with PD-
L1 or PD-L2 and is, like Icos, highly expressed on TFH cells (Crotty, 2011). CD28 is 
constitutively expressed in naïve T cells, whereas Icos is induced upon T cell stimulation and 
the inhibitory molecules Ctla-4 as well as PD-1 act as safeguards during an expiring immune 
response to ensure reduced T cell activity. In 2018, James P. Allison and Tasuku Honjo were 
awarded with the Nobel Prize in Medicine for their discovery of checkpoint inhibitors as 
revolutionary immune cancer therapies. They found that antibodies blocking either PD-1, PD-
L1 or Ctla-4 release a break in T cells with high Ctla-4 or PD-1 expression and unleash the T 
cells to attack tumor cells (Ishida et al., 1992; Leach et al., 1996).  
The cytoplasmic domain of CD28 harbors two motifs that can further proceed into different 
downstream signaling cascades. First, signaling via CD28 promotes activation of NF-kB, 
NFAT, the anti-apoptosis family BCL, mTOR and GLUT1 (glucose transporter type 1) (Boomer 
and Green, 2010). The transcription factors NF-kB, NFAT and AP-1 together directly induce 
IL-2 signaling by binding the IL-2 and CD25 (IL-2 receptor a chain) promoters, thereby 
guaranteeing IL-2-mediated T cell responses and survival. Second, CD28 signaling results in 
complex signaling intermediates that promote JNKs, ERK1 and ERK2 activation. Interestingly, 
CD28-/- mice have impaired class-switching after viral infection and reduced T helper cell 
activity with defects in IL-2 production (Shahinian et al., 1993). Additionally, those mice lack 
germinal centers and TFH cells and have drastically reduced numbers of Treg cells (Ferguson 
et al., 1996; Salomon et al., 2000; Walker et al., 1999), emphasizing the importance of CD28 
in T cell mediated immune responses. 
Even though the intracellular domains of CD28 and Icos are structurally similar, they have 
divergent functions. Icos harbors intracellularly a unique SH2 domain that induces the Icos-
PI3K-AKT cascade promoting the expression of IL4, IL-10 and IL-21 which are necessary 
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cytokines for TH2 and TFH differentiation (Simpson et al., 2010). Furthermore, Icos involves the 
c-MAF pathway inducing IL-10, IL-4 and IL-21 secretion (Kroenke et al., 2012). The expression 
of Icos plays an important role in the germinal center reaction, as CD4 T helper cells that 
express Icos provide help to B cells to induce class-switch. Mice deficient for Icos secrete 
reduced levels of IL-4 and IL-17 but show increased IFN-g expression and additionally 
completely lack TFH cells, suggesting that TFH and TH1 differentiation highly depends on Icos 
(Akiba et al., 2005; Dong et al., 2001; McAdam et al., 2001; Tafuri et al., 2001). 
Mutating the cytoplasmic domain of Ctla-4 interferes with its function in modulation of T cell 
activation, suggesting that downstream signaling events are necessary for Ctla-4-induced 
inhibition of T cell responses. Ctla-4 engages with SHP2 (SH2 domain-containing tyrosine 
phosphatase 2) and PP2A (serine/threonine protein phosphatase 2A) that dephosphorylate 
the TCR-CD3z complex, LAT (linker for activation of T cells) and ZAP70 (zeta-chain associated 
protein) reducing cell cycle progression and cytokine production. Furthermore, Ctla-4 dampens 
ERK and JNK phosphorylation (Rudd et al., 2009).  
The inhibitory molecule PD-1 harbors an ITIM (immunoreceptor tyrosine-based inhibition motif) 
and ITSM (immunoreceptor tyrosine-based switch motif), which, like Ctla-4, recruits SHP1 and 
SHP2. This again, results in inhibition of downstream activation of molecules like PCKq 
(Sheppard et al., 2004; Yokosuka et al., 2012). 
1.1.4.2 The TNF receptor family 
Receptors of the TNF receptor family are expressed upon T cell activation and function in a 
bundle of three monomers via interacting with trimerized ligands on the APCs. Co-stimulatory 
function is only accomplished by some structurally diverse TNF family members amongst them 
the type-V family proteins including 4-1BB (CD137), Ox40 (Tnfrsf4), CD27 (Tnfrsf7), GITR 
(Tnfrsf18) and CD30 (Tnfrsf8) (Croft et al., 2012). Upon trimeric ligand-receptor engagement, 
cytoplasmic TRAF (TNF-receptor associated factor) adaptor proteins are recruited 
(Chattopadhyay et al., 2009) and enable several signaling pathways including canonical and 
non-canonical NF-kB, JNK, MAPK (p38 mitogen-activated protein kinase), AP1 (activator 
protein 1), ERK and NFAT. The mechanism of how the individual TRAF adaptor proteins 
integrate co-stimulatory signals with downstream signaling pathways is not solved yet (Croft, 
2003). 4-1BB, Ox40 and CD27 co-stimulation induces anti-apoptotic factors like Bcl-2, Bcl-XL 
and Bcl2a1 thereby promoting survival of T cells. In addition, 4-1BB and Ox40 enable AKT 
which further activates cyclins and cell-cycle-dependent kinases (Croft, 2009).  
The most prominent member of the TNF receptor superfamily is Ox40 that is like Icos not 
expressed on naïve T cells but gets induced during T cell activation and is highly abundant on 
TFH cells. Ox40 expression correlates with increased expression of anti-apoptotic factors and 
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increased cytokine production thereby controlling survival of T cells. (Rogers et al., 2001). 
Additionally, it promotes proliferation of T cells during memory formation, which is in line with 
Ox40-deficient mice having reduced numbers of memory T cells and reduced T cell 
proliferation in response to viral infections (Gramaglia et al., 2000). 
Integrating TCR antigen stimulation together with co-stimulatory receptor stimulation of either 
CD28 family or TNF receptor family with downstream signaling cascades is a complex network 
that is a mandatory process to determine cell fate decisions and survival of T cells.  
The effect of antigen-specific T cell effector functions has been efficiently applied in cancer 
immune therapy. Here, chimeric antigen receptors (CARs) are utilized to engineer a patient’s 
T cell ex vivo to clear tumors expressing certain antigens (Irving and Weiss, 1991). The 
extracellular domain of CARs consists of a scFv (single chain fragment variable) from a 
monoclonal antibody that recognizes a tumor-associated antigen combined with the 
intracellular signaling domain of TCR CD3z chain and CD28 or 4-1BB. This second-generation 
CAR technology improves antigen-specific tumor clearance by enhancing T cell activation and 
proliferation due to increased secretion of IL-2 (Finney et al., 1998).  
1.1.4.3 Atypical NF-kB inhibitors and their role in immune responses 
One of the major signaling pathways in controlling lymphocyte activation, proliferation and 
expansion is the NF-κB signaling cascade. Briefly, p50/105, p52/100, p65 (RelA), cRel and 
RelB form the NF-κB transcription factor family by sharing a Rel homology domain (RHD) that 
comprises dimerization and DNA-binding. They associate to hetero- or homodimers and, in 
the presence of a transcription activation domain (TAD), modulate expression of target genes 
(Gerondakis et al., 2014; Hayden and Ghosh, 2012; Sen and Baltimore, 1986). In an inactive 
state they are prevented to enter the nucleus by classical NF-κB inhibitors (IκBa, IκBb and 
IκBe), which bind to RHD and thereby cover the nuclear localization signal (NLS) (Kanarek and 
Ben-Neriah, 2012). In T cells, activation via the TCR and co-stimulation induces IκB kinase 
complex activation, which phosphorylates the NF-κB-bound inhibitors and induces 
proteasomal degradation of IκBs and release of NF-κB transcription factor dimers to the 
nucleus where they bind κB sites on the DNA. Atypical NF-κB inhibitors such as Bcl-3, IκBζ, 
IκBNS, IκBh and IκBL can fine-tune NF-κB activation when cytoplasmic inhibitors are degraded 
upon initial NF-κB activation. Unlike classical inhibitors, they are induced upon stimulation and 
localized in the nucleus, but they share an ankyrin-repeat domain (ARD) and can interact with 
NF-κB family members in the nucleus (Fiorini et al., 2002; Kitamura et al., 2000; Wulczyn et 
al., 1992; Yamauchi et al., 2010). IκBζ, which interacts with p50 and p65, plays an important 
role in TH17-mediated autoimmunity, since mice deficient for IκBζ, are resistant to EAE but 
suffer from spontaneous autoimmunity (Okamoto et al., 2010). The TH17 subset specifying 
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cytokines IL-6 and TGF-b induce the expression of IκBζ, which associates via TAD and ARD 
with the promoter of Il17a thereby enhancing the binding of transcriptional activators like ROR 
nuclear receptors to drive Il17a expression (Okamoto et al., 2010). Comparably, IκBNS, 
encoded by the Nfkbid gene, plays a role in TH1 and TH17 proliferation and polarization. It 
directly associates with the Il10 gene, but how this is mediated is still unknown, since IκBNS, 
like IκBζ, lacks a DNA-binding domain (Annemann et al., 2015). IκBNS can have transcriptional 
activity by directly engaging with c-Rel and p50 at the Foxp3 gene locus. Consequently, IκBNS-
deficient mice have reduced Treg cells in thymus and lymphoid organs, suggesting a function 
in the development of Treg cells. Of note, also mice deficient for the NF-κB factor cRel have 
comparably reduced numbers of regulatory T cells, while mice double-deficient for cRel and 
Nfkbid developed a much stronger loss of Treg cells. Besides controlling T cell differentiation, 
IκBNS is an essential regulator of B cell development, since IκBNS-deficiency results in a 
defective development of B1 B cells, plasma cells and marginal zone B cells (Touma et al., 
2011).  
Intriguingly, the expression of IκBNS and IκBζ in T cells is tightly controlled by post-
transcriptional gene regulation. The RNA-binding proteins Roquin and Regnase-1 regulate the 
mRNA expression of Nfkbid and Nfkbiz in naïve T cells thereby contributing to cell fate 
decisions of the TH17 subset (Jeltsch et al., 2014). Dissecting the requirements for Roquin-
mediated regulation of the Nfkbid 3′-UTR will be one subject of this thesis.  
1.1.5 Tolerance mechanisms and the development of autoimmunity 
While central tolerance of T lymphocytes is achieved in the thymus to eliminate potential self-
reactive T and B lymphocytes, peripheral tolerance is a second fail-safe mechanism to prevent 
autoimmunity by neutralizing or suppressing autoreactive cells that have escaped from the 
thymus (Bouneaud et al., 2000). Several mechanisms like the expression of inhibitory 
molecules, anergy, suppression by regulatory T cells and ignorance have evolved to ensure 
peripheral tolerance of autoreactive T and B cells.  
Expression of inhibitory molecules (i.e. Ctla-4, PD-1, LAG-3) on T and B lymphocytes controls 
excessive immune responses. Mice deficient for Ctla-4 develop a strong autoimmune 
phenotype supporting the importance of controlling peripheral tolerance (Paterson and Sharpe, 
2010).  
In the absence of co-stimulation or inflammation, binding of the TCR alone causes a reversible 
hyporesponsiveness in mature T cells, which is termed T cell anergy. This is, amongst others 
like inhibition of TCR proximal signaling, a result of reduced production of IL-2, which in turn 
causes less activation of necessary signaling pathways or reduced cell cycle progression 
(Fathman and Lineberry, 2007). Interestingly, anergic T cells give rise to precursors of 
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peripheral Treg differentiation that further reduce immunopathology and autoimmunity (Kalekar 
et al., 2016).  
As described previously, thymic and peripherally-induced Treg cells actively suppress 
autoreactivity by expression of inhibitory molecules, cytolysis, interference with metabolic 
processes or modulation of DC’s maturation and function by direct cell-cell contact with the 
effector cells (Liu et al., 2015). The importance of regulatory T cells in controlling peripheral 
tolerance becomes evident in mutational analyses of the master transcription factor Foxp3. A 
truncated version of the Foxp3 gene causes autoimmunity in the so-called scurfy mice 
(Brunkow et al., 2001; Godfrey et al., 1991) and in humans, mutations in the Foxp3 gene result 
in multiorgan autoimmunity in IPEX (‘immunodysregulation, polyendocrinopathy, enteropathy’) 
patients (Bacchetta et al., 2018).  
Due to anatomical barriers at ‘immunological privileged’ organs like brain, testis and eyes, 
autoreactive lymphocytes become ignored because of reduced access to tissue-specific 
antigens at these sites (Forrester et al., 2008).  
However, failure of these levels of protection – first clonal selection in the thymus, then 
peripheral tolerance mechanisms - ends in an inappropriate activation of autoreactive T cells 
by autoantigens causing autoinflammatory and autoimmune diseases. Interestingly, the T cell 
compartment itself plays a major role in the development of autoimmunity: On the one hand, 
autoreactive CD4 T cells provide help to B cells to produce autoantibodies and, on the other 
hand, CD8 T cells infiltrate into organs and directly induce damage of tissues by secretion of 
pro-inflammatory cytokines. In humans, several systemic and organ-specific autoimmune 
diseases like type 1 diabetes mellitus (T1D), multiple sclerosis (MS), rheumatoid arthritis (RA) 
or systemic lupus erythematosus (SLE) have been described. The latter of these diseases are 
characterized by the production of antibodies against autoantigens, induce immune complex 
deposition and progress towards tissue damage. Patients suffering from SLE produce 
autoantibodies against chromatin or splice factors (Murphy and Weaver, 2017). T1D is driven 
by autoreactive T lymphocytes that secrete pro-inflammatory cytokines such as IFN-g, IL-1 and 
TNF-a thus causing apoptosis in b cells of the endocrine pancreas (Paschou et al., 2018). 
Most likely, several parameters including genetic variation and environmental variables pre-
dispose to autoimmunity by weakening tolerance mechanisms. Strong evidence on 
environmental cues influencing pathogenesis of T1D derives from studies of monozygotic 
twins where incidence of the disease is highly variable (Beyan et al., 2012). The development 
of SLE is influenced by genetic predispositions together with environmental factors such as 
UV light exposure, Epstein-Barr virus infection and hormonal changes (Tsokos et al., 2016). 
Interestingly, polymorphisms of genes encoded in the MHC gene locus, including genes 
involved in innate and adaptive immune responses, have been linked to high susceptibility to 
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autoimmune diseases and the majority of genes predisposing to T1D are located within the 
MHC region (Paschou et al., 2018). Sexual dimorphism in autoimmune diseases like SLE or 
MS with a higher incidence of autoimmunity in female support the huge impact of genetics. 
Our current knowledge about autoimmune disorders highly benefits from gene knockout 
studies in mice. Mutating or deleting genes encoding for important immune regulators, helps 
to gain novel insight in the causes of autoimmune diseases especially by dissecting 
autoantibody production or organ-infiltration of T cells. Hence, genes encoding for cytokines 
(like Ifng, Tnfa, Il2), co-receptors (Cd28), co-stimulatory molecules (Ctla4, Pd1) or genes 
involved in antigen-signaling cascades or apoptosis have been found to control the outcome 
of autoimmunity (Baccala et al., 2007; Paterson and Sharpe, 2010; Salomon et al., 2000). 
Besides these genes directly encoding factors of the immune system, autoimmune regulators 
that encode for proteins controlling the expression of those immune-associated genes post-
transcriptionally or -translationally are susceptible to develop autoimmunity.  
To identify novel autoimmune regulators, Christopher Goodnow and Carola Vinuesa 
performed a mouse genome-wide screen by treating mice with ethyl nitrosourea to introduce 
single-base substitutions at a rate of 1/0.5 megabases and identifying the development of 
autoimmunity by testing for anti-nuclear autoantibodies (ANAs). Thereby, the so-called 
sanroque mouse strain was isolated, which harbors a single point-mutation (methionine 199 
to arginine, M199R) in the so far unknown gene Rc3h1 encoding for the Roquin-1 protein, 
respectively. This protein comprises a highly conserved CCCH-zinc-finger domain present in 
many RNA-binding proteins and is localized to stress granules suggesting a functional role in 
mRNA stability (Vinuesa et al., 2005).  
In the recent years, the role of post-transcriptional gene regulation in preventing and controlling 
autoimmunity and immune pathologies has become more and more important in the field. The 
subsequent chapters will give an overview of the basic mechanisms of post-transcriptional 
gene regulation and will focus in detail on the RNA-binding proteins Roquin and Regnase-1, 
which are key players in controlling immune regulation in the adaptive immune system. Their 
important role in preventing autoimmunity will be one major subject of this thesis.  
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1.2 Post-transcriptional gene regulation of immune cells  
Constant exposure to pathogens and intra- and extracellular changes require fast and reliable 
adaptations of the immune response. Dynamic alterations can be achieved by post-
transcriptional gene regulation of messenger RNAs (mRNAs) encoding for immune-related 
proteins such as cytokines or transcription factors that need to be stabilized or degraded in a 
flexible manner. Over the past decades post-transcriptional gene regulation has been of great 
interest owing to observations that an imbalance of mRNA decay and excessive expression of 
immune-related mRNAs promotes the development of autoimmune diseases. Post-
transcriptional gene regulation has evolved by a compound network requiring structures in the 
mRNA predominantly located in the 5’- and 3’- untranslated regions (UTRs) of the mRNA, that 
are targeted by trans-acting factors such as RNA-binding proteins (RBPs) or microRNAs 
(miRNAs). Consequently, gene regulation by post-transcriptional mechanisms is a complex 
system that rapidly changes expression levels of genes in the immune system in response to 
environmental cues. The following section will discuss the principles of mRNA degradation 
particularly by the RNA-binding proteins Roquin and Regnase-1.  
1.2.1 Principles of induced mRNA decay 
The central dogma of molecular biology implies a basic two-step process by which DNA is 
transcribed into mRNA that is then further translated into protein. Of course, this process is not 
as simple as it seems and needs to be tightly and strictly controlled by a multiplicity of 
mechanisms to facilitate proper protein expression, which is crucial for maintaining health of 
an organism. Briefly, after transcribing eukaryotic mRNAs from DNA in the nucleus by a 
complex process requiring RNA-Polymerases, the mRNA is equipped with a 5’ 7-
methylguanosine cap (5’-cap) and a 3’ poly(A)-tail. To initiate translation, the eukaryotic 
initiation factors eIF4E/G/A bind the 5’-cap and promote translation initiation through 
recruitment of ribosomes. Then, initiation factors interact with the poly(A)-binding protein 
(PABP) bound to the poly(A)-tail by circularization of the mRNA-protein complex and protecting 
the transcript from exoribonucleolytic degradation (Figure 2 a) (Garneau et al., 2007). Next to 
translational control of the transcript, mRNA turnover is a fundamental mechanism to control 
protein expression. This is facilitated by numerous protein/RNA-complexes involving factors of 
the mRNA decay machinery, RNA-binding proteins and miRNAs that stabilize or destabilize 
the mRNA.  
The first step of mRNA degradation is initiated by shortening of the poly(A)-tail involving PAN2-
4 proteins that remove PABP which interferes with eIF4E interaction and disrupts the circle 
formation (Figure 2 b).  
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Figure 2 ç The principles of mRNA decay. 
After splicing, mature messenger RNA (mRNA) harbors a 5’-untranslated region (UTR) with an m7G-
cap structure, a coding-sequence (CDS) and a 3′-UTR complemented with a poly(A)-tail. For initiation 
of translation, eukaryotic initiation factors 4A, G and E (eIF4A/G/E) bind the 5’-cap structure and the 
poly(A)-tail is bound by poly(A)-binding proteins (PABP). PABP and initiation factors interact, resulting 
in circularization of the protein-mRNA complex (a). Ribosomes start the translation of the CDS thereby 
producing polypeptide chains. b) mRNA degradation is initiated due to Pan 2, 3 and 4 proteins removing 
PABP and thereby facilitating binding of the Ccr4-Caf1-NOT complex that eliminates the poly(A)-tail. 5’ 
à 3’ decay involves decapping enzymes (Dcp1, Dcp2, Edc1 and Edc3) and the Lsm1-7 ring structure. 
After decapping, mRNA is degraded from 5’ by the Xrn1 exonuclease. In turn, the exosome complexes 
degrade mRNA 3’ à 5’, whereas the residual 5’-cap structure is digested by DcpS. c) Direct cleavage 
of circulated mRNAs by endonucleases is an additional way of mRNA degradation. Here, the two 
resulting mRNA fragments are eliminated by Xrn1 and the exosome complex. Adapted from (Garneau 
et al., 2007; Mugridge et al., 2018).  
 
Subsequently, the Ccr4-Caf1-NOT multi-protein deadenylase complex is recruited to the 3’ 
end (Wolf and Passmore, 2014), where it facilitates removal of the poly(A)-tail via its 
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exonuclease activity (Collart, 2016). After successful subtraction of the poly(A)-tail, mRNA 
degradation can be initiated from either 5’ (5’ à 3’) and/ or 3’ site (3’à5’).  
5’ à 3’ degradation is activated by decapping of the 5’ cap which requires several proteins, 
amongst them decapping enzymes (Dcp1 and Dcp2), the heptameric Lsm1-7 complex 
together with Pat1 associating with the 3’ end as well as the enhancer of decapping Edc1 and 
Edc3 followed by an initial degradation of the mRNA by the exoribonuclease XRN1 (Jonas and 
Izaurralde, 2015; Kshirsagar and Parker, 2004; Tharun and Parker, 2001).  
3’ à 5’ mRNA turnover occurs via a large exosome complex. Proteins building this complex 
exhibit phosphorylytic exonuclease and RNA helicase function and thereby degrade the mRNA 
from the 3’ end (Houseley et al., 2006; Zinder and Lima, 2017). The remaining oligomer 
carrying the 5’-cap is then finally degraded by the scavenger decapping enzyme DcpS 
(Houseley et al., 2006; Liu et al., 2002). Both degradation pathways have redundant function, 
since knocking out either component of one pathway leaves mRNA decay rates unaffected 
(Houalla et al., 2006).  
As a third pathway, endonucleases can directly cleave mRNAs resulting in a two-fragmented 
transcript that is subject to 3’ à 5’ decay by the exosome complex or 5’ à 3’ degradation via 
the exoribonuclease XRN1 (Figure 2 c). 
Translation of mature mRNA transcripts into proteins is a highly complex mechanism. Errors 
occurring during translation bear tremendous consequences, therefore several control 
mechanisms have evolved. Aberrant transcripts with a premature stop-codon within 20-25 nt 
5’ of the exon junction complex producing truncated proteins, can be eliminated by nonsense-
mediated decay (NMD), which involves the helicases UPF1, 2 and 3 (Lykke-Andersen and 
Jensen, 2015). In contrast, non-stop-decay (NSD) senses transcripts that lack a stop codon. 
Here, the adaptor protein Ski7 binds and facilitates release of the ribosome and recruits the 
cytoplasmic SKI complex and the exosome to degrade the transcript 3’ à 5’ (Frischmeyer et 
al., 2002; van Hoof et al., 2002). A third mechanism, referred to as no-go decay (NGD) 
recognizes transcripts with ribosomal elongation stalls and initiates degradation by 
endonucleases in proximity to the stalled ribosome resulting in two transcript fragments that 
are targeted for degradation by XRN1 or the exosome (Doma and Parker, 2006). 
1.2.2 Subcellular locations of mRNA decay 
mRNAs are in a constant equilibrium of active translation and mRNA degradation to rapidly 
respond to changes in the microenvironment and subsequently adapt the gene expression. 
Turnover of mRNA and protein is not only controlled temporally but also spatially. Cytoplasmic, 
membrane-less foci termed processing- (P-) bodies contain translationally-repressed mRNAs 
and mRNA decay factors such as Ccr4-NOT, Dcp1/2, Pat1-LSM1-7, Edc3 and Xrn1, 
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suggesting that this serves as a site to accelerate mRNA decay. However, components of the 
mRNA decay machinery have also been found outside of P-bodies in the cytoplasm and it was 
suggested that these cytoplasmic foci are dynamically forming upon increased abundance of 
translationally silenced mRNAs that are targeted for degradation. Deletion of Dcp1, 
interestingly, elevated p-body abundance and inhibited mRNA decay (Parker and Sheth, 
2007). Upon cellular stress, cytoplasmic foci, so-called stress granules, form. Different to P-
bodies, stress granules are sites of mRNA storage to protect RNAs from reactive agents in the 
cytoplasm (Kedersha et al., 2005). Formation of P-bodies and stress granules arises via liquid-
liquid phase separation (LLPS), which is influenced by increasing protein and RNA 
concentration, changes in salt concentration, temperature and crowding agents (Guo and 
Shorter, 2015). Proteins with low complexity sequence domains (LCDs) are prone to develop 
these protein-rich droplets. Recently, a dynamic process termed mRNA cycle was described 
whereby mRNA-protein complexes can vigorously move between polysomes, P-bodies and 
stress granules facilitating efficient balance of transcript turnover and translation (Decker and 
Parker, 2012). 
1.2.3 The interplay of cis-regulatory elements and trans-acting factors 
Besides mRNA degrading enzymes, trans-acting factors are located within P-bodies, 
emphasizing their role in controlling mRNA transcript levels. Stabilizing and de-stabilizing 
trans-acting factors such as RNA-binding proteins (RBPs), microRNAs (miRNAs) and long-
non-coding RNAs impact on RNA stability by recognizing cis-elements either as linear 
sequence motifs or secondary structures. These RNA elements are predominantly encoded in 
the untranslated regions (UTRs). Whereas 5′-UTR binding typically controls translation 
initiation, elements in the 3′-UTRs bound by trans-acting factors often influence mRNA decay 
and translational efficiency (Rissland, 2017). 
Approximately 30 years ago, heterogeneous AU-rich elements (ARE) were described as the 
first mRNA-stability elements and several studies identified genes of cytokines, proto-
oncogenes and transcription factors to contain such sites in their 3′-UTRs. The zinc finger 
(ZnF) protein TTP (tristetraproline) acts as an mRNA decay factor by binding the ARE of Tnfa. 
It directly promotes deadenylation of the mRNAs by shortening of the poly(A)-tail due to its 
interaction with Ccr4 (Carballo et al., 2000; Lai et al., 1999; Lykke-Andersen and Wagner, 
2005). The ARE in the TNF-a transcript is additionally targeted for translational inhibition by 
TIA-1 (T-cell-restricted intracellular antigen-1) as macrophages from TIA-1-deficient mice have 
elevated levels of TNF-a protein and the Tnfa mRNA shifted from fractions containing 
monosomes to fractions with polysomal association of mRNAs with ribosomes, while its mRNA 
degradation rate is not affected (Piecyk et al., 2000).  
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Besides linear, heterogeneous AU-rich elements, secondary RNA structures have been 
identified as constitutive decay elements (CDEs) in the Tnfa 3′-UTR (Stoecklin et al., 2003). 
The CDE comprises a 17 nt-long fragment that forms a secondary stem loop structure with a 
7 nt base-pairing stem and a triloop bearing a pyrimidine-purine-pyrimidine (py-pu-py) 
sequence. Interestingly, comparison of Tnfa CDE sequences from 19 mammalian species 
reveals almost 100% sequence identity. Mutational analysis of the CDE structure uncovers 
that the formation of a secondary structure and the loop sequence are mandatory for efficient 
mRNA decay of the Tnfa 3′-UTR in reporter assays (Leppek et al., 2013). Pulldown with cell 
lysates and the Tnfa CDE RNA allowed for identification of enriched RNA-binding proteins by 
mass spectrometry. Here, the RNA-binding protein Roquin-1 (i.e. Rc3h1) and its homolog 
Roquin-2 (i.e. Rc3h2) showed the strongest peptide enrichment. Besides binding of the CDE, 
Roquin also induces CDE-mediated mRNA degradation.  
Interestingly, the endonuclease Regnase-1, encoded by the Zc3h12a gene respectively, also 
destabilize mRNA transcripts that harbor CDE-like triloop structures such as Il6, Il2 or its own 
mRNA (Mino et al., 2015; Uehata et al., 2013). The exact mechanism of Roquin- and Regnase-
1-mediated mRNA regulation of immune-associated targets and their role in controlling 
immune homeostasis is one subject of this thesis and will be discussed in greater detail in the 
subsequent sections.  
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1.3 The trans-acting factors Roquin and Regnase-1 
1.3.1 The Roquin protein family 
In 2005, Roquin-1 was first identified in a screen for autoimmune regulators in mice with a 
homozygous single point mutation (M199R) causing a severe SLE-like autoimmune disease 
in the so-called sanroque mice (Rc3h1san/san). Later studies, identified Roquin as an RNA-
binding protein involved in mRNA degradation and linked its post-transcriptional gene 
regulation of immune-related genes to the prevention of autoimmunity.  
1.3.1.1 Roquin mouse models 
The sanroque mice develop a profound autoimmune phenotype not only by generating 
autoantibody-producing B cells but also by exhibiting splenomegaly and lymphadenopathy, 
which additionally involves spontaneous formation of germinal centers in the B cell follicles. 
Consequently, B cells produce polyclonal hypergammaglobulinemia of all T-dependent 
isotypes and activated effector-memory-like CD4 and CD8 T cells accumulate and show 
profound expression of the co-stimulator Icos. In line with increased Icos expression, additional 
markers of TFH cells like Cxcr5, Ccl5 and IL-21 are drastically elevated. To test the contribution 
of the aberrant Icos expression to the phenotype of the sanroque mice, Icos gene expression 
levels were halved in Rc3h1san/san; Icos+/- mice. This correlated with reduced splenomegaly, 
lymphadenopathy, less TFH and germinal center B cell expansion (Yu et al., 2007). However, 
complete ablation of Icos in sanroque mice did not rescue splenomegaly or hyperactivation of 
T cells and rather decreases regulatory T cell numbers, but maintains autoantibody production 
of sanroque mice. These findings suggest that the overexpression of Icos in sanroque mice 
does not simply explain the development of autoimmunity, suggesting that additional factors 
might contribute to this phenotype (Lee et al., 2012). 
To test whether the single point mutation in the sanroque mouse results in loss-of-function of 
the Roquin-1 protein, different deletion systems in mice were of high interest. The systemic 
knockout of the Roquin-1-encoding gene (Rc3h1-/-) resulted in perinatal lethality (Bertossi et 
al., 2011). The newborn animals died within 6h after birth suffering from decreased expansion 
of alveoli of the lung. Surprisingly, heterozygous mice (Rc3h1+/-) were healthy and showed no 
pathology, suggesting that already a half dose expression of Roquin-1 is sufficient for survival. 
To investigate cell-type-specific functions of Roquin-1, mice with loxP-flanked alleles for Rc3h1 
(Rc3h1fl/fl) were crossed to mice with different cre-recombinase systems to induce conditional 
deletion in different cell subsets: Cd4-cre (T cell-specific deletion), Cd19-cre (deletion in B 
cells) and vav-cre for deletion in all hematopoietic cells. Overall, Roquin-1 deficiency in these 
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various hematopoietic cell types did not cause breakdown of tolerance or induction of 
autoimmunity. Despite a moderate increase in Icos expression, conditional deletion in T cells 
causes an effector-memory phenotype in CD8 T cells (CD44high CD62Llow). Loss of Roquin in 
all hematopoietic cells results in a slight activation of CD4 and CD8 T cells with higher Icos 
surface expression and spontaneous formation of GC B cells but no change in TFH cells. 
Additionally, Treg cells, eosinophils and macrophages were altered in vav-cre mice. These 
findings were phenocopied by B-cell-specific deletion utilizing the CD19-cre system. The data 
suggest that the autoimmune syndrome in the sanroque mice may not be simply explained by 
a loss-of-function mutant of Roquin-1.  
The Roquin protein family not only comprises Roquin-1 (Rc3h1), but also a paralog termed 
Roquin-2 or MNAB (membrane-associated nucleic acid-binding protein), encoded by the 
Rc3h2 gene, respectively (Siess et al., 2000). Gene duplication occurred in higher vertebrates 
from zebrafish to humans in turn resulting in the presence of both paralogs, whereas in 
drosophila melanogaster and caenorhabditis elegans only one homolog exists (Heissmeyer 
and Vogel, 2013). Systemic deletion of Rc3h2 induced post-natal death within the first days 
after birth in most animals and the reduced expansion of lung alveoli is in line with the Rc3h1 
gene ablation in mice. Surprisingly, mice with a conditional deletion of Rc3h2 in T cells develop 
no detectable sign of autoimmunity or hyperactivated T cells (Vogel et al., 2013). To validate 
whether Roquin-1 and Roquin-2 have redundant functions, mice with a combined conditional 
deletion of Rc3h1 and Rc3h2 genes in T cells were generated. Indeed, Rc3h1/2fl/fl; Cd4-cre 
mice shared phenotypes with the sanroque mice: These mice develop splenomegaly and 
lymphadenopathy, spontaneous activation of CD4 and CD8 T cells with elevated Icos 
expression levels. Additionally, Roquin deficiency causes formation of GCs due to increased 
frequencies of TFH and GC B cells comparable to Rc3h1san/san mice (Vogel et al., 2013). 
Additionally, lack of Roquin-1 and -2 in T cells results in an inflammatory lung phenotype 
characterized by infiltration of TH17 cells and neutrophils in the lungs and secretion of 
autoantibodies directed against pancreatic tissue (Jeltsch et al., 2014). Natural killer T cells 
(NKT), which are a specialized subset of glycolipid-recognizing T cells involved in autoimmune 
and malignant diseases, were shown to be strictly dependent on Roquin. Deficiency of both 
paralogs during early thymic NKT development results in a drastic cell-intrinsic increase of the 
NKT17 subset but a complete loss of peripheral mature NKT cells, suggesting a role in 
preventing excessive differentiation into NKT17 cells. (Drees et al., 2017). In addition, Treg-
specific deletion using Foxp3-cre, revealed that Roquin is required for Treg function since Treg 
cells lacking Roquin proteins adopt a TFR phenotype and lose suppressive function of Treg cells 
(Essig et al., 2017). Overall, these data suggest that deletion of the Roquin paralogs in T cells 
phenocopies many of the autoimmune phenotypes of the sanroque mice. However, the 
functional Roquin-2 protein in the sanroque mice is not capable of rescuing the phenotype and 
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additionally, Roquin-1 M199R does not interfere with RNA binding ability (Athanasopoulos et 
al., 2010). Therefore, the molecular basis for the altered function of M199 in Roquin-1 is still 
under debate and of high interest in the field.  
1.3.1.2 Domain organization and molecular functions of Roquin proteins 
Comparing the phenotypes in the different Roquin mouse models suggest that the Roquin 
RNA-binding proteins play an important role in the homeostasis of the adaptive immune 
response. Both protein family members are localized in the cytoplasm and especially enriched 
in P-bodies and, upon induction of stress, relocalize to stress granules (Athanasopoulos et al., 
2010; Glasmacher et al., 2010; Srivastava et al., 2015; Vinuesa et al., 2005). However, Roquin-
1 protein levels are significantly higher in comparison to Roquin-2 in lymphoid tissues, but both 
paralogs have redundant functions in T cells where Roquin-2 can compensate for the absence 
of Roquin-1 (Pratama et al., 2013; Vogel et al., 2013).  
The functional redundancy of both paralogs becomes clear when comparing the domain 
organization of their amino acid sequences (Figure 3). The first 500 amino acids reveal high 
sequence similarity harboring several domains: a RING- (really interesting new gene) domain, 
a ROQ-domain embedded in HEPNN (higher eukaryotes and prokaryotes nucleotide-binding, 
N-terminal) and HEPNC (C-terminal) stretches, a CCCH-type zinc finger followed by a varying 
conservation in the C-terminus. A proline-rich region (PRR) can be found in the carboxy 
terminus of Roquin-1, whereas Roquin-2 owns a hydrophobic stretch.  
 
 
Figure 3 ç Domain organization and sequence similarity of Roquin family proteins. 
Schematic representation of the domain structures of Roquin-1 and Roquin-2. Both proteins share a 
RING domain (really interesting new gene), a ROQ-domain embedded in HEPNN (higher eukaryotes 
and prokaryotes nuclear-binding domain, N-terminal) and HEPNC (C-terminal), a CCCH-type zinc finger 
(ZnF) and a proline-rich region (PRR). Carboxyl-terminal Roquin-1 harbors a coiled-coil domain, 
whereas Roquin-2 has a hydrophobic region at its C-terminus. Amino acid (aa) positions of the domains 
are depicted. Scissor symbols represent MALT1 cleavage sites. Structure and sequence similarity 
information are adapted from Jeltsch & Heissmeyer, 2016; Pratama et al., 2013, Schlundt et al., 2016 
and Srivastava et al., 2015. 
 
The function of the RING domain is not completely solved, yet. In the C. elegans homolog 
RLE-1 it exhibits E3 ubiquitin ligase activity (Li et al., 2007), whereas the Roquin-2 RING-
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domain was found to have ubiquitination function of ASK1 (apoptosis-signaling kinase 1) thus 
inducing proteasomal degradation thereof (Maruyama et al., 2014). 
Roquin-1 mutants lacking the RING-domain are incapable of localizing to stress granules 
(Athanasopoulos et al., 2010). In addition, this domain has been associated to auto-
ubiquitination of Roquin-1 and counteracting AMPK (adenosine monophosphate-activated 
protein kinase) function resulting in aberrant mTOR signaling and TFH accumulation (Ramiscal 
et al., 2015). 
The ROQ-domain is a unique domain with high sequence conservation in Roquin family 
proteins. It is embedded in HEPNN and HEPNC domains that fold together and can bind double-
stranded RNA independent of the ROQ-domain (Srivastava et al., 2015). High-resolution 
structure analyses have been solved for the ROQ-domain of both paralogs and indeed 
identified this domain to directly interact with RNA (Sakurai et al., 2015; Schlundt et al., 2014; 
Schuetz et al., 2014; Tan et al., 2014). It directly binds CDE elements in the 3′-UTR of mRNAs 
with characteristic secondary RNA structures consisting of 5-7 nucleotides and a py-pu-py 
triloop sequence (Leppek et al., 2013) (Figure 4). As mentioned previously, the CDE-element 
has first been described in the Tnfa 3′-UTR, however in the meantime several additional mRNA 
targets have been reported to harbor CDE or CDE-like stem loop structures including Icos, 
Nfkbid, Nfkbiz and Ox40 (Braun et al., 2018; Codutti et al., 2015; Janowski et al., 2016; Jeltsch 
et al., 2014; Leppek et al., 2013; Schlundt et al., 2014; Vogel et al., 2013).  
 
 
Figure 4 ç RNA structures and sequences targeted by Roquin. 
Schematic representation of sequences of the Roquin-targeted constitutive decay element (CDE of the 
Tnfa 3′-UTR), alternative decay element (ADE) identified by SELEX (Systematic Evolution of Ligands 
by Exponential Enrichment) and linear binding element (LBE) consensus sequence. Structures were 
adapted from Schlundt et al., 2015; Janowski et al., 2015 and Essig et al., 2018. 
 
Mutational analysis revealed that the Roquin-RNA interaction depends at least on three critical 
amino acids (Lys220, Lys239 and Arg260) for binding of Icos, Tnfa and Ox40 mRNA and these 
residues are crucial for efficient post-transcriptional gene regulation, respectively (Schlundt et 
al., 2014). Recently, a second type of secondary structure for Roquin-mediate gene regulation 
was identified as alternative decay element (ADE) (Figure 4). This motif comprises a U-rich 
hexaloop embedded in a 5-8 nt base-pairing stem with one unpaired base. Interestingly, an 
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ADE-like hexaloop stem loop was found in the Ox40 3′-UTR. Crystal structure and mutational 
analysis of the Roquin-Ox40 interaction revealed that this interaction requires the amino acid 
Tyr250 for binding and gene regulation (Janowski et al., 2016). My contribution to this finding, 
the functional importance of amino acid Tyr250 for Ox40 regulation, will be discussed in more 
detail in the results section of this thesis. Recently, our group also identified a novel 15 nt-long 
linear sequence consisting of a CAC trinucleotide flanked by U-rich sequences as a linear 
binding element (LBE) of Roquin-1 (Essig et al., 2018) (Figure 4).  
Roquin proteins are not capable of directly degrading the target mRNAs. Therefore, several 
investigations have been made to identify the mechanism of Roquin-mediated post-
transcriptional gene regulation. The C-terminus of Roquin proteins including the proline-rich 
region (PRR) interacts with the deadenylation machinery involving the Ccr4-NOT complex thus 
inducing the first steps of mRNA decay. This is in line with Roquin localization to P-bodies that 
requires the carboxyl-terminal glutamine and asparagine-rich sequence stretch, which is 
required for protein-protein-interaction in post-transcriptional gene regulation (Glasmacher et 
al., 2010; Leppek et al., 2013; Murakawa et al., 2015; Reijns et al., 2008). However, the 
localization of human Roquin to stress granules has also been demonstrated (Athanasopoulos 
et al., 2010). As a second mRNA decay pathway, N-terminal Roquin involving ROQ-domain 
and ZnF directly associates with the decapping factors Edc4 and Rck, whereas the function of 
Rck is crucial for Roquin-mediated Icos repression (Glasmacher et al., 2010). Recently, the 
direct interaction of N-terminal Roquin with the CCCH-type ZnF protein NUFIP2, which acts as 
a co-factor for Roquin-mediated repression of the human ICOS and OX40 mRNA, has been 
described. Here, tandem stem loops containing cis-elements are bound with higher affinity by 
Roquin in the presence of NUFIP2 thereby facilitating repression of the mRNA (Rehage et al., 
2018).  
Is Roquin-mediated initiation of mRNA degradation the only way of controlling expression of 
its targets? As part of this thesis, we identified Roquin to also play a role in controlling 
translation, which I studied for its target Nfkbid (Essig et al., 2018). Whether this translational 
control mechanism of Roquin is mediated by interaction with translational regulators or by 
direct engagement of ribosomal proteins is still unknown and is subject to further 
investigations.  
1.3.1.3 Control of Roquin protein expression 
As mentioned before, Roquin controls the expression of several essential immune-related 
genes encoding for Icos, Ctla-4 or Ox40. During an active immune response, these proteins 
must fulfill their functions and need to escape Roquin-mediated repression. Therefore, a 
mechanism has evolved to control Roquin protein abundance and allow expression of Roquin-
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targeted genes. Upon stimulation of the TCR with cognate antigen and co-stimulation of CD28 
by APCs, the paracaspase MALT1 gets activated and cleaves both Roquin paralogs. Roquin-
1 bears two cleavage sites, whereas for Roquin-2, one cleavage site has been described so 
far (Figure 3). T cells treated with the MALT1 inhibitor Mepazine or MALT-1 deficient T cells 
as well as T cells with an inactive form of MALT1 are incapable of cleaving Roquin proteins 
(Gewies et al., 2014; Jeltsch et al., 2014). However, whether the residing cleavage products 
(1-510 or 1-579 aa) that still own the essential ROQ-domain, are functional, has not been 
addressed so far. Additionally, in human Jurkat T cells autoregulation of Roquin through its 
own 3′-UTR has been proposed (Cui et al., 2017). Furthermore, Roquin-1 and Roquin-2-
encoding mRNAs were enriched in pulldown experiments with Roquin-1, whereas both 
mRNAs were predicted to contain CDE elements (Leppek et al., 2013). Interestingly, the 
endonuclease Regnase-1 is targeted for degradation in a very comparable way and will 
therefore be discussed in more detail in the subsequent section. 
1.3.2 The endonuclease Regnase-1 
Besides Roquin proteins and TTP, the Regnase family proteins are essential regulators of 
immune-related mRNAs. Zc3h12a encodes for monocyte chemoattractant protein-1-induced 
protein (MCPIP1), which was later, due to its endonucleolytic function, termed Regnase-1. The 
initial name MCPIP1 derived from identifying a role as a transcription factor-like protein in 
cardiomyocytes upon monocyte chemoattractant protein-1-mediated inflammation (Zhou et al., 
2006). A few years later the kinetic of Regnase-1 expression in murine macrophages was 
described as strongly increased upon LPS stimulation. After LPS stimulation, the expression 
of Regnase-1 declines again, suggesting that its expression is tightly controlled during an acute 
immune response (Matsushita et al., 2009). It is highly abundant in cells of the innate as well 
as the adaptive immune system such as macrophages, T and B cells, where it functions in the 
degradation of target mRNAs. In addition, several studies investigated the function of 
Regnase-1 in non-immune cells and cancer. Regnase-1 was reported to induce apoptosis in 
cancer cell lines by degrading mRNAs from anti-apoptotic genes like Bcl2l1, RelB and Bcl3 
and controlling neuroblastoma proliferation and survival (Boratyn et al., 2017; Lu et al., 2016). 
Moreover, genes involved in fat and iron metabolism are under control of Regnase-1 
(Habacher et al., 2016; Yoshinaga et al., 2017). Additionally, its role in targeting viral mRNAs 
and restricting HIV-infections has been extensively studied in the past (Lin et al., 2013; Lin et 
al., 2014; Liu et al., 2013b). These data support the central role of Regnase-1 in protecting 
from infections and cancer in various cell types. However, this thesis will focus on the function 
of Regnase-1 in immune cells, especially the T cell subset. 
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1.3.2.1 Regnase-1 mouse models 
To study the function of Regnase-1, Zc3h12a-/- mice were generated independently by two 
research groups. Loss of Regnase-1 resulted in a strong autoimmune phenotype characterized 
by splenomegaly and lymphadenopathy, multiorgan infiltration of plasma cells and the 
production of antibodies of all immunoglobulin subtypes as well as anti-double-stranded DNA 
antibodies. On cellular level, Regnase-1-deficient mice develop class-switched B cells and 
accumulate highly activated splenic T cells. Macrophages lacking Regnase-1 and stimulated 
with LPS revealed increased expression of the cytokines IL-6 and IL-12b (Liang et al., 2010; 
Matsushita et al., 2009). In addition, all lymphoid organs are drastically disorganized including 
spleen, lymph nodes and thymus (Miao et al., 2013). However, combining Zc3h12a deficiency 
with a knockout of either Il6 or Il12p40, encoding for IL-12b, did not rescue the phenotype. 
Generating mice with conditionally deleted Regnase-1 in T cells, revealed that the autoimmune 
phenotype in the systemic knockout mice is T-cell intrinsic. Indeed, Zc3h12afl/fl; Cd4-cre mice 
have profound hyperactivated T cells, accumulate plasma cells and secrete elevated levels of 
all immunoglobulin subtypes and anti-nuclear autoantibodies (Uehata et al., 2013).  
1.3.2.2 Domain organization and function of Regnase family members 
Next to Regnase-1, the Regnase protein family comprises three additional members: 
Regnase-2, Regnase-3 and Regnase-4 encoded by Zc3h12b, Zc3h12c and Zc3h12d, 
respectively. By comparing the structural domains of these family members (Figure 5), it 
becomes evident that they all share a CCCH-type zinc finger similar to Roquin-1 and Roquin-
2 (Figure 3) (Liang et al., 2008). In addition, all Regnase proteins bear a PilT N-terminal (PIN)-
like RNase domain (NYN domain) that, in Regnase-1, comprises endoribonuclease activity 
which is facilitated by a catalytic center composed of magnesium ion complexed by acidic 
residues (Asp141, Asp225, Asp226, Asp244 and Asp248) (Xu et al., 2012). This surface is 
probably forming an RNA-interaction platform, however the co-crystal structure of Regnase-1 
in association with RNA has not been solved, yet (Anantharaman and Aravind, 2006; 
Matsushita et al., 2009; Mino et al., 2015). 
The physiological role of Regnase-2 is hardly understood whereby cells of the immune system 
exhibit only low expression thereof (Liang et al., 2008).  
Regnase-3 is involved in vascular inflammation by counteracting inflammatory responses due 
to inhibiting the NF-kB pathway and pro-inflammatory gene expression (Liu et al., 2013a). Very 
recently, the knowledge about Regnase-3 has been expanded by a study that demonstrates a 
role as endonuclease in regulating mRNA degradation of transcripts involved in the IFN-g 
pathway and immune homeostasis which is functional complement to Regnase-1. Here the 
authors showed that systemic Regnase-3 deficiency causes strong IFN signaling thereby 
Introduction 
 
 
49 
suppressing GC formation. Interestingly, Regnase-3 exhibits endonucleolytic function thereby 
degrading mRNAs, such as Zc3h12a, localized to endosomes (von Gamm et al., 2019). 
 
 
Figure 5 ç Domain organization of Regnase family proteins. 
Schematic representation of the domain organization of Regnase-1, Regnase-2, Regnase-3 and 
Regnase-4. All proteins share a PilT N-terminal (PIN)-like RNase domain and a CCCH-type zinc finger 
(ZnF), whereas Regnase-1 harbors a C-terminal proline-rich region (PRR) and S435 as well as S439 
are sites for phosphorylation (P). Amino acid (aa) positions of the domains are indicated. Black Scissor 
symbol represents proven and grey scissor symbols indicate predicted MALT1 cleavage sites. 
Structures are adapted from Jeltsch & Heissmeyer, 2016 and Takeuchi, 2017. 
 
Regnase-4 like Regnase-1 exhibits endonucleolytic function thereby regulating gene 
expression of Il6, Il1b and Tnf via their 3′-UTRs. In addition, interactions between Regnase-1 
and -4 have been suggested (Huang et al., 2012; Wawro et al., 2017; Zhang et al., 2015). 
However, Regnase-4-deficient mice appear healthy, but stimulation of T cells ex vivo induces 
hyperactivation, suggesting a role for Regnase-4 in controlling T cell effector functions 
(Minagawa et al., 2014). 
It is still unknown whether Regnase family members are functionally redundant, but 
differentially expressed, or if they have evolved to fulfill entirely different functions. Sites for 
MALT1-targeted cleavage have been predicted for Regnase-2, 3 and 4, but have not been 
proven, yet. Therefore, more investigations are required to understand the function of the 
Regnase family members 2, 3 and 4 in the immune response.  
1.3.2.3 Molecular functions of Regnase-1  
In the last years, Regnase-1 has been intensively studied and a variety of molecular functions 
have been identified. The PIN-like domain of Regnase-1 allows deubiquitylation by association 
with USP10, which in turn negatively regulates NF-kB by removing polyubiquitylation chains 
of the IkB kinase subunit IKKg or NEMO. Moreover, Regnase-1 removes ubiquitin moieties 
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from TRAF proteins by involving the CCCH ZnF thereby negatively regulating JNK and NF-kB 
activity. Yet, it is unsolved how this contributes to the function of Regnase-1 (Liang et al., 2010; 
Niu et al., 2013). It was additionally suggested that the PIN domain of Regnase-1 has the 
capacity to form head-to-tail oligomers, which is mandatory for bona fide RNase activity in vitro 
(Yokogawa et al., 2016). The before-mentioned CCCH-zinc finger is highly conserved among 
different species and Regnase family member genes and the ZnF of Regnase-1 is engaged in 
direct RNA interaction but is not essential for mRNA degradation (Matsushita et al., 2009; 
Yokogawa et al., 2016). The C-terminal PRR in Regnase-1 could serve as a protein-protein-
interaction surface as it was reported for other PRR-containing proteins before (Yokogawa et 
al., 2016). In accordance, the carboxy terminus in human Regnase-1 enables oligomerization 
of multiple Regnase-1 proteins therefore facilitating cleavage of pre-miRNAs and antagonizing 
Dicer function (Suzuki et al., 2011). However, a later study claimed that miRNAs are not 
targeted for Regnase-1-mediated degradation since Regnase-1 deficient MEF cells did not 
show elevated abundance of several miRNAs in comparison to WT MEF cells (Mino et al., 
2015).  
As mentioned before, Regnase-1 is capable of recognizing stem loop structures mainly 
localized in 3′-UTRs and thus facilitating degradation of its target mRNAs. These target mRNAs 
encode for co-stimulatory receptors like Ox40, Icos and Ctla-4, cytokines like IL-2, IL-6 or IL-
12b or transcription factors such as c-Rel, Irf4 or IkBz and IkBNS. RNA regulation requires the 
RNase catalytic center in the PIN-domain of Regnase-1, since a point mutation of Asp141 to 
Asn (D141N) abrogates the mRNA degradation capacity (Behrens et al., 2018; Jeltsch et al., 
2014; Mino et al., 2015; Uehata et al., 2013). The degradation of target mRNAs was reported 
to be independent of the CCCH ZnF, but NMR studies showed that the ZnF can indeed bind 
Il6 mRNA (Yokogawa et al., 2016). Additionally, Regnase-1 directly cleaves circular and linear 
Il6 mRNA, whereas the recognition of a stem loop is mandatory for degradation, indicating that 
Regnase-1 acts as an endonuclease (Mino et al., 2015).  
On the one hand Regnase-1 facilitates the degradation of its target mRNAs by direct cleavage 
dependent on its RNase catalytic center (Lipert et al., 2017; Matsushita et al., 2009). On the 
other hand, Regnase-1 engages with other post-transcriptional gene regulators. The helicase 
UPF1, which is essential for the induction of NMD, directly interacts with Regnase-1 and its 
helicase activity is critical for Regnase-1-mediated transcript degradation (Mino et al., 2019; 
Mino et al., 2015). Not only mRNA degradation, but also inhibition of translation has been 
attributed to Regnase-1. A conserved translational silencing element (TSE) in the 3’-UTR of 
human Nfkbiz is targeted for degradation by Regnase-1. Here, two highly conserved SL (SL 4 
and 5) structures are targeted by Regnase-1 to induce mRNA decay, whereas three tandem 
SL structures (SL1-3) are required in addition to SL4 and 5 for translational silencing by 
Regnase-1 (Behrens et al., 2018). Interestingly, SL4 and SL5 share sequence and structure 
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similarities with the Roquin-targeted CDE element. These findings indicate that Regnase-1 
serves a broad spectrum of molecular functions to guarantee post-transcriptional gene 
regulation during an acute immune response. 
1.3.2.4 Control of Regnase-1 protein expression 
Since the endonuclease Regnase-1 plays important roles in controlling immune responses, its 
expression needs to be under tight control to facilitate expression of target genes. In 
macrophages, Regnase-1 is phosphorylated at the canonical DSGXXS (Ser435, Ser439) 
sequence motif by the inhibitor of transcription factor NF-kB kinase (IKK) complex upon 
signaling of TLRs or IL-1R stimulation resulting in ubiquitination and degradation of Regnase-
1 (Figure 5). Interestingly, self-regulation of Regnase-1 has been reported whereby Regnase-
1 targets its own transcript for degradation via a stem loop structure in its 3′-UTR (Iwasaki et 
al., 2011; Mino et al., 2015). These mechanisms facilitate a tightly coordinated expression of 
Regnase-1 in macrophages and therefore a release of Regnase-1 target genes like Il6 from 
mRNA degradation. In T cells, TCR stimulation and co-stimulation triggers cleavage of 
Regnase-1 by the paracaspase MALT1 at amino acid 111 (Gewies et al., 2014; Jeltsch et al., 
2014; Uehata et al., 2013). Intriguingly, the degradation kinetic is analogous to the cleavage 
of Roquin proteins depending on TCR signal strength (Figure 5). 
1.3.3 The overlapping functions of Roquin and Regnase-1 in the 
control of immune responses 
In the previous chapter, the role of the RNA-binding proteins Roquin and Regnase-1 in shaping 
the adaptive immune response and how their molecular function is integrated into an efficient 
immune response have been discussed. However, by comparing both types of RNA 
regulators, it becomes clear that they potentially possess overlapping functions. In T cells, the 
protein abundance of both factors is strictly controlled by T cell stimulation, when MALT1 
cleaves both proteins, thereby facilitating release of targeted mRNAs. Additionally, target 
transcripts of Roquin and Regnase-1 overlap and require a similar stem loop structure for the 
recognition of either trans-acting factor. Most interestingly, mice deficient for Roquin paralogs 
or Regnase-1 in T cells develop an autoimmune-like phenotype with similar characteristics, 
emphasizing their importance in controlling the same steps of T cell biology. 
Previously, three publications have discussed the possible overlapping roles of Roquin and 
Regnase-1 and whether they are functionally redundant, non-redundant or if they cooperate in 
regulating gene expression in immune cells. 
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Figure 6 ç Current models of Roquin- and Regnase-1-mediated gene regulation. 
Left side: Jeltsch et al. suggested in 2014 a cooperative gene regulation by Roquin and Regnase-1 in 
CD4 T cells. Here, Roquin and Regnase-1 regulate target mRNAs with similar stem loop structures and 
the RNA-binding domain of Roquin is mandatory for mRNA regulation. These target mRNAs involve 
genes that encode for co-stimulatory receptors (Ctla-4, Icos, Ox40), cytokines (IL-6, TNF-a), 
transcription factors (Irf4, cRel) and modulators of transcription factors (IkBNS, IkBz). Upon TCR 
stimulation and co-stimulation, Roquin and Regnase-1 proteins are cleaved by the paracaspase MALT1 
and release targeted mRNAs from repression. Right side: Mino and colleagues published in 2017 a 
model wherein Roquin and Regnase-1 have spatial-temporally compartmentalized functions. In innate 
immune cells, Roquin and Regnase-1 control expression of mRNAs that are induced upon toll-like 
receptor (TLR) stimulation. In bone-marrow-derived macrophages, Roquin is located to P-bodies and in 
stress granules upon stress induction and regulates translationally-inactive mRNAs by recruiting the 
Ccr4-Caf1-NOT deadenylation complex. In contrast to that, Regnase-1 was reported to associate with 
ribosomes and controls translationally-active mRNAs by interaction with the helicase UPF1 and other 
components of the nonsense-mediated decay pathway. 
 
In 2014, our group identified the first links of a cooperative type of Roquin- and Regnase-1- 
mediated gene regulation (Jeltsch et al., 2014) (Figure 6). Briefly, we identified that Roquin 
and Regnase-1 control target genes that facilitate TH17 differentiation including Nfkbid, Nfkbiz, 
cRel and Irf4 in a cooperative manner. We found that Roquin-1/2 and Regnase-1 can 
downregulate an ICOS-GFP reporter under the control of the Icos, cRel, Ctla4, Il6 and Irf4 3′-
UTRs with either overexpression of Roquin in Roquin-deficient or Regnase-1 in Regnase-1-
deficient MEF cells. Intriguingly, the repression of a reporter having the CDE of Tnfa was only 
efficient in the presence of the other protein. In addition, this cooperative regulation depends 
on the RNase activity of Regnase-1 and the RNA-binding capacity of Roquin-1, which we 
proved by employing a chimeric construct consisting of the ROQ-domain of Roquin fused to 
Regnase-1. MALT1-induced cleavage of Roquin and Regnase-1 is TCR-signal strength 
dependent and therefore results in elevated release of Roquin- and Regnase-1 targeted 
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genes. Collectively, in this study a cooperative mode of gene regulation by these RBPs is 
suggested, whereby Roquin involves its ROQ-domain for identifying SL structures and the 
catalytic RNase domain of Regnase-1 is crucial for mediating mRNA degradation. 
One year later, the group of Osamu Takeuchi further expanded the knowledge about Roquin 
and Regnase-1-mediated gene regulation (Mino et al., 2015) (Figure 6). However, they 
suggested a quite different model for post-transcriptional gene regulation.  
By performing RNA-immunoprecipitation and sequencing (RIP-Seq) they confirm that Roquin 
and Regnase-1 target genes significantly overlap in HeLa cells. Interestingly, they identified 
the mRNA of Regnase-1 itself (Zc3h12a) as significantly enriched. Additionally, Regnase-1 
predominantly targets py-pu-py triloop stem loops like the CDE and Roquin recognizes SLs in 
Tnfa, Nfkbiz, Ptgs2 and Il6 in a comparable manner identified by HITS-CLIP (high-throughput 
sequencing of RNA isolated by crosslinking immunoprecipitation). However, they suggest 
different subcellular localizations of Roquin and Regnase-1: Here, Regnase-1 localizes to the 
rough ER-membrane proposing a role in active translation of membrane or secreted proteins, 
whereas Roquin is found at sites of P-bodies and stress granules upon arsenite treatment in 
NIH/3T3 mouse cells. In polysomal fractionations, Regnase-1 associates in non-polysomal and 
polysomal fractions whereas Roquin was only found in fractions with low ribosomal 
abundance. These data were interpreted that Regnase-1 rather controls mRNAs during active 
translation and Roquin regulates translationally-inactive transcripts. Additionally, Regnase-1 
associates with UPF1, a helicase involved in NMD, and depends on the helicase activity of 
UPF1, whereas Roquin functions completely independent of UPF1, supporting two distinct 
regulatory mechanisms by Roquin and Regnase-1. Finally, the authors compared the gene 
expression of Regnase-1-deficient, Rc3h1san/san MEF cells and cells with a combined deletion/ 
point mutation upon LPS treatment. Here, the Regnase-1-deficiency affected genes at early 
timepoints of stimulation, whereas Rc3h1san/san impacted gene expression at later timepoints 
and the deletion/ point mutation cell line showed an additive and increased expression of the 
target genes Il6, Tnf and Ptgs2. Together, the authors promoted the concept that Roquin and 
Regnase-1 are functioning in a spatial- and temporally compartmentalized way. 
A third publication claiming that Regnase-1 and Roquin have non-redundant functions was 
released in 2017 (Cui et al., 2017). Here, the authors generated mice combining the 
Rc3h1san/san (sanroque) mutation, which is expressed in all cells, with a conditional deletion of 
Regnase-1 only in T cells (Zc3h12afl/fl; Cd4-cre) and compared this to either single knockout 
or Rc3h1san/san mutant mice. The combined deletion/point mutation mouse mutant showed 
hyperactivation of T cells tending to differentiate towards TH1 shown by high IFN-g production, 
increased abundance of B cells producing high immunoglobulin levels and cardiac 
inflammation. All analyzed phenotypes were strongest in the combined deletion/point mutation 
mouse mutant whereas the single knockout or sanroque point mutant revealed a less severe 
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outcome. mRNA-sequencing of isolated T cells of those mice revealed that TH1-signature 
genes like Furin and Il12rb1 are enriched in deletion/ point mutation mice in comparison to 
wild-type controls. Here, they claim that the cardiac inflammation seen in deletion/ point 
mutation mice could be TH1-cell related since high IFN-g levels have been reported to promote 
fibrosis, however the impact of TH1 cells in fibrogenesis is still under debate. In addition, the 
authors addressed the autoregulation of Zc3h12a and Rc3h1/2 mRNA by Roquin and 
Regnase-1 themselves. Regnase-1 controls Rc3h1 and Zc3h12a mRNA expression while 
Roquin is not able to regulate Regnase-1-encoding mRNA but can de-stabilize its own 
transcript in the human T cell line Jurkat.  
In summary, all discussed studies share the overlap of Roquin and Regnase-1 target genes 
and regulation of these targets through RNA stem loops that have comparable structural 
requirements. Still, the molecular mechanism of Roquin and Regnase-1-mediated gene 
regulation in T cells remains open as well as the mutual inhibition and autoregulation of Roquin 
and Regnase-1 is contradictory. Moreover, it is unclear how enhanced phenotypes observed 
in Rc3h1san/san; Zc3h12afl/fl; Cd4-cre mice can be interpreted, since these may either result from 
nonredundant or cooperative functions in T cells or cooperative effects of Roquin-1 and 
Regnase-1 in different cell types. Accordingly, it would be of high interest to combine deletion 
of Roquin-1, Roquin-2 and Regnase-1 in the same cells to analyze the phenotypic 
consequences of a system lacking these essential RBPs individually and in combination. 
Therefore, most of this thesis will focus on analyzing the functional association of Roquin-1, 
Roquin-2 and Regnase-1 and whether these essential mRNA decay factors cooperate in their 
target gene regulation and consequently together control autoimmunity. 
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2 Aim 
The RNA-binding protein Roquin-1 and its paralog Roquin-2 are essential post-transcriptional 
regulators of mRNAs encoding proteins involved in T cell activation and differentiation. 
Consequently, mice with a T cell-specific deletion of Roquin-1/2 partially phenocopy the severe 
autoimmune disease of mice with a single point mutation in Roquin-1 (M199R). Roquin 
proteins mediate mRNA degradation of target mRNAs by interacting with secondary stem loop 
structures, the so-called constitutive decay elements (CDE), in 3′-UTRs. However, in the recent 
years more and more concepts of Roquin-mediated gene regulation have been proposed, 
suggesting a complex, cooperative network of gene regulation. The aim of this PhD thesis is 
to unravel the cooperative function of Roquin proteins in controlling mRNA degradation of 
immune-related mRNAs.  
In the first part of this thesis, the cooperation of multiple Roquin proteins on the prototypical 
Roquin targets Ox40 and Nfkbid, that encode essential factors in CD4 T helper cell fate 
decisions, were studied in detail. This first required a structural and conservational analysis of 
cis-regulatory elements in the 3′-UTRs of Ox40 and Nfkbid to identify potential new Roquin 
binding sites. A detailed and complex mutational analysis of Roquin binding secondary 
structure elements of the Nfkbid and Ox40 3′-UTRs should uncover a potential cooperativity of 
multiple Roquin proteins on these prototypical Roquin targets.  
The concept of a cooperative gene regulation by Roquin was further extended in the second 
part of this thesis, which focused on the cooperative gene regulation with the endonuclease 
Regnase-1. The starting point of this project were the investigations by Jeltsch and colleagues 
in 2014 who discovered that Roquin and Regnase-1 have overlapping target mRNAs and thus 
might cooperate in their target gene regulation. The finding that TCR signaling triggers 
cleavage of both Roquin and Regnase-1 proteins by the paracaspase MALT1 further 
strengthened this concept. Studies on mouse embryonic fibroblasts with overexpression of 
Roquin and Regnase-1 confirmed a possible cooperativity in this cell system. However, 
whether the cooperative regulation is true in CD4 T cells was not proven yet, since further 
conceptual models were proposed by different groups that rather suggest redundancy and a 
spatially- and temporally-distinct gene regulation by Roquin and Regnase-1 in immune cells 
(Cui et al., 2017; Mino et al., 2015). Since deficiency of Roquin proteins and Regnase-1 in T 
cells caused similar autoimmune-like phenotypes in mice, we generated conditional triple-
knockout mice of Roquin-1/2 and Regnase-1 in T cells to identify potential overlapping 
functions of Roquin and Regnase-1 in controlling autoimmunity. Comparative analysis of all 
three genotypes should uncover cooperative functions of Roquin and Regnase-1. To further 
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prove if the phenotypes identified in the conditionally deleted mice are cell-intrinsic, mixed bone 
marrow chimeric mice were generated with bone marrow from wild-type mice and mice 
conditionally deleted for Roquin and Regnase-1 in T cells.  
To identify if the autoimmune phenotype of these mice is a consequence of an altered RNA 
expression profile of T cells lacking Roquin and Regnase-1, we performed mRNA-sequencing 
in CD4 T cells deficient for Roquin-1 and Roquin-2, Regnase-1 and all three genes and 
compared the differential gene expression pattern. Additionally, reconstitution assays with 
Roquin or Regnase-1 overexpression on selected target genes in CD4 T cells should help to 
strengthen the concept of cooperativity. Finally, the physical interaction, which is most likely a 
requirement for cooperativity, should be tested by co-immunoprecipitation experiments. 
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3  Material and Methods 
3.1 Material 
3.1.1 Mice 
Rc3h1/2fl/fl mice are transgenic for the Roquin-1-encoding gene Rc3h1 harboring loxP-sites 
flanking exon 4 to 6 (Bertossi et al., 2011) as well as the Roquin-2-encoding gene Rc3h2 with 
loxP-flanked exon 4 (Vogel et al., 2013). Zc3h12afl/fl mice have loxP-sites flanking exon 3 of 
the Regnase-1-encoding gene Zc3h12a (Li et al., 2017). Transgenic Rc3h1/2 fl/fl mice were 
crossed to Zc3h12afl/fl mice to reach the final genotype of Rc3h1/2fl/fl; Zc3h12afl/fl resulting in 
six floxed alleles in Rc3h1, Rc3h2 and Zc3h12a. 
 
 
Figure 7 ç Schematic representation of genetically modified alleles of Rc3h1, Rc3h2 and Zc3h12a. 
Schematic representation of targeting strategy in Rc3h1, Rc3h2 and Zc3h12a and position of loxP-
flanked sites within the respective genes. 
 
Mice with loxP-flanked genes were crossed to either Cd4-Cre (Lee et al., 2001; Sawada et al., 
1994) or Cd4-CreERT2 (Sledzinska et al., 2013) mice to induce recombination of genes. Cd4-
cre is a transgene that drives Cre recombinase expression under the Cd4 promoter allowing 
conditional deletion in the T cell lineage. In Cd4-CreERT2 transgenic mice, Cre recombinase 
is fused to estrogen-receptor 2 (ERT2) and is expressed under the CD4 promoter, which 
induces deletion exclusively in the CD4 T cell subsets by treatment with 4’OH-tamoxifen. In 
this study this system was used to induce deletion of loxP-flanked alleles either in vitro for 24h 
with 4’OH-tamoxifen or in vivo in mice by oral administration of tamoxifen.  
Rc3h1/2fl/fl; Cd4-creERT2; rtTA-M2 mice were generated by crossing Rc3h1/2fl/fl; Cd4-creERT2 
mice with Gt(ROSA)26Sortm1(rtTA*M2)Jae (Hochedlinger et al., 2005). These mice allow expression 
of an optimized form of reverse tetracycline-controlled transactivator (rtTA-M2) protein, which 
is compatible with doxycycline-inducible studies utilizing rtTA/tet-ON systems. In this study, 
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CD4 T cells isolated from these rtTA-expressing mice were in vitro retrovirally transduced with 
a pRetroXTight vector (Takara Clontech) to express a gene of interest under the control of 
PTight, a modified Tet-responsive promoter that is blocked in the presence of rtTA-M2 and 
transcription can be induced by administration of doxycycline. All mice were bred on a C57/Bl6 
background and housed in a special pathogen-free barrier facility at Helmholtz Zentrum 
München or Biomedical Center Munich in accordance with the Helmholtz Zentrum München 
and Biochemical Center Munich institutional, state and federal guidelines. 
 
Table 1 çMouse lines utilized in this thesis. 
3.1.2 Cell Culture and cell lines  
Rc3h1/2 fl/fl; creERT2 mouse embryonic fibroblasts (MEF) were generated from Rc3h1/2 fl/fl; 
creERT2 mice (Vogel et al., 2013) and Rc3h1/2-/- MEF cells were generated from Rc3h1/2 fl/fl 
mice stably transduced with Cre recombinase to delete the respective exons (Table 1).  
To produce Rc3h1/2 -/-; rtTA3 MEF cells, Rc3h1/2 -/- MEFs were stably transduced with a 
retrovirus encoding rtTA3 (Table 2). Media used for cultivating cell lines (DMEM supplemented 
with 10% FCS, 1% Pen-Strep and 1% HEPES) and primary T cells (DMEM supplemented with 
10% FCS, 1% Pen-Strep, 1% HEPES, 1% non-essential amino acids and b-Mercaptoethanol) 
are described in Table 3. 
 
Table 2 çCell lines utilized in this study. 
 
  
Mouse line Name 
Cd4-cre WT 
Cd4-creERT2 WT 
Rc3h1/2fl/fl; rtTA-M2 WT, rtTA 
Rc3h1/2fl/fl; Cd4-cre DKOT 
Rc3h1/2fl/fl; Cd4-creERT2 iDKO 
Rc3h1/2fl/fl; Cd4-creERT2; rtTA-M2 iDKO, rtTA 
Rc3h1/2fl/fl; Zc3h12afl/fl; Cd4-cre TKOT 
Rc3h1/2fl/fl; Zc3h12afl/fl; Cd4-creERT2 iTKO 
Zc3h12afl/fl; Cd4-cre KOT 
Zc3h12afl/fl; Cd4-creERT2 iKO 
Cell Line Species 
HEK293 Homo sapiens 
Rc3h1/2 fl/fl; creERT2 MEF  Mus musculus 
Rc3h1/2 -/-; rtTA3 MEF Mus musculus 
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Table 3 çCell Culture components and media for mouse embryonic fibroblast (MEF) and T cell 
culture. 
3.1.3 Oligonucleotides 
Oligonucleotides were purchased from MWG Eurofins or IDT DNA. DNA Oligonucleotides 
were salt-free purified and oligonucleotides used in real-time qPCR were HPLC-purified. 
 
Table 4 çDNA oligonucleotides for cloning.  
Mutations inserted by QuikChange II XL Site directed mutagenesis are shown in bold letters. 
Name Sequence (5' - 3') Application 
Nfkbid(1-263) for GACCGAAACCCAGAACCTGGAC cloning 
Nfkbid(1-263) rev CTAGAGTGTTTCACAGAAACAATCAAG- cloning 
Nfkbid(1-559) for TAGCTACAGGGATACACAGACCAA cloning 
Nfkbid(1-559) rev TGAGGCCAAATTGAGTTTAATTGG cloning 
Nfkbid(1-410) for ATCGATGGACCGAAACCCAGAACCTG cloning 
Nfkbid(1-410) rev GGCCTTAATGGCCTCTCAGGGGTGTGGGTCC cloning 
Nfkbid(112-559) for ATCGATGAGGGTCTTACATTAAAACTCCA cloning 
Nfkbid(112-559) rev GGCCTTAATGGCCTGAGGCCAAATTGAGTTTAATG cloning 
Nfkbid(209-559) for ATCGATGCTAGGTGATTTCTGTGAAATC cloning 
Nfkbid(209-559) rev GGCCTTAATGGCCTGAGGCCAAATTGAGTTTAATTG cloning 
Nfkbid SL1 LM for AAACCCAGAACCTGGACTGCAAAAACAGTCCCCACCGTCCCGTG 
QC 
mutagenesis 
Nfkbid SL1 LM rev CACGGGACGGTGGGGACTGTTTTTGCAGTCCAGGTT CTG GGT TT 
QC 
mutagenesis 
Nfkbid SL2 LM for ACTGATTTTCCAGTCCCCACGCAGGGGTGGGACAGTC AGCGTATGCT 
QC 
mutagenesis 
Nfkbid SL2 LM rev AGCATACGCTGACTGTCCCACCCCTGCGTGGGGACTGGAAAATCAGTC 
QC 
mutagenesis 
Nfkbid SL3 LM for TATCCTGCCATTAGGGTCTTAACGTAAAACTCCAAAGTGGCACGGG 
QC 
mutagenesis 
Nfkbid SL3 LM rev CCCGTGCCACTTTGGAGTTTTACGTTAAGACCCTAATGGCAGGATAT 
QC 
mutagenesis 
Nfkbid SL4 LM for GGGAGGTGAGCAGTCTCCAAACATTGGGGTCTGTGACAC 
QC 
mutagenesis 
Nfkbid SL4 LM for GTGTCACAGACCCCAATGTTTGGAGACTGCTCACCTCCC 
QC 
mutagenesis 
MEF cell culture medium Supplier 
DMEM (Dulbecco’s modified eagle medium + 4,5 g/l D-
Glucose + L-Glutamine + Pyruvate) Thermo Fisher Scientific 
10% FCS PAN Biotech 
1% Penicillin-Streptomycin (10.000 U/ml) Thermo Fisher Scientific 
1% HEPES-Buffer pH 7.4 (1 M) Thermo Fisher Scientific 
T cell culture medium Supplier 
DMEM (Dulbecco’s modified eagle medium + 4,5 g/l D-
Glucose + L-Glutamine + Pyruvate) Thermo Fisher Scientific 
10% FCS PAN Biotech 
1% Penicillin-Streptomycin (10.000 U/ml) Thermo Fisher Scientific 
1% HEPES-Buffer pH 7.4 (1M) Thermo Fisher Scientific 
1 mM b-Mercaptoethanol (50 mM) Sigma-Aldrich 
1x MEM non-essential amino acids (100x) Thermo Fisher Scientific 
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Nfkbid SL5 LM for AGGGGCTTTCTAGGTGATTTCGTGGAAATCGAGCCCACTTGATTG 
QC 
mutagenesis 
Nfkbid SL5 LM rev CAATCAAGTGGGCTCGATTTCCACGAAATCACCTAGAAAGCCCCT 
QC 
mutagenesis 
Nfkbid SL6 LM for TCGAGCCCACTTGATTGTTTCACAGAAACACTCTAGGGCCATTAA 
QC 
mutagenesis 
Nfkbid SL6 LM rev TTAATGGCCCTAGAGTGTTTCTGTGAAACAATCAAGTGGGCTCGA 
QC 
mutagenesis 
Nfkbid SL1 SM for ACCGAAACCCAGAACCTGCTGTGATTTTCCAGTCCCCA 
QC 
mutagenesis 
Nfkbid SL1 SM rev CGTGGGGACTGGAAAATCACAGCAGGTTCTGGGTTTCGGT 
QC 
mutagenesis 
Nfkbid SL2 SM for ACTGATTTTCCAGTCCGGTCCGTCCCGTGGGACAG 
QC 
mutagenesis 
Nfkbid SL2 SM rev CTGTCCCACGGGACGGACCGGACTGGAAAATCAGT 
QC 
mutagenesis 
Nfkbid SL3 SM for AATATATGTGTAATATCCTGCAAACCTCATCTTACATTAAAACTCCAAAG 
QC 
mutagenesis 
Nfkbid SL3 SM rev CTTTGGAGTTTTAATGTAAGATGAGGTTTGCAGGATATTACACATATATT 
QC 
mutagenesis 
Nfkbid SL4 SM for AGTGGCACGGGGGGGAGGTGATGTCTGGGCAATATTTGGGGTCTGTGACA 
QC 
mutagenesis 
Nfkbid SL4 SM rev TGTCACAGACCCCAAATATTGCCCAGACATCACCTCCCCCCCGTGCCACT 
QC 
mutagenesis 
Nfkbid SL5 SM for CTACAAGGGGCTTTCTAGGTCTATTCTGTGAAATCGAGCCCAC 
QC 
mutagenesis 
Nfkbid SL5 SM rev GTGGGCTCGATTTCACAGAATAGACCTAGAAAGCCCCTTGTAG 
QC 
mutagenesis 
Nfkbid SL6 SM for CTGTGAAATCGAGCCCACTTGATACATTCTGTGAAACACTCTAGGG 
QC 
mutagenesis 
Nfkbid SL6 SM rev CCCTAGAGTGTTTCACAGAATGTATCAAGTGGGCTCGATTTCACAG 
QC 
mutagenesis 
Nfkbid SL1 hexa-tri LM for CCAGAACCTGGACTGTGTCAGTCCCCACCGTCC QC mutagenesis 
Nfkbid SL1 hexa-tri LM rev 5GGACGGTGGGGACTGACACAGTCCAGGTTCTGG 
QC 
mutagenesis 
Nfkbid SL2 hexa-tri LM for CCAGTCCCCACTGTGTGGGACAGTC QC mutagenesis 
Nfkbid SL2 hexa-tri LM rev CAGTGTCCCACACAGTGGGGACTGG QC mutagenesis 
Nfkbid SL5 tri-hexa LM for GGGCTTTCTAGGTGATTTCATTTTCGAAATCGAGCCCACTTGAT 
QC 
mutagenesis 
Nfkbid SL5 tri-hexa LM rev ATCAAGTGGGCTCGATTTCGAAAATGAAATCACCTAGAAAGCCC 
QC 
mutagenesis 
Nfkbid SL1 Reverse Stem 
Mutation for 
CCAGAACCTGCTGTGATTTTCCACAGCCCACCGT
CCCG 
QC 
mutagenesis 
Nfkbid SL1 Reverse Stem 
Mutation rev 
CGGGACGGTGGGCTGTGGAAAATCACAGCAGGT
TCTGG 
QC 
mutagenesis 
Nfkbid SL2 Reverse Stem 
Mutation for GTCCGGTCCGTCCCGACCGACAGTCAGCGTATG 
QC 
mutagenesis 
Nfkbid SL2 Reverse Stem 
Mutation rev CATACGCTGACTGTGGGACGGGACGGTCCCGAC 
QC 
mutagenesis 
Nfkbid SL5 Reverse Stem 
Mutation for 
AAGGGGCTTTCTAGGTCTATTCTGTGAATAGGAG
CCCACTTGATTG 
QC 
mutagenesis 
Nfkbid SL5 Reverse Stem 
Mutation rev 
CAATCAAGTGGGCTCCTATTCACAGAATAGACCT
AGAAAGCCCCTT 
QC 
mutagenesis 
Nfkbid boxB (1-263) 
Gibson Cloning Insert for TCCACTGTGGAATTCGCCCTTCGATGGACCGAA 
Gibson 
cloning 
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Nfkbid boxB (1-263) Gibson 
Cloning Insert rev GCTGGGTCGAATTCGCCCTTGGCCTTAATGGCC 
Gibson 
cloning 
Nfkbid boxB (1-263) 
Gibson Cloning vector for CGAATTCGACCCAGCTTTCTTGT 
Gibson 
cloning 
Nfkbid boxB (1-263) 
Gibson Cloning vector rev GAATTCCACAGTGGATATCAAGC 
Gibson 
cloning 
λN-Roquin-p2A- 
mCherry cloning insert for 
GGCGGCTCAGGCGGCCCTGTACAAGCTCCACAA
TGG 
Gibson 
cloning 
λN-Roquin-p2A-mCherry 
cloning insert rev 
GGCTCCGGAACCTGAGGGAGCAGAATTGGAAAC
AACTC 
Gibson 
cloning 
λN-Roquin-p2A-mCherry 
cloning vector for TCAGGTTCCGGAGCCACGAA 
Gibson 
cloning 
λN-Roquin-p2A-mCherry 
cloning vector rev GCCGCCTGAGCCGCCT 
Gibson 
cloning 
Nfkbid boxB (283-559) 
Gibson Cloning Vector for CTTGTACAAAGTGGTTCGATGACGG 
Gibson 
cloning 
Nfkbid boxB (283-559) 
Gibson Cloning Vector rev TTACTTGTACAGCTCGTCCATGCCG 
Gibson 
cloning 
Roquin-1 Y250A for CATGTTGTTCAGCTCCTCGCCAGAGCCTCCTGCTTCAA 
QC 
mutagenesis 
Roquin-1 Y250A rev TTGAAGCAGGAGGCTCTGGCGAGGAGCTGAACAACATG 
QC 
mutagenesis 
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Table 5 çDNA oligonucleotides and probes from the Universal Probe Library (UPL) system 
(Roche) used for RT-qPCR analyses. 
Name Sequence (5' - 3') UPL probe 
Bcl2l1 for TGACCACCTAGAGCCTTGGA 2 
Bcl2l1 rev GCTGCATTGTTCCCGTAGA 2 
Cd69 for AACGGAAAATAGCTCTTCACATCT 29 
Cd69 rev TCCTTCATGATGCTTCTCAAAA 29 
Cebpd for GAGAGTGCAGGAACTTCTTGGT 4 
Cebpd rev GACCCCATGGCTTTCTCTC 4 
cKit for GATCTGCTCTGCGTCCTGTT 15 
cKit rev CTTGCAGATGGCTGAGACG 15 
cRel for TTGCAGAGATGGATACTATGAAGC 93 
cRel rev CACCGAATACCCAAATTTTGAA 93 
D1ertd622e for GGAACTTGCACAGTGACATCAT 64 
D1ertd622e rev GGTACTTCTGGAATCCCCATTT 64 
Hprt for TCCTCCTCAGACCGCTTTT 95 
Hprt rev CCTGGTTCATCATCGCTAATC 95 
Hdac2 for CTCCACGGGTGGTTCAGT 45 
Hdac2 rev CCCAATTGACAGCCATATCA 45 
Icos for AACCTTAGTGGAGGATATTTGCAT 33 
Icos rev CTACGGGTAGCCAGAGCTTC 33 
Irf4 for AGCACCTTATGGCTCTCTGC 3 
Irf4 rev TGACTGGTCAGGGGCATAAT 3 
Nfkbid for TTTCTACCCTCCGTCAGACC 9 
Nfkbid rev TACAGCCGGGTATCCAGAGA 9 
Nfkbiz for GAGTCCCGTCCCAGAGGT 27 
Nfkbiz rev TTCACGCGAACACCTTGA 27 
Rc3h1 for GAGACAGCACCTTACCAGCA 22 
Rc3h1 rev GACAAAGCGGGACACACAT 22 
Rc3h2 for TTGTCAGCCACCGAATGAC 98 
Rc3h2 rev TTCAAATGACCACAAGGTTCC 98 
Stat5a for TTGACGTTTCTTACCTGCAAAG 70 
Stat5a rev GCTCCTGACGGCTCTTGA 70 
Tnfrsf4 for GCTTGGAGTTGACTGTGTTCC 79 
Tnfrsf4 rev GGGTCTGCTTTCCAGATAAGG 79 
Tnfrsf8 for AAGATGGAGCAGACAGATTCCT 5 
Tnfrsf8 rev TCAACTTGTGTCCCGTGCT 5 
Ywhaz for CGCTAATAATGCAGTTACTGAGAGA  2 
Ywhaz rev TTGGAAGGCCGGTTAATTTT 2 
Zc3h12a for GAAGCAATGTGGCCATGAG 76 
Zc3h12a rev CCTCGCTCCAGAAACCAG 76 
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3.1.4 Chemicals and consumables      
Table 6 çChemicals and consumables. 
Description Supplier 
1.5 ml, 2 ml centrifuge tubes Eppendorf, Beckmann 
2-Isopropanol Roth 
4’OH-tamoxifen Sigma-Aldrich 
5 ml FACS tubes Falcon 
15 ml, 50 ml tubes Sarstedt 
25 cm2 
75 cm2 cell culture flask 
175 cm2 
BD 
96-well plate V- bottom Roth 
96-well plate qPCR Lightcycler 4titude 
100 mm cell culture dish 
150 mm 
BD 
VWR 
384-well plate qPCR Lightcycler 4titude 
Acrylamide 4K (30%) AppliChem 
Agarose Biozym 
Album Fraction V Roth 
Ammonium-peroxide sulfate (APS) Roth 
Ampicillin AppliChem 
Barrier food wrap Saran 
b-Mercaptoethanol Roth Invitrogen 
Bradford Reagent Bio-Rad 
Brefeldin A Sigma 
BSA (98%) Sigma 
Calcium chloride Roth 
CASY cups Ols-bio 
CASY ton Ols-bio 
Cell culture plates Falcon 
Cell strainer 40 µM 
Cell strainer 100 µM Falcon 
Centrifuge Maxtract Qiagen 
Chloroform Sigma 
Chloroquine Sigma 
Complete Protease Inhibitor Cocktail Tablets Roche 
Corn Oil Sigma 
Cryo Tubes Thermo Scientific 
Dextran sulphate Amersham Biosciences 
DMSO Sigma 
DNase/ RNase-free H2O Invitrogen 
dNTP Fermentas 
Doxycycline-hyclat Sigma 
DTT (Dithiothreitol) AppliChem 
Dulbecco’s Modified Eagle Medium (DMEM) low glucose Invitrogen 
Dynabeads Protein A 
Dynabeads Protein G Invitrogen 
ECL reagent GE Healthcare Invitrogen 
EDTA Roth 
Ethanol (100%) Roth 
Ethanol (denatured) Roth 
Ethidium bromide Roth 
Fetal Calf Serum (FCS) Sigma 
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Filter paper Whatman 3mm Whatman 
Filter tips Sarstedt Molecular BioProducts 
Fixable blue Indo-1 viability dye Thermo Fisher 
Fixation and Developing Solution Agfa 
Formaldehyde (37%) VWR 
Glass pipettes 5 ml,10 ml Hirschmann ® 
Glassware Schott 
Glycerol Roth 
HaltTM Phosphatase Inhibitor Thermo Fisher 
HEPES Buffer (1M) Invitrogen 
Immobilon PVDF Membrane Merck Millipore 
Ionomycin Calbiochem 
Isopropanol bucket Merck 
Kanamycin Roth 
Laboratory film Parafilm® 
LB Agar Applichem 
LB Medium (Miller) Roth 
Methanol Roth 
Milk powder Roth 
MgCl2 solution (25 mM) PCR Perkin Elmer 
MilliQ water Millipore 
Neubauer Counting Chamber Roth 
NP-40 Sigma 
Parafilm Fleischhacker 
Pasteur pipettes Brand 
PCR tubes Thermo 
Penicillin / Streptomycin (Pen-Strep) Thermo Fisher 
Petri Dishes Greiner 
Pipette tips Rainin 
PMA (Phorbol-12-myristate-13-acetate) Calbiochem 
Polybrene Sigma 
Proteinase K Sigma 
RNasinÒ Promega 
Saponin VWR 
SBA Clonotyping System-AP Southern Biotech 
Sodium acid (NaN3) Roth 
Sodium dodecyl sulfate (SDS) Roth 
Spectinomycin Roth 
Syringe filter 0,45 µM VWR 
Tamoxifen Sigma 
Temed Roth 
Tris-HCl pH 7,5 Invitrogen 
Triton X-100 Sigma 
Trizol Ambion 
Trypan blue Roth 
Trypsin/Ethylenediaminetetraacetic acid (EDTA) (0,05%) Invitrogen 
Tween-20 AppliChem 
Whatman-membrane VWR 
X-ray films Röntgen Bender 
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3.1.5 Kits, markers and enzymes 
Table 7 çKits and markers. 
Kit/ Marker Supplier 
BD Cytofix/Cytoperm BD Biosciences 
DNA 2-log-ladder Biolabs 
DNA ladder 1 kb Fermentas 
EasySep™ Mouse CD4+ T Cell Isolation Kit Stem Cell Technologies 
EasySep™ Mouse Naïve CD4+ T Cell Isolation Kit Stem Cell Technologies 
Foxp3 staining buffer set eBioscience 
Gene Ruler 1 kb DNA ladder Invitrogen 
In-Fusion® HD Cloning Kit Takara Clontech 
Light CyclerÒ 480 pobes master Roche 
NucleobondÒ Xtra Midi/Maxi Macherey-Nagel 
NucleoSpin Gel and PCR Clean Up Kit Macherey-Nagel 
NucleoSpin RNA Macherey-Nagel 
peqGold Protein Marker IV Peqlab 
Protein Marker VI prestained 10-245 kDa AppliChem 
PureYield Plasmid Miniprep System Promega 
QIAÒqick gel extraction Kit Qiagen 
Quantitect Reverse Transcriptase Kit Qiagen 
QuikChange II XL Site-Directed Mutagenesis Kit  Agilent Technologies 
RevertAid Reverse Transcriptase Thermo 
RNeasyÒ Mini Kit Qiagen 
Universal Probe Library Roche 
 
Table 8 çEnzymes. 
Enzyme Supplier 
GatewayÒ BP clonase enzyme mix Life technologies 
GatewayÒ LR clonase II enzyme mix Life technologies 
RevertAid Reverse Transcriptase Qiagen 
SUPERase IN Promega 
Taq Polymerase Invitrogen NEB 
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3.1.6 Buffers 
Table 9 ç Buffers. 
Description Composition 
Blocking solution 5% Milk powder TBS 
Cell culture freezing medium FCS 10% DMSO 
Citrate-Phosphate Buffer 
4,7g Citric Acid 
9,2 g Na2HPO42H2O 
pH 5.0 
FACS buffer 
2% FCS 
0,01% NaN3  
PBS 
HBS (2x) pH 6,95 – 7.0 
280 mM NaCl 
50 mM HEPES 
1.5 mM Na2HPO4 
Laemmli loading buffer (5x)  
314 mM Tris 
50% Glycerol (v/v) 
5% SDS (v/v) 
5% β-Mercaptoethanol (v/v) 
0.01% Bromophenol blue (w/v), adjust buffer to pH 6.8 
LB agar  LB medium 1.5% Bacto agar (w/v) 
LB Medium 
1.0% Tryptone (w/v) 
0.5% Yeast extract (w/v) 
1.0% NaCl (w/v 
Meister Lysis buffer 
20 mM Tris-HCl pH 7.5 
150 mM NaCl 
0,25% NP-40 
1.5 mM MgCl2 
NP40 lysis Buffer (5x) 
250 mM HEPES, pH 7.5 
750 mM KCl 
10 mM EDTA 
5 mM NaF 
2,5% (v/v) NP-40 
PBS  
137 mM NaCl 
2.7 mM KCl 
10 mM Na2HPO4, pH 7.4 
Saponin buffer 
0,5 % Saponin 
1% BSA 
PBS 
SDS running buffer 
20 mM Tris 
200 mM Glycine 
0,1 % SDS 
TAC lysis buffer 13 mM Tris 140 mM NH4Cl, pH 7.2 
TBE (1x) 89 mM Tris-borate 2 mM EDTA, pH 8.0 
TBS (1x) 50 mM Tris-HCl, pH 8.0 150 mM NaCl 
TBS-T TBS with 0,05% Tween-20 
T cell buffer 
2% FCS 
1 mM EDTA 
PBS 
Transfer buffer for WB 
25 mM Tris 
39 mM Glycine 
20% Methanol (v/v) 
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3.1.7 Antibodies 
Table 10 ç Antibodies used for flow cytometry, immunoblotting and T cell cultures. 
Antibody Clone Source Application Dilution/ Concentration 
α-CD3 2C11 E. Kremmer TH1 culture 0,25 μg/ml 
α-CD4  GK1.5 eBioscience Flow Cytometry 1:200 
α-CD5 53-7.3 eBioscience Flow Cytometry 1:200 
α-CD8a 53-6.7 eBioscience Flow Cytometry 1:200 
α-CD21/CD35  7G6 BD Flow Cytometry 1:200 
α-CD23  B3B4 eBioscience Flow Cytometry 1:200 
α-CD24 M1/69 Biolegend Flow Cytometry 1:200 
α-CD28 37.5N E. Kremmer TH1 culture 2,5 μg/ml 
α-CD25  PC61.5 eBioscience Flow Cytometry 1:200 
α-CD40L  MR1 eBioscience Flow Cytometry 1:200 
α-CD44  IM7 eBioscience Flow Cytometry 1:200 
α-CD45.2  A20 eBioscience Flow Cytometry 1:200 
α-CD45.2  104 eBioscience Flow Cytometry 1:200 
α-CD45R (B220) RA3-6B2 eBioscience Flow Cytometry 1:200 
Α-CD62L  MEL-14 eBioscience Flow Cytometry 1:200 
α-CD69 H1.2F3 BD Flow Cytometry 1:200 
α-CD90.1 OX-7 BD Flow Cytometry 1:200 
α-CD117 (c-Kit) ACK2 Fisher Scientific Flow Cytometry 1:200 
α-CD127 (IL-7Rα) A7R34 eBioscience Flow Cytometry 1:200 
α-CD134 (Ox40) OX-86 eBioscience Flow Cytometry 1:200 
α-CD152 (Ctla-4) UC10-4B9 eBioscience Flow Cytometry 1:200 
α-CD185 (Cxcr5) L138D7 Biolegend Flow Cytometry 1:50 
α-CD196 (Ccr6) R6H1 eBioscience Flow Cytometry 1:100 
α-CD197 (Ccr7) 4B12 eBioscience Flow Cytometry 1:100 
α-CD278 (Icos) 7E.17G9 eBioscience Flow Cytometry 1:200 
α-CD278 (Icos) C398.4A eBioscience Flow Cytometry 1:200 
α-CD279 (PD1) J43 eBioscience Flow Cytometry 1:200 
α-CD357 (GITR) DTA-1 eBioscience Flow Cytometry 1:200 
α-cleaved 
caspase-3 D3EP Cell signaling Flow Cytometry 1:200 
α-cRel  1RELAH5 Invitrogen Flow Cytometry 1:200 
α-cRel 1RELAH5 eBioscience Western Blot 1:500 
α-CyclinA2 E23.1 Invitrogen Western Blot 1:500 
α-GFP 7.1/13.1 Roche Immunoprecipitation 25 μg/ μl 
α-GFP 3E6 Invitrogen Western Blot 1:1.000 
α-Foxp3 FJK-16S eBioscience Flow Cytometry 1:100 
α-GAPDH 6C5 Merck Millipore Western Blot 1:10.000 
α-GL-7 GL7 eBioscience Flow Cytometry 1:200 
α-goat-α-rat MRG2a-8.3 Biolegend Flow Cytometry 1:200 
α-hamster IgG polyclonal MP Biochemicals T cell culture 2.5 mg/ml 
α-HDAC2 3F3 Santa Cruz Biotechnology Western Blot 1:10.000 
α-IFNg XMG1.2.1 In house production TH17 culture 5 μg/ml 
α-IFNg XMG1.2 eBioscience Flow Cytometry 1:200 
α-IgM II/41 BD Flow Cytometry 1:200 
α- IkBz LK2NAP eBioscience Flow Cytometry 1:200 
α-IkBNS 4C1 In house production Flow Cytometry 1:100 
α-IL-2 JES6-5H4 eBioscience Flow Cytometry 1:200 
α-IL-4 11B11 eBioscience Flow Cytometry 1:40 
α-IL-4 11B11 In house production TH1 culture 10 μg/ml 
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α-IL-10 JES5-16E3 eBioscience Flow Cytometry 1:200 
α-IL-12 C17.8 in house production TH17 culture 10 μg/ml 
α-Irf4 E34 eBioscience Flow Cytometry 1:200 
α-Ly-6G (Gr1) RB6-8C5 eBioscience Flow Cytometry 1:200 
α-mouse IgG-
HRP  Cell Signaling Western Blot 1:3.000 
α-NK1.1 PK136 eBioscience Flow Cytometry 1:200 
α-rat IgG-HRP  Cell Signaling Western Blot 1:3.000 
α-rabbit IgG-HRP  Biolabs Western Blot 1:3.000 
α-Regnase-1 604421 R&D Western Blot/ Immunoprecipitation 1:500 
α-Regnase-1 15D11 In house production Western Blot Flow Cytometry 1:10 
α-Roquin-1 polyclonal Bethyl Western Blot 1:1.000 
α-Roquin-1/2 3F12 In house production Western Blot Flow Cytometry 1:10 
α-Streptavidin  eBioscience Flow Cytometry 1:200 
α-TCRb H57-597 eBioscience Flow Cytometry 1:200 
α-TCRgd eBioGL3 eBioscience Flow Cytometry 1:200 
3.1.8 Cytokines 
Cytokines applied in T cell differentiations and T cell cultures. For concentrations used in 
different T cell culture systems see Table 17. 
 
Table 11 ç Cytokines used for T cell cultures. 
Antibody Source Application 
hIL-2 Novartis T cell culture 
rmIL-6 R&D System TH17 culture 
rmIL-12 p79 BD Pharmingen TH1 culture 
rhTGF-b1 R&D System TH17/ Treg culture 
3.1.9 Plasmids 
DNA-plasmids were utilized for retroviral production in HEK293 cells. The retroviral expression 
plasmids MSCV-hICOS-GFP-Nfkbid(1-263)-IRES-Thy1.1 (MSCV-Nfkbid(1-263)) and MSCV-
hICOS-GFP-Nfkbid(1-559)-IRES-Thy1.1 (MSCV- Nfkbid(1-559)) were kindly provided by Dr. 
Sven Brenner.  
All modifications within MSCV-Nfkbid(1-263) were introduced by QuikChange II XL Site-
directed mutagenesis (Agilent Technologies).  
The RetroXTM Tet-ONâ advanced inducible expression system was purchased at Takara 
Clontech. Instead of the puromycin resistance gene in the expression vector pRetroX-Tight-
Pur, a chloramphenicol resistance and CcdB gene were introduced, which are flanked by 
Gateway-cloning-compatible attR1 and attR2 sites. This allows recombination of a gene 
sequence from a Gateway entry vector into the modified pRetroXTight vector (see section 
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3.2.1.2). Plasmids for expression of doxycycline-inducible GFP-fusion proteins like 
pRetroXTight-GFP, -GFP-Roquin-1, -GFP-Regnase-1 and -GFP-Regnase-1(D141N) were 
kindly supplied by Dr. Gesine Behrens and Sascha Wani. The pRetroXTight-lN-fusion proteins 
and the MSCV-Nfkbid(1-263)-boxB constructs were generated by Gibson Assembly utilizing 
the In-Fusionâ HD cloning Kit (Takara Clontech). 
 
Table 12 ç Retroviral expression plasmids. 
Destination vector Insert Application 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263) Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL1LEM Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL1LM Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL1RSM Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL1SM Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL2LEM Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL2LM Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL2RSM Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL2SM Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL3LM Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL3SM Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL4LM Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL4SM Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL5LM Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL5SM Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL6LM Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL6SM Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL3+4LM Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL5+6LM Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL3+4+6LM Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL2+3+4+6LM Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL2+3+4+5+6LM Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL1_boxB Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL2_boxB Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL5_boxB Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL125_boxB Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL5_boxB Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-263)-SL125_boxB Retroviral expression 
MSCV-hICOS- GFP-CcdB-IRES-Thy1.1 Nfkbid(1-559) Retroviral expression 
pRetroXTight-CcdB GFP Retroviral expression 
pRetroXTight-CcdB GFP-Roquin-1 Retroviral expression 
pRetroXTight-CcdB GFP-Regnase-1 Retroviral expression 
pRetroXTight-CcdB GFP-Regnase-1(D141N) Retroviral expression 
pRetroXTight-CcdB Roquin-1 Retroviral expression 
pRetroXTight-CcdB Roquin-1(Y250A) Retroviral expression 
pRetroXTight-CcdB Roquin-1 (K220A+K239A+R260A) Retroviral expression 
pRetroXTight-CcdB lN-p2A-mCherry Retroviral expression 
pRetroXTight-CcdB 
lN-Roquin-1 
(K220A+K239A+R260A)-p2A-
mCherry 
Retroviral expression 
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Table 13 ç Entry vectors for Gateway cloning. 
Entry vector Insert 
pCR8/GW/TOPO Roquin-1 
pCR8/GW/TOPO Roquin-1(K220A-K239A-R260A) 
pCR8/GW/TOPO Roquin-1(Y250A) 
3.1.10 Software and technical devices 
Table 14 ç Software. 
Software Application Supplier 
Adobe Illustrator CS6 
Adobe Photoshop CS6 Image processing Adobe 
ApE Sequence alignment http://jorgensen.biology.utah.edu/wayned/ape/ 
Endnote X7 Organization of citations Clarivate analytics 
FlowJo 10 Flow cytometry data analysis Treestar 
Microsoft® Excel  
Microsoft® PowerPoint 
Microsoft® Word 
Data processing Microsoft  
Prism 5.0 Data processing Graphpad 
 
Table 15 ç Technical devices and instruments. 
Description Supplier 
-80°C freezer Thermo Scientific 
-20°C freezer Liebherr 
4°C fridge Liebherr 
37°C bacterial incubator Memmert 
37°C mammalian cell incubator New Brunswick 
Autoclave (Varioklav) H+R 
BD Canto II Beckman Dickinson 
BD Fortessa 5 Laser Beckman Dickinson 
Casettes for SDS-PAGE Life Technologies 
Cell counter Casy Cell Counter, Innovartis 
Centrifuges 
Eppendorf 5417R (1.5ml reaction tubes) 
Eppendorf Centrifuge 5810R (15 and 50ml reaction tube) 
Beckmann-Coulter 
SS34 
Cytoflex Beckman Dickinson 
Developer machine Curix 60 Agfa 
Film cassettes VWR 
Fluorescence microscope Leica 
Freezing box Isopropanol Roth 
Gel documentation system Bio-Rad 
Gel electroporation chamber Bio-Rad 
Gel cassettes SDS gel Bio-Rad 
Hood (Tissue Culture) Clean Air 
Ice machine Scotsman 
Incubation shaker Eppendorf 
Light cycler 480Ò Roche 
Magnet stirrer IKA 
Microscopes Zeiss 
Microwave LG 
Neubauer counting chamber Brand 
pH-Meter InoLab pH 720 
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Photometer Eppendorf 
Pipetboy Eppendorf 
Pipettes Rainin 
Power supply Bio-Rad 
Rotating wheel Neolab, VWR 
Shaker Roth 
Spectrophotometer Nanodrop ND100, Peqlab 
SD semi-dry transfer cell Biorad 
Thermocycler Analytic Jena, Biozym 
Thermomixer 5436 Eppendorf 
Vacuum pump VWR 
Vortexer IKA 
X-ray machine XStrahl RS225 
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3.2 Methods 
3.2.1 Molecular biology methods 
3.2.1.1 Polymerase chain reaction 
Polymerase chain reaction (PCR) allows for exponential amplification of DNA fragments by 
utilizing gene-specific forward and reverse primers, heat-stable DNA Polymerases and primer- 
and polymerase-specific cycling temperatures. A standard PCR reaction is shown in Table 16. 
Here, the Taq Polymerase by New England Biolabs was utilized. 
 
Table 16 ç Reagents and PCR-cycle conditions used in a standard PCR reaction. 
reagent final concentration 
 50 μl 
reaction 
Taq Reaction Buffer (10x) 1x 5 μl 
dNTPs (10 mM) 200 μM 1 μl 
forward primer (10 μM) 0,2 μM 1 μl 
reverse primer (10 μM) 0,2 μM 1 μl 
Taq DNA Polymerase 1,25 units 0,25 μl 
template DNA 1-100 ng variable 
nuclease-free H2O  to 50 μl 
 
step temperature  time 
Initial 
denaturation 95°C 30 s 
30 cycles 
95°C 30 s 
45 – 68 °C 15-60 s 
68°C 1 min/kb 
Final 
extension 68°C 5 min 
 
The reaction mix contained about 1-100 ng DNA as template, 5 μl 10x reaction buffer, 1 μl 
dNTP Mix (10 mM each), 1 μl MgCl2 (50 mM), 2 μl forward and reverse primer (10 mM each) 
and 1 μl Taq Polymerase. Deionized water was added to reach the final volume of 50 μl. The 
PCR was performed for 30 cycles with denaturation at 95°C for 30 sec, annealing at 52°C for 
30 sec and elongation at 72°C for 45 sec. The reaction products were size separated by 
electrophoresis on a 1.5% (w/v) agarose gel in 1x TBE buffer and visualized by UV light. The 
band with the correct size was cut, and DNA purified using the QIA®quick gel extraction Kit 
according to the given instructions.  
3.2.1.2 Cloning methods 
Different cloning techniques were applied to produce expression plasmids utilized for retroviral 
transduction (Table 12). All primer pairs are given in Table 4. 
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Gatewayâ Cloning: 
The Gatewayâ cloning method (Invitrogen) relies on bacteriophage att-site-mediated gene 
recombination within entry (pCR8/GW/TOPO) and destination vector (MSCV-IRES-Thy1.1 or 
pRetroXTight) systems (Table 12 and Table 13). For generation of doxycycline-inducible 
expression plasmids, the pCR8/GW/TOPO plasmid containing the gene of interest flanked by 
attL-sites was used to integrate the gene of interest into modified pRetroXTight retroviral 
plasmid harboring attR-recombination sequences via Gateway LR recombination according to 
manufacturer’s protocol.  
QuikChange II XL Site directed mutagenesis: 
QuikChange II XL Site-Directed mutagenesis (Agilent Technologies) was used to introduce 
mutations in retroviral reporter plasmids by PCR amplification with primers containing the 
mutated sequence flanked by gene-specific sequences 5’ and 3’ of the mutation and a high-
proof-reading Pfu Polymerase. Mutations in Nfkbid sequence within the MSCV-ICOS-GFP-
Nfkbid 3′-UTR-IRES-Thy1.1 reporter were generated using site-directed mutagenesis.  
In-Fusionâ HD Cloning: 
In-Fusionâ HD Cloning (Takara Clontech) relies on the Gibson assembly strategy that allows 
integration of an insert into a linearized backbone based on complementary 15 nt-overhangs 
within double-stranded insert and backbone, which are digested by a T5-exonuclease at the 
5’-end allowing hybridization of sticky ends. DNA-Polymerase and Ligase then amplify and join 
insert and backbone. To introduce three or one λN binding sequences (boxB RNA stem-loops) 
in the Nfkbid(1-263) 3′-UTR, the corresponding DNA constructs were synthesized by IDT and 
cloned into the MSCV-ICOS-GFP-IRES-Thy1.1 reporter by Gibson assembly using the In-
Fusion HD cloning Kit. Cloning of the boxB binding protein λN-p2A-mCherry or the fusion 
protein λN-Roquin(K220A, K239A, R260A)-p2A-mCherry was performed by PCR-amplification 
followed by Gibson assembly (Table 12). These constructs were then sub-cloned into a 
modified pRetroXTight vector backbone by Gibson assembly.  
3.2.1.1 Transformation  
Frozen chemical-competent DH5α E. coli cells (in-house production) were thawed on ice. 50 
μl of bacteria suspension were gently mixed with plasmid DNA. The solution was incubated on 
ice for 20 min, subsequently exposed to a heat shock at 42°C for 30 sec and immediately 
cooled down on ice for 2 min. After addition of 100 μl LB media bacteria cells were incubated 
for 1 h at 37°C. Then cells were plated onto selective LB Plates containing appropriate 
antibiotics (100 μg/ml) and incubated ON at 37°C. 
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3.2.1.2 Bacterial culture and preparation of plasmid DNA 
E. coli bacteria were grown in 3 ml of LB medium (small-scale, “mini”-culture) or 250 ml (large-
scale, “maxi”-culture) supplemented with the appropriate antibiotic (100 μg/ml ampicillin) at 
37°C overnight while constantly shaking with 160 rpm. Cultures were then harvested by 
centrifugation (4.122 x g, 4°C) and the plasmids were isolated using PureYield Plasmid 
Miniprep System for small-scale or Nucleobondâ Xtra Midi/Maxi kit for large-scale DNA 
isolation following the manufacturer’s protocol.  
3.2.1.3 Agarose Gel Electrophoresis 
Size separation of DNA fragments was performed by electrophoresis on agarose gels (0.75% 
- 1.5% w/v agarose in TBE) containing 0.5 μg/ml ethidium bromide. Bands were visualized 
under UV light (254 – 366 nm). 
3.2.2 Cell biology methods 
3.2.2.1 Definition of cell numbers 
Cell suspensions isolated from mouse organs were counted by the Casy cell counter according 
to manufacturer’s instruction. Cell numbers of adherent cell lines were defined by cell counting 
with a Neubauer counting chamber. Here, cells of a specific density were mixed with Trypan 
blue. Cells were then distributed onto the Neubauer Counting Chamber and cells in the 4 
quadrants were counted. The mean of counted cells was determined and the dilution factor of 
1x 104 was included in the calculation to define the final cell concentration.  
3.2.2.2 Cryo-conservation of cell lines 
Cells were counted as described above and a desired number of cells was centrifuged and 
washed once in PBS. After another centrifugation step, the cell pellet was taken up in 1 ml 
FCS + 10% DMSO and immediately frozen at -80°C in an isopropanol freezing bucket. 
To thaw frozen cells, the vials were briefly put in a 37°C water bath and cells were quickly 
taken up in 10 ml of fresh DMEM culture medium. After one centrifugation step, the cells had 
been cultivated in an appropriate cell culture vessel.  
3.2.2.3 Cultivation of eukaryotic cell lines 
Adherent cell lines e.g. HEK293 cells and mouse embryonic fibroblasts (MEFs), were 
cultivated in a 37°C, 10% CO2 incubator with DMEM cell culture medium containing 10% fetal 
calf serum (FCS), 1% Penicilin-Streptinomycin (Pen-Strep) and 1% HEPES-Buffer (Table 3). 
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Cell lines were splitted each 3 to 4 days until reaching a specific cell density. To avoid 
overgrowing of adherent cells, the cell culture medium was aspirated, and cells were washed 
with PBS. After removing PBS, the cells had been relieved from the cell culture plate by 
incubation with Trypsin-EDTA and taken up again in fresh DMEM cell culture medium and 
cultivated in the incubator.  
3.2.2.4 Isolation and cultivation of primary CD4 T cells 
For cultivation of primary CD4 T cells, mice were sacrificed at an age of 6-12 weeks by CO2 
euthanasia and cervical dislocation and spleen as well as cervical, axillary, brachial, inguinal 
and mesenteric lymph nodes were dissected and pooled. To perform phenotypic flow 
cytometry analysis, spleen, thymus and peripheral as well as mesenteric lymph nodes were 
taken from sacrificed mice and cells were purified individually. Organs were squished and 
passed through a 100 μm filter. Erythrocytes were eliminated in spleens by tris-ammonium-
chloride (TAC)-lysis. After one additional filtration step through a 150 μm filter, the cell 
suspension was either directly used for flow cytometry analysis (see 3.2.2.11) or CD4 T cells 
were isolated by negative selection using Stem Cell Mouse CD4+ T cell isolation Kit according 
to manufacturer’s protocol. Purified CD4 T cells were then cultured in DMEM T cell culture 
medium supplemented with 10% FCS, 1% Pen-Strep, 1% HEPES-Buffer, 1% non-essential 
amino acids (NEAA) and 1 mM b-Mercaptoethanol (Table 3).  
 
 
Figure 8 ç Schematic representation of T cell culture under TH1 conditions. 
CD4 T cells were isolated from spleen and lymph nodes and stimulated with a-CD3/ CD28 under TH1 
conditions for 2 days (Table 17). Cells were then expanded and cultured with T cell medium containing 
IL-2 and analysis of cells was performed on day 3, 4 or 5. 
 
To culture primary CD4 T cells, TH1 differentiation was performed. Therefore, 4-5 Mio purified 
CD4 T cells were taken up in T cell medium containing 0,25 μg/ml α-CD3, 2.5 μg/ml α-CD28, 
10 μg/ml α-IL-4 and 10 ng/ml IL-12 (Table 11) and cultured on α-hamster IgG pre-coated 6-
well culture plates for 40-48h. Cells were cultured in medium supplemented with 20 U/ml hIL-
2 in a 10% CO2 incubator and expanded for 3-4 days, whereas cells were fed with fresh IL-2-
containing medium every 24h and cultured at a density of 0.5 - 1 Mio cells/ ml (Figure 8).  
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3.2.2.5 In vitro deletion of loxP-flanked genes by 4’OH-tamoxifen 
Mouse embryonic fibroblasts that express creERT2 and loxP-flanked alleles for Roquin-1 and 
Roquin-2 (Rc3h1/2) were treated with 0.32 μM 4’-hydroxy (OH)-tamoxifen for 24h to induce 
deletion. Purified CD4 T cells from mice that were heterozygous for Cd4-creERT2 and 
expressed loxP-flanked alleles were treated with 1 μM 4’OH-tamoxifen for 24h to induce 
deletion of loxP-flanked genes. Cells were washed once in T cell culture medium and then 
activated in T cell medium under TH1 conditions (Table 11) and seeded on a goat-α-hamster 
IgG pre-coated plate. Cells were further cultured and expanded as described in 3.2.2.4 (Figure 
9). 
 
 
Figure 9 ç Schematic representation of T cell culture under TH1 conditions with 4’OH-tamoxifen-
induced gene deletion.  
CD4 cells were isolated from Cd4-creERT2 (WT), Rc3h1/2 fl/fl; Cd4-creERT2 (iDKO), Zc3h12a fl/fl; Cd4-
creERT2 (iKO) or Rc3h1/2 fl/fl; Zc3h12a fl/fl; Cd4-CreERT2 (iTKO) mice and deletion of loxP-flanked 
alleles was induced in vitro by 4’OH-tamoxifen treatment for 24h. After T cell stimulation under TH1 
conditions (Table 17) and IL-2 culture for 2d, cells were used for further analysis. 
3.2.2.6 Calcium-phosphate-transfection of HEK293 cells and retrovirus 
production 
Retroviral transduction was used to stably integrate transgenes into MEF cells and primary 
CD4 T cells. Therefore, retrovirus was produced in HEK293 cells by Calcium-phosphate-
transfection of plasmids (MSCV=Murine Stem Cell Virus or modified pRetroXTight, Table 12) 
containing an SV-40 promoter and the transgene flanked by long terminal repeat (LTR) 
sequences together with a pCl-Eco vector expressing viral packaging and envelope genes 
(gag-pol and env). In detail, HEK293 cells were seeded at a density of 8 million cells on 15 cm 
culture dishes one day prior to the experiment. On the day of transfection, the medium was 
replaced by 17 ml DMEM supplemented with chloroquine (100 µM) and incubated for 1h at 
37°C, 5% CO2. Meanwhile the transfection mix was prepared by mixing 50 µg of plasmid DNA 
with 5 µg of the packaging vector pCl-Eco, 125 mM CaCl2 and H2O to reach a final volume of 
1250 µl. The DNA-CaCl2 mixture was then supplemented with 1250 µl HBS (pH 6.95-7.05) 
while vortexing. This mix was incubated for 15-20 min at RT and then added dropwise on 
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HEK293 cells containing chloroquine-medium. 7h after transfection the medium was 
exchanged with fresh DMEM medium. After 48h, the cell culture supernatant containing 
retrovirus particles was harvested and passed through a 0.45 µm syringe filter and either used 
freshly or stored at -80°C. 
3.2.2.7 Retrovirus transduction of MEF cells or primary CD4 T cells 
For stable integration of transgenes into cell genomes, retroviral infection was performed. MEF 
cells were seeded at a density of 50.000 cells in a 6-well plate at 37°C for 16-18h. Cells were 
then spin infected with retrovirus supplemented with 5 µg/ml polybrene in a centrifuge at 300 
x g at 32°C for 2hr. After 6h, virus supernatant was removed, and fresh medium was added to 
the cells. When using MEF cells expressing the reverse tetracycline-dependent transactivator 
rtTA3 and transduced with pRetroXTight constructs, doxycycline was administered for 16h to 
induce expression of genes. Transduction efficiency was measured by flow cytometry 
detecting the marker Thy1.1 (MSCV-reporter) or GFP (pRetroXTight-expression plasmid).  
Retroviral transduction of primary CD4 T cells expressing rtTA-M2 (Rc3h1/2 fl/fl; rtTA (WT, rtTA) 
or Rc3h1/2 fl/fl; Cd4-creERT2; rtTA-M2 (iDKO, rtTA)) was performed during T cell activation 
with α-CD3/CD28. 40h after seeding cells onto pre-coated goat-α-hamster IgG plates (see 
3.2.2.4), cell culture medium was replaced by retrovirus-containing medium and 5 µg/ml 
polybrene. After spin-infection via centrifugation at 2.000 rpm at 18°C for 1h, cells were 
incubated at 37°C, 5% CO2 for 6h. Then virus-containing medium was aspirated and cells were 
resuspended in T cell culture medium containing hIL-2 and further cultivated as described 
above. Gene expression was induced by administration of 1 µg/ml doxycycline for 6-16h prior 
to analysis (Figure 10). 
 
 
Figure 10 ç Schematic representation of T cell culture under TH1 conditions with 4’OH-tamoxifen-
induced gene deletion and retroviral transduction.  
CD4 cells were isolated from Rc3h1/2 fl/fl; rtTA-M2 (WT, rtTA) or Rc3h1/2 fl/fl; Cd4-creERT2; rtTA-M2 
(iDKO, rtTA) both expressing the reverse tetracycline-dependent transactivator rtTA-M2 and deletion of 
loxP-flanked alleles was induced in vitro by 4’OH-tamoxifen treatment for 24h. After 40h of T cell 
stimulation under TH1 conditions (Table 17), cells were transduced with a pRetroXTight retrovirus 
harboring a doxycycline-inducible cassette. Cells were cultured in IL-2-containing medium for 2 d. 
Expression of retrovirally integrated plasmids was induced by administration of doxycycline for 6-16h 
prior to further analysis. 
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Rc3h12-/-, rtTA3 MEF cells were first transduced with retroviruses encoding the Nfkbid reporter 
harboring either boxB RNA structures or the wild-type Nfkbid reporter. Two days after the first 
transduction, these cells were super-transduced with retroviruses encoding λN-Roquin 
(K220A, K239A, R260A)-p2A-mCherry fusion protein or λN-p2A-mCherry itself. 
Overexpression of λN-constructs was induced by the addition of 1 μg/ml doxycycline for 14h 
two days after superinfection. The infected cells were analyzed by flow cytometry.  
3.2.2.8 Ex vivo stimulation of CD4 T cells with PMA and ionomycin 
To measure cytokine expression of ex vivo isolated cells from spleen, 1 - 2 Mio splenocytes 
were taken up in T cell medium containing 20 nM PMA and 1 μM ionomycin. PMA and 
ionomycin stimulation lead to the activation of T cells by inducing different signaling pathways 
that lead to cytokine secretion of T cells. After an incubation time of 2.5h, cells were 
supplemented with 10 μg/ml Brefeldin A and further incubated for another 2.5h. Brefeldin A 
inhibits protein transport from the golgi apparatus and thus cytokines remain in the cytoplasm 
and can be analyzed by flow cytometry. Therefore, cells were intracellularly stained with 
antibodies against cytokines (see Table 10) and analyzed on a flow cytometer.  
3.2.2.9 Tamoxifen gavage and in vitro differentiation of naïve CD4 T cells 
To examine the differentiation capacity of naïve T cells with deficiency of Roquin- and 
Regnase-1 alleles, deletion was induced in mice by oral administration of tamoxifen. Therefore, 
mice received 50 mg tamoxifen diluted in corn oil on 3 consecutive days whereas on the last 
day mice got 2 doses of tamoxifen. Mice were sacrificed three days after treatment and naïve 
T cells were isolated from spleen and LNs by applying the EasySep™ Mouse Naïve CD4+ T 
Cell Isolation Kit according to manufacturer’s protocol. 
 
Table 17 ç Antibody and cytokine concentrations for T helper cell differentiations. 
 TH0 TH1 TH17 Treg 
α-CD3 0,25 ng/ml 0,25 ng/ml 0,25 ng/ml 0,25 ng/ml 
α-CD28 2,5 µg/ml 2,5 µg/ml 2,5 µg/ml 2,5 µg/ml 
α-IFN-g - - 5 µg/ml - 
α-IL-2 - - 2,5 µg/ml - 
α-IL-4 - 10 µg/ml 10 µg/ml - 
α-IL-12 - - 10 µg/ml - 
IL-2 - - - 100 IE/ml 
IL-6 - - 60 ng/ml - 
IL-12 - 10 ng/ml - - 
TGF-b - - 10 ng/ml 2 ng/ml 
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T cells were then activated under TH1, TH17, Treg or TH0 conditions (Table 17) for 3.5d on a 
goat-α-hamster IgG pre-coated 96-well plate and split on the 2nd day. Cells were restimulated 
with PMA and ionomycin as described above. Cells were then stained for intracellular cytokine 
expression and analyzed on a flow cytometer (Figure 11). 
 
 
Figure 11 ç Schematic representation of in vitro differentiation of naïve T cells deleted by 
tamoxifen gavage in vivo.  
Cd4-creERT2 (WT), Rc3h1/2fl/fl; Cd4-creERT2 (iDKO), Zc3h12afl/fl; Cd4-creERT2 (iKO) and Rc3h1/2fl/fl; 
Zc3h12afl/fl; Cd4-creERT2 (iTKO) mice were treated with tamoxifen on three consecutive days, whereas 
on the third day mice received two pulses of tamoxifen. Three days later, naïve CD4 T cells were isolated 
and stimulated under TH0, TH1, TH2, TH17 and Treg conditions (Table 17). After a 3 days culture in IL-2-
containing medium, cells were split and 24h later cells were restimulated with PMA and ionomycin in 
the presence of Brefeldin A (BfA) and cytokine expression was analyzed by flow cytometry. 
3.2.2.10 Generation of mixed bone marrow chimeric mice 
Bone marrow cells were isolated from following donor mice: CD45.1+ WT (WT CD45.1), CD45.2+ 
Cd4-cre (WT CD45.2) or CD45.2+ Rc3h1/2fl/fl; Zc3h12afl/fl; Cd4-cre (TKOT CD45.2). Here, femurs and 
tibias were taken, and bones were rinsed with PBS to isolate bone marrow cells. After one 
washing step in PBS + 3% FCS, cells were frozen in FCS containing 10% DMSO and stored 
at -80°C until injected into mice. CD45.1/2 heterozygous recipient mice were lethally irradiated 
with 5,5 Gy (=550 rad) g-radiation of a 137Cs-source twice on two consecutive days. Frozen 
bone marrow cells were thawed, counted and 2 Mio CD45.1+ WT cells were either mixed with 
2 Mio CD45.2+ WT cells (WT CD45.1/ WT CD45.2) or 2 Mio CD45.2+ TKOT cells (WT CD45.1/ TKO T 
CD45.2) and diluted in 200 µl PBS. 4h after second radiation, CD45.1/2 heterozygous recipient 
mice received 4 Mio mixed bone marrow cells either WT CD45.1/ WT CD45.2 or WT CD45.1/ TKO T 
CD45.2 by intravenous injection. Mice were treated for two weeks with water supplemented with 
antibiotics and 9 weeks after irradiation, the reconstituted cells were analyzed by flow 
cytometry. Irradiation and injection were performed together with Dr. Taku Kureha. 
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3.2.2.11 Antibody staining for flow cytometry and data analysis with FlowJo 
To analyze antigen expression by flow cytometry, single-cell suspensions were washed in PBS 
and stained for viability with a live-dead dye for 20 min at 4°C. After one washing step with 
FACS Buffer, cell suspensions were stained with antibodies against the appropriate cell 
surface proteins. Ccr6 and Ccr7 surface staining was performed for 30 min at 37°C, prior to 
surface staining. For staining of intracellular antigens with in-house produced hybridoma 
supernatants cells were fixed with 2% formaldehyde at RT for 15 min, washed with Saponin 
permeabilization buffer and then stained with the appropriate antibody in Saponin Buffer. For 
commercially available intracellular antibodies cells were fixed with Foxp3 Fixation/Perm Buffer 
according to manufacturer’s protocol for 30 min at 4°C, followed by one washing step in Foxp3 
permeabilization Buffer and staining with antibodies diluted in Foxp3 permeabilization Buffer 
for 40 min at 4°C. Intracellular staining of cleaved caspase-3 was conducted according to 
Breed et al., 2019. After staining, cells were acquired on different flow cytometer devices: BD 
Fortessa (5-laser), FACS Canto II (3-laser) or Cytoflex (4-laser). The data were further 
processed with the software FlowJo (Figure 12). 
 
 
Figure 12 ç Common flow cytometry gating strategy for splenocytes and thymocytes using the 
software FlowJo. 
This first gating strategy was applied to all cell subsets that were defined by flow cytometry analyses in 
this thesis. After choosing splenocytes or thymocytes (FSC-A, SSC-A), duplets were excluded by SSC-
H and SSC-W and FSC-H and FSC-W discrimination and live cells were gated. (FSC = forward side 
scatter, SSC = sideward side scatter, A = area, H = height, W = width) 
3.2.3 Biochemical methods 
3.2.3.1 Protein extraction, SDS-PAGE and immunoblotting 
To analyze protein expression in T cells, cells were harvested, washed once in PBS and 
subsequently lysed in Meister lysis Buffer supplemented freshly with protease inhibitor (PI) and 
dithiothreitol (DTT), corresponding to three times the cell pellet size. After incubation for 10 
min on ice with repeated mixing, cells were centrifuged at 13.000 g for 15 min to separate the 
protein-containing lysate from cell debris. Protein concentration was determined using Bio-Rad 
Protein assay based on the method of Bradford (Bradford, 1976). 30-50 µg protein lysate was 
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electrophoretically resolved according to the size on 8-10% SDS-polyacrylamide gels. Protein 
samples were denatured in 5x Laemmli loading buffer, boiled at 95°C for 5 min and loaded 
next to a pre-stained size marker. After electrophoresis was carried out in SDS running buffer 
at 110 V, the gels were further used for immunoblotting. Therefore, electrophoretic transfer of 
resolved proteins from an SDS-PAGE to a PVDF membrane was conducted by wet blotting 
using the Bio-Rad System. Blotting was either carried out for .,25h at 100V on ice or ON at 
40V in the cold room. For immunodetection of distinct proteins, the membrane was first blocked 
in TBS containing 5% milk powder for 2h. Primary antibody incubations were performed ON at 
4°C under constant agitation. Primary antibodies were either diluted in 1% milk powder in TBS-
T for hybridoma supernatants (Roquin 3F12 and Regnase-1 15D11) or for commercially 
available antibodies according to the manufacturer’s recommendation. Membranes were 
washed three times for 10 min with 1% milk powder in TBS-T. Appropriate horseradish 
peroxidase (HRP)-conjugated secondary antibodies diluted in 1% milk powder in TBS-T were 
added to the membrane for 1h at room temperature, followed by three additional washing steps 
with TBS-T. The signals were detected using different ECL substrates for HRP depending on 
the intensity of the expected bands and subsequently exposed to x-ray films in a dark room. 
3.2.3.2 Co-Immunoprecipitation (Co-IP) 
To analyze interaction of Roquin and Regnase-1 proteins, co-immunoprecipitation was 
performed. Therefore, 100 μl Protein-A dynabeads were coupled under constant rotation to 10 
μg antibody directed against Regnase-1 (R&D) at 4°C, ON followed by 1h at RT. Cell lysates 
were prepared as described with Meister lysis buffer supplemented additionally with 0.2 U/ μl 
RNase inhibitor (RNasin, Promega) and 1x HaltTM Phosphatase inhibitor. After washing of the 
antibody-coupled beads with Phosphate-Citrate Buffer containing DTT and PI, washed beads 
were incubated with 15 mg protein lysate in 900 μl Meister Buffer for 4h at 4°C while 
continuously rotating. Then, beads were washed three times with Meister Buffer supplemented 
freshly with PI and DTT and resuspended in 40 μl 1x Laemmli Buffer. The samples were boiled 
at 95°C for 5 min and co-immunoprecipitation was analyzed by polyacrylamide gel separation 
and immunoblotting with antibodies recognizing Regnase-1 and Roquin.  
3.2.3.3 Enzyme-linked immunosorbent assay (ELISA) 
Whole blood from mice was taken immediately after CO2 euthanasia by puncture of the heart 
from the sternum with a 26Gx1 needle. Blood was directly centrifuged at 10.000 g for 10 min 
at 4°C to isolate antibody-containing serum from cells. For determination of immunoglobulin 
concentrations in the blood, enzyme-linked immunosorbent assays (ELISAs) were performed 
by Elaine Wong using the SBA Clonotyping System-AP according to manufacturer’s 
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recommendation. After addition of substrate, optical density at 405 nm was measured on an 
ELISA reader and concentrations were calculated by using standard serum as a reference. 
3.2.4 RNA methods 
3.2.4.1 RNA isolation and cDNA synthesis 
RNA isolation was performed by phenol-chloroform extraction method using Trizol (Ambion) 
or by column-based RNA isolation utilizing the RNeasy Kit by Macherey-Nagel. Isolation was 
performed according to manufacturer’s protocol. RNA was then transcribed into cDNA by a 
Reverse Transcriptase, whereas either the Quantitect RT Kit or the RevertAid RT Kit were 
utilized according to manual. 
3.2.4.2 Real-Time qPCR 
To quantify gene expression, the UPL Probe Library System by Roche and the Roche Light 
Cycler were utilized. This method is based on a combination of gene-specific oligonucleotide 
amplification and a fluorescent-probe binding to the gene of interest. During amplification 
cycles the fluorescent signal is measured. This fluorescent intensity is then used to calculate 
the amount of cDNA in the sample. Oligonucleotides and probes used to amplify gene 
expression are given in Table 5. 
3.2.4.3 Polysome profiling 
For the preparation of polysomes, 1.0 × 107 CD4 T cells were harvested, washed with PBS 
containing cycloheximide (0.1 mg/ml) and frozen at -80°C. Polysome Profiling was performed 
by Dr. Gesine Behrens and Anneke Doerri in the group of Prof. Dr. Helmut Holtmann at the 
Medical School Hannover. After centrifugation at 500 x g for 7 min, pellets were incubated in 
extraction buffer (20 mM Tris-HCl, pH 8.0, 140 mM KCl, 0.5 mM DTT, 5 mM MgCl2, 0.5% 
Nonidet-P40, 0.1 mg/ml cycloheximide, and 0.5 mg/ml heparin) for 5 min on ice. Extracts were 
centrifuged for 10 min at 12.000 x g and approximately 500 μl of supernatant was layered onto 
a 12-ml linear sucrose gradient (10–50% sucrose (w/v) in 20 mM Tris-HCl, pH 8.0, 140 
mM KCl, 0.5 mM DTT, 5 mM MgCl2, 0.1 mg/ml cycloheximide, and 0.5 mg/ml heparin) and 
centrifuged at 4 °C in an SW40Ti rotor (Beckman, Palo Alto, CA) at 35.000 rpm without brake 
for 80 min. The gradients were collected in 12 fractions and absorbance profiles at 260 nm 
recorded (ISCO, UA-6 detector). The samples were supplemented with 0.1 volume of 
3 M sodium acetate (pH 5.2) and 1 volume of isopropyl alcohol and precipitated ON at −20 °C. 
RNA was purified using NucleoSpin RNA Kit (Macherey & Nagel) according to the 
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manufacturer's protocol. RNA was reverse transcribed into cDNA and genes associated with 
the ribosome fractions were analyzed by RT-qPCR. 
3.2.5 Secondary structure prediction of the Nfkbid 3′-UTR 
Secondary structure predictions were performed by Anne Hoffman and Dr. Kristin Reiche in 
the group of Prof Dr. Jörg Hackermüller at the Helmholtz Center for Environmental Research 
– UFZ Leipzig. Briefly, mRNA and sequence data were acquired from the NCBI Reference 
Sequence Database (RefSeq) collection release (McGarvey et al., 2015). All mRNAs of Nfkbid, 
which amounted to sequences of 68 mammalian species were extracted. Extracted mRNAs 
that harbor an incompletely annotated 3'-UTR were re-annotated by 3'-terminally appending 
the corresponding genomic sequence. The coordinates of the appended genomic sequence, 
that were resulting from the best BLAT hit, while using BLAT version 3.5 with standard 
parameter settings (Kent, 2002). To guarantee a minimum quality the resulting elongated 
mRNAs were subsequently aligned with the corresponding genomic sequences using BLAT. 
mRNA sequences with an alignment mean pairwise identity greater than 95 percent were 
retained. To determine sequence and structure conservation of the SL elements over the 68 
mammalian genomes, a progressive multiple sequence alignment of the mRNA sequences 
using T-coffee v 10.00.r1613 was prepared with standard parameter settings (Notredame et 
al., 2000). Additionally, a blastn search of the mouse SLs against the data set were generated 
with a word size of 7, an e-value of 100 and applying the blastn-short command (Camacho et 
al., 2009). Sequence regions of the mRNAs corresponding to the genomic coordinates of the 
known SL elements were extracted and a five nucleotide long flanking region to the predicted 
SLs added. Simultaneously local-progressive sequence and structure alignments of the 
predicted SLs with the known mouse SLs were generated using mLocARNA (Will et al., 2007). 
3.2.6 Next generation sequencing and bioinformatical analysis 
CD4 T cells were prepared as described in the results section 4.3.3 (Figure 43). After 
restimulation of T cells, cells were taken up in Trizol Reagent and libraries were prepared and 
Illumina Next Generation Sequencing was performed by Dr. Stefan Krebs at the LAFUGA 
platform of Dr. Helmut Blum (Laboratory of functional genome analysis, LMU München). To 
generate high quality sequence reads the samples were sequenced with a length of 100 bp 
paired-end and 15 Mio reads/ sample. After sequencing, the bioinformatic analysis was done 
by Dr. Gergely Csaba from the group of Prof. Dr. Ralf Zimmer at the Institute for Informatics 
(LMU München).   
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4 Results 
4.1 Roquin recognizes multiple types of cis-elements 
The trans-acting factors Roquin-1 and its paralog Roquin-2 have been extensively studied in 
the past for their interaction with stem loop (SL) structures in the 3′-UTRs of their target 
mRNAs. Binding of the so-called constitutive decay element (CDE) in the Tnf 3′-UTR was one 
of the first breakthroughs in understanding the molecular function of Roquin proteins (Leppek 
et al., 2013). It was reported that the ROQ domain adopts an extended winged helix fold that 
recognizes rather the shape of hairpins than the sequence, thereby involving the three amino 
acids namely Lys220 (K220), Lys239 (K239) and Arg260 (R260). However, the pyrimidine-
purine-pyrimidine (py-pu-py loop) sequence is mandatory for Roquin-recognition, since 
changes to pu-py-pu bases completely abolished gene regulation by Roquin. (Leppek et al., 
2013; Schlundt et al., 2016). Besides the CDE, a second cis-element was identified in our 
group by a SELEX (Systematic Evolution of Ligands by Exponential Enrichment) approach and 
was termed the alternative decay element (ADE), consisting of a hexaloop hairpin structure 
(Janowski et al., 2016). Moreover, we recently identified a linear binding element (LBE) that 
was strongly enriched in a PAR-CLIP (Photoactivatable-ribonucleoside-enhanced crosslinking 
immunoprecipitation) approach in mouse embryonic fibroblasts (Essig et al., 2018). The next 
chapter will focus on the regulation of different types of cis-elements (CDE, ADE and LBE) by 
Roquin proteins and describe how Roquin contributes to the regulation of the mRNAs by 
involving multiple regulatory cis-elements. The subsequently discussed data on Ox40 
regulation by Roquin were published in 2016 (Janowski et al., 2016) and the gained knowledge 
about the cooperative regulation of the Nfkbid 3′-UTR by multiple Roquin proteins resulted in 
a manuscript that was published in 2018 (Essig et al., 2018). Dr. Katharina Essig included the 
latter publication as part of her cumulative PhD thesis. 
4.1.1 The ROQ domain of Roquin harbors residues required for cis-
element recognition in the Ox40 3′-UTR 
One highly conserved ADE-like as well as one CDE-like structure are found in the Tnfrsf4 3′-
UTR encoding for the co-stimulatory receptor Ox40 (Janowski et al., 2016), suggesting that 
Roquin might recognize these structures (Figure 4). It was previously described that Roquin 
targets the Tnfrsf4 mRNA, but the exact molecular mechanism has not been described, yet 
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(Jeltsch et al., 2014; Vogel et al., 2013). To identify how Roquin can recognize the novel ADE-
like SL structure, the co-crystal structure of the Roquin-1 ROQ domain bound to the ADE-like 
SL was solved. From this structure, additional amino acid residues (Lys220, Thr240, Lys239, 
Tyr250, Ser253, Arg260, Leu266) were proposed to form an interaction surface with the 5’-
side of the RNA stem within the Tnfrsf4 ADE-like SL. Mutation of Tyr250 to Ala (Y250A) results 
in an almost complete loss of binding of the ROQ-domain to the ADE-like SL in electrophoretic 
mobility shift assays (EMSAs) (Janowski et al., 2016). To prove the contribution of the key 
residue Y250 in Roquin-1 to Tnfrsf4 mRNA recognition and regulation, a retroviral 
reconstitution system in Roquin-deficient CD4 T cells was utilized. Here, Rc3h1/2fl/fl; Cd4-
creERT2; rtTA-M2 mice were generated to genetically combine loxP-flanked Roquin-1/2 
encoding alleles, a 4’OH-tamoxifen-inducible cre recombinase and the reverse tetracycline-
controlled transactivator rtTA-M2. The isolated CD4 T cells were treated in vitro with 4’OH-
tamoxifen to induce deletion of Roquin-1/2. The cells were then transduced with doxycycline-
inducible retroviral vectors to reconstitute Roquin-1 with either wild-type Roquin-1 or mutant 
forms thereof (Y250A and K220A, K239A, R260A) (Figure 10).  
 
 
Figure 13 ç Mutational analysis of Roquin-1 for the regulation of Ox40 and Icos. 
Flow cytometry of Ox40 and Icos surface expression on CD4 TH1 cells from Rc3h1/2fl/fl; Cd4-creERT2; 
rtTA-M2 mice treated with 4’OH-tamoxifen (+ tam) to induce Roquin-1/2 deletion or left untreated (- tam). 
The cells were then either left untransduced (UT) or transduced with retrovirus containing a doxycycline-
inducible cassette to express Roquin-1 wild-type (WT), Roquin-1 Y250A or Roquin-1 K220A, K239A 
and R260A mutants. Data are representative of two independent experiments. 
 
Depletion of Roquin proteins by 4’OH-tamoxifen treatment (+tam) strongly increased surface 
expression of Ox40 and Icos (Figure 13). This increase was partially suppressed in cells with 
doxycycline-induced reconstitution with Roquin-1 WT protein. No downregulation was similarly 
observed upon expression of Roquin-1 with the mutation of Y250A, which binds to ADEs or 
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the K220A, K239A, R260A mutant, which was strongly impaired in CDE SL interactions. 
Therefore, our analyses showed that the Y250 residue was essential for Roquin interaction 
and regulation of Ox40, and potentially also for other Roquin targets such as Icos. Since the 
Icos 3′-UTR has a length of about 2500 nt, there is high possibility for hexaloop structures 
being formed. These data also suggest, that multiple Roquin proteins might potentially 
recognize several regulatory elements within one 3′-UTR to tightly control gene expression of 
its target mRNAs. The combination of the inducible knockout system with short-term 
doxycycline-induced reconstitution allows to analyze short term effects on endogenous target 
regulation and makes this overexpression a good tool for studying target genes in more depths.  
4.1.2 Nfkbid is a prototypical Roquin target 
In our previous study, Roquin-1/2-deficient CD4 T cells showed increased expression of the 
atypical NF-κB inhibitor IkBNS and this increase contributed to elevated IL-17A production and 
increased TH17 differentiation (Jeltsch et al., 2014). Additionally, Nfkbid was identified in RNA-
IP experiments to be directly bound by Roquin and secondary structure predictions revealed 
that the Nfkbid 3′-UTR harbors two CDE elements that could be potentially targeted by Roquin 
(Leppek et al., 2013). Hence, the control of IkBNS expression by Roquin proteins is potentially 
an important mechanism to specify cell fate decisions in T cells. 
The following section focuses on the regulation of the Nfkbid 3′-UTR via multiple Roquin 
proteins binding to six highly conserved stem loops. This multiple binding enables a tight 
control of the expression of the atypical inhibitor IkBNS. Furthermore, this multiple interaction 
can contribute to a translational inhibition by Roquin. The work in the following section was 
published in Essig K., Kronbeck N., et al., in 2018 (Essig et al., 2018). 
4.1.2.1 The minimal response element of the Nfkbid 3′-UTR harbors six 
conserved stem loops that are targeted by Roquin 
To define a minimal response element in the Nfkbid 3′-UTR for Roquin-mediated regulation, 
we made use of a reporter system. Here, the human ICOS coding-sequence (CDS) was fused 
to green-fluorescence protein (GFP), whereas the expression of ICOS-GFP was under the 
control of the 559 nt long Nfkbid 3′-UTR (Figure 14 b). To analyze the binding motifs of the 
Roquin-regulated target Nfkbid we retrovirally introduced the reporter expressing ICOS-GFP 
and the 3′-UTR in a MEF cell line (Rc3h1/2 fl/fl; CreERT2) that allows depletion of endogenous 
Roquin proteins by 4′OH-tamoxifen treatment (iDKO) in vitro. The inducible deletion system 
allowed us to compare the impact of complete deletion of endogenous Roquin-1 and Roquin-2 
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on the expression of the 3′-UTR reporter without overexpression (Figure 14 a). This 
experimental setup will be utilized throughout section 4.1.2. 
 
 
Figure 14 ç Defining the minimal response element of the Nfkbid 3′-UTR for Roquin-mediated 
regulation. 
a) Immunoblot analysis of Roquin expression in Rc3h1/2 fl/fl; CreERT2 MEF cells treated with 4′OH-
tamoxifen (iDKO) or left untreated (WT). b) Schematic overview of the reporter utilized in the following 
experiment. The human Icos CDS (ICOS) is fused to GFP, followed by the full-length Nfkbid 3′-UTR 
(559 nucleotides), which harbors two CDE and one LBE elements or truncated versions thereof. c) Flow 
cytometry analysis of GFP in Rc3h1/2 fl/fl; CreERT2 MEF cells retrovirally transduced with the indicated 
reporter construct, either treated with 4′OH-tamoxifen (iDKO) or left untreated (WT). Median fluorescent 
intensities (MFI) of GFP for WT (red) and iDKO (blue) MEF cells are indicated at the corresponding 
histogram. Data are representative of three (a,c) independent experiments. The immunoblot was 
performed by Dr. Katharina Essig. 
 
Using deletion mutagenesis of the full length 3′-UTR, we mapped a response element of 1-263 
nucleotides, which was required and sufficient to confer strong upregulation of the ICOS-GFP 
reporter upon induced deletion of Roquin encoding alleles in MEF cells (Figure 14 c). 
Interestingly, the linear U-rich LBE motif did not contribute to the Roquin-mediated repression, 
although it was highly abundant in our Roquin PAR-CLIP data set and additionally present in 
an independent PAR-CLIP experiment with human cells (Murakawa et al., 2015).  
To our surprise, the two tandem high-affinity CDE elements were not sufficient to confer full 
regulation when the more 5′ located sequences of the minimal response elements were 
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missing (112-559 and 209-559 nt). These data propose a novel type of gene regulation that 
requires multiple RNA-binding elements targeted by one or more RBPs.  
To prove our hypothesis, we examined if the minimal response element has the potential to 
form further secondary structures in addition to the two CDE elements.  
Therefore, Dr. Jörg Hackermüller, Dr. Kristine Reiche and Anne Hoffmann from the 
Department of Molecular Systems Biology at the Helmholtz Centre for Environmental 
Research-UFZ Leipzig performed sequence and structure predictions using the mLocARNA 
multiple alignment algorithm, which first predicts stem-loop forming sequences and then aligns 
this sequence for conservation amongst different species (Smith et al., 2010; Will et al., 2007). 
The conservation analysis of the Nfkbid 3′-UTR was performed on 68 mammalian species, 
resulting in the prediction of six highly conserved stem loops (SL1-6). Figure 15 a depicts the 
individual conserved sequences for each stem loop and how often these conserved sequences 
differed over the 68 mammalian species. Here, the tandem CDE elements were identified as 
SL5 and SL6 and one ADE-like element showed the highest sequence conservation in the 
nucleotides involved in forming the structure (SL1). Additionally, one non-ADE hexaloop (SL2) 
as well as two triloops (SL3 and SL4) were predicted. The base pairs involved in forming the 
stems of the consensus CDE SL5 and SL6, but also those forming SL3 are highly conserved, 
and those of SL1, a bona-fide ADE, are even invariant over 58 species. The consensus Nfkbid 
3′-UTR structure and conservation of individual nucleotides according to mLocARNA algorithm 
is depicted in Figure 15 b. The structure prediction of these six highly conserved stem loops 
was utilized for the design of mutations on the individual SL structures in the ICOS-CDS-GFP 
reporter (Figure 15 c).  
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Figure 15 ç The Nfkbid 3′-UTR minimal response element harbors six conserved stem loops. 
a) Structural and sequential conservation analysis of the minimal response element of the mouse Nfkbid 
3'-UTR (1-263) by using mLocARNA. Out of 68 analyzed mammalian species the number of species in 
which the respective sequence occurred is listed to the left of the sequences in the conservation pattern. 
A conservation model for the consensus secondary structure of the six stem loops (SL) is shown below. 
Nucleotides are color coded according to their base pair conservation. The graphical representation of 
a mLocARNA alignment depicts at each site the number of sequences forming a base pair and the 
number of compensatory mutations (e.g. when base pair AU is mutated to base pair UA or GU or UG 
or GC or CG). The color code for compensatory mutations is as follows: red=no compensatory mutation; 
ochre=2 different base pairs, i.e. one compensatory mutation; green, turquoise, blue, and violet highlight 
base pairs with 2, 3, 4 and 5 compensatory mutations, respectively. The higher the opacity of the color 
the more sequences form a base pair at this site. b) Consensus secondary structure prediction of the 
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minimal response element of the Nfkbid 3′-UTR (1-263) by mLocARNA. Consensus sequences of SL1 
(residues 19-36), SL2 (residues 37-50), SL3 (residues 112-132), SL4 (residues 161-175), SL5 (residues 
214-230), and SL6 (residues 243-257) are represented. The color code is described in a). c) Schematic 
representation of the minimal response element and its cis-elements ADE and CDE in the ICOS-CDS-
GFP reporter. 
4.1.2.2 Mutational analyses of the Nfkbid 3′-UTR for identifying the 
contributions of single SLs to Roquin-mediated regulation 
We then tested the importance of stem loop recognition by converting the nucleotides in the 
SL sequences in the reporter construct (loop mutation, LM) from purine (pu) to pyrimidine (py) 
bases and vice versa, since it was shown that the py-pu-py triloop sequence in the CDE is 
crucial for recognition by Roquin (Leppek et al., 2013). Loop mutations (LM) impacted full 
regulation of the reporter by Roquin only when located in SL1 and SL2, whereas the sequences 
in the loops of SL3-6 appeared not essential for the regulation, since they were comparably 
regulated to the wild-type 1-263 3′-UTR (Figure 16 a).  
Considering the strong conservation of sequences in SL5 and SL6 (Figure 15 a), we 
hypothesized that both CDEs may compensate for each other’s loss-of- function. Indeed, when 
we combined those mutations in SL5 and SL6 that had no effect when introduced individually 
(combining SL5 LM with SL6 LM), we observed the same strong impairment of Roquin-
mediated regulation as for mutations in the essential SL1 and SL2 (Figure 16 b). In addition 
to loop mutations, we also introduced individual mutations in the stem of the hairpin structures. 
Thus, we disrupted base-pairing of 3-8 nucleotides in the stem sequences by converting 
nucleotides to complementary sequences (Figure 17). We again identified a strong 
contribution of SL1, SL2 and SL5, whereas SL3, SL4 and SL6 showed no effect upon stem 
mutation.  
In summary, this mutagenesis revealed that Roquin-mediated regulation of the Nfkbid mRNA 
involves a complex and composite cis-element. Its function requires stem loop formation and 
loop recognition of SL1, SL2 and SL5/SL6, whereas introduction of mutations in SL3 and SL4 
had no effect on Roquin-mediated regulation of the reporter. 
To check whether the recognition of loop structure was sequence- and shape-specific, we 
individually exchanged the hexaloop sequence (Loop Exchange, LE) of SL1 or SL2 with the 
CDE triloop sequence of SL5 and likewise changed the triloop of SL5 to the hexaloop of SL1 
and then dissected if Roquin was still able to regulate these reporter constructs (Figure 18).  
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Figure 16 ç Mutational analysis of loop structures within the Nfkbid minimal response element. 
a) Schematic representation of the loop sequences from the six conserved SL structures within the 3′-
UTR of mouse Nfkbid. Wild-type loop structures (grey) of the six SLs were modified by individual loop 
mutations (LM: change of purine and pyrimidine bases, green). Flow cytometry analysis of GFP in 
Rc3h1/2 fl/fl; CreERT2 MEF cells retrovirally transduced with the ICOS-GFP-Nfkbid 3′-UTR (1-263) 
reporter without mutation, with individual LMs or with combined LMs (b). MEF cells were either treated 
with 4′OH-tamoxifen (iDKO) or left untreated (WT). Median fluorescent intensities (MFI) of GFP for WT 
(red) and iDKO (blue) MEF cells are indicated. Data are representative of six (a) and three (b) 
independent experiments.  
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Figure 17 ç Mutational analysis of stem sequence within the Nfkbid minimal response element. 
Schematic representation of the six conserved SL structures within the 3′-UTR of mouse Nfkbid. Wild-
type sequences (grey) of the six conserved SLs were modified by introducing stem mutations (SM, 
orange) that result in the disruption of base-pairing within the individual stem sequence. Flow cytometry 
analysis of GFP in Rc3h1/2 fl/fl; CreERT2 MEF cells retrovirally transduced with the ICOS-GFP-Nfkbid 
3′-UTR (1-263) reporter without mutation or with individual SMs. MEF cells were either treated with 4′ 
OH-tamoxifen (iDKO) or left untreated (WT). Median fluorescent intensities (MFI) of GFP for WT (red) 
and iDKO (blue) MEF cells are indicated. Data are representative of six independent experiments.  
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Figure 18 ç Introducing Loop Exchange (LE) mutations in SL1, SL2 and SL5. 
Nucleotide sequences of the loop structures of wild-type mouse Nfkbid 3′-UTR stem loops (SL) 1, 2, 
and 5 (grey) and introduced loop exchange mutations (LE: change of hexa- to tri-loops and vice versa, 
blue) are depicted above. Flow cytometry analysis of GFP in in Rc3h1/2fl/fl; CreERT2 MEF cells 
retrovirally transduced with the ICOS–GFP-Nfkbid 3′-UTR (1–263) reporter containing LE mutations in 
the indicated SLs MEF cells were either treated with 4′OH-tamoxifen (iDKO) or left untreated (WT). MFI 
of GFP is shown for WT (red) and iDKO (blue) MEF cells. Data are representative of six independent 
experiments. 
 
The LE mutations were fully functional for Roquin-mediated regulation, suggesting that Roquin 
has no preference for ADE or CDE loop sequences in the context of the Nfkbid 3′-UTR and 
that SL1, SL2 and SL5 contribute to the full regulation individually. Here, we found that Roquin 
not solely involves one stem loop structure, but indeed requires multiple stem loop structures 
to ensure full gene regulation of the Nfkbid 3′-UTR.  
4.1.2.3 Analyzing cooperativity of multiple Roquin proteins in the regulation 
of the Nfkbid mRNA 
We next wanted to address if multiple Roquin proteins contribute to the regulation of the Nfkbid 
mRNA, since single LMs and SMs in SL1, SL2 and SL5 showed a strong impairment in Roquin-
mediated regulation. Additionally, we aimed to elucidate the contribution of the non-essential 
stem loops SL3 and SL4 and therefore progressively combined the LMs with the essential SL1, 
2 and 5 (Figure 19). Combined mutation of the non-essential SL3, SL4 and SL6 showed a 
gradual de-repression comparable to the single LM in the crucial SL2. Additional mutation of 
SL2 and SL6 then resulted in a complete loss of regulation by Roquin. This led us to the 
hypothesis that multiple Roquin proteins might contribute individually by binding of different 
stem loops in the Nfkbid 3′-UTR. 
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Figure 19 ç Analyzing the contribution of multiple stem loops in the Nfkbid 3′-UTR for Roquin-
mediated regulation. 
Flow cytometry analysis of GFP in in Rc3h1/2 fl/fl; CreERT2 MEF cells retrovirally transduced with the 
ICOS–GFP-Nfkbid 3′-UTR (1–263) reporter without UTR or harboring single or combined LMs as 
introduced in Figure 16. MEF cells were either treated with 4′OH-tamoxifen (iDKO) or left untreated 
(WT). MFI of GFP is shown for WT (red) and iDKO (blue) MEF cells. Data are representative of three 
independent experiments. 
 
To prove whether post-transcriptional regulation of the Nfkbid 3′-UTR requires binding of 
multiple Roquin proteins, we made use of a λN-boxB-tethering assay system (Gehring et al., 
2008). As it was shown in Figure 13, mutating Roquin-1 at K220, K239 and R260 reduces the 
ability to regulate ADE- as well as CDE-containing mRNAs like Tnfrsf4 and Icos. Hence, we 
mutated Roquin-1 at these three critical amino acids in its ROQ domain (K220A, K239A, and 
R260A) to weaken physiologic stem loop recognition and fused this mutant protein to a 
bacteriophage lambda N peptide (λN) that confers high affinity binding to boxB stem loop 
structures. We reconstituted Rc3h1/2-/- MEF cells expressing the reverse-tetracycline-
dependent transactivator rtTA3 with λN-Roquin-1(K220A, K239A, R260A)-p2A-mCherry or 
λN-p2A-mCherry alone by doxycycline administration and after retrovirally introducing the 
ICOS-GFP reporter (Appendix 1). In the reporter we substituted the essential SL1, SL2 and 
SL5 either individually or in combination with boxB structures, which are RNA stem loops that 
are bound by λN with high affinity (Figure 20 a). The reporter regulation was then analyzed by 
flow cytometry and the fold-change regulation was calculated (Figure 20 b).  
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Figure 20 ç Nfkbid regulation requires Roquin-1 to interact with at least three SLs. 
a) Flow cytometry analysis of GFP in the λN-boxB-tethering system in Rc3h1/2-/- MEF cells stably 
expressing the reverse tetracycline-controlled transactivator rtTA3. MEF cells were first either 
transduced with a retrovirus containing the ICOS–GFP reporter with the wild-type Nfkbid 3′-UTR (1–
263) or mutants containing one (at position of SL1, SL2, or SL5) or three (at all positions of SL1, SL2, 
and SL5) boxB RNA structures. The cells were additionally transduced with a retrovirus encoding for 
λN-p2A-mCherry or λN-Roquin-1(K220A, K239A, R260A)-p2A-mCherry containing a doxycycline-
inducible cassette. Overexpression of the λN-constructs was induced by doxycycline administration for 
14h. MFI of GFP for wild-type Nfkbid 3′-UTR (1–263) (grey) and boxB mutants (orange) are indicated. 
b) Fold-change of GFP MFI levels in cells as described in (a) normalized to mean of wild-type Nfkbid 
(1–263). Error bars indicate mean ± SEM. Data are representative of three independent experiments. 
 
With this system we were able to tether λN-fused Roquin-1(K220A, K239A, R260A) to RNA 
structures in the Nfkbid 3′-UTR and thereby elucidate the amount of Roquin proteins that was 
required for full repression of the reporter. 
Introduction of either one or three boxB stem loops at the position of SL1, SL2, or SL5 within 
the minimal response element induced λN-Roquin-1-mediated repression of the reporter. 
However, the three boxB binding sites, that enable simultaneous interactions with three 
molecules of overexpressed λN-Roquin-1 protein, lead to a much stronger repression. These 
findings uncovered that complex and composite Roquin- recognized cis-elements in the 3′-
UTR precipitate a strong cooperative repression of target mRNA expression. So far, 
cooperation of multiple Roquin proteins has not been considered as a type of post-
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transcriptional gene regulation. By performing mutational and functional analyses on the Nfkbid 
3′-UTR, I was able to identify this new type of Roquin-mediated gene regulation. 
4.1.2.4 Roquin induces mRNA degradation and translational inhibition 
Recruitment of factors involved in mRNA deadenylation (Ccr4-NOT) and decapping 
(Ddx6/Rck) are mechanisms for Roquin-mediated target repression (Glasmacher et al., 2010; 
Leppek et al., 2013; Murakawa et al., 2015). However, when we blocked deadenylation and 
decapping of the Nfkbid 3′-UTR-bearing mRNA individually and in combination, Roquin-
mediated reporter regulation was not at all or only partially impaired, suggesting that the mRNA 
degradation pathways of deadenylation and decapping have redundant functions. We 
consequently interpreted, that the residual regulation of the reporter assay could be due to 
translational inhibition. Therefore, we performed in collaboration with the group of Prof. Dr. 
Helmut Holtmann at the MH Hannover polysome profiling, which uses sucrose gradient 
centrifugation to separate monosomal from polysomal fractions from cell lysates and 
accordingly RNAs isolated from these fractions were either strongly (polysomes) or weakly 
(monosomes) translated.  
 
 
Figure 21 ç Polysome Profiling of Nfkbid mRNA in WT and Roquin-deficient CD4 T cells. 
Representative polysome profiles of endogenous Nfkbid and Hprt in Rc3h1/2fl/fl; Cd4-creERT2 CD4 T 
cells treated with (iDKO) or without (WT) 4'OH-tamoxifen. Cytoplasmic lysates from these cells were 
fractionated on sucrose gradients. The amount of mRNA in each fraction was analyzed by RT-qPCR 
and are shown in percent of the sum detected in all fractions (Frac). Fractions 2, 3 and 4 represent the 
40S, 60S and 80S ribosomal units. Fractions 2-5 comprise subpolysomal and fractions 6-10 polysomal 
fractionations. The respective absorbance profile at 260 nm of the gradient fractionation is shown in 
Appendix 2. Data are representative of two independent experiments. 
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The presence of the ribosomal subunits 40S, 60S and 80S and polysomes were controlled by 
absorbance profiles at 260 nm during fractionation of gradients (Appendix 2). Indeed, when 
we analyzed the abundance of ribosomes on the mRNA by performing polysome profiling, we 
realized that endogenous Nfkbid in T cells revealed profound Roquin-induced repression on 
the level of translation (Figure 21). Roquin was able to induce translation inhibition of the 
Nfkbid mRNA, since this mRNA shifted from monosomal to polysomal fractions of sucrose 
gradients of cell extracts when Roquin encoding alleles were conditionally deleted in CD4 T 
cells. 
My colleague Dr. Katharina Essig and our collaborator Dr. Joao C. Guimaraes (Computational 
and Systems Biology, Biozentrum, University of Basel), combined ribosome profiling with 
mRNA-sequencing in Roquin-deficient and Roquin-1-overexpressing MEF cells. The 
technique of ribosome profiling identifies fragments of RNA that are occupied by ribosomes, 
which consequently indicates stronger translational activity (Ingolia et al., 2009). By globally 
comparing the abundance of RNA and the ribosome-protected fragments (RPF), conclusions 
about translational efficiency can be drawn and we thereby identified that some Roquin target 
genes show translational inhibition, respectively. Amongst them we identified Nfkbid. We found 
that targets with more Roquin binding sites showed increased regulation of the mRNA and 
RPFs and that a significantly higher proportion of translationally regulated targets had Roquin- 
binding sites corresponding to four or more binding elements. In this work we have 
demonstrated how a complex cis-element composed of nonessential and essential binding 
sites in the Nfkbid 3′-UTR responds to Roquin expression by inducing deadenylation, 
decapping and translational inhibition. Consequently, Roquin facilitates target gene regulation 
in a cooperative manner: multiple Roquin proteins enable a strong depression of the target 
mRNA controlling transcript abundance. 
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4.2 Investigating the phenotypic consequences of 
conditional deletion of Roquin and Regnase-1 in T cells 
In the previous chapter I have focused on cooperative and composite cis-elements targeted 
by Roquin proteins. Based on these analyses we found that robust regulation of mRNA 
transcripts requires several post-transcriptional gene regulators and involves multiple 
mechanisms including mRNA degradation and translational inhibition. 
The following chapters of this thesis will focus on elucidating the cooperative function of the 
post-transcriptional gene regulators Roquin and Regnase-1. By comparing the phenotypic 
consequences of conditionally deleting Roquin and/ or Regnase-1 in T cells of mice, I aimed 
to learn about the physiological functions of Roquin and Regnase-1 for the prevention of 
autoimmunity. Then, the potential cooperative gene regulation will be studied in more detail by 
performing a global mRNA-sequencing analysis in inducible knockout T cells and by 
investigating the molecular mechanism underlying the functional cooperation.  
4.2.1 Published mouse models of Roquin and Regnase-1 
Since Roquin and Regnase-1 mouse models have already been published, I will first 
summarize the phenotypes of the genetically deleted or mutated mice (Table 18). Here, the 
comparison of hyperactivated CD4 and CD8 T cells, increased differentiation of CD4 T cells to 
the TFH cell lineage and accompanying GC B cells expansion implies an aberrant, 
lymphoproliferative phenotype. 
The production of autoantibodies as well as increased abundance of immunoglobulins of all 
subtypes (hypergammaglobulinemia) and changes in regulatory T (Treg) cell expansion hint 
towards an autoimmune-like phenotype in the mouse models. The sanroque (Rc3h1san/san) 
mouse strain shows an aberrant phenotype of all parameters including the production of 
autoantibodies. In contrast to that, the single knockout of either Roquin-1 or Roquin-2 in T cells 
shows no alteration in neither of the determinants. Solely, Roquin-1 ablation induces activation 
of the CD8 T cell compartment. But, a combined deficiency of both paralogs drastically 
increases the frequency of CD4 and CD8 effector-memory-type T cells, elevated levels of TFH 
and GC B cells as well as Treg cells, suggesting that, Roquin deficiency can lead to the onset 
of autoimmunity. Interestingly, a lack of Regnase-1 in T cells comparably hyperactivates CD4 
and CD8 T cells and causes elevated production of autoantibodies as well as immunoglobulin 
levels of all subtypes. Whether Regnase-1 controls the GC response by influencing TFH 
differentiation and GC B cell expansion like Roquin still needs to be clarified. Overall these 
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comparisons suggest that Roquin and Regnase-1 have potential overlapping functions in the 
prevention of autoimmunity. 
 
Table 18 ç Comparison of previously published phenotypes in sanroque mice and mice deficient 
for Roquin-1, Roquin-2 and Regnase-1 in T cells. 
Published phenotypes of Rc3h1 san/san (Vinuesa et al., 2005), Rc3h1fl/fl; Cd4-cre (Bertossi et al., 2011), 
Rc3h2fl/fl; Cd4-cre, Rc3h1/2fl/fl; Cd4-cre (Vogel et al., 2013) and Zc3h12afl/fl; Cd4-cre (Uehata et al., 2013) 
mice. Comparison of effector-memory (EM) phenotype of CD4 and CD8 T cells, differentiation of 
follicular helper T cells (TFH) and germinal center (GC) B cell formation, autoantibody (ANA) and 
hypergammaglobulinemia and frequencies of regulatory T cells (Treg) in the different knockout situations. 
–: comparable to WT control mice, +: frequency increased or impairment, ++: strong changes in 
frequencies or impairment, /: not investigated. 
phenotype 
Rc3h1san/san  
(Linterman et 
al., 2009; 
Vinuesa et al., 
2005) 
Rc3h1fl/fl;  
Cd4-cre 
(Bertossi et 
al., 2011) 
Rc3h2fl/fl;  
Cd4-cre 
(Vogel et al., 
2013) 
Rc3h1/2fl/fl;  
Cd4-cre 
(Vogel et al., 
2013) 
Zc3h12afl/fl;  
Cd4-cre 
(Uehata et al., 
2013) 
CD4 EM + - - + ++ 
CD8 EM + + - ++ + 
TFH + - - + / 
GC B cell formation + - - + / 
ANA + - - - + 
hypergammaglobulinemia + - - - + 
Treg + - - + - 
 
To investigate the role of Roquin and Regnase-1 proteins in preventing autoimmunity, we 
generated mice with a conditional deletion of the Roquin-1-, Roquin-2- and Regnase-1-
encoding alleles, respectively (Figure 7). We utilized the cre recombinase under the control of 
the CD4 promoter, which deletes loxP-flanked alleles Rc3h1fl/fl, Rc3h2fl/fl and Zc3h12afl/fl during 
T cell development of CD4-, CD8-, CD25lo, CD44lo (DN4) lymphocytes in the thymus (Lee et 
al., 2001; Sawada et al., 1994). Rc3h1/2fl/fl; Zc3h12afl/fl; Cd4-cre mice are in the following 
termed TKOT and the phenotype was compared to Rc3h1/2fl/fl; Cd4-cre (DKOT) and Zc3h12afl/fl; 
Cd4-cre (KOT) as well as to wild-type controls either Cd4-cre or Rc3h1/2fl/fl; Zc3h12afl/fl mice 
(WT). 
I would like to point out that we did not use the same genetically targeted mouse for deleting 
Regnase-1-encoding alleles as Uehata et al., 2013 (Table 18). The Zc3h12afl/fl mouse was 
provided by Dr. Mingui Fu (Li et al., 2017). As Figure 7 implies, the loxP sites are flanking exon 
3, resulting in cre-mediated deletion of the PIN domain of Regnase-1. In comparison to that, 
the Zc3h12afl/fl generated by Uehata et al. resulted in cre-mediated deletion of exon 4-6 lacking 
the C-terminal part of the protein and the 3′-UTR.  
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Figure 22 ç Validation of knockouts in Rc3h1/2fl/fl; Zc3h12afl/fl; Cd4-cre (TKOT) mice. 
Immunoblot analysis of Roquin and Regnase-1 protein expression in CD4 T cells isolated from spleens 
of Rc3h1/2fl/fl; Zc3h12afl/fl; Cd4-cre (TKOT) and Rc3h1/2fl/fl; Zc3h12afl/fl (WT) mice. The molecular weight 
in kDa is depicted at the left. Data are representative of two independent experiments. 
 
The cre-mediated deletion of loxP-flanked alleles in Roquin-1-, Roquin-2- and Regnase-1 
encoding alleles in TKOT mice was successful as shown in the immunoblot in Figure 22 on 
full-length protein levels in CD4 T cells isolated from spleens.  
In the following section, the consequences of a phenotypic deletion were compared in TKOT, 
KOT and DKOT mice by applying flow cytometry. We were aiming to dissect the individual or 
shared contributions of Roquin and Regnase-1 in shaping T cell-mediated immunity and to 
uncover a potential cooperativity of these factors. 
Due to space limitations I will in the following figures show representative flow cytometry 
analyses of at least WT and TKOT mice, but always include a quantification of all genotypes.  
4.2.2 Analyzing thymic T cell development in mice lacking Roquin- 
and Regnase-1 in T cells 
To investigate the components of the adaptive immune system, we started investigating the 
cell compositions of the thymus, the organ where T cells originate and gain their antigen-
specificity. The thymi of TKOT and KOT mice were drastically reduced in absolute cell numbers, 
whereas DKOT showed no change. This drastic loss of cell numbers can be explained by a 
strong decline of DP thymocytes (Figure 23 a-c). Lymphocytes that were negative for CD4 
and CD8 (DN) were decreased in frequencies, but not significantly in cell numbers. DN 
thymocytes can be further discriminated by CD25 and CD44 expression in DN1-4 (Figure 23 
d-e). Thymocytes at the DN1 stage were increased in frequency in TKOT mice, which was not 
reflected in total cell numbers of CD44hi, CD25lo cells. Since important stages in T cell 
development seemed to be dysregulated, the selection processes and maturation of 
thymocytes were validated by flow cytometry.  
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Figure 23 ç Determination of thymic T cell development in Roquin- and Regnase-1-deficient mice. 
Total numbers of thymocytes were defined for WT, DKOT, KOT and TKOT mice (a). The stages of T cell 
development are determined by flow cytometry analysis of CD4 and CD8 and frequencies (b) and 
absolute numbers (c) thereof were calculated. Discrimination of maturation stages (DN1-4) of double 
negative (DN) thymocytes by flow cytometry analysis of CD25 and CD44. Frequencies (d) and absolute 
numbers (e) of DN1-4 were calculated. The bars represent the mean value in each group and data are 
representative for 6 (b) and 4 (d) independent experiments. Statistical significances were calculated by 
one-way analysis of variance (ANOVA) with Bonferroni post test. 
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In Figure 24 a-b, the expression pattern of CD69 and TCRb during the process of positive 
selection resulted in 5 different stages that can be controlled for CD4 and CD8 expression (Fu 
et al., 2009; Wang et al., 2012).  
Population 1 and 2 represented pre-positive selection stages with low CD69 and TCRb 
expression still devoid of CD4 and CD8 SP cells. The expression of CD69 in stage 3 correlated 
with decreased CD4 and CD8 expression on DP thymocytes and then resulted in CD4 and 
CD8 SP thymocytes by induced TCRb on the cell surface (stage 4). In the post-positive 
selection stage 5 cells lost CD69 and became mature CD4 and CD8 SP thymocytes. 
Interestingly, in mice with ablation of Roquin and Regnase-1 DP thymocytes were still strongly 
detectable in stage 5. The overall frequencies of the different stages revealed that TKOT mice 
showed slightly increased frequencies of thymocytes in stage 4-5, but stronger changes in 
stage 3. (Figure 24 b). This phenotype was not shared by mice deficient for either Roquin-1/2 
or Regnase-1 (Appendix 3). Calculating the ratio of mature (CD24lo, TCRbhi) to immature 
(CD24hi) thymocytes (right panel), resulted in an elevated proportion of mature CD4 SP cells 
in TKOT mice, whereas mature CD8 SP cells were only slightly affected by conditional deletion 
of Roquin and Regnase-1 in T cells (Figure 24 c). These findings suggested that positive 
selection and maturation potentially proceeded faster in the absence of Roquin and 
Regnase-1.  
Since the selection process in the thymus results in regulatory T cell formation, we were 
wondering if the differentiation of thymic-derived Treg cells was impaired in TKOT mice. In all 
knockout genotypes we discovered increased frequencies of regulatory T cells in the thymus 
(Figure 25 a), whereas absolute numbers were only elevated in KOT and TKOT thymi. To rule 
out that the large frequency of regulatory T cells results from recirculating peripheral Treg cells, 
we determined the expression of the chemokine receptors Ccr6 and Ccr7. Ccr6+ Ccr7- Foxp3+ 
CD4 T cells were previously described to re-enter the thymus from the periphery (Cowan et 
al., 2016). Interestingly, the frequency of Ccr6+ Ccr7- Foxp3+ cells was not altered in all 
genotypes, suggesting that the strong induction of regulatory T cells in TKOT and KOT mice 
potential arose in the thymi of these mice (Figure 25 b). Most of the increase in Treg frequencies 
was caused by an elevation of CD25- Treg cells (Figure 25 c), which have been reported to 
derive from diverted, potentially autoreactive thymocytes that have less repressive capacity 
than CD25+ regulatory T cells and are prone to become TFH cells (Zhan et al., 2011).  
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Figure 24 ç Analyzing positive selection and maturation of SP T cells in TKOT mice. 
a) Positive selection was determined in live, CD45.2+ cells of thymi from WT, DKOT, KOT and TKOT by 
CD69 and TCRb expression in populations 1-5. Representative flow cytometry analysis is shown in the 
left panel and frequencies of populations 1-5 are depicted in the right. b) CD4 and CD8 expression in 
the 5 populations defined by TCRb and CD69 expression in a) of WT and TKOT thymocytes. c) Flow 
cytometry analysis of CD24 and TCRb in CD4 and CD8 SP thymocytes represents mature (CD24lo, 
TCRbhi) and immature (CD24hi) thymocytes (left contour plot). The ratio of mature to immature T cells 
was calculated for CD4SP and CD8 SP in WT, DKOT, KOT and TKOT mice (right panels). Genotypes 
are indicated in the figure and data are representative for 3 (a-c) independent experiments. 
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Figure 25 ç Altered thymic Treg development in KOT and TKOT mice.  
a) Thymic regulatory T cells (Treg) were determined in WT, DKOT, KOT and TKOT CD45.2+, CD4+ T cells 
by intracellular flow cytometry analysis of Foxp3 expression. A representative contour plot is shown in 
the left panel and frequencies and absolute numbers of all genotypes are shown in the right. b) 
Regulatory T cells as defined in a) were investigated for their recirculating capacity by Ccr6 and Ccr7 
chemokine receptor expression by flow cytometry and quantifications thereof are shown. c) Proportion 
of CD25 expression on Foxp3+ CD4+ T cells was analyzed by flow cytometry and quantified. Genotypes 
are indicated in the figure and data are representative of at least 2 (b) and 5 (c) individual mice per 
genotype. 
 
To further investigate the development of regulatory T cells, we determined the pre-Treg stages 
(I-V) defined by GITR, CD25 and Foxp3 expression (Figure 26 a-d). Maturation of regulatory 
CD4 T cells occurs via induction of GITR (I: GITR- CD25-; II: GITRint CD25-; III: GITR+ CD25-), 
followed by the expression of the IL-2 receptor CD25 (IV: GITR+ CD25+) upon strong TCR 
interaction with p:MHC on antigen-presenting cells or epithelial cells in the cortex and medulla 
of the thymus. When GITR+ CD25+ precursor cells encounter IL-2 and IL-15, they induce the 
expression of Foxp3 (V: GITR+ CD25+ Foxp3+) and become mature Treg cells (Burchill et al., 
2007; Lio and Hsieh, 2008). 
TKOT mice had significantly increased numbers of cells in the last stages of Treg formation (IV 
and V). Previous studies showed that these last stages of Treg development are impaired in the 
absence of the atypical NF-kB inhibitor IkBNS and the NF-kB transcription factor cRel (Schuster 
et al., 2012; Schuster et al., 2017). As shown in the previous chapter, the Nfkbid gene, 
encoding for IkBNS, and cRel are targets of Roquin and Regnase-1 (Jeltsch et al., 2014; Leppek 
et al., 2013; Mino et al., 2015; Murakawa et al., 2015; Uehata et al., 2013).  
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Figure 26 ç Analyzing IkBNS and cRel protein expression during thymic Treg development. 
Regulatory T cell development in the thymus is defined by step-wise expression of GITR, CD25 and 
Foxp3: I: GITR- CD25-, II: GITRint CD25-, III: GITR+ CD25-, IV: GITR+ CD25+, V: GITR+ CD25+ Foxp3+. 
These stages are shown in a representative contour blot of GITR, CD25 (a) and Foxp3 and forward side 
scatter (FSC) (b) by flow cytometry in CD45.2+, CD4+ T thymocytes of WT and TKOT mice. Absolute 
numbers of populations I, II, III, IV (c) and V (d) were calculated for WT, DKOT, KOT and TKOT mice. 
Expression of cRel (e) and IkBNS (f) were determined by intracellular flow cytometry analysis. 
Representative histograms of protein expression in WT and TKOT mice of DP, I, II, III, IV and V 
populations are shown in the left panel and at the right the foldchange mean-fluorescence intensity (MFI) 
of cRel and IkBNS in the different stages and genotypes were calculated. MFIs were normalized to WT 
expression in CD4 and CD8 DP thymocytes. Genotypes are indicated in the figure and data are 
representative of at least 6 (a-d) and 3 (e-f) individual mice per genotype. Statistical significances were 
calculated by one-way analysis of variance (ANOVA) with Bonferroni post test. 
 
Results 
 
 
107 
We therefore investigated the protein expression of IkBNS and cRel in WT, DKOT, KOT and 
TKOT mice in the different stages of Treg development as defined in Figure 26 a-b. Elevated 
expression of IkBNS and cRel was detected by flow cytometry throughout all stages (Figure 26 
e-f) in TKOT mice, whereas cRel expression was not further increased in the last stage V. 
Calculating foldchange expression for IkBNS and cRel in all analyzed genotypes, revealed that 
TKOT mice showed the strongest induction of IkBNS and cRel, whereas the single and double 
knockouts had weaker effects. These data suggest that Roquin- and Regnase-1-deficiency 
strongly impacts on IkBNS and cRel expression in the thymus and that this could consequently 
result in aberrant regulatory T cell formation in these mice. 
Overall, one can conclude that the thymic T cell development in the thymus was impaired in 
the TKOT mice and this aberrancy was also seen partially in KOT mice. Here, there might be a 
developmental defect during T cell selection, since the TKOT mice had less DP thymocytes, 
whereas the SP CD4 and CD8 proportion was increased.  
4.2.3 Investigating cell-intrinsic effects of Roquin- and Regnase-1-
deficiency 
To prove whether these effects were cell-intrinsic or if the drastic changes in thymic cell 
compositions resulted from an inflamed microenvironment that induced cytokine storm in the 
thymus, we next generated mixed bone marrow (BM) chimeric mice. Here, I made use of 
congenic mouse strains with allelic variants of CD45 (CD45.1, CD45.2 and heterozygous 
CD45.1/2) to track hematopoietic cells. Either WT (CD45.2) or TKOT (CD45.2) BM cells were 
mixed at a 1:1 ratio with WT (CD45.1) BM cells and intravenously injected into lethally 
irradiated recipient mice that were heterozygous for both congenic markers (CD45.1/2) (Figure 
27). After 9 weeks, the reconstitution of the hematopoietic system was completed and the cells 
were tracked by flow cytometry with antibodies specifically discriminating between CD45.1 and 
CD45.2. The immune cell compartments were always compared between CD45.1- and 
CD45.2-expressing cells within the same mouse and mice reconstituted with WT CD45.1 and WT 
CD45.2 BM cells were generated as additional controls. 
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Figure 27 ç Generation of mixed bone marrow chimeric mice. 
WT CD45.1/2 heterozygous recipient mice were lethally irradiated and reconstituted with 4 Mio bone 
marrow (BM) cells either containing TKOT or WT CD45.2 BM mixed at a 1:1 ratio with WT CD45.1 BM 
cells. After 9 weeks, the reconstituted immune system was analyzed by flow cytometry of thymocytes 
with monoclonal antibodies identifying either CD45.1 or CD45.2 cells in the recipient mice. 
 
In total, two WT/WT mice (reconstituted with WT CD45.1 and WT CD45.2 BM cells) and three 
WT/TKOT mice (reconstituted with WT CD45.1 and Roquin-1/2- and Regnase-1-deficient TKOT 
CD45.2 BM cells) were generated and analyzed. As shown in Figure 27, irradiation and 
reconstitution were successful, since the CD45.1/2 recipients were devoid of endogenous 
heterozygous CD45 cells and the mice received CD45.1 and CD45.2 cells. Investigating the 
thymic T cell development by analyzing CD4 and CD8 expression, revealed that the loss of 
DP thymocytes as seen in the TKOT mice was potentially explained by an extrinsic effect, for 
example strong inflammation in the thymus, since no aberrant T cell development was seen in 
the WT 45.1/ TKOT CD45.2 mixed BM chimeric mice (Figure 28). In the following experiments, only 
representative flow cytometry plots for the WT 45.1/ TKOT CD45.2 mice are depicted, but total 
frequencies and ratios are additionally compared to the WT 45.1/ WT CD45.2 control mice. 
 
lethal irradiation 
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Figure 28 ç T cell development in WT 45.1/ TKOT CD45.2 mixed BM chimera mice. 
Flow cytometry analysis of CD4 and CD8 expression in live, CD45.1+ or CD45.2+ cells of WT 45.1/ WT 
CD45.2 or WT 45.1/ TKOT CD45.2 mice (left) and frequencies of double-negative (DN), double-positive (DP), 
CD4 single-positive (SP) and CD8 SP thereof (right panel). Data are representatives of two (WT/WT) 
and three (WT/TKOT) individual mice. 
 
We further investigated if the selection processes in the thymus were impaired in mice that 
received TKO T CD45.2 bone marrow. Therefore, we again analyzed steps of positive selection 
by comparing CD69 and TCRb expression within the CD45.1+ and CD45.2+ cells of both 
WT/WT control and WT/TKOT BM chimeric mice (Figure 29 a). Here, the frequencies of pre-
selected cells (population 1, TCRblo and CD69lo) were increased, whereas stages 3 and 5 
comprising selected cells were reduced in the TKOT CD45.2 cell compartment in comparison to 
WT cells of mixed bone marrow chimeric mice. These data were not consistent with the 
observed increased frequencies of stages 3-5 in the conditional TKOT mice (Figure 24). 
Analyzing the distribution of CD4 and CD8 within these populations in CD45.1+ and CD45.2+ 
cells of WT/TKOT BM chimeric mice revealed that the TKOT CD45.2 cells had slightly elevated 
levels of double-positive (DP) thymocytes within population 5 (Figure 29 b), which was in 
accordance with the phenotype of TKOT mice (Figure 24). However, CD8 single-positive (SP) 
cells in stage 4 and 5 were reduced in TKOT CD45.2 in comparison to the WT CD45.1 compartment. 
Investigating maturation of CD4 and CD8 SP T cells showed that the ratio of mature to 
immature T cells was different in all controls (WT CD45.1/WT CD45.2 and WT CD45.2) and the TKOT 
CD45.2 cells (Figure 29 c). These data suggest that the competitive mixed bone marrow situation 
caused strong changes in the phenotype of the TKOT CD45.2 cells and therefore no conclusion 
can be drawn about the cell-intrinsic influence of a conditional knockout of Roquin and 
Regnase-1 on positive selection.  
 
 
Results 
 
 
110 
 
Figure 29 ç Investigating positive selection in thymi of mixed BM chimera mice. 
a) Flow cytometry analysis and quantification of CD69 and TCRb-expressing cells of live, CD45.1+ and 
CD45.2+ cells in WT/TKOT and WT/WT mixed BM chimeric mice in populations 1-5. b) Flow cytometry 
of CD4 and CD8 expression in populations 1-5 within CD45.1+ and CD45.2+ cells of WT/TKOT mice. c) 
Investigation of maturation of CD4 single-positive (SP) or CD8 SP cells within WT/TKOT BM chimeric 
mice by flow cytometry analysis of CD24 and TCRb (left). Ratio of mature to immature CD4 or CD8 SP 
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cells between CD45.1+ and CD45.2+ cells of WT/WT and WT/TKOT mice was calculated (right). Data 
are representatives of two (WT/WT) and three (WT/TKOT) individual mice. 
 
Very recently, a flow cytometry-based assay to measure thymic clonal deletion in the 
polyclonal repertoire of WT mice was published (Breed et al., 2019). Elimination of self-reactive 
T cells in the thymus either induces apoptosis due to death by neglect or clonal deletion.  
 
 
Figure 30 ç Determination of apoptosis in thymi of mixed BM chimeric mice. 
a) Flow cytometry analysis of signaled (CD5hi, TCRbhi) and non-signaled (CD5lo, TCRblo) CD45.1+ or 
CD45.2+ cells within WT/TKOT mixed bone marrow chimeric mice and quantification thereof in 
comparison to CD45.1+ and CD45.2+ cells within WT/WT bone marrow chimeras. b) Analyzing cleaved 
caspase-3 expression by flow cytometry in non-signaled (death by neglect) and signaled (clonal 
deletion) CD45.1+ or CD45.2+ cells within WT/TKOT mixed bone marrow chimeric mice (left). 
Quantification of CD45.1+ or CD45.2+ cells either undergoing death by neglect or clonal deletion in 
WT/WT or WT/TKOT mixed BM chimeric mice. Data are representatives of two (WT/WT) and three 
(WT/TKOT) individual mice. 
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Here the authors measured apoptosis by intracellular antibody-staining of cleaved caspase-3, 
a marker of induced apoptosis. They combined this with TCRb and CD5 to distinguish between 
cells that have already undergone TCR signaling (signaled, clonal deletion) or cells that have 
been eliminated due to no or weak p:MHC interaction (non-signaled, death by neglect). 
Applying this protocol to the mixed BM chimeras, revealed that the TKOT CD45.2 cells within the 
WT/TKOT mixed BM chimeric mice, showed overall no alteration between signaled and non-
signaled cells in comparison to WT CD45.1 cells (Figure 30 a). However, non-signaled cells that 
undergo death by neglect appeared decreased in the TKOT CD45.2 cells in comparison to either 
WT CD45.1 control within the same mouse or WT/WT mixed BM chimeric mice. In contrast to 
that, cleaved caspase-3 staining in signaled cells did not show any alterations in cells 
undergoing clonal deletion (Figure 30 b).  
Since the generation of regulatory T cells develops alongside with clonal deletion, thus 
requiring strong p:MHC-TCR interaction, we further wanted to investigate the cell-intrinsic 
effects on the development of regulatory T cells. Indeed, the frequency of Foxp3-expressing 
regulatory T cells in TKOT CD45.2 mixed bone marrow chimeras phenocopies the abnormal 
generation of Treg cells seen in mice with a conditional deletion of Roquin and Regnase-1 in T 
cells (Figure 25). The frequency of Foxp3-expressing CD4 T cells in TKOT CD45.2 was drastically 
increased in comparison to WT CD45.1 cells as well as to WT/WT mixed BM chimeric controls 
(Figure 31 a).  
 
 
Figure 31 ç Altered frequencies of regulatory T cells in thymi of mixed bone marrow chimeric 
mice. 
Flow cytometry analysis of Foxp3 expression in CD45.1+ or CD45.2+ cells within WT/TKOT mixed bone 
marrow chimeric mice and quantification thereof in comparison to CD45.1+ and CD45.2+ cells within 
WT/WT bone marrow chimeras. b) Quantification of CD25 expression within Foxp3+ CD4+ T cells in 
CD45.1+ or CD45.2+ cells of WT/TKOT or WT/WT mixed bone marrow chimeric mice. Data are 
representatives of two (WT/WT) and three (WT/TKOT) individual mice. 
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The proportion of CD25- cells of Foxp3+ CD4 T cells was drastically elevated in the TKOT CD45.2 
cells in comparison to WT controls in accordance with the data generated in conditional TKOT 
mice. Since the development of regulatory T cells was impaired potentially due to aberrant 
IkBNS or cRel expression in the conditionally deleted mice (Figure 25), we next sought to 
investigate if this phenotype was cell-intrinsic. Indeed, mixed BM chimeric mice that lack 
Roquin and Regnase-1 in their CD45.2 (TKOT CD45.2) compartment, showed drastically 
increased expression of Foxp3 in the early stages of Treg development (Figure 32 a-b). 
Interestingly, Treg cells from TKOT CD45.2 cells had elevated IkBNS expression when directly 
compared to the WT CD45.1 counterpart in the same mouse (Figure 32 c).  
In summary these data revealed that the overall dramatic changes in thymic T cell development 
seen in the TKOT mice and partially in KOT mice was not cell-intrinsic. However, the selection 
processes, especially clonal deletion, were impaired in the CD45.2+ counterpart of the 
WT/TKOT mice which lacks Roquin and Regnase-1 in T cells. Cells deficient for Roquin and 
Regnase-1 revealed less apoptosis, which rather suggests a support of anti-apoptotic 
mechanisms. Additionally, the development of regulatory T cells occurred faster, since already 
early stages of Treg development with low CD25 levels had high expression of Foxp3. This 
could be due to the impact of Regnase-1 and Roquin-deletion on target genes that impaired T 
cell selection or Treg development such as IkBNS. One further possibility therefore could be that 
T cells lacking Roquin and Regnase-1 had higher TCR signal strength that then results in 
impaired selection processes. 
 Since, clonal deletion as well as thymic regulatory T cell development was strongly influenced 
by Roquin and Regnase-1 cell-intrinsically, we next addressed the phenotypic consequences 
of conditional deletion in the periphery especially focusing here on phenotypes linked to 
autoimmunity and aberrant T cell activation. 
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Figure 32 ç Impaired Treg development in TKOT CD45.2 cells of mixed BM chimeric mice. 
a) Investigating regulatory T cell development in the thymus by flow cytometry of step-wise expression 
of GITR, CD25 and Foxp3: I: GITR- CD25-, II: GITRint CD25-, III: GITR+ CD25-, IV: GITR+ CD25. The 
stages are shown in a representative contour blot of GITR, CD25 (left) and Foxp3 and forward side 
scatter (FSC) by flow cytometry (right) in CD45.1+ or CD45.2+ cells within WT/TKOT mixed bone marrow 
chimeric mice. b) Frequencies of Foxp3 expression in I, II, III and IV of CD45.1+ and CD45.2+ cells within 
WT/WT and WT/TKOT mixed BM chimeric mice. c) Expression of IkBNS within I, II, III and IV determined 
by intracellular flow cytometry analysis in CD45.1+ or CD45.2+ cells of WT/TKOT or WT/WT mixed bone 
marrow chimeric mice. Data are representatives of two (WT/WT) and three (WT/TKOT) individual mice. 
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4.2.4 T-cell-specific deletion of Roquin and Regnase-1 induces 
autoimmunity in mice 
Both, Roquin-1/2 and Regnase-1 deficiency in T cells resulted in an autoimmune-like 
phenotype in mice (Table 18). Therefore, we investigated whether a deletion of all three genes 
in mouse T cells would recapitulate or even amplify the phenotype. All analyzed mice were 
sacrificed at an age of 6 weeks, because TKOT mice showed signs of illness with increased 
volume of the abdomen. The reason for this enlarged abdomen became clear when measuring 
the size of spleens. The mice developed splenomegaly and lymphadenopathy of all peripheral 
(pLN) as well as the abdominal mesenteric lymph nodes (mLN).  
 
 
Figure 33 ç Analysis of the T cell composition in spleens and lymph nodes of mice with a T cell-
specific deletion of Roquin and Regnase-1. 
a) Representative image of spleen, peripheral and mesenteric lymph nodes from WT and TKOT mice. 
b) Spleen weight and number of splenocytes in WT, DKOT, KOT and TKOT mice. c) Representative 
contour plots of frequencies of CD4 and CD8 populations in live, CD45.2+ splenocytes of WT and TKOT 
mice and absolute numbers thereof and of mesenteric LNs (mLN) and peripheral lymph nodes (pLN) 
(d) in WT, DKOT, KOT and TKOT mice. Genotypes are indicated in the figure and data are representative 
of at least 14 (b) and 3 (c-d) individual mice per genotype.  
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Augmented spleen weights correlated with elevated numbers of total splenocytes (Figure 33 
a-b). Splenomegaly of TKOT and KOT mice was most severe, whereas DKOT mice showed a 
less prominent expansion of cells in spleens. Analyzing frequencies of total CD4 and CD8 T 
cells indicated increased absolute numbers of CD4 T cells in spleens, mLNs and pLNs in KOT 
and TKOT, whereas DKOT, at this age, showed comparable numbers to WT mice. CD8 T cells 
were expanded in DKOT, KOT and TKOT in spleens, but only KOT mice had elevated numbers 
of CD8 cells in pLNs and mLNs (Figure 33 c-d). 
 
 
Figure 34 ç Discrimination of naïve, central-memory and effector-memory T cells in mice with a 
T cell-specific ablation of Roquin and Regnase-1. 
Representative contour plot (left panel) and frequencies (right panel) of naïve (CD62Lhi CD44lo), effector 
memory-like (EM, CD62Llo CD44hi) and central memory-like (CM, CD62Lhi CD44hi) CD4 (a) and CD8 T 
cells (b). Genotypes are indicated in the figure and data are representative of at least 4 (a-b) individual 
mice per genotype.  
 
The activation status of these T cells revealed that DKOT, KOT and TKOT CD4 T cells showed 
gradually higher frequencies of an effector memory-like (EM, CD62Llo CD44hi) and central-
memory like (CM, CD62Lhi CD44hi) phenotype, which in turn resulted in a relative decrease in 
naïve (CD62Lhi CD44lo) CD4 T cells (Figure 34 a). The increase of CD8 T cells in double 
knockout animals was ameliorated in the triple knockout, particularly on the level of total cell 
numbers. Excessive EM formation and loss of naïve T cells was apparent in CD8 T cells of 
DKOT and TKOT mice and was less pronounced in WT and KOT CD8 T cells (Figure 34 b). 
The highly activated CD4 and CD8 T cells in TKOT mice prompted us to investigate the 
functionality and differentiation of CD4 T cells. Since an autoimmune-like phenotype was 
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described for DKOT and T cell specific knockout of Regnase-1 (Table 18), the germinal center 
response in spleens was analyzed.  
 
 
Figure 35 ç Analyzing the GC reaction and antibody response of mice with T cell-specific deletion 
of Roquin and Regnase-1. 
a) Pre-TFH and TFH cells were determined by flow cytometry analysis of Cxcr5 and PD-1 in live, CD45.2+, 
CD4+ cells in the indicated genotypes. Representative contour blots are shown in the left panel and 
calculated frequencies and absolute numbers are given in the right. b) Live, CD45.2+, B220+, CD4- cells 
were determined as germinal center (GC) B cells by the expression of CD95 and GL-7. Contour blots 
of WT and TKOT mice are shown in the left and the frequencies and absolute numbers of GC B cells for 
all analyzed genotypes are given in the right panel. Serum levels of different immunoglobulin subclasses 
(IgM, IgG1, IgG2b, IgG3, IgA and total IgG) (c) as well as anti-nuclear autoantibodies (d) were defined 
by enzyme-linked-immunosorbant assay (ELISA) in WT, DKOT, KOT and TKOT mice. Data are 
representative of at least 4 (a-b) and 3 (c-d) individual mice per genotype. Statistical significances were 
calculated by one-way analysis of variance (ANOVA) with Bonferroni post test. 
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Frequencies and numbers of TFH cells, characterized by the expression of Cxcr5 and PD-1, 
were significantly elevated in TKOT mice, whereas a significant increase was also detected for 
DKOT and KOT mice (Figure 35 a). This observation was in line with increased numbers and 
frequencies of GC B cells (B220+, GL-7+ and CD95+) and aberrant concentrations of 
immunoglobulins in sera of the mice (Figure 35 b-c). Here, IgM was significantly enhanced in 
KOT and TKOT mice, whereas total IgG and IgA as well as subtypes IgG1 and IgG2b had a 
mild increase in KOT and TKOT. The Roquin DKOT only caused slightly raised levels of IgG2b. 
The autoimmune phenotype in TKOT mice was supported by the secretion of anti-nuclear 
autoantibodies (ANAs) (Figure 35 d), which is highly elevated in KOT and TKOT mice, but not 
prominent in DKOT mice. The large increase in TFH cells prompted us to further investigate if 
these cells have the character of follicular regulatory T (TFR) cells by the expression of the 
transcription factor Foxp3. Indeed, we identified a significant abundance of TFR cells in TKOT 
mice (Figure 36 a). In addition, the frequency of regulatory T cells showed a drastic increase 
in all knockout-genotypes, whereas this was only represented in absolute numbers by KOT 
and TKOT mice (Figure 36 b). 
 
Figure 36 ç Determining frequencies and absolute numbers of Foxp3-expressing CD4 T cells in 
mice conditionally deleted for Roquin and Regnase-1 in T cells. 
a) Contour blot showing follicular regulatory T cells (TFR) by expression of PD-1 and Cxcr5 in live, 
CD45.2+, CD4+, Foxp3+ T cells of WT and TKOT mice (left panel) and corresponding frequencies and 
absolute numbers, thereof. b) Foxp3 levels in live, CD45.2+, CD4+ cells in WT and TKOT mice shown 
as representative contour plot and frequencies and absolute numbers in WT, DKOT, KOT and TKOT 
mice. Genotypes are indicated in the figure and data are representative of at least 4 (a) and 6 (b) 
individual mice per genotype. Statistical significances were calculated by one-way analysis of variance 
(ANOVA) with Bonferroni post test. 
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In summary, the phenotypes of the TKOT mice were in most analyzed T cell subsets reasoned 
in a cooperative effect of Roquin and Regnase-1 deficiency. This was especially seen for the 
hyperactivation of CD4 T cells or frequencies of TFH and GC B cells. The cellular phenotypes 
of mice lacking either Roquin-1/2 or Regnase-1 were almost comparable, but in some cases 
the deficiency of Regnase-1 in T cells exhibited a more severe phenotype such as the 
production of autoantibodies. Interestingly, mice ablated for Roquin and Regnase-1 in T cells 
were less prone to develop autoantibodies. Additionally, as seen in the thymus, regulatory T 
cells were significantly increased in all analyzed genotypes and the proportion of TFR cells was 
drastically elevated in peripheral lymphoid organs.  
The mixed bone marrow chimeric mice that were described in section 4.2.3 to partially have 
a cell-intrinsic thymic phenotype, were additional analyzed for their capacity to form follicular 
T helper cells, regulatory T cells, regulatory follicular T helper cells and the effector-memory 
phenotype of CD4 and CD8 T cells.  
 
 
Figure 37 ç Flow cytometry analysis of splenocytes from mixed bone marrow chimeric mice. 
a) Flow cytometry analysis of CD45.1 and CD45.2 expression in live cells of WT 45.1/ WT CD45.2 or WT 
45.1/ TKOT CD45.2 mice. b) Representative contour blots of CD4 and CD8 naïve, central-memory- (CM) 
and effector-memory-like (EM) CD4 and CD8 T cells in live, CD45+ and CD4+ T cells of WT 45.1/ TKOT 
CD45.2 mice and quantification thereof and WT 45.1/ WT CD45.2 mixed bone marrow chimeric mice. Data are 
representatives of two (WT/WT) and three (WT/TKOT) experiments. 
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The reconstitution of CD45.1 and CD45.2 cells in the periphery of mixed bone marrow chimeric 
mice is depicted in Figure 37 a. Indeed, mice that received bone marrow from mice lacking 
Roquin and Regnase-1 developed hyperactivated EM-like CD4 and CD 8 T cells and increased 
central-memory-like CD4 T cells (Figure 37 a).  
 
 
Figure 38 ç Analyzing TFH, TFR and Treg populations in splenocytes from mixed bone marrow 
chimeric mice. 
a) Representative contour blot of pre-TFH and TFH cells of live, CD45+ and CD4+ T cells of WT 45.1/ TKOT 
CD45.2 mice and quantification thereof and WT 45.1/ WT CD45.2 mixed bone marrow chimeric mice. b) 
Representative contour blot of Foxp3+, live, CD45+ and CD4+ T cells of WT 45.1/ TKOT CD45.2 mice and 
quantification thereof and WT 45.1/ WT CD45.2 mixed bone marrow chimeric mice. c) Representative 
contour blot of TFR cells of live, CD45+, CD4+ and Foxp3+ cells of WT 45.1/ TKOT CD45.2 mice and 
quantification thereof and WT 45.1/ WT CD45.2 mixed bone marrow chimeric mice. Data are representatives 
of two (WT/WT) and three (WT/TKOT) experiments. 
 
Additionally, mice receiving bone marrow devoid of Roquin and Regnase-1 showed a strong 
differentiation towards TFH and TFR cells (Figure 38 a, c). Different from the thymic phenotype, 
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the TKOT CD45.2 mixed bone marrow chimeric mice only had a mild increase in the peripheral 
Treg compartment (Figure 38 b). 
Overall these data suggest that the cellular phenotype in the TKOT mice characterized by 
strongly activated effector-memory CD4 and CD8 T cells and an elevated germinal center 
response due to the formation of TFH and TFR cells, is cell-intrinsic and a result of Roquin and 
Regnase-1 deficiency. 
4.2.5 Roquin and Regnase-1 proteins control T cell activation and 
differentiation 
T helper cell subsets are defined by a unique pattern of master transcription factor expression 
and cytokine secretion and have distinctive functions in host defense (Figure 1). Roquin and 
Regnase-1 were already described to control TH17 differentiation by influencing gene 
expression of TH17- related genes such as IkBNS or IkBz. Additionally, the highly activated CD4 
T cells identified in DKOT, KOT as well as TKOT mice, prompted us to further investigate, 
whether these cells have the tendency to differentiate into distinct T helper cell subsets.  
By ex vivo stimulation of CD4 T cells with PMA (Phorbol-myristate-acetate) and ionomycin in 
the presence of Brefeldin A, we were able to analyze intracellular cytokine production of CD4 
T cells, which then can uncover predispositions for certain differentiation programs (Figure 
39). All cytokines were significantly elevated in TKOT in comparison to WT cells. IFN-g levels 
were augmented in DKOT, KOT and TKOT mice, whereas the changes were overall not 
significant. The signature cytokine of TH17 cells IL-17A was significantly increased in all 
analyzed knockout (Figure 39 a-d), whereas IL-4 was augmented only in TKOT mice (Figure 
39 b-d). Treg cells are characterized by the expression of CD25 and were reported to secrete 
IL-10. IL-10 production in CD25+, CD4+ T cells was enhanced in DKOT and TKOT mice (Figure 
39 c-d). 
To further validate these findings, we utilized an inducible deletion system by crossing 
Rc3h1/2fl/fl (iDKO), Zc3h12afl/fl (iKO) and Rc3h1/2fl/fl; Zc3h12afl/fl (iTKO) mice with Cd4-creERT2 
mice (Figure 7). Here, we made use of the Cd4-creERT2 system, which enables deletion of 
loxP-flanked sites with a cre-recombinase that is fused to the estrogen receptor 2 (ERT2), 
which, upon administration of tamoxifen, enters the nucleus and induces deletion of loxP-
flanked genes by its cre activity. Cd4-creERT2 was generated by a knock in of the fusion 
protein into the CD4 locus, thus these mice can only be bred with heterozygous expression of 
the transgene. To induce the deletion of loxP-flanked alleles in CD4-expressing cells in vivo, 
mice were treated with tamoxifen by oral gavage (Figure 40 a). 3 days after the last treatment 
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with tamoxifen, naïve CD4 T cells were isolated and stimulated towards TH1, TH17 or Treg with 
cytokine and antibody mixes (Table 17). 
 
 
Figure 39 ç Ex vivo cytokine expression levels of CD4 T cells from WT, DKOT, KOT and TKOT 
mice. 
Total CD4 T cells from WT, DKOT, KOT and TKOT cells were isolated and stimulated with PMA (Phorbol-
myristate-acetate) and ionomycin in the presence of Brefeldin A to evaluate intracellular cytokine 
expression. Flow Cytometry analysis of CD4+ cells for their expression of IL-17A and IFN-g (a), IL-4 and 
IFN-g (b) and IL-10 and CD25 (c). Frequencies thereof were calculated in d). Genotypes are indicated 
in the figure and data are representative of at least 2 mice per genotype. Statistical significances were 
calculated by one-way analysis of variance (ANOVA) with Bonferroni post test. 
 
The expression of the T helper cell specific cytokines was validated by flow cytometry analyses 
for IFN-g on TH1 cells and IL-17A for cells differentiated towards TH17 (Figure 40). Treg cells 
were validated according to CD25 and Foxp3 expression. Naïve CD4 T cells of iTKO mice 
showed a higher capacity to differentiate into the TH17 lineage (Figure 40 c). Elevated 
production of the TH17 cytokine IL-17A was also partially visible in iDKO and iKO mice.  
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Figure 40 ç Flow cytometry analysis of naïve CD4 T cells from WT, iDKO, iKO and iTKO mice 
differentiated into TH1, TH17 and Treg cells. 
WT, iDKO, iKO and iTKO mice were treated with tamoxifen orally and naïve CD4 T cells were isolated 
from these mice and stimulated under TH1, TH17 and Treg conditions. a) Immunoblot analysis of Roquin 
and Regnase-1 expression in WT, iDKO, iKO and iTKO CD4 T cells. Flow cytometry analysis of IFN-g 
on TH1 differentiated cells (b), IL-17A for cells differentiated towards TH17 (c) and Foxp3 and CD25 on 
cells differentiated towards Treg cells (d). The left panel shows a representative contour plot and the right 
a quantification of all genotypes. The molecular weight in kDa is depicted at the left of the immunoblot. 
Genotypes are indicated in the figure and data are representative of 3 individual experiments. Statistical 
significances were calculated by one-way analysis of variance (ANOVA) with Bonferroni post test. 
 
Naïve CD4 T cells from iTKO mice were impaired in iTreg differentiation and the differentiation 
capacity decreased with loss of Regnase-1 (iKO) and Roquin (iDKO) expression. Interestingly, 
all knockout genotypes had higher expression of CD25 (Figure 40 d). IFN-g levels were 
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different in all three inducible knockout mice, but the alteration was not statistically significant 
(Figure 40 b). These data support the observations in Figure 39, suggesting that Roquin and 
Regnase-1 proteins control T helper cell differentiation of naïve T cells. Especially the 
differentiation towards the TH17 lineage was regulated by both Roquin and Regnase-1, 
suggesting that this differentiation program was under the influence of shared target genes. 
Thus, the reciprocal differentiation programs of TH17 and Treg were under control of Roquin 
and Regnase-1 and T cells lacking Roquin and Regnase-1 were biased to differentiate towards 
TH17. 
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4.3 Analyzing the functional cooperativity of Roquin and 
Regnase-1 proteins in T cell differentiation 
To analyze whether the different phenotypes in individual and combined knockouts correlate 
with augmented RNA expression levels we investigated the mRNA targets of Roquin and 
Regnase-1.  
4.3.1 Roquin and Regnase-1 share a mRNA target set in immune cells 
The role of the post-transcriptional gene regulators Roquin and Regnase-1 has been 
extensively studied in the past years and various mRNA targets have been identified so far in 
different cell types. Table 19 gives an overview of the identified Roquin and Regnase-1 mRNA 
targets in studies analyzing their function in immune cells.  
 
Table 19 ç Previously published Roquin-1/2, sanroque and Regnase-1 target genes in cells of the 
immune system. 
Data of target genes identified in immune cells were obtained from the indicated publications. Genes 
that were described as potential targets of Roquin and/or Regnase-1 proteins are depicted. Genes 
potentially targeted by both Roquin and Regnase-1 are shown in bold letters. 
Gene name Rc3h1/2 Rc3h1san/san Zc3h12a 
A20 (Murakawa et al., 2015) - - 
Acta2 - (Cui et al., 2017) (Cui et al., 2017) 
Bmpr1a (Leppek et al., 2013) - - 
Calcr - - (Matsushita et al., 2009) 
Ccr4 (Cui et al., 2017) - (Cui et al., 2017) 
Ccr5 (Cui et al., 2017) - (Cui et al., 2017) 
Ccr6 (Cui et al., 2017) - (Cui et al., 2017) 
Ccl20 - - (Nakatsuka et al., 2018) 
Ccl28 - - (Nakatsuka et al., 2018) 
Cd40lg - - (Uehata et al., 2013) 
Cd69 - - (Uehata et al., 2013) 
Cebpd - - (Lipert et al., 2017) 
Csf3 (Braun et al., 2018) - (Nakatsuka et al., 2018) 
Col22a1 - - (Mino et al., 2015) 
Ctla4 (Jeltsch et al., 2014) - (Uehata et al., 2013) (Jeltsch et al., 2014) 
Cxcl1 - - (Mino et al., 2015) 
Cxcl2 - - (Mino et al., 2015) 
Cxcl3 - - (Mino et al., 2015) 
Cxcl5 - - (Nakatsuka et al., 2018) 
Cxcl10 - (Cui et al., 2017) (Cui et al., 2017) 
Cxcl17 - - (Nakatsuka et al., 2018) 
Cxcr3 - - (Cui et al., 2017) 
Furin - (Cui et al., 2017) (Cui et al., 2017) 
Hmgxb3 (Leppek et al., 2013) (Tan et al., 2014) - - 
Icos 
(Glasmacher et al., 2010) 
(Vogel et al., 2013) 
(Pratama et al., 2013) 
(Jeltsch et al., 2014) 
(Schlundt et al., 2014) 
(Rehage et al., 2018) 
(Vinuesa et al., 2005) 
(Yu et al., 2007) 
(Linterman et al., 2009) 
(Cui et al., 2017) 
(Uehata et al., 2013) 
(Jeltsch et al., 2014) 
(Cui et al., 2017) 
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Id1 - - (Mino et al., 2015) 
Ier3 (Leppek et al., 2013) - (Mino et al., 2015) 
Ifng (Lee et al., 2012; Pratama et al., 2013) - 
(Matsushita et al., 2009) 
(Cui et al., 2017) 
Il2 - (Cui et al., 2017) (Cui et al., 2017) 
Il12p40 - - (Matsushita et al., 2009) 
Il2ra - - (Uehata et al., 2013) 
Il6 (Tan et al., 2014) (Jeltsch et al., 2014) 
(Mino et al., 2015) 
(Cui et al., 2017) 
(Matsushita et al., 2009) 
(Iwasaki et al., 2011) 
(Uehata et al., 2013) 
(Jeltsch et al., 2014) 
(Mino et al., 2015) 
(Cui et al., 2017) 
Irf4 (Vogel et al., 2013) (Jeltsch et al., 2014) - (Jeltsch et al., 2014) 
Itch (Essig et al., 2018) - - 
Mafk (Mino et al., 2015) - (Mino et al., 2015) 
Metap1  - (Mino et al., 2015) 
Nfkbia (Murakawa et al., 2015) - - 
Nfkbid 
(Leppek et al., 2013) 
(Jeltsch et al., 2014) 
(Murakawa et al., 2015) 
(Essig et al., 2018) 
- (Mino et al., 2015) 
Nfkbiz (Leppek et al., 2013) (Jeltsch et al., 2014) - 
(Mino et al., 2015) 
(Behrens et al., 2018) 
Ptgs2 - - (Mino et al., 2015) 
Pten (Essig et al., 2018) - - 
Rc3h1 (Leppek et al., 2013) (Cui et al., 2017) - (Cui et al., 2017) 
Rc3h2 (Leppek et al., 2013) - - 
Rel (Jeltsch et al., 2014) - (Uehata et al., 2013) (Jeltsch et al., 2014) 
Shcbp1l - - (Mino et al., 2015) 
Sprr2f - - (Matsushita et al., 2009) 
Sprr2h - - (Matsushita et al., 2009) 
Sprr2j - - (Matsushita et al., 2009) 
Sprr2k - - (Matsushita et al., 2009) 
Tgfb - (Cui et al., 2017) (Cui et al., 2017) 
Tm2d3 (Braun et al., 2018) - (Mino et al., 2015) 
Tnf 
(Leppek et al., 2013) 
(Pratama et al., 2013) 
(Jeltsch et al., 2014) 
(Schlundt et al., 2014) 
(Braun et al., 2018) 
(Mino et al., 2015) 
(Cui et al., 2017) 
(Jeltsch et al., 2014) 
(Mino et al., 2015) 
(Cui et al., 2017) 
Tnfrsf1b - - (Uehata et al., 2013) 
Ox40 
(Tnfrsf4) 
(Vogel et al., 2013) 
(Schlundt et al., 2014) 
(Janowski et al., 2016) 
- (Uehata et al., 2013) 
Ucp3 (Braun et al., 2018) - - 
Zc3h12a 
(Braun et al., 2018) 
(Cui et al., 2017) 
(Jeltsch et al., 2014) 
(Mino et al., 2015) 
- 
(Iwasaki et al., 2011) 
(Mino et al., 2015) 
(Cui et al., 2017) 
 
The classified mRNA targets of the Roquin paralogs are displayed together, because both 
proteins have redundant functions in T cells (Vogel et al., 2013). Rc3h1san/san (sanroque) 
targets are depicted in a separate column, since the function of the M199R mutation in Roquin-
1 has not been fully elucidated yet.  
One must mention here, that the cited publications used distinctive cell types (mouse T cells, 
human Jurkat T cells, HeLa cells, HEK cells and bone-marrow-derived macrophages) and 
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consequently analyzed different species (human and mouse). Moreover, various techniques 
have been utilized for discovering the mRNA targets, e.g. mRNA expression analysis in wild-
type vs. knockout cells, luciferase and reporter assays, global analyses (mRNA-sequencing), 
CDE predictions, RNA-immunoprecipitations and global binding profiles (CLIP experiments). 
Not all genes can be considered as direct targets, but nevertheless can provide insights about 
overlapping functions of Roquin and Regnase-1. Some genes have been described to be 
targeted by Roquin and Regnase-1 (shown in bold in Table 19). Amongst them are the co-
stimulatory receptors Icos (Icos), Ctla-4 (Ctla4) and Ox40 (Tnfrsf4) as well as proinflammatory 
cytokines like IL-6 (Il6), TNF-a (Tnfa) and IFN-g (Ifng). Several chemokine receptors have been 
proposed to be targeted by Roquin and Regnase-1 as well as transcription factors like cRel 
(Rel) and Irf4 (Irf4) and modulators of transcription factors as IkBNS (Nfkbid) and IkBz (Nfkbiz). 
Interestingly, Regnase-1 (Zc3h12a) itself has been identified as Roquin and Regnase-1 target 
gene. 
4.3.2 Roquin and Regnase-1 control overlapping immune-associated 
target mRNAs 
To validate already described target genes of Roquin and Regnase-1 that were described in 
the literature, we utilized inducible knockout mice as described in the previous chapter (4.2.5). 
CD4 T cells of WT, iKO and iDKO mice were isolated, and knockouts were induced by 
administration with 4’OH-tamoxifen or cells were left untreated as wild-type controls.  
Analyzing protein expression of Roquin and Regnase-1 target genes revealed that the induced 
knockout of Roquin and Regnase-1 led to an increased expression of cRel, IkBz, Ctla-4 and 
Icos. Whereas, IkBNS, Irf4 and Ox40 are mainly affected upon ablation of the Roquin paralogs. 
A20, which was described as a Roquin-1 target gene (Murakawa et al., 2015), showed almost 
no change on protein expression upon inducible Roquin or Regnase-1 knockout (Figure 41 a-
b). A comparable type of expression was detectable on RNA level. Here, Zc3h12a, Tnfrsf4, 
Irf4 and Ctla4 were mainly upregulated in the absence of Roquin-1 and Roquin-2. In turn, a 
knockout of Regnase-1 affected Icos, Nfkbiz and slightly Ctla4 expression (Figure 41 c). 
Interestingly, Regnase-1 showed a robust upregulation on protein and mRNA level upon 
knockout of Roquin-1 and Roquin-2, suggesting it to be a strong Roquin target gene. The 
expression of Ox40 being exclusively altered upon inducible Roquin knockout was in line with 
the data shown in chapter 4.1.  
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Figure 41 ç Protein and RNA expression levels of known Roquin and Regnase-1 targets in WT, 
iDKO and iKO CD4 T cells.  
CD4 T cells were isolated from Rc3h1/2fl/fl; Cd4-creERT2 (iDKO), Zc3h12afl/fl; Cd4-creERT2 (iKO) and 
Cd4-creERT2 (WT) mice and treated with 4’OH-tamoxifen (+tam) for 24h in vitro to induce deletion of 
loxP-flanked genes or left untreated (-tam). After 2d of IL-2 culture under TH1 conditions, cells were 
analyzed for target protein expression by immunoblotting (a) or flow cytometry (b) and RNA expression 
was measured by RT-qPCR (c). The molecular weight in kDa is depicted at the left of the immunoblot. 
Data are representative of 3 (a-c) individual experiments.  
 
Overall these data showed that prototypic target genes were influenced by Roquin and 
Regnase-1, whereas all targets were increased upon Roquin knockout and some only reacted 
weakly or not at all on Regnase-1 deficiency. Especially, Nfkbid and Nfkbiz expression was 
selectively controlled by Roquin and Regnase-1 proteins, respectively. 
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4.3.3 Global mRNA-sequencing analysis in Roquin and Regnase-1-
deficient CD4 T cells  
Observing exclusive and cooperative gene regulation on selected targets made us question 
how Roquin and Regnase-1 regulate mRNA expression on a global scale and if different 
modes of gene regulation exist. 
4.3.3.1 Design of the mRNA-sequencing experiment 
In order to define the types of regulation, it was crucial to compare CD4 T cells of the single 
knockout of Regnase-1 (iKO) and the double knockout of Roquin-1 and Roquin-2 (iDKO) to 
cells deficient for all three proteins. For this reason, we generated Rc3h1/2fl/fl; Zc3h12afl/fl; Cd4-
creERT2 mice that can be in vitro deleted for their expression of Roquin-1, Roquin-2 and 
Regnase-1 by administration of 4’OH-tamoxifen. For validation of the inducible triple-knockout 
(iTKO), CD4 T cells from these mice were isolated and activated under TH1 conditions for 40h, 
cultured for 2d with IL-2 and then analyzed for the knockouts on protein level by flow cytometry 
and immunoblotting (Figure 9). As a comparison iDKO and iKO T cells were included in the 
analyses (Figure 42). 
 
 
Figure 42 ç Validation of the inducible triple knockout (iTKO) of Roquin and Regnase-1. 
CD4 cells were isolated from Cd4-creERT2 (WT), Rc3h1/2fl/fl; Cd4-creERT2 (iDKO), Zc3h12afl/fl; Cd4-
creERT2 (iKO) and Rc3h1/2fl/fl; Zc3h12afl/fl; Cd4-creERT2 (iTKO) mice and deletion of loxP-flanked 
alleles was induced in vitro by 4’OH-tamoxifen treatment. After T cell stimulation under TH1 conditions 
and IL-2 culture for 2d, knockouts were confirmed by flow cytometry with monoclonal antibodies specific 
for Roquin and Regnase-1. Data are representatives of three independent experiments. 
 
Flow Cytometry analysis with Roquin and Regnase-1-specific monoclonal antibodies 
confirmed a successful knockout in Rc3h1/2fl/fl; Zc3h12afl/fl; Cd4-creERT2 (iTKO) CD4 T cells 
(Figure 42). iDKO and iTKO cells were devoid of Roquin expression and iKO cells expressed 
Roquin at comparable levels to WT cells. Regnase-1 expression was completely diminished 
in iKO and iTKO cells, whereas iDKO cells showed an increase in 1.5 log levels of Regnase-1 
protein levels, suggesting that Regnase-1 itself is a strong target for Roquin-mediated 
regulation. 
Results 
 
 
130 
After evaluation of successful knockouts in T cells, we performed mRNA-sequencing to 
compare the gene expression patterns of WT, iDKO, iKO and iTKO CD4 T cells. Therefore, 
four replicates of WT, iDKO, iKO and iTKO TH1 cells were prepared by inducing deletion of 
loxP-flanked genes in vitro with 4’OH-tamoxifen and stimulation with a-CD3/CD28 under TH1 
conditions. After IL-2 culture, cells were restimulated with a-CD3/CD28 for 1, 2 and 4h or left 
unstimulated (0h) (Figure 43).  
 
 
Figure 43 ç Schematic overview of TH1 cell culture for mRNA-sequencing experiment. 
CD4 cells were isolated from Cd4-creERT2 (WT), Rc3h1/2fl/fl; Cd4-creERT2 (iDKO), Zc3h12afl/fl; Cd4-
creERT2 (iKO) and Rc3h1/2fl/fl; Zc3h12afl/fl; Cd4-creERT2 (iTKO) mice and deletion of loxP-flanked 
alleles was induced in vitro by 4’OH-tamoxifen treatment. After T cell stimulation with a-CD3/CD28 under 
TH1 conditions and IL-2 culture for 2d, cells were restimulated with a-CD3/CD28 for 1, 2 and 4h or left 
unstimulated (0h). Cells were resuspended in Trizol Reagent and submitted to Dr. Stefan Krebs for 
library preparation and mRNA-sequencing. 
 
Most of the known Roquin and Regnase-1 target genes are associated with T cell 
differentiation and activation. Therefore, we included restimulated T cells in the analyses to 
identify genes involved in T cell activation. After restimulation, RNA of cells was preserved by 
Trizol reagent and submitted to Dr. Stefan Krebs from the group of Dr. Helmut Blum at the 
Laboratory of functional genome analysis (LAFUGA, LMU München), who prepared the library 
and performed deep sequencing. After sequencing, the bioinformatic analysis was conducted 
by Dr. Gergely Csaba from the group of Prof. Dr. Ralf Zimmer at the Institute for Informatics 
(LMU München).  
4.3.3.2 Global mRNA-sequencing analysis of CD4 T cells deficient for 
Roquin and Regnase-1 
Global mRNA-sequencing in Roquin-1/2-deficient (iDKO), Regnase-1-deficient (iKO) and cells 
devoid of Roquin-1/2 as well as Regnase-1 (iTKO) was performed to identify gene expression 
patterns and consequently learn about a potential cooperative, molecular mechanism of 
Roquin- and Regnase-1-mediated gene regulation. To validate differentially expressed genes 
in the three different knockout situations, genes in unstimulated wild-type cells (WT, 0h) were 
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taken as a reference to calculate foldchange (FC) gene expression of iDKO, iKO and iTKO 
over the analyzed timepoints of T cell stimulation (0h, 1h, 2h and 4h).  
First, we sought to determine the overall global gene expression pattern in the different 
knockout situation. Figure 44 shows heatmaps of absolute numbers of genes significantly 
upregulated (a) or downregulated (b) in the knockouts at indicated timepoints in comparison 
to WT, 0h. Here, only significantly expressed genes (p-value £ 0.05) and genes with a minimum 
foldchange-expression of log2(FC) ³1 (upregulated) and log2(FC) £1 (downregulated) were 
considered.  
 
 
Figure 44 ç Quantitative analysis of the overall gene expression in unstimulated and restimulated 
WT, iDKO, iKO and iTKO CD4 T cells.  
Heatmap showing absolute numbers of significantly upregulated (a) or downregulated (b) genes in WT, 
inducible Roquin-1/2 double knockout cells (iDKO), inducible Regnase-1 knockout cells (iKO) and 
inducible Roquin-1/2 and Regnase-1 triple knockout cells (iTKO) without stimulation (0h) or restimulated 
for 1, 2 or 4h with a-CD3/CD28. Here, significantly expressed genes with a p-value of £ 0.05 and a 
log2(FC) ³1 (upregulated) and log2(FC) £1 (downregulated) are depicted. The color key shows the 
numbers of expressed genes and corresponding color code. Count represents how often these numbers 
of genes occurred over all analyzed samples. 
 
Comparing the quantity of significantly upregulated genes in the different knockout situations 
revealed that equally more genes in iKO and iDKO T cells were expressed in comparison to 
WT during all timepoints of T cell stimulation, whereas knockout of Roquin and Regnase-1 
(iTKO) in CD4 T cells resulted in an even stronger increase in the overall gene expression 
which reached the highest number of genes with 4h of stimulation (approximately 2000 genes) 
(Figure 44 a).  
The amount of significantly downregulated genes strongly increased during T cell stimulation 
and reached a maximum at 2h (approximately 2000-2200 genes) of stimulation and declined 
with 4h (Figure 44 b). Here, only a weak difference between the knockouts was detectable 
and overall the number of downregulated genes in the three knockout situations was 
comparable to wild-type during all investigated timepoints.  
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This first expression analysis revealed that there were quantitative differences of upregulated 
genes expressed in iKO, iDKO and iTKO CD4 T cells, which were most prominent in iTKO at 
0, 1, 2 and 4h of stimulation. Overall within downregulated genes, the number of genes was 
comparable between the knockouts and wild-type. Here, solely T cell stimulation changed the 
overall abundance of genes independent of the knockout.  
To further characterize concordant regulation of the genes in the knockout cells, Dr. Gergely 
Csaba performed cluster analysis to identify dominant patterns of gene regulation. The aim 
was to identify genes that significantly changed in the knockout T cells in comparison to WT(0h) 
and characterize them according to their molecular function and biological process with the 
help of gene ontology (GO).  
 
 
Figure 45 ç Cluster analysis of genes identified by mRNA-sequencing in WT, iDKO, iKO and iTKO 
CD4 T cells. 
Significantly expressed genes in WT, iDKO, iKO and iTKO during stimulation and without stimulant were 
considered to define 4 major clusters of gene regulation: Cluster 1 consisted of 1134 genes that showed 
55 significant gene ontology (GO) hits in ion channel activity. 801 genes were summarized as cluster 2, 
consisting of genes involved in translation and chromatin modification with 25 significant GO hits. Cluster 
3 was defined by 491 genes involved in mitosis and cell division (41 significant GO hits). Immune-
response related genes were comprised by cluster 4, including 217 significantly expressed genes within 
63 significant GO hits. In the left panel box plots of log2(FC) expression of all genes within the respective 
cluster normalized to WT(0h) are shown and the right plot represents the median change thereof. On 
the right, the top five biological process gene ontology (GO) hits and respective p-values are depicted. 
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Here, 2913 differentially expressed genes were described by four clusters: Cluster 1 included 
1134 genes, cluster 2 801 genes, cluster 3 491 genes and cluster 4 consisted of 217 genes. 
Cluster 1 and 3 represented downregulated genes, whereas cluster 2 and 4 comprised 
upregulated genes in all genotypes. In the following, the single clusters will be discussed in 
detail: 
Cluster 1 and 3:  
Overall genes identified by cluster 1 and cluster 3 were downregulated in the three different 
knockout situations in comparison to WT(0h) genes during T cell stimulation. In cluster 1 this 
pattern was maintained during T cell stimulation and the knockout of Roquin-1/2 (iDKO) as 
well as Regnase-1 deficiency (iKO) lead to a prominent decrease in gene expression in 
comparison to WT, whereas the knockout of Roquin-1/2 and Regnase-1 (iTKO) consequently 
resulted in a downregulation of 2-3 log2 fold-changes (FC). Stimulation for 4h altered gene 
expression in all samples in comparison to shorter stimulation, which suits to the global pattern 
of negatively regulated genes (Figure 44 b). GO analysis revealed genes in this cluster to be 
associated with ion channel signaling.  
Even though differentially expressed genes in cluster 3 were downregulated, the pattern was 
distinct to cluster 1: the expression just slightly declined during stimulation and solely a 
combined deficiency of Roquin and Regnase-1 affected total gene expression without 
stimulation or with stimulation for 1h. Genes identified in this cluster were associated with DNA 
replication and cell division.  
Since a negative effect on gene expression has not been reported for Roquin and Regnase-1 
yet, we were wondering if these downregulated genes might appear due to an elevated 
abundance of genes encoding for transcriptional repressors or epigenetic modulators in the 
inducible knockout situations. Therefore, we screened bioinformatically for transcription factors 
significantly changed in iDKO, iKO and iTKO vs. WT(0h) and again performed cluster formation 
to find patterns of upregulated transcription factors that could explain the expression pattern 
of cluster 1 or cluster 3. The transcription factor cluster analyses resulted in overall 9 clusters 
with unique gene expression patterns (data not shown).  
We were not able to identify transcriptional repressors or epigenetic modifiers that could 
explain the regulation of ion channel associated genes in cluster 1. Considering readcounts of 
genes in cluster 1, we realized that the amplified readcounts in the mRNA-sequencing analysis 
was overall quite low for genes in cluster 1. Suggesting that these genes might only be weakly 
expressed and therefore sequencing depths would have to be increased to make a reliable 
statement, here. 
One transcription factor cluster, which positively correlated with cluster 3 is shown in Figure 
46 a. This cluster contained 9 genes that expressed transcriptional modulators, amongst them 
the histone deacetylase 2 (Hdac2). Histone deacetylases on the one hand function as 
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epigenetic regulators by catalyzing removal of acetyl functional groups from lysine residues of 
histone and non-histone proteins and thereby impact on the chromatin status of DNA in cells 
(Seto and Yoshida, 2014). On the other hand, Hdac2 and its family member Hdac1 have been 
characterized as transcription factors by being recruited to DNA as corepressors (Yang et al., 
1996). Moreover, a knockout of Hdac2 and Hdac1 in mouse embryonic fibroblasts, causes an 
elevated expression of genes associated with cell cycle and reduced proliferation (Yamaguchi 
et al., 2010). Analyzing the log2(FC) expression of Hdac2 in the different knockout situations 
in comparison to WT(0h) in the mRNA-seq data showed a slight induction upon Roquin and 
Regnase-1 knockout (iTKO) in comparison to WT(0h) and a weak increase in gene expression 
upon TCR stimulation (Figure 46 b).  
The expression pattern of Hdac2 identified in the mRNA-seq experiment was validated by RT-
qPCR in unstimulated WT, iDKO, iKO and iTKO CD4 T cells (Figure 46 b). Analyzing cell 
cycle associated genes from Cluster 3 of the mRNA-seq data (Figure 45) like Cdk1, Ccna2 
and Cdca8 (encoding for cyclin-dependent kinase 1, Cyclin A2 and cell division cycle 
associated 8) revealed a gene regulation pattern which is inversely correlating to the 
differential gene expression of Hdac2 in the knockout situations vs. WT(0h) (Figure 46 c). 
Interestingly, these cell cycle-associated genes have already been described to be affected by 
an inhibition of HDACs in breast cancer cell lines (Borbely et al., 2015). Immunoblot analysis 
of Hdac2 and Cyclin A2 protein expression in WT, iDKO, iKO and iTKO CD4 T cells mirrored 
the mRNA expression: T cells deficient for Roquin and Regnase-1 showed induced Hdac2 
expression, whereas the protein abundance of its potential target Cyclin A2 was decreased in 
iTKO cells (Figure 46 d). Consequently, an upregulation of Hdac2 expression upon knockout 
of Roquin-1/2 and Regnase-1 could explain the inverse correlating gene expression pattern of 
downregulated genes such as Ccna2 in cluster 3.  
Overall, these data support the idea that epigenetic remodelers or repressors, which could be 
directly or indirectly targeted by Roquin and Regnase-1, influence the negative differential 
gene expression in cluster 1 and 3. 
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Figure 46 ç Analyzing gene expression of Hdac2 and potential target genes thereof in cluster 3. 
Cluster analysis of differential expressed genes encoding for transcription factors resulted in nine 
different clusters. a) One transcription factor cluster consisting of nine genes showed a gene expression 
pattern that inversely correlated to the gene expression pattern in the previously defined cluster 3 (Figure 
45). b) mRNA-sequencing analysis of the differential gene expression of Hdac2 in iDKO, iKO and iTKO 
cells in comparison to WT(0h) unstimulated or restimulated for 1, 2 and 4h (left panel) and qPCR 
validation of Hdac2 expression in WT, iDKO, iKO and iTKO CD4 T cells in vitro deleted with 4’OH- 
tamoxifen and cultured under TH1 conditions for 2d (right panel). c) Differential gene expression plots of 
Ccna2, Cdca8 and Cdk1 as in b. d) Immunoblot analysis of Hdac2 and CyclinA2 in WT, iDKO, iKO and 
iTKO CD4 T cells in vitro deleted with 4’OH-tamoxifen and cultured under TH1 conditions for 2d. 
 
Cluster 2:  
Cluster 2 was comprised of genes that were upregulated upon Roquin and Regnase-1-
deficiency. The gene expression of T cells from iKO and iDKO were gradually increased with 
a median log2(FC) of 1, whereas knockout of all three genes (iTKO) again caused the strongest 
change in gene expression. The mild changes in gene expression during stimulation implied 
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that the majority of genes was not induced upon T cell stimulation and potentially not involved 
in T cell differentiation or rather stably expressed during T cell activation. This was reflected 
by the top five GO biological process hits, suggesting these genes to rather function in common 
processes like translation and control of gene expression.  
 
Table 20 ç Differential expressed genes identified in cluster 2. 
Top 20 list of differentially expressed genes from cluster 2 in iTKO, iDKO and iKO vs. WT without 
stimulation (0h) and stimulated (1,2,4h) rated according to the highest log2(FC) in iTKO at 0h. Red color 
indicates high log2(FC) up to 2.8 and white color basal gene expression of 0, whereas blue represent 
negative log2(FC) values down to -1.44. 
  
 
 
Table 20 represents the top 20 genes with the strongest differential expression in cluster 2. 
Besides Ctla4, this cluster did not contain already described Roquin and Regnase-1 target 
genes (Jeltsch et al., 2014; Uehata et al., 2013).  
 
Cluster 4:  
Most interestingly, cluster 4 comprised genes involved in immune processes such as cytokine 
production and inflammatory response. The global gene expression pattern of genes in WT T 
cells changed with the duration of T cell stimulation, emphasizing the importance of these 
genes for T cell differentiation and stimulation. T cells deficient for Regnase-1 (iKO) showed a 
slight increase in gene expression in comparison to WT during T cell stimulation. Comparably, 
deletion of Roquin-1/2 (iDKO) influenced the gene expression pattern like the Regnase-1 
knockout. Most interestingly, knockout of Roquin-1/2 and Regnase-1 (iTKO) affected gene 
Gene W
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O
Klk1b27 0,00 0,00 0,78 3,07 0,00 0,00 2,10 2,93 0,00 0,00 1,37 1,79 0,00 0,00 0,00 0,26
Pkdcc 0,00 0,00 0,00 2,76 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Hap1 0,00 0,05 1,15 2,73 0,00 0,00 0,33 1,55 -0,20 0,00 0,93 1,06 0,00 -0,60 0,00 0,00
Rims3 0,00 1,22 1,14 2,71 -0,11 1,51 0,99 2,36 -0,49 0,76 0,40 2,04 -0,97 0,83 -0,31 1,39
1100001G20Rik 0,00 0,00 0,00 2,61 0,00 0,00 0,00 2,47 0,00 0,00 0,00 2,52 0,00 0,00 0,00 2,60
Nme4 0,00 0,39 0,84 2,60 0,00 1,11 1,44 2,57 -0,08 0,91 1,27 2,17 0,14 1,42 1,34 2,47
Adap1 0,00 1,10 1,70 2,60 0,00 1,00 1,40 2,09 0,01 0,88 1,18 1,84 -0,07 0,96 0,57 1,53
Clip3 0,00 1,10 1,48 2,59 0,00 1,64 1,73 2,27 -0,81 0,20 0,65 1,37 -0,93 -0,09 0,02 1,32
Ctla4 0,00 0,67 1,56 2,58 -0,16 0,94 1,77 2,76 -1,08 0,40 0,71 1,63 -1,24 0,29 0,09 1,50
Klk1b11 0,00 0,00 0,42 2,56 0,00 0,00 1,30 1,96 0,00 0,00 0,00 1,71 0,77 0,00 0,00 1,14
Plcd1 0,00 0,21 1,06 2,51 -0,71 0,22 1,47 2,30 -0,46 0,06 0,83 1,76 -0,69 -0,54 0,00 1,26
Dmwd 0,00 0,24 1,19 2,51 0,19 0,20 1,37 2,49 -0,24 -0,36 1,16 2,31 0,00 0,71 1,23 2,35
Tmem121 0,00 0,61 1,18 2,51 0,00 0,00 1,14 1,97 0,00 0,00 0,00 0,00 0,23 0,68 0,26 2,10
Sqrdl 0,00 0,22 0,74 2,50 -0,51 0,00 0,45 2,07 -0,55 -0,34 0,16 1,55 -0,50 -1,18 -0,44 0,96
H1fx 0,00 0,34 0,00 2,47 0,00 1,09 0,00 2,32 0,00 1,30 0,00 2,51 0,00 0,00 0,00 0,82
Kynu 0,00 0,09 0,75 2,47 -0,64 -0,16 1,10 2,62 -0,61 -0,62 0,14 1,29 -0,45 -0,75 0,00 1,19
Pnpla3 0,00 0,44 1,62 2,47 0,08 0,00 2,04 2,38 0,02 0,00 1,42 1,31 0,42 0,29 1,70 1,18
Asb2 0,00 0,84 1,42 2,42 0,00 1,26 1,32 2,25 0,25 1,09 0,93 1,33 -1,42 -0,65 -0,87 0,01
Zbtb18 0,00 1,65 1,23 2,41 0,09 2,14 1,23 2,17 0,23 2,00 1,13 1,63 -0,45 0,68 0,00 0,45
6430571L13Rik 0 0,59 1,99 2,39 0,46 0,62 1,44 1,54 0,53 0,45 1,54 0,91 0,12 0 0,97 1,03
0h 1h 2h 4h
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expression during all timepoints the most, hinting towards an additive influence of Roquin-1/2 
and Regnase-1 on the overall mRNA expression in this cluster.  
 
Table 21 ç Differential expressed genes identified in cluster 4. 
Top 20 list of differentially expressed genes from cluster 4 in iTKO, iDKO and iKO vs. WT without 
stimulation (0h) and stimulated (1,2,4h) rated according to the highest log2(FC) in iTKO at 0h. Red color 
indicates high log2(FC) up to 6.69 and white color basal gene expression of 0, whereas blue represent 
negative log2(FC) values down to -2.72.  
 
 
 
Since we already identified that Roquin and Regnase-1 might have an additive or even 
cooperative function in the prevention of autoimmunity in mice, we further aimed to validate 
these immune related target genes in cluster 4 for their regulation by these RNA-binding 
proteins. Table 21 depicts the genes of cluster 4 with the highest log2(FC) expression in iTKO 
T cells. Interestingly, amongst the top 20 list we found genes that have already been defined 
as targeted by Regnase-1 and Roquin such as Cebpd and Icos. In addition, we performed 
hierarchical clustering of genes expressed in cluster 4 to gain insights about similarities in gene 
expression by Roquin and Regnase-1 (Figure 47).  
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Gm15987 0,00 3,45 1,28 5,48 0,14 3,98 2,28 5,03 0,07 4,81 3,14 5,19 0,00 4,08 2,29 4,46
Cebpd 0,00 1,25 0,72 5,46 0,00 2,46 1,32 5,40 0,00 5,20 3,26 6,78 0,80 5,15 2,73 5,83
Kit 0,00 1,98 1,93 4,98 1,76 4,70 3,81 5,68 1,88 4,99 3,51 5,53 0,59 3,51 1,30 4,58
Tnfrsf8 0,00 0,65 2,14 4,79 -0,28 0,53 2,80 4,72 -0,72 1,61 2,51 4,84 -0,28 2,15 1,90 4,32
Dlk1 0,00 0,16 0,42 4,76 0,00 0,00 1,09 4,87 0,00 0,00 0,42 4,98 0,57 0,00 1,58 4,75
Tlr9 0,00 1,30 2,45 4,64 0,09 3,30 3,10 4,45 0,00 2,99 2,32 3,52 0,00 1,60 1,41 2,22
Wnt10b 0,00 0,00 1,20 4,56 1,32 2,00 3,39 4,82 2,45 3,37 5,19 6,69 2,22 2,84 3,89 5,98
Gm14718 0,00 1,72 2,01 4,51 1,78 4,20 3,89 5,22 2,07 4,29 4,28 5,04 1,05 4,24 3,13 4,73
Zcchc18 0,00 2,60 2,68 4,37 0,10 3,24 3,05 4,27 -1,30 2,72 2,32 3,52 -2,72 1,56 0,32 2,11
Fam43a 0,00 0,79 1,19 4,36 -0,22 2,54 1,98 5,67 0,29 2,23 1,37 4,05 0,72 0,78 0,22 2,93
Ebi3 0,00 0,97 3,28 4,13 0,25 1,75 4,08 4,54 -0,42 1,48 3,72 4,50 0,00 0,97 2,43 4,05
Tox2 0,00 0,37 1,56 4,06 -0,45 0,68 1,63 4,04 0,63 2,07 2,23 3,65 0,33 1,25 0,83 1,86
Ppic 0,00 1,76 1,36 3,99 0,99 2,76 1,86 4,36 1,11 3,17 2,21 4,65 1,13 3,40 1,99 4,68
Prickle1 0,00 2,17 1,07 3,88 -0,50 4,28 2,61 5,43 0,17 4,81 3,20 5,30 0,19 4,11 2,78 4,23
Fcrl1 0,00 0,98 0,71 3,67 -0,15 1,51 0,99 3,70 1,05 2,65 1,67 3,92 1,95 2,85 1,18 2,64
Icos 0,00 1,87 2,37 3,55 0,03 2,18 2,29 3,38 0,15 2,36 1,69 2,75 0,00 1,90 0,79 2,24
Mpzl1 0,00 1,10 0,94 3,51 -0,25 1,03 0,16 3,21 0,47 2,13 0,81 3,38 1,29 2,70 1,89 3,72
Cpd 0,00 1,04 1,84 3,42 1,23 2,78 3,35 4,20 2,41 4,18 4,12 4,95 3,06 4,03 3,74 4,31
Csn2 0,00 0,47 0,00 3,40 0,00 2,16 0,00 4,40 0,00 2,87 0,00 4,29 0,00 2,88 0,00 3,64
Lmna 0,00 0,35 1,56 3,34 2,30 2,71 3,42 4,58 2,06 2,24 3,02 4,45 0,83 1,30 1,37 3,49
0h 1h 2h 4h
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Figure 47 ç Hierarchical clustering of genes identified in cluster 4. 
Hierarchical cluster heat map of genes identified in cluster 4 from WT, iDKO, iKO and iTKO CD4 T cells 
unstimulated or stimulated for 1, 2 and 4h with a-CD3/CD28. Color code represents log2(FC) expression 
of knockout genes relative to WT(0h) and the histogram in the legend represents the numbers of counts 
with the respective log2(FC). Known Roquin and Regnase-1 target genes are indicated at the right side 
of the heatmap. 
 
This analysis revealed the highest similarity of gene expression in iDKO and iTKO, followed 
by iKO genes, which is maintained during stimulation. Genes of WT samples showed strongest 
divergency from genes in knockouts at all analyzed timepoints. But with 2h and 4h of 
stimulation the overall gene expression in WT CD4 T cells was retained, suggesting that gene 
expression reached a plateau with 2h of TCR stimulation. Interestingly, cluster 4 contained 
already described target genes of Roquin and Regnase-1: Batf, Cd44, Cd69, Furin, Icos, Irf4, 
Nfkbiz, Rel, Stat5a, Cebpd and Tnfrsf4 (Ox40) (Table 19).  
We then validated the mRNA-sequencing data of genes we found significantly enriched in 
cluster 4 by RT-qPCR of T cells isolated from the respective genotypes that were cultured in 
the same way as the cells used for mRNA-sequencing (Figure 48).  
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Figure 48 ç Genes identified by mRNA-sequencing in Cluster 2 and 4 and RT-qPCR validation 
thereof. 
The upper panel of each gene represents the gene expression data obtained by mRNA-sequencing in 
WT, iDKO, iKO and iTKO T cells unstimulated (0h) or stimulated for 1, 2 or 4h with a-CD3/CD28. Shown 
is the log2(FC) regulation in comparison to WT(0h). The lower panel of each gene represents RT-qPCR 
validation in WT, iDKO, iKO and iTKO cells in unstimulated (0h) condition. Gene expression pattern of 
Bcl2l1, Cd69, and Cebpd (a) and Kit, Rel and Tnfrsf8 (b). RT-qPCR experiments are representatives of 
at least two individual experiments. 
 
Amongst them were the transcription factor cRel encoded by Rel and the transcriptional 
activator Cebpd (Cebpd), the activation markers CD30 (Tnfrsf8) as well as CD69 (Cd69) and 
the anti-apoptotic factor Bcl-XL (Bcl2l1) and the surface tyrosine-protein kinase cKit encoded 
by Kit. Cebpd, cKit, and Tnfrsf8 belonged to the top 20 genes identified in cluster 4 and Cd69, 
Rel and Bcl2l1 were previously identified target genes of Roquin and Regnase-1 (Table 19).  
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By RT-qPCR analysis we could indeed verify the differential gene expression pattern identified 
by mRNA-sequencing analysis of WT, iDKO, iKO and iTKO T cells.  
4.3.3.3 Identifying different types of post-transcriptional gene regulation by 
Roquin and Regnase-1 
Since we found an overlap of genes differentially expressed in the knockout situations, we 
were wondering if this gene expression analysis can serve as a tool to identify different modes 
of gene regulation by Roquin and Regnase-1. To prove if Roquin and Regnase-1 cooperatively 
regulate most of their target mRNAs or if genes that were exclusively targeted by Roquin or 
Regnase-1 exist, we combined the upregulated genes in cluster 2 and cluster 4 and analyzed 
the respective 1018 genes by their foldchange expression in the different knockout situations 
in comparison to WT. We proposed the following types of post-transcriptional gene regulation 
by Roquin and Regnase-1 proteins: cooperative, Roquin exclusive, Regnase-1 exclusive and 
redundant. Here, we utilized gene expression of unstimulated (0h) samples to determine the 
mode of regulation, since Roquin and Regnase-1 are functionally expressed (Figure 41).  
 
Table 22 ç Definition of different types of gene regulation by Roquin and Regnase-1 by log2(FC) 
expression in mRNA-sequencing analyses. 
Cooperative, Roquin exclusive, Regnase-1 exclusive and redundant gene regulation in genes identified 
in cluster 2 and cluster 4 were defined according to their log2(FC) expression in unstimulated (0h) iDKO, 
iKO or iTKO cells in comparison to WT(0h). Cooperative target genes have a log2(FC) ³ 0.35 in iDKO 
and iKO vs. WT(0h) and a log2(FC) ³ 0.7 in iTKO T cells. In addition, the difference of log2(FC) regulation 
between iTKO and iDKO or iKO must be higher than 25% (log2(FC)(iTKO/iDKO) ³ 1.25 and 
log2(FC)(iTKO/iKO) ³ 1.25). Roquin or Regnase-1 exclusive target genes show per definition a log2(FC) 
³ 0.35 in the respective knockout and in the iTKO, whereas the other knockout must have a log2(FC) < 
0.35. In Roquin exclusive target genes the log2(FC) expression of iTKO is less than 25% higher in 
comparison to iDKO target genes (log2(FC)(iTKO/iDKO) £ 1.25). Accordingly, Regnase-1 exclusive 
targets have a log2(FC) (iTKO/iKO) that is less than 25% different to iTKO (log2(FC)(iTKO/iKO) £ 1.25). 
Redundant target genes have per definition a log2(FC) £ 0.35 in iDKO and iKO T cells in comparison to 
WT(0h), whereas the log2(FC) expression in iTKO v. WT is ³ 0.7. Here the difference between iTKO 
and iDKO and iKO should be higher than 25% (log2(FC)(iTKO/iKO) ³ 1.25 and log2(FC)(iTKO/iDKO) ³ 
1.25). Applying these definitions we identified 294 to be cooperatively regulated by Roquin and 
Regnase-1, 87 and 9 genes to be exclusively regulated by Roquin or Regnase-1 and 52 genes to have 
a redundant type of post-transcriptional gene regulation. 
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Table 22 gives an overview of the thresholds and calculations we defined to determine 
cooperative, Roquin or Regnase-1 exclusive and redundant target transcripts. 
Cooperative target genes were per definition regulated by both Roquin and Regnase-1 
proteins, therefore they were expected to be highly abundant in iDKO and iKO in comparison 
to WT, but showed an even higher expression in iTKO CD4 T cells. Therefore, cooperatively 
regulated target genes were defined to have a log2(FC) expression ³ 0.35 in iDKO and iKO in 
comparison to WT(0h) and the log2(FC) expression in iTKO should exceed 0.7. In addition, we 
wanted to verify that the expression of each cooperatively regulated gene has a 25% higher 
log2(FC) expression in iTKO than in iDKO and iKO, consequently we included 
log2(FC)(iTKO/iDKO) and log2(FC)(iTKO/iKO) ³ 1.25. By applying these calculations, we 
identified 294 potentially cooperative target genes.  
We described Roquin or Regnase-1 exclusive target genes as strongly expressed in either 
iDKO or iKO with a comparably high expression in iTKO cells. Therefore, we applied following 
definitions to Roquin and Regnase-1 exclusive target genes: The log2(FC) expression in iDKO 
and iTKO in comparison to WT(0h) should exceed 0.35 in a Roquin exclusive target gene and 
the log2(FC) in iKO T cells should be < 0.35. Correspondingly, Regnase-1 exclusive target 
genes revealed a log2(FC) ³ 0.35 in iKO and iTKO, whereas the iDKO should not influence the 
mRNA expression by owing a log2(FC) < 0.35. To verify that the expression of the single 
knockouts did not vary from the inducible triple knockout more than 25%, we further applied a 
log2(FC)(iTKO/iDKO) £ 1.25 to define Roquin exclusive targets and log2(FC)(iTKO/iKO) £ 1.25 
to define Regnase-1 exclusive target genes. We identified 87 genes to be exclusively targeted 
by Roquin, but surprisingly, only 9 mRNAs revealed Regnase-1 exclusivity.  
Redundancy was per definition, a mode of gene regulation that implies that only the absence 
of all three proteins influences the gene expression. Therefore, the log2(FC) of mRNAs in iDKO 
and iKO vs. WT(0h) was expected to be < 0.35, whereas loss of Roquin and Regnase-1 in 
iTKO T cells should result in a log2(FC) ³ 0.7. Further, the differential gene expression in iTKO 
T cells should be at least 25% higher than in iDKO and iKO cells, which is determined by 
log2(FC)(iTKO/iDKO) and log2(FC)(iTKO/iKO) ³ 1.25. In consideration of these definitions, we 
found 52 genes to be redundantly regulated by Roquin and Regnase-1. A complete list of the 
genes is attached in the appendix (Appendix 4-7). 
With the help of these differential gene expression analysis, we were able to identify that most 
genes showed a cooperative type of gene regulation, in turn almost no Regnase-1 exclusive 
target genes were found. We further wanted to verify these findings by selecting exemplified 
target genes and study the mode of gene regulation in detail.  
As a cooperative target gene, I chose Icos, since this is an already well-studied Roquin target 
and it appeared in the top 20 list of cluster 4. The gene regulation of Ox40 (Tnfrsf4) has already 
Results 
 
 
142 
been investigated in this thesis (chapter 4.1.1) and thus we wanted to further extend and verify 
our knowledge about this prototypic Roquin exclusive target gene. Amongst the 9 Regnase-1 
exclusive target genes we hardly found interesting candidates. Therefore, I decided to select 
the cooperative target gene D1ertd622e for further investigations, because it showed strong 
Regnase-1 requirement. In contrast, Ctla4 was chosen as an additional cooperative target 
gene that in turn strongly depended on Roquin. Indeed, we were able to verify the gene 
expression pattern identified by mRNA-sequencing with real-time qPCR analysis of T cells 
from WT, iDKO, iKO and iTKO mice (Figure 49).  
 
 
Figure 49 ç Icos, Ox40, D1ertd622e and Ctla4 expression in Roquin- and Regnase-1-deficient CD4 
T cells. 
Genes identified by mRNA-sequencing (a) were further confirmed by RT-qPCR (b) in CD4 cells isolated 
from Cd4-creERT2 (WT), Rc3h1/2fl/fl; Cd4-creERT2 (iDKO), Zc3h12afl/fl; Cd4-creERT2 (iKO) and 
Rc3h1/2fl/fl; Zc3h12afl/fl; Cd4-ceERT2 (iTKO) mice in vitro deleted for loxP-flanked alleles by 4’OH- 
tamoxifen treatment, stimulated with a-CD3/CD28 under TH1 conditions and cultured in IL-2-containing 
medium for 2d. RNA was isolated, transcribed into cDNA and RT-qPCR was performed using probe-
based gene-specific amplification. Data are representatives of two independent experiments (b). 
 
The expression of the cooperative target Icos was under the control of Roquin and Regnase-1, 
whereas the effect upon Roquin-deficiency was stronger. Ox40 expression was only affected 
by Roquin-deficiency (iDKO) and iTKO, whereas D1ertd622e was influenced by a loss of all 
three proteins (iTKO) and Regnase-1 (iKO). Therefore, these genes were verified as Roquin 
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and Regnase-1 exclusive target genes. In turn, Ctla4 was more affected by a loss of Roquin 
and was therefore defined as a more Roquin-dependent mRNA. 
4.3.4 Analyzing the functional cooperativity of Roquin and Regnase-1 
For identifying direct mRNA targets of RNA-binding proteins, CLIP (crosslinked-
immunoprecipitation) experiments are the common method of choice. Briefly, mRNAs are 
crosslinked by UV irradiation of a specific wavelength to the RBP, followed by 
immunoprecipitation, RNA radiolabeling with [g32P]-ATP, Proteinase K digest of the protein 
bound to RNA and library preparation and next generation sequencing of the 
immunoprecipitated RNA. CLIP experiments with overexpressed Roquin or Regnase-1 in 
mouse embryonic fibroblasts or HEK293 cells have been described previously (Essig et al., 
2018; Mino et al., 2015). For identifying the physiological cooperation of Roquin and Regnase-
1 on the mRNA, I tried to establish PAR-CLIP with endogenous Regnase-1 in primary CD4 T 
cells. CLIP experiments highly depend on the abundance of protein to be immunoprecipitated 
to obtain enough RNA for appropriate library preparation and deep sequencing. Due to 
relatively low expression of endogenous Regnase-1 in comparison to the so far established 
PAR CLIP experiments with overexpressed proteins, my PAR-CLIP experiments were not 
successful. Therefore, alternative methods were established to prove the functional interaction 
and cooperation of Roquin and Regnase-1 proteins in T cells. 
4.3.4.1 Validation of target genes ex vivo in Cd4-cre mice 
To validate the defined types of gene regulation we found in cluster 2 and 4, flow cytometry 
analysis of the encoded proteins was performed in splenocytes of WT, DKOT, KOT and TKOT 
mice. Under these more physiological conditions, Roquin and Regnase-1 target genes should 
also be elevated in the conditional T-cell-specific knockout situations (Figure 50). 
Indeed, flow cytometry analysis of endogenous protein expression of the target genes 
supported the in vitro generated mRNA-sequencing data. Icos and Ctla-4 were defined as 
more cooperative target genes, which was proven in the ex vivo flow cytometry analysis. Here, 
TKOT showed a strong derepression on protein level, but deficiency of Regnase-1 (KOT) and 
Roquin-1/2 (DKOT) influenced protein expression in comparison to WT levels. Ox40, 
comparably to the in vitro expression and the previously published data, represented a Roquin 
exclusive target gene, since loss of Roquin-1/2 (DKOT) and the deficiency of all three genes 
(TKOT) caused an upshift of Ox40 protein levels. For C5orf30 homolog, encoded by 
D1ertd622e, no flow cytometry antibody is commercially available and therefore the protein 
expression in the knockout T cells could not be further verified. 
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Figure 50 ç Flow cytometry analysis of Roquin and Regnase-1 targets in splenocytes of WT, KOT, 
DKOT and TKOT mice. 
Flow cytometry analysis of Icos, Ox40 and Ctla-4, in CD45.2+, CD4+ splenocytes of Rc3h1/2fl/fl; 
Zc3h12afl/fl (WT), Rc3h1/2fl/fl; Cd4-cre (DKOT), Zc3h12afl/fl; Cd4-cre (KOT) and Rc3h1/2fl/fl; Zc3h12afl/fl; 
Cd4-cre (TKOT) mice. Data are representatives of three experiments. 
 
In summary, the ex vivo protein levels correlated with the findings of the mRNA-sequencing 
analyses and the mRNA expression data, supporting the existence of different types of Roquin- 
and Regnase-1-induced gene regulation in CD4 T cells. 
4.3.4.2 Reconstitution experiments to prove cooperativity of Roquin and 
Regnase-1 
Because the obtained gene expression profiles do not represent direct engagement of the 
RNA to Roquin or Regnase-1 and could also partially represent indirectly affected genes (as 
seen for Cluster 3), we used a reconstitution experiment to identify if Regnase-1 requires 
Roquin for repressing target mRNAs and whether Regnase-1 can function in the absence of 
Roquin. We hypothesize that binding of the RNA is facilitated via the ROQ domain of Roquin 
whereas degradation of the mRNA can either be induced via Regnase-1-mediated degradation 
(e.g. endonucleolytic cleavage), which depends on its catalytic center comprised by Asp141 
(D141) or via recruitment of factors involved in decapping, deadenylation or translational 
inhibition by Roquin proteins (Essig et al., 2018; Glasmacher et al., 2010; Leppek et al., 2013; 
Murakawa et al., 2015). To test our hypothesis, we reconstituted either wild-type or Roquin-
1/2-deficient CD4 T cells with doxycycline-inducible Roquin-1, Regnase-1 or the loss-of-
function mutant Regnase-1(D141N) fused to GFP and checked for protein expression of 
targets. Briefly, CD4 T cells from Rc3h1/2fl/fl; Cd4-creERT2; rtTA-M2 mice (iDKO, rtTA) were 
treated with 4’OH-tamoxifen to induce Roquin-1/2 deletion or cells from Rc3h1/2fl/fl; rtTA-M2 
(WT, rtTA) mice were used as WT controls (Figure 10). After activation with a-CD3/CD28, 
CD4 cells were transduced with a doxycycline-inducible retrovirus expressing the GFP-fusion 
constructs. Cells were cultured in IL-2-containing medium, expression of retrovirally integrated 
genes was induced by doxycycline administration and subsequently targets were analyzed by 
flow cytometry (Figure 51).  
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Figure 51 ç Reconstitution of Roquin and Regnase-1 in WT and Roquin-deficient CD4 T cells. 
CD4 T cells from Rc3h1/2fl/fl; Cd4-creERT2; rtTA-M2 mice (iDKO, rtTA) or Rc3h1/2fl/fl; rtTA-M2 mice 
(WT, rtTA) were treated with 4’OH-tamoxifen to induce Roquin-1/2 deletion in cre-positive mice. Cells 
were cultured under TH1 conditions and transduced with a retrovirus containing a doxycycline-inducible 
cassette to express GFP-Roquin-1, GFP-Regnase-1 or GFP-Regnase-1(D141N). After 1.5 d of IL-2 
culture, cells were treated with doxycycline for 6h and protein expression of GFP, Ctla-4, Icos and Ox40 
was measured by flow cytometry. The experiment was performed together with Dr. Gesine Behrens. 
These results are representatives of two independent experiments. 
 
Protein expression of Ctla-4 was fully repressed by Roquin-1 reconstitution in Roquin-deficient 
T cells. Interestingly, GFP-Regnase-1 downregulated Ctla-4 even in the absence of Roquin 
and this depended on the RNase activity of Regnase-1, suggesting that Regnase-1 can 
downregulate Ctla-4 independent of Roquin. Different from that, Icos protein levels were 
influenced by Roquin-1 and Regnase-1 overexpression in WT and iDKO situations. Here, 
GFP-Regnase-1 only slightly regulated Icos and cRel expression in the absence of 
endogenous Roquin. Contrary, in the wild-type situation, Regnase-1 altered Icos expression 
and these effects were diminished with the loss-of-function mutant of Regnase-1. GFP-Roquin-
1 alone only partially rescued Roquin-1/2-deficiency, proposing that here Roquin-1 and 
Regnase-1 might depend on the presence of Roquin-2. As an exemplary Roquin exclusive 
target, Ox40 was chosen for reconstitution experiments. Here, GFP-Regnase-1 wild-type or 
D141N overexpression had no effect either in the presence nor in the absence of Roquin, 
whereas Roquin-1 overexpression in iDKO cells fully reduced Ox40 expression to protein 
levels comparable to WT. These data strongly support the findings in previous experiments 
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showing strong Roquin-dependency for Ox40 gene regulation, but no effect upon Regnase-1-
deficiency (Figure 13 and Figure 41) (Janowski et al., 2016).  
As shown in Figure 41, Regnase-1 protein and mRNA levels were drastically increased in 
Roquin-deficient T cells proposing that Regnase-1 itself is strongly targeted by Roquin 
proteins. Since autoregulation of Regnase-1 was suggested by several independent studies, 
we were wondering if Regnase-1 itself can repress its own target mRNA and if this 
autoregulation depends on the presence of Roquin proteins. The fact that Roquin-deficient T 
cells had enormous amounts of Regnase-1, made us hypothesize that Regnase-1 itself is not 
able to repress its own expression and is therefore a high affinity cooperatively targeted gene. 
To get insights about the regulation of Regnase-1 itself, we reconstituted Roquin-deficient 
(iDKO, rtTA) and wild-type (WT, rtTA) T cells as described above with either GFP-Roquin-1 or 
GFP-Regnase-1 and analyzed endogenous Regnase-1 expression levels in these cells. Since 
flow cytometry analysis was performed with a monoclonal antibody against Regnase-1, this 
antibody recognizes endogenous as well as overexpressed GFP-Regnase-1 simultaneously. 
To avoid a mixed signal here, we mutated the amino acids that form the epitope as such that 
the antibody was incapable of identifying overexpressed GFP-Regnase-1 (GFP-Regnase-
1invisible) and consequently the signal measured by flow cytometry resulted exclusively from 
endogenous Regnase-1.  
As a positive control for proving full functionality of GFP-Regnase-1invisible protein, Ctla-4 was 
included in the measurement. Ctla-4 was comparably repressed by GFP-Regnase-1 and GFP-
Regnase-1invisible demonstrating that the mutation did not influence the activity of Regnase-1. 
The results in Figure 52 clearly state that Regnase-1 was only capable to regulate its own 
expression in the presence of Roquin proteins, since overexpression in Roquin-deficient CD4 
T cells had no impact on Regnase-1 expression. Taken together, Roquin as well as Regnase-
1 overexpression results in downregulation of many targets including endogenous Regnase-
1. However, Regnase-1 requires the presence of Roquin and therefore represents a first target 
with mandatory cooperative regulation.  
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Figure 52 ç Reconstitution of Regnase-1 in WT and Roquin-deficient CD4 T cells. 
CD4 T cells from Rc3h1/2fl/fl; Cd4-creERT2; rtTA-M2 mice (iDKO) or Rc3h1/2fl/fl; rtTA-M2 mice (WT, 
rtTA) were treated with 4’OH-tamoxifen to induce Roquin-1/2 deletion in cre-positive mice. Cells were 
cultured under TH1 conditions and transduced with retrovirus containing a doxycycline-inducible 
cassette to express GFP-Roquin-1, GFP-Regnase-1 or GFP-Regnase-1invisible. After 1.5 d of IL-2 culture, 
cells were treated with doxycycline for 6h and protein expression of GFP, Regnase-1 and Ctla-4 was 
measured by flow cytometry. The amino acid sequence of the GFP-Regnase-1invisible mutant in 
comparison to wild-type Regnase-1 is depicted above. This experiment was performed by Dr. Gesine 
Behrens and the results are representatives of three independent experiments. 
 
The reconstitution experiments clearly demonstrated the dependency of Regnase-1 and 
Roquin in post-transcriptional gene regulation in CD4 T cells. By utilizing this reconstitution 
system, we were able to distinguish between Roquin exclusive target genes like Ox40, but, in 
addition, separate cooperative target genes that clearly depend on the presence of both 
proteins (Regnase-1) from targets that are regulated by both Roquin and Regnase-1 but more 
in an independent fashion like Ctla-4.  
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4.3.4.1 Co-Immunoprecipitation of Roquin and Regnase-1 
To prove cooperation of Roquin and Regnase-1 proteins, we were wondering if the proteins 
physically interact and therefore conducted co-immunoprecipitations. Since until now there 
was no proof for a direct interaction of Roquin and Regnase-1 yet, we first established the co-
immunoprecipitation with overexpressed Regnase-1 in WT CD4 T cells. 
 
 
Figure 53 ç Proving direct interaction of Roquin and Regnase-1 by co-immunoprecipitation. 
a) CD4 T cells were isolated from of Zc3h12afl/fl; Cd4-creERT2 (iKO) or Rc3h1/2fl/fl; rtTA-M2 mice (WT, 
rtTA), treated with 4’OH-tamoxifen to induce deletion in iKO cells, activated under TH1 condition with a-
CD3/CD28 and cultured in IL-2 containing medium for 2d. WT cells were transduced with a doxycycline-
inducible retrovirus expressing GFP-Regnase-1. Expression was induced after 2d of IL-2 culture with 
doxycycline for 16h. b) CD4 T cells of Zc3h12afl/fl; Cd4-creERT2 (iKO) or Zc3h12afl/fl mice (WT) that 
were treated with 4’ OH-tamoxifen to induce deletion in iKO cells, activated under TH1 condition with 
anti-CD3/CD28 and cultured in IL-2-containing medium for 3d. Immunoprecipitation of a) and b) was 
performed with a polyclonal antibody against Regnase-1 (R&D) coupled to Protein-A-dynabeads. 50 µg 
protein input and immunoprecipitate (IP) were analyzed on an SDS gel and Roquin and Regnase-1 
protein expression were measured by immunoblotting with specific antibodies.  
 
Therefore, CD4 T cells were isolated from Rc3h1/2 fl/fl; rtTA-M2 (WT, rtTA) or Zc3h12afl/fl; Cd4-
creERT2 mice (iKO). After 4’OH-tamoxifen-induced deletion, cells were activated with a-
CD3/CD28 and transduced with a doxycycline-inducible retrovirus expressing GFP fused to 
Regnase-1. Cells were expanded in IL-2-culture medium and expression of GFP-Regnase-1 
was induced by doxycycline (Figure 10). Co-immunoprecipitation of cell lysates was 
performed with a monoclonal antibody against Regnase-1 (R&D) in the presence of RNase 
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inhibitors and phosphatase inhibitors, followed by immunoblotting to control for co-
immunoprecipitated Roquin proteins (Figure 53 a). Since, we successfully immunoprecipitated 
Roquin with overexpressed GFP-Regnase-1, we further tested an endogenous interaction of 
Roquin and Regnase-1 proteins. Immunoprecipitation was performed with protein extracts 
from CD4 T cells isolated from Zc3h12afl/fl; Cd4-creERT2 (iKO) or Zc3h12afl/fl mice (WT), 
treated with 4’OH-tamoxifen to induce deletion in iKO cells, activated with a-CD3/CD28 and 
cultured with IL-2. Co-immunoprecipitation was performed with the same monoclonal anti-
Regnase-1 antibody and pulldown of Roquin was tested by immunoblotting (Figure 53 b).  
Even though the abundance of enriched Roquin with endogenous Regnase-1 was rather weak, 
we were able to prove interaction of both proteins on endogenous levels in WT CD4 T cells. 
In summary, I was able to show that Roquin and Regnase-1 proteins were not only functionally 
cooperating in the gene regulation of their shared target genes, but that the underlying 
molecular mechanism involves a physiologic interaction of both proteins.  
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5 Discussion  
In this research project, the cooperative roles of the post-transcriptional gene regulators 
Roquin-1 and Roquin-2 together with the endonuclease Regnase-1 in controlling autoimmunity 
were studied. 
The first part of this thesis concentrated on the control of complex cis-regulatory elements by 
Roquin proteins. Here, I was, on the one hand, able to show that Roquin not only recognizes 
a triloop CDE-like element, but also an integrated hexaloop ADE structure to control 
expression of its mRNA target Ox40. On the other hand, I demonstrated that multiple Roquin 
proteins enable full regulation of the Nfkbid 3′-UTR in a cooperative manner, thereby targeting 
complex cis-regulatory elements consisting of triloop CDE-like and hexaloop ADE-like 
structures. This complex regulatory mechanism induces several degradation pathways: We 
found that an mRNA harboring the Nfkbid 3′-UTR can be degraded via decapping and 
deadenylation in a redundant manner, and, in addition, be translationally inhibited by Roquin. 
The focus of the second part of this work was to elucidate the possible cooperative role of 
Roquin with the endonuclease Regnase-1 in controlling T cell immunity. First, the generation 
of mice with a conditional deletion of Roquin and Regnase-1 in T cells, helped to gain insights 
into the overlapping functions of Roquin and Regnase-1 in controlling autoimmunity. 
Comparing the phenotypes of the triple-knockout mice to either double-knockouts of Roquin 
encoding genes or Regnase-1 single knockouts, supported the idea of a cooperative 
regulation. In addition, global mRNA-sequencing analysis of T cells deficient for either Roquin-
1/2, Regnase-1 or all three proteins revealed that mRNAs are targeted by both Roquin and 
Regnase-1, which has the potential to enable a robust and strong gene regulation in T cells to 
control autoimmunity. 
5.1 Binding of multiple Roquin proteins enables a 
cooperative post-transcriptional gene regulation of 
complex cis-regulatory elements 
5.1.1 Roquin-mediated regulation involves cis-elements with multiple 
binding sites 
As described in the introduction, RNA binding proteins recognize specific cis-elements mostly 
located in the 3′-UTRs of their target mRNAs by involving RNA-binding domains such as zinc 
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fingers. The RNA-binding protein Roquin involves its ROQ-domain to recognize stem loop 
structures in its target transcripts. Initially, the CDE element was identified as a high affinity 
binding element for Roquin-mediated regulation. The repertoire for Roquin-targeted cis-
elements was expanded by a novel U-rich hexaloop element termed ADE (alternative decay 
element). This element was found in an unbiased manner by performing SELEX (Systematic 
Evolution of Ligands by Exponential Enrichment), which basically enriches RNAs from a 
random oligonucleotide library bound to a biotinylated N-terminal fragment of the Roquin-1 
protein. A homologous ADE-like sequence was identified in the Ox40 3′-UTR, which is 
positioned 5’ to another, CDE-like, stem loop structure. The recognition of ADE and CDE 
element is similarly mediated by residues located in the ROQ-domain of Roquin, whereas, for 
the hexaloop binding, Roquin additionally involves the amino acid Tyr250, which is not needed 
for CDE triloop interaction. By introducing wild-type and mutated versions of Roquin-1 into CD4 
T cells lacking the Roquin paralogs, I was able to show that the regulation of endogenous Ox40 
requires Tyr250, but additionally involves Lys220, Lys239 and Arg260, which have also been 
reported to be mandatory for CDE recognition (Figure 13). This publication contained the first 
proof that Roquin involves multiple binding sites in its cis regulatory elements, namely CDE 
and ADE-like in Ox40 to ensure full target regulation.  
The knowledge about the robustness of this system was further extended by investigating the 
3′-UTR of the prototypic Roquin target Nfkbid (Jeltsch et al., 2014). Comparing a reporter 
system under the control of the Nfkbid 3′-UTR in wild-type and Roquin-deficient MEF cells, I 
identified a minimal response element within the 3′-UTR that is highly upregulated upon 
induced depletion of endogenous Roquin proteins. In a PAR-CLIP approach our group 
identified even another binding motif, a linear binding element (LBE), which is present in the 
Nfkbid 3′-UTR as well. Intriguingly, in MEF cells Roquin did not require this LBE for full 
regulation of the minimal response element (Figure 14). Even though this sequence motif is 
bound by Roquin via its ROQ-domain and is highly abundant in Roquin targets, it had no 
influence on regulation of the reporter and, in addition, it is a rather low-affinity binding element. 
Therefore, we would speculate that this motif serves as an element that may either support 
regulation of lower affinity targets or enable regulation in a more specialized cellular context. 
To identify possible secondary structure elements within the Nfkbid 3′-UTR, we performed 
mLocARNA secondary structure predictions together with RNAalifold in collaboration with the 
group of Dr. Jörg Hackermüller. This method enables detection of evolutionary conserved 
structural motifs based on multiple sequence alignment in combination with secondary 
structure predictions and is therefore a useful tool to reveal RNA secondary structures with 
conserved functions (Will et al., 2007). Overall, we identified six highly conserved tandem stem 
loops within the 263 nucleotides minimal response element of Nfkbid of which two had 
prototypic CDE structures (SL5, SL6) and the highest conservation was seen for an ADE-like 
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U-rich hexaloop element (SL1) (Figure 15). In a comprehensive mutational analysis of the six 
conserved SL structures in the Nfkbid reporter construct, I was able to distinguish essential 
and non-essential stem loops for Roquin-mediated regulation. Essential stem loops already 
affected Roquin-mediated gene regulation when either stem or loop mutations were introduced 
in the individual stem-loop (SL1, SL2). Interestingly, the CDE-type SL structures 5 and 6 
exhibited redundant functions, since reporter expression was only affected with double-
mutants thereof. Mutating the non-essential SLs 3 and 4 reduced reporter regulation only in 
combination with mutation of one of the redundant SLs 5 or 6 (Figure 16). Mutating five of six 
SLs abolished Roquin-mediated reporter repression completely (Figure 19). This mutational 
analysis suggests that Roquin prefers specific loop structures over others and that multiple 
Roquin proteins are required to enable robust and strong regulation. We hypothesize that even 
the non-essential SLs could contribute, potentially by forming a higher order structure or by 
supporting correct folding of the RNA. We further excluded the possibility that one Roquin 
protein might interact with two SLs simultaneously by introducing long, random sequences 
between tandem SL1 and 2, which did not affect the regulation by Roquin (data not shown).  
Since we exchanged up to 8 nucleotides within SL structures in our mutational analysis, we 
asked whether the folding of the other SL structures is not influenced by introducing non-
canonical nucleotides into individual SLs. Therefore, Anne Hoffmann from the group of Dr. 
Jörg Hackermüller investigated during her master thesis the structural components of the 
Nfkbid 3′-UTR. She calculated realization probabilities that predicted how exchanges of 
nucleotides on one stem loop influence folding of the residual five stem loops of Nfkbid. 
Consequently, I designed the mutations in stems and loops according to her predications to 
avoid misfolding of the whole minimal response element. 
The fact that multiple highly conserved stem loop structures are strongly responding to the 
presence of Roquin, made us question if several Roquin proteins are indeed involved in this 
complex regulation. Therefore, I performed a tethering assay where I introduced boxB RNA 
SL structures at the positions of the essential SLs 1, 2 and 5 and artificially tethered lN-Roquin 
to these high-affinity boxB elements in MEF cells that lacked endogenous Roquin-1 and 
Roquin-2 (Figure 20). These experiments clearly demonstrated that with a gradual increase of 
boxB elements and therefore Roquin proteins on the RNA, the repression of the reporter was 
enhanced, emphasizing that simultaneous binding of multiple Roquin proteins enables 
stronger gene regulation.  
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5.1.2 Roquin controls mRNA stability by integrating multiple decay 
pathways 
We furthermore identified that Roquin redundantly induced either deadenylation or decapping 
of the Nfkbid 3′-UTR. This could be explained by Roquin independently interacting with the 
deadenylation machinery i.e. the Ccr4-Not complex or factors of decapping including Ddx6/Rck 
via its carboxy- or amino-terminal region, respectively (Glasmacher et al., 2010; Leppek et al., 
2013; Murakawa et al., 2015). In addition, we found that Roquin enables inhibition of translation 
of the Nfkbid mRNA as determined by polysome profiling (Figure 21). This finding was further 
supported by a global approach. Here, my colleague Dr. Katharina Essig compared global 
mRNA-sequencing with sequencing of ribosome-protected fragments in MEF cells with 
overexpressed Roquin-1. In these experiments, we found some target genes that have 
reduced translational efficiency upon overexpression of Roquin-1, amongst them Nfkbid. By 
further investigating the structural features of these translationally-inhibited target genes, we 
identified an enrichment of mRNAs containing 4 or more Roquin binding sites in their 3′-UTRs. 
Altogether these analyses suggest, that Roquin, in addition to mRNA decay, also induces 
translational repression of some target genes in a 3′-UTR-specific manner resulting from its 
simultaneous interaction with multiple binding sites. However, how this translational inhibition 
is induced by Roquin is still not solved. One possibility could be that Roquin requires multiple 
and mutually exclusive interactions with other post-transcriptional repressors or with effector 
proteins that can inhibit ribosomal occupancy or processivity.  
Very recently, the 3′-UTR of the atypical NF-kB inhibitor IkBz, encoded by Nfkbiz, was 
investigated for its post-transcriptional gene regulation by Regnase-1 (Behrens et al., 2018). 
Here, the authors identified a translational silencing element (TSE) of the human NFKBIZ 
which forms a very similar structure to the mouse Nfkbid 3′-UTR. The TSE consists of five 
conserved stem loop structures, whereas SL4 and SL5 show strong conservation and are 
defined as CDE elements. SL4 and 5 effectively induce mRNA degradation, but translational 
silencing by Regnase-1 is only mediated upon additional presence of SL1-3 in the reporter 
assays. However, the mechanism of Regnase-1-mediated translational silencing is still under 
debate. Strikingly, the expression of both Nfkbid and Nfkbiz are tightly regulated not only on 
the level of mRNA decay, but also on the level of translational inhibition ensuring controlled 
protein expression of IkBz and IkBNS. The cooperation of Roquin and Regnase-1 in regulating 
overlapping target mRNAs by translational inhibition could be one potential way how 
translational silencing is achieved for Nfkbiz and Nfkbid. Since IkBz and IkBNS have high 
sequence homology and were reported to have overlapping functions in controlling TH17 
differentiation, the post-transcriptional gene regulation by RNA-binding proteins conferred via 
complex cis-elements, is an important mechanism to control T cell-driven immune responses.  
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In the future, it would be of high interest to identify the complex regulatory network of RNA-
binding proteins, translational silencers, mRNA decay factors and stabilizing factors on mRNAs 
such as Nfkbid. An interesting tool to study this would be a combination of the lN-boxB 
tethering assay with an approach termed BioID. BioID utilizes a biotin ligase (BirA), which 
biotinylates proteins based on proximity (Roux et al., 2018). By tethering BirA-lN to boxB 
structures in the Nfkbid 3′-UTR one could identify the regulatory protein network present at an 
approximal 10 nm labelling radius of a CDE or ADE element. Experiments to reach this goal 
are currently under way in our laboratory.  
In conclusion, this detailed analysis of the Nfkbid 3′-UTR has expanded our knowledge about 
post-transcriptional gene regulation. Induction of deadenylation, decapping and translational 
inhibition by interaction with non-essential and essential binding sites enables a cooperative 
gene regulation by multiple Roquin proteins on the same target mRNA. Of course, interaction 
with other post-transcriptional gene regulators could contribute to robustness of regulation. It 
ensures tight regulation of mRNA abundance in immune cells and therefore prevents an 
imbalance of gene expression that can result in failures of the immune system. 
5.2 The cooperative molecular function of Roquin and 
Regnase-1 in T cells  
The first part of this thesis proved a cooperative concept of gene regulation by multiple Roquin 
proteins bound on complex cis-elements. This concept was further expanded by investigating 
another level of cooperativity by Roquin proteins: the interaction and molecular cooperation 
with the endonuclease Regnase-1.  
Many research groups have studied the role of RNA-binding proteins in the past, establishing 
many methods to identify direct mRNA target sites and novel potential mRNA target sets 
globally. The method of choice is CLIP (UV cross-linking and immunoprecipitation), that 
isolates short RNA fragments cross-linked to RNA-binding proteins via specific 
immunoprecipitation and analysis by mRNA-sequencing. More and more advanced and further 
developed CLIP methods have been established in the last years such as PAR-CLIP 
(Photoactivable ribonucleoside-enhanced CLIP), HITS-CLIP (High-throughput sequencing of 
RNA isolated by CLIP) and iCLIP (Individual-nucleotide resolution CLIP) (Lee and Ule, 2018). 
mRNA targets of Roquin and Regnase-1 have been globally identified by PAR-CLIP and HITS-
CLIP experiments in the past (Essig et al., 2018; Mino et al., 2015). However, these 
experiments involved overexpression systems in non-immune cells. My goal was to assess 
the cooperation of Roquin and Regnase-1 in the most physiological condition. Therefore, I 
aimed to establish several methods to validate direct mRNA targets of Roquin and Regnase-
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1 in a cooperative setting. I tried to establish PAR-CLIP with endogenous Regnase-1 in primary 
CD4 T cells, which was not successful due to insufficient read numbers. Additionally, I 
overexpressed Roquin-1 for PAR-CLIP experiments in Roquin-deficient cells, because these 
cells have high levels of Regnase-1 and thus I wanted to improve immunoprecipitation of 
endogenous protein. But, already small overexpression of Roquin-1 almost completely 
reduced endogenous Regnase-1, which made an identification of cooperative target genes 
impossible. Finally, I performed RNA-immunoprecipitations with endogenous Regnase-1 and 
subsequently analyzed the RNA by RT-qPCR. Unfortunately, again, only unspecific RNAs and 
low RNA amounts were detectable, indicating a need for improved technology. In sum, I was 
not able to verify a cooperative mRNA regulation by Roquin and Regnase-1 proteins under 
physiological conditions in primary T cells. There might be several reasons to explain this: 
First, Regnase-1 could endonucleolytically cleave its bound mRNA targets and thus the RNA 
is rapidly degraded and not detectable. Second, Regnase-1 itself is not capable of binding 
mRNAs on its own and thus requires an additional factor, such as Roquin or UPF1 that 
mediates RNA-interaction or unwinds the mRNA stem loop. Third, the physiological complex 
of Roquin, Regnase-1 and the mRNA is dynamically formed, short-lived or unstable and is 
therefore hard to detect in immunoprecipitation experiments.  
Finally, we decided to globally capture mRNAs that are expressed under wild-type conditions 
and compare this mRNA set to the global mRNA expression of inducible Roquin-1/2 (iDKO), 
Regnase-1 (iKO) and Roquin-1/2 and Regnase-1 knockout (iTKO) CD4 T cells by performing 
mRNA-sequencing.  
5.2.1 Identifying new target genes of Roquin and Regnase-1 
The analysis of differentially expressed genes in T cells lacking Roquin (iDKO), Regnase-1 
(iKO) and all three genes (iTKO) in comparison to the mRNA expression of wild-type (WT) T 
cells helped us to gain more insights into the gene regulation by Roquin and Regnase-1. By 
performing cluster analyses in combination with gene ontology we were able to identify already 
known direct targets in cluster 4 and therefore assumed that this cluster might contain the 
majority of direct target genes.  
Surprisingly, I identified two gene clusters (cluster 1 and 3) that were downregulated upon 
inducible knockout of Roquin and Regnase-1 (Figure 45). These downregulated genes 
probably represent genes that were indirectly affected by an inducible knockout of Roquin and 
Regnase-1, since so far, no directly stabilizing effect by Roquin and Regnase-1 on mRNA has 
been reported.  
A possible explanation for the slight downregulation of genes in cluster 3 has already been put 
forward in the results section 4.3.3.2. We propose that Roquin and Regnase-1 might together 
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repress genes encoding for regulators of gene expression including transcription factors or 
translational repressors but also epigenetic modifiers that then influence expression of genes 
identified in cluster 3. As exemplified in Figure 46, we found the epigenetic regulator Hdac2 as 
potential direct or indirect target of Roquin and Regnase-1 since the upregulated pattern of 
Hdac2 observed in cells that lack Roquin and Regnase-1 inversely correlated with the gene 
expression in the mRNA-sequencing data of already described Hdac2 target genes we found 
in cluster 3 such as Ccna2 or Cdk1. Thus, the influence of Roquin and Regnase-1 on target 
genes consequently impacted on downstream genes that we detected in the global mRNA-
sequencing approach. 
As mentioned in the results section 4.3.3.2, the ion-channel-associated genes in cluster 1 
could be connected to the sequencing depth. The read counts of the genes in this cluster were 
low and therefore increasing the sequencing depth could help to further support the regulation 
within this cluster, but more importantly, protein expression of the candidate genes would have 
to be analyzed to infer a biological function to this regulation. Nevertheless, the differential 
gene expression showed a significantly increased expression in an inducible triple-knockout in 
comparison to Roquin- and Regnase-1-deficiency alone and thus the effect could be triple-
knockout-specific. Remarkably, overexpression of the anti-apoptotic factor Bcl-2 accelerates 
the downregulation of potassium channel genes such as Kcna1, Kcna5, and Kcnb1 in vascular 
smooth muscle cells (Ekhterae et al., 2001). Thus, the direct regulation of Bcl-2 family genes 
by Roquin and Regnase-1, which will be discussed in more detail later, might be another 
potential way to negatively influence ion channel associated genes. 
As expected, we identified prominent upregulation of genes upon knockouts of Roquin and 
Regnase-1, which are represented in 2 clusters (cluster 2 and 4). Interestingly, we found 
already described target genes such as Nfkbiz, Icos, Ox40, cRel and Ctla4 in both clusters, 
which made us combine the genes and further investigate these two clusters (Figure 48). 
Besides validation of already known target transcripts, I moreover identified very interesting 
new candidate target genes in these clusters.  
The negative regulators of the mitochondrial apoptotic pathway Bcl2a1 (Bcl2-related protein 
A1) and Bcl2l1 (Bcl-XL) have been reported independently as Regnase-1 and Roquin target 
candidates. Regnase-1 overexpression promotes death of breast cancer cells by selectively 
enhancing mRNA degradation of anti-apoptotic gene transcripts, such as Bcl2l1, Bcl2a1, RelB, 
Birc3 and Bcl3 (Lu et al., 2016). In addition, a former PhD student in our lab identified Bcl-2 
protein family genes (Bcl2a1a, Bcl2a1b, Bcl2a1d and Bcl2l1) significantly upregulated in 
Roquin-deficient T cells (unpublished data). But so far, no correlation of Roquin and Regnase-
1 working together to ensure gene regulation of anti-apoptotic factors was made. 
Concordantly, in the mRNA-sequencing data I identified Bcl2l1 expression significantly 
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elevated upon knockout of Roquin-1/2 (iDKO), Regnase-1 (iKO) and combined Roquin-1/2 and 
Regnase-1 (iTKO) in Cluster 4 (Figure 48).  
One of the highest differential expressed genes was Kit encoding for the transmembrane 
receptor tyrosine kinase cKit, which interacts with stem cell factor (SCF) produced by stromal 
cells (Table 21). cKit is expressed in germ cells, hematopoietic stem cells, early hematopoietic 
progenitors such as double-negative thymocytes (DN1 and DN2) and mast cells. Its expression 
is lost during cellular differentiation as it is seen for double-negative thymocytes (Waskow et 
al., 2002). The high differential expression of cKit in T cells lacking Roquin and Regnase-1 
(log2(FC) of 5) is very exciting, because so far, its expression on mature T cells was neither 
reported nor investigated. Very recently, a study on human CD8 T cells and cKit was published 
(Frumento et al., 2019). Briefly, the authors identified that upon T cell activation cKit expression 
is induced on CD8 T cells. Thus, cKit expression is linked to TCR signaling and it is conceivable 
that a TCR-dependent cleavage of Roquin and Regnase-1 by MALT1 releases cKit from being 
repressed (Jeltsch et al., 2014). Still, the authors did not identify cKit expression on CD4 T 
cells and all experiments were performed with human T cells. However, this study was a first 
link between cKit and mature lymphocytes. For future perspectives it would be exciting to test 
whether Roquin and Regnase-1 together function in dampening the cKit expression on double-
negative thymocytes, where cKit is highly expressed. In T cells lacking Roquin and Regnase-
1, I saw a remarkable expression of cKit in mature CD4 and CD8 T cells, but I was not able to 
study their function in early hematopoietic precursors, since Cd4-cre deletes loxP-flanked 
alleles between the late DN and DP stage. One option would be to cross Rc3h1/2; Zc3h12afl/fl 
mice to vav-cre mice to achieve deletion in hematopoietic cells and study the function of Roquin 
and Regnase-1 on cKit expression there. However, this would most probably increase the risk 
of lethality of these mice. Therefore, it would also be possible to consider an inducible deletion 
system, such as transgenic mice expressing cre-ERT2 in combination with loxP-flanked alleles 
of Roquin and Regnase-1. Isolation of the respective cell types such as mast cells or DN 
thymocytes from these mice and in vitro 4’OH-tamoxifen-induced deletion would represent a 
good tool to study the role of Roquin and Regnase-1 on endogenous cKit expression.  
5.2.2 Roquin and Regnase-1 enable distinct ways of cooperativity  
Since we identified around 1018 genes in cluster 2 and 4, we were wondering if we can identify 
the major mode of gene regulation by Roquin and Regnase-1. To do so, we compared the 
differentially expressed genes in the different knockouts with wild-type gene expression. By 
setting specific thresholds of log2(FC) differential expression (Table 22), I defined four possible 
major types of gene regulation by Roquin and Regnase-1: cooperative, Regnase-1 exclusive, 
Roquin exclusive and redundant (Figure 54). By applying these definitions, we indeed 
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identified that the main way of gene regulation by Roquin and Regnase-1 is cooperativity, since 
294 genes out of 1018 genes showed this kind of gene expression pattern (Table 22). 
 
 
Figure 54 ç Schematic representation of different types of regulation by Roquin and Regnase-1. 
Modes of gene regulation by Roquin and Regnase-1 are defined by log2(FC) differential gene expression 
of iDKO, iKO and iTKO vs. WT in unstimulated cells (0h). -: low log2(FC); +: intermediate log2(FC) and 
++: high log2(FC). In cooperative target genes, knockout of Regnase-1 and Roquin-1/2 results in 
increased differential gene expression (+), whereas iTKO gene shows stronger differential expression 
(++). Roquin and Regnase-1 exclusive target genes are high in the respective knockout (+), not 
increased in the other knockout situation (-) and similarly high expressed in iTKO vs. WT (+). Redundant 
target genes are exclusively elevated in the absence of Roquin-1/2 and Regnase-1 (+).  
 
Cooperativity of a trans-acting factor, as it was studied in chapter 4.1 for the Roquin targets 
Ox40 and Nfkbid, can occur on multiple stem loop structures. Since it was reported that 
Regnase-1 and Roquin interact with similar RNA hairpin structures (Leppek et al., 2013; Mino 
et al., 2015; Uehata et al., 2013), binding of the same stem loop by Roquin and Regnase-1 or 
even an interaction of these proteins with each other on the target mRNA could be possible, 
although a direct interaction has not been reported yet. Studies with chimeric constructs that 
harbor the ROQ-domain of Roquin fused to Regnase-1 in either Roquin- or Regnase-1-
deficient MEF cells, revealed that the RNA-binding domain of Roquin is sufficient to repress 
an UTR-reporter if artificially fused to Regnase-1 (Jeltsch et al., 2014). Therefore, a functional 
cooperativity of Roquin and Regnase-1 either on one stem loop or on multiple stem loop 
structures is possible. We cannot exclude, that additional factors are involved in the mRNP 
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complex and thus help to induce mRNA degradation. Regnase-1 has been reported to interact 
with the helicase UPF1 (Mino and Takeuchi, 2015), but an interaction of Roquin with UPF1 
has not been described so far. Within cooperatively regulated genes, we identified already 
described target genes such as Icos, Cebpd, Ctla4, Furin and Nfkbiz (Appendix 4). 
Redundancy and cooperativity are functionally distinct from each other, but experimentally 
difficult to discriminate. We defined redundant target genes as only de-repressed in the 
absence of Roquin and Regnase-1, therefore interaction of either one of the RBPs shall be 
sufficient to confer full regulation. By applying this definition to our target set we identified 52 
redundant target genes. Surprisingly, we found only 9 Regnase-1 exclusive target genes, but 
87 Roquin exclusive targets.  
We tried to also determine the mode of regulation with reconstituted Roquin and Regnase-1 
GFP-fusion proteins in WT and inducible Roquin knockout (iDKO) CD4 T cells and could 
indeed prove different degrees of cooperativity for several of the targets. By comparing GFP-
Regnase-1 overexpression to the functionally impaired GFP-Regnase-1(D141N) mutant, 
conclusions about the dependency on the RNase activity of Regnase-1 can be drawn. We 
proved our hypothesis on 4 target genes of Roquin and Regnase-1 (Figure 51): Icos, Ctla4, 
Ox40 and Zc3h12a.  
Icos is one of the best-studied Roquin target genes and was identified as cooperatively 
regulated gene. Icos protein expression strongly reacted to Roquin-overexpression in WT and 
iDKO T cells, but the effect of Regnase-1 overexpression on Icos strongly depended on the 
presence of Roquin and the enzymatic activity of Regnase-1. Consequently, Regnase-1 and 
Roquin-1 can cooperatively repress Icos expression. 
Ctla-4 expression also showed Roquin- and Regnase-1-cooperativity, but in a distinct way as 
Icos. Roquin and Regnase-1 both regulated Ctla-4 expression, but Regnase-1 functioned 
independently from Roquin, but required its catalytic activity, suggesting that Roquin and 
Regnase-1 might target different stem loop structures in the Ctla4 3′-UTR. 
Intriguingly, Regnase-1 is known to negatively control its own mRNA (Iwasaki et al., 2011; 
Mino et al., 2015), but Regnase-1 itself also appears as one of the best cooperative target 
genes, which we already assumed by detecting tremendous amounts of Regnase-1 in Roquin 
deficient T cells (Figure 41). If Regnase-1 would autoregulate its own expression 
independently from Roquin proteins as it was described in several studies, it could efficiently 
downregulate its own mRNA in Roquin-deficient T cells. Indeed, when we overexpressed 
Regnase-1 in Roquin-deficient cells, the endogenous Regnase-1 expression levels were 
stable, suggesting that Regnase-1 required Roquin expression to repress its own mRNA 
(Figure 52). These results disproved the findings of Cui et al., which suggested that Roquin is 
not able to regulate Regnase-1 and strongly supported our hypothesis of a mandatory 
cooperative gene regulation by Roquin and Regnase-1.  
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Analyzing Ox40 regulation by Roquin proteins (chapter 4.1.1), showed that Ox40 is exclusively 
regulated by Roquin, since knockout of Regnase-1 did not affect Ox40 protein or mRNA 
expression (Figure 41). This was also verified in the reconstitution experiments: Neither 
Regnase-1 overexpression nor the Regnase-1(D141N) mutant affected Ox40 expression.  
Of the 9 Regnase-1 exclusive target genes, we hardly found a candidate that we could link to 
T cell immunity. Therefore, I validated D1ertd622e encoding for C5orf30 homolog, which we 
identified per definition as cooperative target gene, but appears much more Regnase-1-
dependent (Figure 49). Little is known about the mouse C5orf30 ortholog with regards to T cell 
immunity or autoimmunity, but human C5orf30 was reported to be highly expressed in 
rheumatoid arthritis synovial fibroblasts (RASF), which contribute to cartilage damage in RA 
and loss of C5orf30 commits to the pathology of arthritis (Muthana et al., 2015). Supporting a 
direct association with Regnase-1, Mino and colleagues enriched C5orf30 in RIP-Seq 
experiments performed with overexpressed Regnase-1(D141N) in human HeLa cells. Thus, 
most likely the mouse and human orthologs of C5orf30 are direct target genes of Regnase-1. 
To prove the impact of Regnase-1 on these target genes it is crucial for future analysis to 
determine the effect in mice deficient for Regnase-1. For this reason, we are currently 
generating Zc3h12afl/fl; Cd4-creERT2; rtTA-M2 (iKO, rtTA) mice to perform inducible 
reconstitution assays in the absence of Regnase-1. 
Hence, most likely Roquin and Regnase-1 exclusive targets do exist as suggested previously 
(Mino et al., 2015), but cooperatively targeted transcripts are much more abundant. 
Recently, a counterplayer of Roquin and Regnase-1, Arid5a has been identified to interact with 
the ADE-like SL structure in the Ox40 mRNA and thereby competing with Roquin and 
Regnase-1 and stabilizing the transcript in TH17 cells. Thus, the observed changes upon 
Roquin and Regnase-1 depletion on mRNA target expression could even appear enhanced 
due to more accessible binding sites and Arid5a-mediated stabilization (Hanieh et al., 2018; 
Masuda et al., 2013). However, it is at the moment unclear, whether Arid5a also exerts direct 
effects on target mRNA expression or whether it only neutralizes Roquin/Regnase-1 effects. 
5.2.3 The physical interaction of Roquin and Regnase-1 supports the 
concept of cooperativity 
A most exciting question was whether Roquin and Regnase-1 directly interact with each other, 
since the widespread cooperativity that we observe may be the result of direct contact. Co-
immunoprecipitations with Regnase-1 successfully confirmed that Roquin is bound to 
Regnase-1, although the signal was weak when compared to the input amount. Nevertheless, 
this was the first confirmation that Roquin and Regnase-1 physically interact in T cells. In future 
experiments it would be exciting to validate which domains within Roquin and Regnase-1 are 
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responsible for the interaction and if this association requires the presence of RNA. Preliminary 
data generated by my colleague Dr. Gesine Behrens revealed that the sanroque mutation of 
Roquin-1 might be embedded in a putative Regnase-1 interaction surface. Finally, confirming 
such a molecular function for the M199R mutation, meaning the disruption of Roquin/Regnase-
1 binding, may explain how the mutation causes a severe autoimmune phenotype. This would 
be a breakthrough in understanding the function of Roquin proteins in autoimmunity and a final 
proof for the importance of the cooperation with the endonuclease Regnase-1, which has been 
established in this thesis.  
5.3 Roquin and Regnase-1 are essential regulators of T 
cell-mediated immune responses 
The cooperation of Roquin and Regnase-1 on the molecular level was also studied by 
analyzing phenotypic consequences of conditionally deleting Roquin-1, Roquin-2 and 
Regnase-1 in T cells of mice. These experiments were designed to better understand the 
cellular processes that are controlled by Roquin and Regnase-1 in the prevention of 
autoimmunity.  
5.3.1 Deficiency of Regnase-1 in T cells affects the cellular 
composition in the thymus due to cell-extrinsic effects 
I investigated the consequences of a T cell-intrinsic deletion of Roquin and Regnase-1 with 
respect to the thymic cell composition. The thymus is the organ of T cell development from 
bone marrow-derived hematopoietic precursors into mature lymphocytes that carry individual 
antigen-specific TCRs. Several selection processes in the thymus ensure that TCRs recognize 
their cognate antigen presented on the MHC of an antigen-presenting cell and are self-tolerant 
to prevent autoimmunity.  
The thymi of mice lacking Roquin and Regnase-1 (TKOT) showed a drastic reduction in size 
and absolute numbers. Comparably, Regnase-1 deficiency (KOT) alone was already enough 
to decrease thymocyte numbers. By analyzing the development of CD4 and CD8 single-
positive (SP) thymocytes, we realized that the absolute numbers of double-positive (DP) 
thymocytes was drastically reduced, which was accompanied by elevated double-negative 
(DN) thymocytes in KOT and TKOT mice (Figure 23). The development of DN thymocytes into 
DP is defined by four stages with an initial expression of CD44 in DN1 and DN2, which is 
replaced by CD25 expression in DN2 and DN3 and then finally lost in DN4. TKOT mice have 
an elevated abundance of DN1 thymocytes. This was unexpected, since Cd4-cre-driven 
Discussion 
 
 
163 
deletion of loxP-flanked alleles occurs between DN4 and the DP stage (Sawada et al., 1994). 
Therefore, we would rather suggest that this is either a T-cell-extrinsic effect, since the 
frequency of DN cells was comparable in mixed bone marrow chimeric mice that received 
TKOT bone marrow (Figure 28), or an inappropriate CD44 expression on CD25 negative cells 
(i.e. on DN4 cells). Cd44 itself was found as a Regnase-1 target gene and consequently, 
deletion of Regnase-1 and Roquin-1/2 in DN4 could raise CD44 protein expression and 
therefore cells that appear as DN1 in flow cytometry due to their high expression of CD44 are 
actual DN4 cells lacking Roquin and Regnase-1.  
The overall loss of size and cellularity has features of thymic involution or thymic atrophy. 
Thymic involution is a physiological progress that arises naturally with aging or stress. In 
contrast, thymic atrophy can occur either systemically or locally. Local effects occur due to 
direct infections of the thymus, whereas systemic refers to the consequences of infections 
outside the thymus that cause thymic atrophy by soluble factors such as glucocorticoids and 
pro-inflammatory cytokines reaching the thymus through the blood stream (Nunes-Alves et al., 
2013). During an acute infection, high glucocorticoids levels can induce rapid apoptotic cell 
death of DP thymocytes and secretion of pro-inflammatory cytokines such as TNF or IFN-g 
upon infections can lead to deletion of DP thymocytes mediated by excessive peripheral T cell 
activation (Deobagkar-Lele et al., 2013). Additionally, stromal cells such as thymic epithelial 
cells (TECs) are the major source of cytokines in the thymus and can in turn influence thymic 
atrophy. Aging-associated thymic involution can be sped up by infections, autoimmune 
diseases and cancer.  
Thus, this phenotype could be a result of extrinsic effects due to increased abundance of pro-
inflammatory cytokines in the thymus caused by an autoimmune- or autoinflammatory 
phenotype in the periphery of mice lacking Roquin and Regnase-1 in T cells. To test cell-
extrinsic effects, I generated mixed bone marrow chimeric mice (Figure 27). Here, I 
reconstituted irradiated recipient mice with mixed bone-marrow cells from TKOT mice and wild-
type mice. Indeed, cells that lack Roquin and Regnase-1 neither showed changes in the total 
thymocyte numbers nor altered frequencies of the developmental stages of T lymphocytes. 
This proved that the thymic atrophy in the TKOT and KOT mice resulted from cell-extrinsic 
effects such as pro-inflammatory cytokine storm in the thymus which are highly influenced by 
a loss of Regnase-1.  
5.3.2 Roquin and Regnase-1 control T cell development 
The most striking phenotype of both bone marrow chimeric mice that received Roquin- and 
Regnase-1-deficient bone marrow and mice with a T cell-conditional deletion of Roquin and 
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Regnase-1, was the tremendous abundance of regulatory T cells in the thymi of these mice. 
What are the underlying mechanisms for this aberrant Treg development in the thymus?  
5.3.2.1 Roquin and Regnase-1 affect thymic selection  
As described in the introduction, the affinity hypothesis of T cell selection in the thymus 
suggests that autoreactive T cells with high affinity for self-peptide presented on MHC are 
clonally deleted, whereas cells without or only very low affinity are prone to die by neglect due 
to apoptosis. The development of regulatory T cells depends on self-peptide affinity which 
resembles an intermediate stage between cells receiving normal signal – that then are 
positively selected and can enter the periphery – and high affinity TCR that undergo clonal 
deletion (Klein et al., 2014).  
I compared the thymic phenotypes of mice conditionally deleted for Roquin and/or Regnase-1 
in T cells with the mixed bone marrow chimeric mice to exclude cell-extrinsic effects. The 
changes of positive selection as well as maturation observed in the conditionally deleted mice 
were not reproduced in the mixed bone marrow chimeric system (Figure 24 and Figure 29). 
Nevertheless, we identified tremendous changes in the Treg population in both conditionally 
deleted and mixed bone marrow chimeric mice. 
We further assessed if the processes of clonal deletion or apoptosis due to death by neglect 
are aberrant in the mixed bone marrow chimeric mice. By flow cytometry analysis of 
intracellular cleaved-caspase 3 in “signaled” and “non-signaled” cells, we indeed found that 
cells depleted for Roquin and Regnase-1 showed a reduced frequency of death by neglect in 
comparison to WT cells in the same mouse, whereas clonal deletion of signaled cells was not 
affected (Figure 30). Hence, we conclude that deficiency of Roquin and Regnase-1 could affect 
apoptosis during early selection processes in a cell-intrinsic manner. As described in the 
previous section of the discussion, several anti-apoptotic Bcl2 genes were identified in the 
global mRNA-sequencing analysis as potential targets of Roquin and Regnase-1. Intriguingly, 
apoptosis of thymocytes strongly depends on the pro-apoptotic Bcl-2 family of proteins 
(Tischner et al., 2010). Here, the pro-apoptotic Bcl-1 homology domain 3 (BH3) only protein 
Bim promotes apoptosis by binding and inhibiting anti-apoptotic Bcl-2 proteins such as Bcl-2, 
Bcl-XL and Mcl-1 which further directly suppress Bax and Bak that disrupt mitochondrial 
membrane integrity (Youle and Strasser, 2008). Mice systemically devoid of Bim develop a 
SLE-like autoimmune disease, indicative of a breakdown in tolerance due to a loss of apoptotic 
events (Bouillet et al., 1999). Interestingly, Bcl2l1 is a direct target of the transcription factor c-
Rel and upregulated in cells expressing a paracaspase-inactive MALT1 point mutant (Gewies 
et al., 2014). Therefore, upregulation of Bcl2l1 or Bcl2a1 might be a downstream effect of 
increased canonical NF-kB activity by cRel, which is strongly induced in Roquin and Regnase-
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1-deficient T cells, since cRel itself is a target for Roquin- and Regnase-1-mediated mRNA 
decay (Jeltsch et al., 2014). Whether pro-apoptotic genes such as Bcl2l1 are direct target 
transcripts of Roquin and Regnase-1 or whether the altered expression is due to an increase 
of the target cRel is not proven yet. However, negative selection - a process that also involves 
apoptosis - seemed to be unchanged in the mixed bone marrow chimeric mice receiving 
Roquin- and Regnase-1-deficient bone marrow. It was reported that a balance between pro-
apoptotic and anti-apoptotic factors governs the degree of apoptosis. Negative selection is 
induced upon strong TCR stimulation which causes translocation of Nur77 and Nor-1 from the 
nucleus to the mitochondria. Here, these proteins bind Bcl2 resulting in the exposure of Bcl2’s 
BH3 domain, which promotes inhibition of anti-apoptotic factors such as Bcl-XL (Kolluri et al., 
2008; Thompson and Winoto, 2008). Thus, this signal could outcompete the increased anti-
apoptotic Bcl-XL expression in Roquin- and Regnase-1-deficient T cells. Consequently, the 
effect of Roquin and Regnase-1 on apoptosis could become only visible in a non- or low-TCR 
signaling situation such as death by neglect. 
5.3.2.2 Deregulation of cRel and IkBNS correlates with altered Treg 
development  
The remarkable changes of gene expression in CD4 T cells lacking Roquin and Regnase-1 as 
shown by global mRNA-sequencing supports the idea that altered gene expression highly 
influences T cell immunity and development.  
As outlined in Figure 26 and Figure 31, the expression of the Roquin and Regnase-1 target 
genes cRel and Nfkbid is highly elevated during Treg developmental stages in the thymus of 
mice lacking Roquin and Regnase-1 as well as in the mixed bone marrow chimeric mice. Many 
studies have investigated the direct influence of cRel on the induction of the master 
transcription factor Foxp3. Besides binding to its conserved non-coding regions (CNS) within 
the Foxp3 locus thereby triggering demethylation of CNS2, recruitment of a cRel-
enhanceosome at the Foxp3 promoter and direct binding to CNS3 and causing TCR and co-
stimulatory signals to induce Foxp3 expression have been reported (Long et al., 2009; Zheng 
et al., 2010). Supporting evidence therefore is the loss of regulatory T cells by deleting cRel in 
mice (Ruan et al., 2009). Studies on cRel- and Nfkbid-deficient mice have demonstrated that 
both factors are mandatory for the development of regulatory T cells in the thymus (Schuster 
et al., 2012; Schuster et al., 2017). Therefore, Roquin and Regnase-1 together are likely to 
shape thymic Treg development by regulating their target genes cRel and Nfkbid post-
transcriptionally. Upon loss of function of both post-transcriptional regulators we hypothesize 
derepression of their targets in thymocytes, which would normally become conventional T cells 
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after positive selection in the thymus. However, mis-expression of IkBNS and cRel in these cells 
may switch their fate and make them become Treg cells.  
5.3.2.3 Model for clonal selection in the thymus under the control of Roquin 
and Regnase-1 
The model in Figure 55 is a hypothesis that I assembled according to the observations I made 
in the mixed bone marrow chimeric mice. The mixed bone marrow chimeras that received 
Roquin-and Regnase-1-deficient bone marrow showed less frequencies of cells that die by 
neglect and a tremendous gain of thymic regulatory T cells.  
 
 
Figure 55 ç Model for changes in the selection processes in mice with a T-cell-intrinsic deletion 
of Roquin and Regnase-1. 
The left model shows the general affinity hypothesis which proposes that the reactivity of TCRs for self-
peptide:MHC defines cell fates of thymocytes. Cells without a TCR or a TCR with very low affinity die 
by neglect due to apoptosis, whereas double positive thymocytes that have low affinity undergo positive 
selection and become mature CD4 or CD8 T cells. Strong affinity to self-peptide presented on MHC 
results in clonal deletion by apoptosis to avoid self-reactivity of thymocytes. However, the agonist 
selection of self-reactive regulatory T cells occurs in a window of positively and negatively selected 
thymocytes. T cells depleted for Roquin and Regnase-1 have reduced frequencies of cells that die by 
neglect, but show a higher proportion of thymic-derived regulatory T cells and no difference for clonal 
deletion (right model). 
 
In summary, Roquin and Regnase-1 could influence clonal selection by several mechanisms 
including target gene regulation such as cRel, Nfkbid or Bcl2a1 directly affecting Treg 
development or apoptosis. This could on the one hand reduce apoptosis in non-signaled cells 
and on the other hand force positively selected conventional T cells in the thymus to become 
regulatory T cells in mice deficient for Roquin and Regnase-1. Consequently, conventional T 
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cells with normal TCR affinity might convert to regulatory T cells. Thus, the repertoire of 
regulatory T cells is diluted resulting in less self-reactive TCRs that might be incapable of 
suppressing autoreactive T cells in the periphery. 
Of course, changes in the TCR repertoire with altered TCR affinity could explain the drastic 
abundance of regulatory T cells in the thymus. Many autoimmune diseases have been linked 
to alterations in the TCR repertoire and this may be one explanation for the break of peripheral 
tolerance. In contrast to a healthy, normal individuum with randomly rearranged TCRs, the 
TCRs in an autoimmune-prone environment is biased in its distribution. The reason therefore 
might be the exposure of autoantigens and epitope expansion (Jia et al., 2018).  
However, the influence of Roquin and Regnase-1 on V(D)J-recombination is rather unlikely. 
The possibility that deficiency of Roquin and Regnase-1 causes changes in the TCR repertoire 
needs to be further proven. One option to validate the TCR repertoire is to perform single-cell 
next-generation sequencing, which provides information on paired alpha and beta chains of 
individual cells. An additional possibility would be to cross the TKOT mice to a Nur77-GFP 
reporter mouse. Nur77 is an immediate early gene expressed upon TCR stimulation in T cells 
and would allow to track TCR signaling throughout clonal selection in mice lacking Roquin and 
Regnase-1. To test whether Roquin and Regnase-1 influence downstream TCR signaling, one 
could isolate CD4 or CD8 thymocytes of these mice and stimulate the cells ex vivo with anti-
CD3 and anti-CD28 and check for signaling strength of downstream pathways such as ERK 
signaling.  
5.3.3 Roquin and Regnase-1 cooperatively prevent autoimmunity 
Another focus of this thesis was to investigate the influence of Roquin and Regnase-1 on T 
cell functions in the periphery. Comparing the phenotypes of peripheral lymphoid organs in the 
conditional knockout mice with the data obtained by mixed bone-marrow chimeras, revealed 
that Roquin and Regnase-1 influence activation of CD4 and CD8 T cells and the germinal 
center reaction resulting in increased formation of TFH, TFR and GC B cells. Interestingly, these 
features display multiple characteristics of systemic lupus erythematosus (SLE). Due to 
diverse phenotypes of patients suffering from SLE, it was proposed that SLE is a polygenic 
disease (Lohr et al., 2005). The previously described sanroque mouse is an outstanding 
mouse model thereof and underscores the importance of the RNA-binding protein Roquin-1. 
However, the exact mechanism of how a single point mutation in the ROQ-domain weakens 
the control over autoimmunity by Roquin-1 is not elucidated, yet. Interestingly, mice lacking 
Roquin and Regnase-1 together in T cells also reveal a comparable SLE-like autoimmune 
phenotype. A critical issue was whether Roquin and Regnase-1 together control autoimmunity 
in a cooperative manner.  
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5.3.3.1 Roquin and Regnase-1 reduce the activation threshold of T cells in 
a cooperative manner 
Splenomegaly and lymphadenopathy are characteristics of SLE-like autoimmune diseases. 
We identified that mice devoid of Regnase-1 (KOT) and Roquin-1/2 and Regnase-1 (TKOT) in 
T cells had a drastic gain of spleen and lymph node sizes in comparison to WT mice, which 
was less severe in DKOT mice (Figure 33). TKOT mice developed hyperactivated CD4 and 
CD8 T cells, whereas the effector-memory phenotype of CD4 T cells depended on both Roquin 
and Regnase-1 equally, but the activation of CD8 T cells was more under the control of Roquin 
(Figure 34). Thus, CD8 T cell activation seems to be more dependent on the presence of 
Roquin, which is further supported by the phenotype of mice devoid of Roquin-1 only in T cells 
having more activated CD8 T cells (Table 18).  
Overall, the accumulation of highly activated T cells could be a consequence of potentially non-
functional regulatory T cells in combination with inappropriate co-stimulation which could select 
these T cells for aberrant T cell activation and subsequent T helper cell differentiation. In the 
following, the co-stimulatory receptors that potentially influence the hyperactivation of T cells 
in mice devoid of Roquin and Regnase-1 in T cells are discussed. 
The co-stimulator Icos is one of the best-studied target genes of Roquin and Regnase-1 and 
has been reported by several studies to confer essential roles in T cell activation, proliferation, 
cytokine production and humoral immune responses (Dong et al., 2001). I identified Icos in the 
mRNA-sequencing analysis as cooperative target gene of Roquin and Regnase-1 (Figure 49 
and Figure 50). The aberrant Icos expression both on protein and RNA level in mice lacking 
Roquin, Regnase-1 and all three proteins suggests that Icos co-stimulatory signaling might 
strongly influence T cell activation. The post-transcriptional control over Icos expression by 
Roquin and Regnase-1 proteins is further supported by mixed bone-marrow chimeric mice that 
were reconstituted with a mix of cells lacking Roquin and Regnase-1 and wild-type cells that 
exhibit a huge increase in frequencies of activated CD4 and CD8 T cells and T follicular helper 
cells (Figure 37).  
Besides Icos, Ox40 is important for the survival of T effector cells (Weinberg, 2010). 
Constitutive Ox40 expression through transgenic expression of Ox40L on T cells results in a 
massive induction of effector-like CD4 T cells (Murata et al., 2002). The mRNA-sequencing 
and flow cytometry data revealed that Ox40 exhibits exclusive gene regulation by Roquin both 
on mRNA and on protein level (Figure 49 and Figure 50). Thus, the impairment of regulating 
Ox40 both in DKOT as well as TKOT mice contributed to the effector-memory phenotype of 
CD4 T cells in these mice. Next to Ox40, another TNF-receptor family protein, CD30, was 
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identified by mRNA-sequencing as a new potential cooperative target gene of Roquin and 
Regnase-1 (Figure 48). Intriguingly, deficiency of Ox40 and CD30 in scurfy mice deficient for 
Foxp3 rescued those mice from developing autoimmunity (Gaspal et al., 2011). Thus, an 
aberrant synergistic expression of CD30 and Ox40 on the surface of T cells in mice depleted 
for Roquin and Regnase-1 could contribute to the development of autoimmunity.  
Mice deficient for Roquin and Regnase-1 in T cells have high abundance of Ctla-4, suggesting 
that Roquin and Regnase-1 together control its degradation and thereby confirm a functional 
T cell activation. Nevertheless, high Ctla-4 levels on T cells deficient for Roquin and Regnase-
1 are in contradiction to the strong T cell activation, since Ctla-4 dampens T cell activation by 
competitive binding to CD80/CD86 thereby preventing CD28 activation. Ctla-4 is primarily an 
intracellular protein, stored in intracellular vesicles, and its surface expression is under strict 
control since minor changes of surface expression highly impact T cell activation (Tai et al., 
2012). Therefore, it is likely that the major Ctla-4 levels measured by flow cytometry are 
intracellular and therefore not functioning on the surface. Or, Ctla-4 expression on the surface 
is not sufficient to dampen T cell activation and is thus outcompeted by strong expression of 
co-stimulatory receptors such as Icos and Ox40 that in turn induce strong activation of T cells.  
The impact of Roquin and Regnase-1 on CD8 T cell function and activation now involves a 
potential of the Roquin/Regnase-1-dependent CD8 T cells in anti-tumor immunity, and in 
response to the CTLA-4 blocking antibodies used in the clinics, which will be investigated in a 
new research project of our lab. 
Based on these observations it is reasonable that loss of Roquin-1, Roquin-2 and Regnase-1 
can cause a reduction of the activation threshold of T cells by controlling the expression of 
several co-stimulatory receptors. Since almost all of the polyclonal T cells become activated 
upon loss of Roquin/Regnase-1 expression, it appears likely that activation occurs in the 
absence of cognate antigen recognition. This is in line with the observed phenotype in the 
thymus, where death by neglect is potentially evaded due to a lower activation threshold 
(Figure 55). 
5.3.3.2 Roquin and Regnase-1 cooperativity is essential for the humoral 
immune response  
My data support the idea that Roquin and Regnase-1 together control the germinal center (GC) 
reaction, since a knockout of either Roquin or Regnase-1 or all three proteins in T cells resulted 
in a drastic increase in T follicular helper cell frequencies (Figure 35). In accordance with that, 
the frequency of B cells in the germinal centers correlated with TFH accumulation.  
Altered expression of Icos in TFH cells is observed in several autoimmune diseases such as 
SLE and its expression is mandatory for the generation and function of TFH formation, for their 
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help during GC formation and antibody class switching (Odegard et al., 2008). Consequently, 
the drastic induction of TFH cells and GC B cells in mice lacking Roquin and Regnase-1 
conditionally in T cells could be explained by an abnormal surface expression of Icos. Blocking 
the interaction of Icos with its ligand on B cells by using a monoclonal antibody directed against 
Icos-L has been reported to inhibit TFH development and reduce anti-dsDNA antibody titers in 
the NZB/NZW (New Zealand Black and New Zealand White) autoimmune mouse model, 
suggesting a mandatory and also a driving role for Icos on the surface of follicular T helper 
cells (Hu et al., 2009). However, deleting Icos in sanroque mice, did not rescue the strong TFH 
cell accumulation. Instead, it was later shown that an excessive production of IFN-g causes 
the formation of TFH cells in sanroque mice which is accompanied by a bias towards TH1 cell 
differentiation (Lee et al., 2012). A systemic IFN-g production was similarly observed upon 
deletion of Regnase-1 in T cells (Cui et al., 2017). Interestingly, the Ox40L-Ox40 axis on T 
cells positively influences TFH cell formation and the generation of autoantibodies in humans 
(Ueno and Blanco, 2015), suggesting that elevated levels of Ox40 on T cells deficient for 
Roquin and Regnase-1 might contribute to the formation of T follicular helper cells.  
Besides a tremendous induction of TFH, GC B cells and Treg cells in the periphery of TKOT mice, 
I identified that T cells lacking Roquin and Regnase-1 also adapt a T follicular regulatory T 
(TFR) cell phenotype in a cell-intrinsic manner (Figure 35 and Figure 38). Again, the high Icos 
expression on T cells deficient for Roquin and Regnase-1 might in addition contribute to the 
conversion of regulatory T cells to TFR cells. Intriguingly, deficiency of TFR cells has been 
associated with the development of autoimmunity and enhanced autoantibody production, 
suggesting that TFR cells dampen humoral autoimmunity (Fu et al., 2018). In Sjogren’s 
syndrome patients, elevated TFR and TFH cells correlated with disease severity (Fonseca et al., 
2018). 
Surprisingly, hypergammaglobulinemia was only partially seen in mice lacking Roquin in T 
cells, whereas the greatest effects appeared in mice devoid of Regnase in either KOT or TKOT 
mice. Significant changes were only detectable for the immunoglobulin subclass IgM. 
Interestingly, elevated serum IgM levels are associated to several autoimmune diseases such 
as SLE or RA (Nguyen and Baumgarth, 2016) and could thus be a consequence of Roquin- 
and Regnase-1-deficiency-driven autoimmunity.  
To our surprise, autoantibodies against ds-DNA were massively abundant in mice deficient for 
Regnase-1 in T cells, whereas TKOT mice had less profound autoantibody secretion and mice 
with depletion of Roquin were completely devoid of autoantibodies which is in line with 
previously published data (Jeltsch et al., 2014). Why is the production of autoantibodies 
stronger in mice with a Regnase-1-deficiency in T cells than mice with a T cell-driven depletion 
of Roquin and Regnase-1? One explanation might be that TKOT mice have a higher 
abundance of TFR cells that could potentially dampen autoantibody production. Additionally, 
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the severity of autoimmunity is weaker than in mice with a T cell-specific deficiency of 
Regnase-1 alone, which correlates with the production of autoantibodies. Notably, our group 
found that serum from conditional Roquin-deficient mice contains antibodies reactive to 
pancreatic antigens, suggesting that these mice have the potential to produce autoantibodies 
(Jeltsch et al., 2014). However, the differences in the autoantibody productions cannot be 
explained on the basis of the GC reaction, since we did not observe a positive correlation 
between activation of T cells, TFH differentiation and the abundance of GC B cells. From the 
mRNA-sequencing data in CD4 T cells, we know that deficiency of Roquin and Regnase-1 
together and depletion of Roquin alone causes strong perturbations in the gene regulation, 
whereas Regnase-1-deficiency only mildly affects gene expression (Figure 45). Potentially, the 
strong alterations in gene expression in mice deficient for Roquin and Regnase-1 (TKOT) and 
Roquin (DKOT) in T cells might exceed a tolerated threshold for the production of 
autoantibodies, which is not reached in KOT mice, yet.  
5.3.4 Roquin- and Regnase-1-deficiency causes expansion of non-
functional Treg cells in the periphery 
Interestingly, when I analyzed the mixed bone marrow chimeric mice that received bone 
marrow from WT and TKOT mice, I realized that the abundance of regulatory T cells is 
unchanged for those cells lacking Roquin and Regnase-1 when compared to wild-type cells 
within the same mouse (Figure 38). This was different to the data obtained in the TKOT mice, 
where I observed a strong increase in the regulatory T cell compartment in spleens of TKOT 
mice, but DKOT and KOT mice showed an even higher frequency of peripheral regulatory T 
cells. Why is there a discrepancy between the phenotypes of the mixed bone marrow chimeric 
mice and the conditionally deleted mice? 
I would hypothesize that the expansion of regulatory T cells in the periphery of conditionally 
deleted mice is rather a result of inflammatory conditions, which is supported by the mixed 
bone marrow chimera experiment representing a non-inflamed situation. Due to the mixed 
bone marrow situation, regulatory T cells originated from wild-type bone marrow dampen 
inflammations, which potentially prevents the expansion of Treg cells from TKOT bone marrow 
in the same mouse. Under inflammatory conditions the conversion of Treg cells to TH17-like Treg 
cells has been reported (Voo et al., 2009). However, whether the regulatory T cells in the 
conditionally deleted mice express the TH17 transcription factor ROR-gT or secrete IL-17 must 
be addressed in future experiments. 
One important question still is why the tremendous abundance of regulatory T cells cannot 
rescue the autoimmune phenotype in T cell specific Roquin- and Regnase-1-deficient mice.  
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There are several possibilities that could explain these observations.  
First, the Treg cells might not have the correct TCR specificity to neutralize the autoreactive T 
cells in the TKOT mice. If we assume that conventional T cells in the thymus with a potentially 
lower TCR-affinity become Treg cells as described above, these regulatory T cells would not be 
able to suppress autoreactive T cells in the periphery. This can to date not be excluded and 
therefore, the TCR repertoire needs to be determined in future experiments. 
The latter hypothesis is supported by studies that have demonstrated that regulatory T cells 
with reduced CD25 expression are completely unfunctional due to the requirement of IL-2R-
signaling for functional programming and activity of regulatory T cells and that these mice are 
prone to develop autoimmunity (Chinen et al., 2016; Toomer et al., 2019). Thus, the 
suppressive capacity of the regulatory T cells from mice with a T cell-specific loss of Roquin 
and Regnase-1 is attenuated due to a higher proportion of CD25- Treg cells with an 
inappropriate functionality (Figure 31). This was already proven for Roquin-deficient regulatory 
T cells, since these cells were incapable of protecting mice from T cell-transfer-induced colitis 
in comparison to wild-type control Treg cells when injected together with naïve CD4 T cells 
(Essig et al., 2017). 
And finally, regulatory T cells originated in mice lacking Roquin and Regnase-1 could be 
instable or have an altered plasticity. The strong regulatory T cell abundance in the thymus 
was not reflected in the periphery of mixed bone marrow chimeric mice receiving TKOT bone 
marrow cells (Figure 38). Appropriately, the frequencies of TFR cells were drastically increased 
in the mixed bone marrow chimeric mice, proposing that thymic derived regulatory T cells 
rather adapted a follicular regulatory T cell phenotype in the absence of Roquin and Regnase-
1. I noticed that regulatory T cells lacking CD25 already in the thymus are highly abundant in 
mice that were reconstituted with bone marrow devoid of Roquin and Regnase-1 expression 
in comparison to wild-type bone marrow cells (Figure 31). This is in line with a previously 
published study, where mice with a Treg-specific deletion of the Roquin paralogs lost CD25 and 
rather adapted a TFR-phenotype (Essig et al., 2017). Indeed, it has been reported that CD25-, 
Foxp3+ T cells can adapt a highly flexible phenotype and develop into germinal center-resident 
TFR cells (Wing et al., 2017). The fact that TFR cells differentiate from thymic-derived naïve 
Foxp3+ precursors (Linterman et al., 2011), further support the hypothesis that the thymic 
regulatory T cells in the TKOT mice adopt a TFR phenotype in the periphery.  
5.3.5 The fate of TH17 cells is under control of Roquin and Regnase-1  
The tremendous activation of T cells prompted us to also investigate the bias of T cells lacking 
Roquin and Regnase-1 to differentiate towards the T helper cell lineages (Figure 1).  
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We assessed expression of the signature cytokines and transcription factors of TH1 (IFN-g), 
TH2 (IL-4), TH17 (IL-17A) or Treg (CD25 and Foxp3) CD4 T cells in either CD4 T cells of mice 
depleted of Roquin or Regnase-1 in T cells (Figure 39) or naïve CD4 T cells from inducible 
knockout mice, that have been deleted in vivo by administration of tamoxifen and were 
differentiated towards TH1, TH17 and Treg in vitro (Figure 40).  
The relatively low bias towards IFN-g producing TH1 T cells that we observed in Roquin-
deficient T cells is in accordance with previous investigations we made in our laboratory 
(Jeltsch et al., 2014; Vogel et al., 2013). There was a strong trend towards high IFN-g 
expression of all knockouts in comparison to wild-type, but was not significant. As mentioned 
previously, increased IFN-g production was linked to autoimmunity in sanroque mice and 
caused accumulation of TH1 cells. Moreover, conditional deletion of Regnase-1 in T cells either 
alone or in combination with the sanroque mutation induced IFN-g-expressing cells that 
infiltrated into multiple organs (Cui et al., 2017). Some studies suggested that Roquin regulated 
the expression of the Ifng mRNA, but whether this effect is direct or indirect is still not solved 
(Li et al., 2007; Vinuesa et al., 2005; Yu et al., 2007). 
Especially, IL-17 showed strong Roquin-dependency, since the increase in expression was 
comparable in T cells from TKOT and DKOT mice, but milder in Regnase-1-deficient KOT mice. 
Recent literature already suggests that Roquin and Regnase-1 control TH17 differentiation by 
regulating genes that confer essential roles in this differentiation pathway (Jeltsch et al., 2014). 
The atypical NF-kB inhibitor IkBNS and IkBz and the NF-kB transcription factor cRel and Irf4 
are required for efficient TH17 differentiation and their function influence susceptibility to murine 
autoimmune diseases such as experimental autoimmune encephalomyelitis (Annemann et al., 
2015; Brustle et al., 2007; Chen et al., 2011; Kobayashi et al., 2014). Since Roquin knockout 
had a stronger effect on IL-17A expression than the single Regnase-1-deficiency, I would 
assume that the robust regulation of IkBNS as it was discussed in section 4.1.2 by Roquin 
dominantly influences the effect on TH17 differentiation, since the expression of several 
cytokines such as IL-17A, IL-17F and IL-10 is dependent on IkBz and additionally IkBNS. 
Nevertheless, in T cells from TKOT mice, the abundance of IL-17-producing cells was still 
higher in both analyzed systems. Therefore, I would suggest that a combination of de-
repressed Roquin and Regnase-1 target genes might strongly influence TH17 differentiation 
and prevent autoimmunity, since aberrant expansion of TH17 cells has been linked to 
autoimmunity such as multiple sclerosis. 
The cell fate decision of either TH17 or Treg cells is reciprocal since both T cell subsets are 
induced in the presence of TGF-b. TH17 differentiation is favored together with pro-
inflammatory cytokines such as IL-6 or IL-21, whereas regulatory T cell differentiation in the 
periphery occurs in the absence of these pro-inflammatory signals, but is promoted by IL-2 
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(Bettelli et al., 2006). The balance of TH17 and Treg differentiation is critical in many autoimmune 
diseases such as RA and MS and a mis-regulation thereof can cause autoimmunity. 
Consistent with increased TH17 differentiation, we found in the in vitro differentiation system 
that regulatory T cell fate is decreased in T cells lacking Roquin and Regnase-1. This loss of 
CD25 and Foxp3 expression is gradually decreasing with Roquin and Regnase-1 deletion, 
which is also in accordance with our previously published data showing that Roquin-deficient 
T cells differentiate less efficiently into iTreg (Jeltsch et al., 2014). CD4 T cells from TKOT mice 
that were stimulated ex vivo showed increased expression of IL-10 and CD25. This result is in 
contradiction to the data obtained by direct Treg differentiation in vitro. The cytokine IL-10 is 
produced by a variety of T helper cell subsets and is therefore not an ideal signature cytokine 
for Treg determination. Therefore, the data obtained by in vitro differentiated T cells are more 
revealing and the Foxp3 expression in the ex vivo data will have to be addressed in future 
experiments. Thus, I would conclude that Roquin- and Regnase-1-deficient CD4 T cells 
receiving signals in the periphery rather favor to differentiate into the TH17 cell fate than into 
the reciprocal fate of regulatory T cells, which is supported by the cytokine expression profiles 
in the knockout mice, and that the elevated frequencies of Treg cells in the TKOT mice is rather 
a result of strong inflammation in these mice. 
The expression of the TH2 signature cytokine IL-4 was assessed in ex vivo isolated T cells 
since the in vitro differentiation of TH2 cells was not efficient. The elevated expression of IL-4 
in T cells from mice lacking Roquin and Regnase-1 was rather influenced by Regnase-1, since 
Regnase-1-deficient T cells also expressed higher levels of IL-4, whereas Roquin-deficiency 
did not alter IL-4 production. Cui et al. investigated the expression of TH2 signature genes such 
as Il4 and Gata3 and found that Regnase-1-deficiency caused upregulation of these genes, 
whereas gene expression in sanroque T cells was unchanged. Therefore, an exclusive 
function for Regnase-1 in controlling TH2 differentiation is possible.  
Collectively, I demonstrated that Roquin and Regnase-1 control T cell activation and 
differentiation, since the absence of Roquin and Regnase-1 in T cells causes an 
unphysiological expression of several cytokines and subset-specifying transcription factors. 
Roquin and Regnase-1 cooperatively control peripheral TH17 and potentially thymic Treg cell 
fate decisions, whereas Regnase-1 might additionally contribute to TH2 responses. TCR 
activation triggers MALT1-induced cleavage of Roquin and Regnase-1 proteins during T cell 
activation, which emphasizes the importance of these RNA-binding proteins during T cell fate 
decisions. How TCR signaling strength influences the expression of Roquin and Regnase-1 
target genes is addressed by a colleague in a different research project.  
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5.3.6 Summarizing the phenotypes of different Roquin and Regnase-1 
mouse models 
Table 23 summarizes the phenotypes observed in mice deficient for Regnase-1 (KOT), the 
Roquin paralogs (DKOT) and a triple-knockout of Roquin and Regnase-1 (TKOT) in T cells in 
comparison to WT mice. To distinguish between cell-intrinsic and -extrinsic effects, I generated 
mixed bone marrow chimeric mice that were irradiated and reconstituted with mixed bone 
marrow from wild-type or Regnase-1-/Roquin-1/2-T-cell-deficient mice (TKOT CD45.2). 
Intriguingly, most observed phenotypes in the thymus were stronger in T cells devoid of 
Regnase-1 in comparison to Roquin-deficient mice. One explanation therefore might be that 
all mice were analyzed at an age of 5-6 weeks, since the KOT and TKOT mice became sick. At 
this point, Roquin-deficient mice were still healthy and therefore it might be interesting to 
analyze thymic development in older mice. Additionally, Regnase-1 was described to interact 
with the helicase UPF1 to induce mRNA degradation. UPF1 is an essential factor in nonsense-
mediated decay, a process in which transcripts with a pre-mature stop codon are targeted for 
degradation. UPF1 itself was described to play an important role during T cell development, 
whereby impaired function of UPF1 and UPF2 proteins cause reduced thymocyte development 
due to a stabilization of out-of-frame transcripts (Frischmeyer-Guerrerio et al., 2011).  
 
Table 23 ç Comparing phenotypes of Cd4-cre driven deletions of Roquin and Regnase-1 mouse 
models and mixed bone marrow chimeric mice. 
Summary of phenotypes in mice conditionally devoid of Regnase-1 (KOT), Roquin-1/2 (DKOT) and 
Roquin and Regnase-1 (TKOT) in T cells compared to cells from mixed bone marrow chimeric mice 
reconstituted with wild-type and bone marrow from TKOT mice (TKO T CD45.2). -: no change in relation to 
wild-type control, --: reduced frequency in comparison to wild-type, +: increased frequency in 
comparison to wild-type control, ++: very strong increase in frequency in comparison to wild-type control 
and /: not analyzed. 
 KOT DKOT TKOT TKOT CD45.2 
thymus 
T cell development + - + - 
death by neglect / / / -- 
positive selection - - + -- 
nTreg ++ + ++ ++ 
negative selection / / / - 
periphery 
EM CD4 + + ++ ++ 
EM CD8 + ++ ++ ++ 
TFH + + ++ ++ 
GC B cells + + ++ / 
hypergammaglobulinemia + - + / 
autoantibodies ++ - + / 
TFR + + ++ ++ 
iTreg ++ ++ + - 
cytokine 
expression 
iTreg + + - / 
TH1 - - - / 
TH2 + - + / 
TH17 + ++ ++ / 
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Indeed, we do see cell-intrinsic effects such as hyperactivation of T cells or thymic regulatory 
T cell accumulation in the mixed bone marrow chimeric mice that received Roquin- and 
Regnase-1-deficient bone marrow, but we cannot distinguish if the effect solely derived from 
lacking Regnase-1 in T cells or if Roquin additionally contributed. Therefore, addressing the 
single contributions of Roquin and Regnase-1 in bone marrow chimeric mice with mixed bone 
marrow from wild-type and either DKOT or KOT mice would be one interesting future 
experiment.  
Mice with Roquin- and Regnase-1-deficiency in T cells developed a strong autoimmune 
phenotype in the periphery, suggesting that Roquin and Regnase-1 cooperatively function in 
the control of autoimmunity, especially by tightly regulating the step of T cell activation and T 
helper cell fate commitment. Here, cooperative control by both Roquin and Regnase-1 was 
observed for TH17 differentiation and TH1 differentiation was also slightly affected. The strong 
abundance of regulatory T cells in the periphery of TKOT, DKOT and KOT mice is most probably 
due to inflammatory conditions resulting in an expansion of peripheral Treg cells. 
The phenotypes of the Roquin and Regnase-1 mouse models support our hypothesis that 
Roquin and Regnase-1 have overlapping functions in the immune system by cooperatively 
controlling transcript expression that regulates not only the activation and differentiation of CD4 
and CD8 T cells, but in addition the GC reaction. However, individual contributions of Roquin 
and Regnase-1 are also possible, since some phenotypes exclusively depend on Regnase-1 
(TH2 differentiation) and Roquin (CD8 T cell activation). 
In summary, this research project helped to gain novel insights into the cellular functions of 
Roquin and Regnase-1. I was able to identify that Roquin and Regnase-1 strongly impact on 
regulatory T cell development in the thymus, the activation threshold of T cells and the germinal 
center reaction controlling humoral immune response and autoimmunity and most of these 
phenotypes equally depended on Regnase-1 and Roquin.  
5.3.7 Can we connect the mouse phenotypes with the global mRNA 
expression data? 
Strikingly, Regnase-1-abrogation in T cells caused a strong autoimmune phenotype in these 
mice characterized by an enormous induction of autoantibodies (Figure 35). However, mRNA-
sequencing analysis of Regnase-1-deficiency in CD4 T cells revealed only a very mild change 
in the overall gene expression (Figure 44).  
Since the mRNA-sequencing analysis was only performed on in vitro cultured TH1 cells, the 
strong autoimmunity could still result from other T cell subsets such as Treg cells or CD8 T cells 
or might only be detectable in vivo. Although the effect on CD8 activation was stronger in mice 
lacking Roquin than those devoid of Regnase-1 in T cells and therefore this might be unlikely. 
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However, the impact of CD8 T cells on the production of autoantibodies is still uncertain and 
therefore the absence of autoantibodies could be reasoned in hyperactivated CD8 T cells that 
lack Roquin. Additionally, I could imagine that the strong effect of Regnase-1 on the pro-
inflammatory cytokine IL-6 might severely impact the immunological environment. Excessive 
IL-6 production induces a life-threatening complication, termed cytokine storm, and causes 
chronic autoimmune diseases such as RA (Kishimoto, 2005). This could in addition also 
explain the strong thymic atrophy apparent in mice KOT and TKOT mice. 
The concept of cooperativity by Roquin and Regnase-1 is further proven by the dramatically 
increased Regnase-1 expression on protein and mRNA level in mice deficient for Roquin in T 
cells (Figure 40). If Regnase-1 or Roquin would bind and regulate the mRNAs in a mutually 
exclusive and compartmentalized fashion as suggested by Mino et al. and Cui et al., we would 
not expect any autoimmune phenotype in Roquin double-knockout mice, since the tremendous 
amounts of Regnase-1 could substitute for Roquin. 
5.3.8 How does the observed cooperativity of Roquin and Regnase-1 
fit with recent concepts? 
Finally, an important aspect is, if we can connect the data generated in this thesis with the 
previously published papers by Jeltsch et al., Mino et al. and Cui et al. (Figure 6).  
These previously reported studies used different cell lines and mouse models and this might 
highly influence the conceptual outcome. While Jeltsch et al., analyzed Roquin- and Regnase-
1-deficient mouse embryonic fibroblasts (MEFs) and mouse T cells, the studies of Mino et al. 
and Cui et al. switched between human and mouse systems by utilizing MEF cells, bone-
marrow-derived macrophages, HeLa cells, HEK cells, Jurkat cells and NIH/3T3 cells. Although 
Roquin and Regnase-1 are highly conserved in human and mouse, we saw that Regnase-1 is 
hardly expressed in MEF cells (data not shown) and it is commonly accepted that MEF cell 
clones are highly variable. Therefore, I performed all experiments exclusively in primary T cells 
either under well-established in vitro conditions or directly ex vivo by flow cytometry. Thus, all 
experiments are highly comparable and reflect the physiological function of Roquin and 
Regnase-1 in T cells. Though Cui et al. used primary T cells, the genetic combination of T-cell-
specific Regnase-1 deletion and sanroque mutation is difficult to interpret, since to date the 
functional and mechanistical role of the M199R mutant of Roquin-1 is still unsolved and 
therefore the interpretation of the phenotypic consequences is questionable. Moreover, 
sanroque mice still express wild-type Roquin-2, which is not addressed in these studies at all, 
even though it can compensate for the loss-of-function of Roquin-1. 
The major claim in the study by Mino and colleagues is that Roquin and Regnase-1 are 
spatially separated in P-bodies and endoplasmatic reticulum and functionally distinct from each 
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other, since Roquin acts on translationally-inactive and Regnase-1 controls the expression of 
translationally-active mRNAs. However, by analysis of the Nfkbid mRNA we were able to show 
that Roquin inhibits translation of some mRNA targets (section 4.1.2) and so does Regnase-1 
for the Nfkbiz mRNA. Therefore, at least in T cells, the distinction of Roquin and Regnase-1 by 
controlling translationally inactive or active mRNAs is not informative. Even though Mino et al., 
claimed that Roquin and Regnase-1 are spatially distinct from each other, their polysomal 
fractionations show that Roquin and Regnase-1 proteins were both present in non-polysomal 
fractions, suggesting that indeed these proteins may be able to function together. Although 
Mino and colleagues did not see association of Regnase-1 in P-bodies, this localization has 
already been described previously (Suzuki et al., 2011). 
Finally, Cui et al., suggested a strong autoregulation of Regnase-1 that is independent of 
Roquin in human Jurkat T cells. Unlike this, I identified a strong de-repression of Regnase-1 
in the absence of Roquin and the regulation of Regnase-1 was highly dependent on both 
Roquin and Regnase-1 (Figure 42 and Figure 52). The differences here might be explained by 
the different cell systems and species being used, however, our data have been obtained in 
primary T cells.  
Collectively, the data I generated in this thesis can expand the current models: The major mode 
of gene regulation by Roquin and Regnase-1 in T cells is cooperativity and less exclusivity or 
redundancy. But, Roquin and Regnase-1 exclusive target genes in T cells most likely exist. 
Roquin and Regnase-1 directly interact, which is in contradiction to a suggested spatial 
compartmentalization. Additionally, Roquin indeed regulates translational active mRNAs such 
as Nfkbid and, at least in T cells, Regnase-1 is not capable of auto-regulating its own 
expression and depends on the presence of Roquin-1. The involvement of other factors such 
as UPF1 or members of the deadenylation or decapping machinery in a huge post-
transcriptional network is likely and thus enables a tightly controlled gene regulation which is 
required to prevent autoinflammation and autoimmunity. 
5.4 Conclusions, model and future perspectives 
A strong evidence for the importance of post-transcriptional gene regulation by RNA-binding 
proteins comes from a very recent study that uncovers a human patient with a homozygous 
nonsense mutation of Roquin-1 (Tavernier et al., 2019). The patient suffers from 
hyperinflammation and uncontrolled cytokine secretion such as TNF, IL-2 and IL-17A 
characterized as hemophagocytic lymphohistiocytosis (HLH). Interestingly, the R687* variant 
of this patient phenocopies aspects of the sanroque point mutation by causing aberrant 
immune cell activation and increased cytokine release.  
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In this thesis, I was able to prove the concept of a cooperative post-transcriptional gene 
regulation in CD4 T cells by the RNA-binding protein Roquin on several levels (Figure 56).  
 
 
 
Figure 56 ç Model for Roquin- and Regnase-1-mediated gene regulation in CD4 T cells. 
Roquin and Regnase-1 have overlapping target genes in CD4 T cells. These target mRNAs involve 
genes that encode for co-stimulatory receptors (Ctla-4, Icos, Ox40), transcription factors (cRel), 
modulators of transcription factors (IkBNS, IkBz) and mitochondrial anti-apoptotic members of the Bcl2 
family such as Bcl-XL. Upon TCR stimulation and co-stimulation, Roquin and Regnase-1 proteins are 
cleaved by the paracaspase MALT1 and release targeted mRNAs from repression. Roquin and 
Regnase-1 target mRNAs can be regulated in several ways: Roquin exclusive (IkBNS, Ox40), 
cooperative by Roquin and Regnase-1 interacting with the same stem loop structure (Icos) or on two 
distinct stem loop structures (Ctla-4) and the involvement of additional post-transcriptional regulators on 
the RNA is possible (grey symbol). The repression of Roquin and Regnase-1 targeted mRNAs controls 
the differentiation of TH17 and TFH cells and potentially apoptotic events and Treg differentiation in the 
thymus.  
 
First, I identified that multiple Roquin proteins act on the regulation of their mRNA targets at 
least in an additive but potentially cooperative or synergistic manner. This was exemplified for 
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the Roquin exclusive target genes Ox40 (Figure 13) and Nfkbid (Figure 20). Here, Roquin 
enables binding of high-affinity stem loop structures to confer strong post-transcriptional gene 
regulation by inducing mRNA decay or mRNA decay and translational inhibition (Figure 21). I 
therefore propose, that the specific mode of regulation in this system is encoded within its very 
different cis-elements. 
Second, the major molecular gene regulation is cooperative, which occurs at different degrees 
– either by Roquin on multiple stem loop structures as shown for the prototypical target Nfkbid 
or by the cooperation with the endonuclease Regnase-1 and may include other, so-far 
unknown, factors. The cooperativity with Regnase-1 results in a selective repression of certain 
target genes presumably harboring mainly cooperative or redundant elements. However, 
Roquin exclusive targets such as Ox40 also exist. This concept was proven by reconstitution 
experiments that enabled a separation of the molecular functions of Roquin and Regnase-1 
(Figure 51). And finally, evaluating the direct interaction of Roquin and Regnase-1, provided 
the molecular mechanism underlying cooperativity (Figure 53). The involvement of additional 
post-transcriptional effectors associated with Regnase-1, such as UPF1, may not contradict 
cooperativity, but rather contribute and increase the regulatory potential. 
The cooperativity of Roquin and Regnase-1 is further supported by comparing conditional T 
cell-specific knockout mice of Roquin and Regnase-1 and mixed bone marrow chimeric mice, 
where we identified that cellular phenotypes such as thymic regulatory T cell development 
(Figure 32) and T cell activation (Figure 37) as well as TH17 differentiation (Figure 39) are 
enhanced in TKOT mice. These phenotypes most likely arise from an aberrant cooperative 
gene regulation of previously described targets (Icos, Ctla-4, IkBNS, IkBz, cRel) and newly 
identified Roquin and Regnase-1 targets (Bcl-XL, cKit, CD30) (Figure 26). Whether or not 
Roquin- and Regnase-1-deficiency influences selection processes in the thymus by direct 
target regulation or indirect effects, and how this affects the development of autoimmunity 
needs to be addressed in the future. 
Additionally, the strong and additive peripheral autoinflammatory and autoimmune phenotype 
of mice devoid of Roquin and Regnase-1 in T cells in comparison to only Roquin- or Regnase-
1-deficiency, support a cooperative regulation of these cellular processes. The autoimmunity 
is characterized by an increased GC reaction accompanied by a defective humoral immune 
response which results in the production of autoantibodies (Figure 35). However, mice 
deficient for Regnase-1 expressed the highest levels of autoantibodies. The degree of 
perturbation of gene expression in T cells deficient for Roquin and Regnase-1 and Roquin-
deficient T cells was much stronger as the gene expression of Regnase-1-deficient T cells. 
Thus, the strong alterations in gene expression in mice deficient for Roquin and Regnase-1 
(TKOT) and Roquin (DKOT) in T cells might quantitatively exceed the gene expression changes 
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that effectively induce the production of autoantibodies, a limitation which is not reached in 
KOT mice, yet. 
Collectively, the data generated in this thesis enable a novel understanding of Roquin and 
Regnase-1, which participate in a complex, cooperative network of post-transcriptional gene 
regulation during activation and differentiation of T cells. The mouse models investigated in 
this study clearly show that an appropriate and dynamic expression of certain genes such as 
co-stimulatory receptors or transcription factors during these fragile immune processes are 
mandatory to prevent the development of autoinflammatory and autoimmune diseases. 
Understanding the molecular function of Roquin and Regnase-1 and how they are connected 
in a post-transcriptional network is critical for the establishment of targeting strategies of the 
system in future therapies of autoimmune diseases. 
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Appendices 
Appendix 1 ç Flow cytometry analysis of Roquin and mCherry expression in Rc3h1-/-, rtTA3 MEF 
cells upon doxycycline-induced expression of lN-Roquin-1(K220A, K239A, R260A) and lN-p2A-
mCherry. 
  
 
 
 
Appendix 2 ç Absorbance profiles at 260 nm obtained during fractionations of sucrose gradients 
in Figure 21. 
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Appendix 3 ç Analyzing positive selection and maturation of CD4 and CD8 T cells in WT, KOT and 
DKOT mice. 
a) Positive selection was determined in thymi of live, CD45.2+ cells from WT, DKOT and KOT mice by 
CD69 and TCRb expression pattern in populations 1-5. b) CD4 and CD8 expression in the 5 populations 
defined by TCRb and CD69 expression in a) of WT, DKOT and KOT thymocytes. 
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Appendix 4 ç Gene list of cooperative targets in cluster 2 and 4. 
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KO TK
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DK
O
Gm15987 4 0,0 3,4 1,3 5,5 1,6 4,3
Cebpd 4 0,0 1,2 0,7 5,5 4,4 7,5
Kit 4 0,0 2,0 1,9 5,0 2,5 2,6
Tnfrsf8 4 0,0 0,6 2,1 4,8 7,4 2,2
Tlr9 4 0,0 1,3 2,4 4,6 3,6 1,9
Gm14718 4 0,0 1,7 2,0 4,5 2,6 2,2
Zcchc18 4 0,0 2,6 2,7 4,4 1,7 1,6
Fam43a 4 0,0 0,8 1,2 4,4 5,5 3,7
Ebi3 4 0,0 1,0 3,3 4,1 4,3 1,3
Tox2 4 0,0 0,4 1,6 4,1 10,9 2,6
Ppic 4 0,0 1,8 1,4 4,0 2,3 2,9
Prickle1 4 0,0 2,2 1,1 3,9 1,8 3,6
Fcrl1 4 0,0 1,0 0,7 3,7 3,7 5,2
Icos 4 0,0 1,9 2,4 3,6 1,9 1,5
Mpzl1 4 0,0 1,1 0,9 3,5 3,2 3,7
Cpd 4 0,0 1,0 1,8 3,4 3,3 1,9
Lmna 4 0,0 0,4 1,6 3,3 9,5 2,1
RP24-312B12.1 4 0,0 2,2 2,0 3,2 1,5 1,7
Zc3h12c 4 0,0 0,4 0,9 3,2 8,8 3,5
Fam84a 4 0,0 0,7 1,2 3,2 4,4 2,6
Upp1 4 0,0 0,6 0,5 3,2 5,5 6,7
Gatm 4 0,0 0,6 1,4 3,1 5,0 2,3
Rhov 4 0,0 0,4 0,8 2,9 7,3 3,5
Tex15 4 0,0 1,0 1,0 2,8 2,9 2,8
Smox 4 0,0 1,1 1,3 2,7 2,4 2,2
Nfkbia 4 0,0 0,8 0,9 2,7 3,4 3,1
Rims3 2 0,0 1,2 1,1 2,7 2,2 2,4
Alcam 4 0,0 1,3 1,3 2,7 2,1 2,1
Marcks 4 0,0 0,5 0,9 2,7 5,8 3,1
Rilpl2 4 0,0 1,6 1,4 2,7 1,6 1,9
Pou2f2 4 0,0 2,0 1,8 2,7 1,3 1,5
Ankrd55 4 0,0 1,2 1,2 2,6 2,2 2,1
Tubb6 4 0,0 0,5 1,2 2,6 5,0 2,3
Nme4 2 0,0 0,4 0,8 2,6 6,7 3,1
Adap1 2 0,0 1,1 1,7 2,6 2,4 1,5
Clip3 2 0,0 1,1 1,5 2,6 2,3 1,8
Asns 4 0,0 0,8 1,0 2,6 3,1 2,6
Gstt1 4 0,0 0,8 1,7 2,6 3,2 1,5
Ctla4 2 0,0 0,7 1,6 2,6 3,8 1,7
Slamf6 4 0,0 1,0 1,9 2,6 2,5 1,3
Tmem121 2 0,0 0,6 1,2 2,5 4,1 2,1
Batf 4 0,0 1,2 1,4 2,5 2,1 1,8
Pnpla3 2 0,0 0,4 1,6 2,5 5,6 1,5
Batf3 4 0,0 0,6 0,5 2,5 4,2 4,5
Sox12 4 0,0 0,6 0,9 2,5 4,4 2,6
Ctsl 4 0,0 0,7 0,9 2,4 3,4 2,8
Furin 4 0,0 1,1 1,3 2,4 2,2 1,8
Zfp827 4 0,0 1,2 1,7 2,4 2,1 1,4
Asb2 2 0,0 0,8 1,4 2,4 2,9 1,7
Zbtb18 2 0,0 1,6 1,2 2,4 1,5 2,0
Sptb 4 0,0 0,4 0,5 2,4 6,9 4,7
Eno2 4 0,0 0,5 1,0 2,4 4,9 2,4
Foxj1 4 0,0 0,5 0,5 2,3 5,1 4,6
Dbndd2 2 0,0 0,5 1,0 2,3 4,5 2,4
Otud5 2 0,0 0,9 1,6 2,3 2,6 1,4
Ceacam16 2 0,0 0,5 0,9 2,3 4,2 2,6
Gpr125 2 0,0 0,6 1,3 2,3 3,6 1,7
Ctsf 2 0,0 0,9 1,4 2,3 2,6 1,7
Slc15a3 4 0,0 0,5 0,7 2,2 4,2 3,4
Pfn2 2 0,0 0,7 1,0 2,2 3,1 2,1
Cd40lg 4 0,0 1,4 1,7 2,2 1,6 1,3
Spock2 2 0,0 0,7 1,0 2,2 3,1 2,2
RP24-113D21.1 4 0,0 1,0 1,1 2,1 2,2 2,0
Fah 2 0,0 1,1 1,0 2,1 1,9 2,1
Zc3h12d 2 0,0 1,0 1,5 2,1 2,2 1,4
Pik3c2b 2 0,0 0,8 1,5 2,1 2,7 1,4
Slc35f5 2 0,0 0,4 1,1 2,1 5,4 1,8
Gpr179 2 0,0 0,5 1,6 2,0 4,4 1,3
Trim71 4 0,0 1,2 0,5 2,0 1,7 4,0
Slc2a6 4 0,0 0,7 0,8 2,0 2,8 2,5
Hif3a 2 0,0 0,4 1,1 2,0 5,4 1,9
Mgrn1 2 0,0 0,7 0,8 2,0 2,7 2,5
Rab31 2 0,0 0,4 0,4 2,0 5,3 5,2
Zak 2 0,0 0,6 0,8 2,0 3,2 2,5
Ankrd34b 4 0,0 0,6 0,6 2,0 3,6 3,4
Irak3 2 0,0 0,9 0,7 2,0 2,1 2,7
Fam213a 2 0,0 0,5 1,4 2,0 3,8 1,4
Milr1 2 0,0 0,9 0,6 1,9 2,2 3,1
Gm7645 2 0,0 0,5 0,9 1,9 3,7 2,3
Abhd17c 4 0,0 1,1 1,0 1,9 1,7 1,8
Perp 4 0,0 0,5 0,6 1,9 3,5 3,0
Usp6nl 2 0,0 1,0 1,0 1,9 1,9 1,9
Tead1 4 0,0 1,2 0,5 1,9 1,6 3,9
Armcx2 2 0,0 0,7 1,0 1,9 2,6 1,9
Ltbp3 2 0,0 0,4 0,9 1,9 4,3 2,2
Ell2 4 0,0 1,0 1,2 1,9 1,8 1,6
Lama5 2 0,0 1,2 1,0 1,9 1,6 1,9
Gm15051 2 0,0 0,4 0,7 1,9 4,2 2,7
Tnp2 2 0,0 0,4 0,8 1,9 4,7 2,2
Gm13012 2 0,0 0,5 0,9 1,8 3,4 2,0
Tmsb15b1 2 0,0 0,9 1,0 1,8 2,0 1,8
Ikzf4 2 0,0 1,1 0,9 1,8 1,6 2,0
Gm20645 4 0,0 0,5 1,0 1,8 4,1 1,8
Gab2 2 0,0 1,0 0,7 1,8 1,8 2,5
Gm12699 4 0,0 0,5 0,8 1,8 4,0 2,4
Plscr1 4 0,0 0,4 1,3 1,8 5,0 1,5
Hrsp12 2 0,0 0,4 1,4 1,8 5,0 1,3
Ifnlr1 2 0,0 0,6 0,6 1,8 2,9 3,1
Slc37a2 4 0,0 0,5 0,9 1,8 3,5 2,1
Ccdc50 4 0,0 0,6 0,9 1,8 3,0 2,0
Fam46a 2 0,0 1,2 1,2 1,8 1,5 1,4
Itgb5 2 0,0 1,0 0,5 1,8 1,8 3,4
Tnfrsf25 2 0,0 0,7 1,2 1,8 2,5 1,4
Espn 2 0,0 0,6 0,8 1,8 2,7 2,3
H2-Eb1 2 0,0 0,6 0,6 1,7 2,8 3,1
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Gm15987 4 0,0 3,4 1,3 5,5 1,6 4,3
Cebpd 4 0,0 1,2 0,7 5,5 4,4 7,5
Kit 4 0,0 2,0 1,9 5,0 2,5 2,6
Tnfrsf8 4 0,0 0,6 2,1 4,8 7,4 2,2
Tlr9 4 0,0 1,3 2,4 4,6 3,6 1,9
Gm14718 4 0,0 1,7 2,0 4,5 2,6 2,2
Zcchc18 4 0,0 2,6 2,7 4,4 1,7 1,6
Fam43a 4 0,0 0,8 1,2 4,4 5,5 3,7
Ebi3 4 0,0 1,0 3,3 4,1 4,3 1,3
Tox2 4 0,0 0,4 1,6 4,1 10,9 2,6
Ppic 4 0,0 1,8 1,4 4,0 2,3 2,9
Prickle1 4 0,0 2,2 1,1 3,9 1,8 3,6
Fcrl1 4 0,0 1,0 0,7 3,7 3,7 5,2
Icos 4 0,0 1,9 2,4 3,6 1,9 1,5
Mpzl1 4 0,0 1,1 0,9 3,5 3,2 3,7
Cpd 4 0,0 1,0 1,8 3,4 3,3 1,9
Lmna 4 0,0 0,4 1,6 3,3 9,5 2,1
RP24-312B12.1 4 0,0 2,2 2,0 3,2 1,5 1,7
Zc3h12c 4 0,0 0,4 0,9 3,2 8,8 3,5
Fam84a 4 0,0 0,7 1,2 3,2 4,4 2,6
Upp1 4 0,0 0,6 0,5 3,2 5,5 6,7
Gatm 4 0,0 0,6 1,4 3,1 5,0 2,3
Rhov 4 0,0 0,4 0,8 2,9 7,3 3,5
Tex15 4 0,0 1,0 1,0 2,8 2,9 2,8
Smox 4 0,0 1,1 1,3 2,7 2,4 2,2
Nfkbia 4 0,0 0,8 0,9 2,7 3,4 3,1
Rims3 2 0,0 1,2 1,1 2,7 2,2 2,4
Alcam 4 0,0 1,3 1,3 2,7 2,1 2,1
Marcks 4 0,0 0,5 0,9 2,7 5,8 3,1
Rilpl2 4 0,0 1,6 1,4 2,7 1,6 1,9
Pou2f2 4 0,0 2,0 1,8 2,7 1,3 1,5
Ankrd55 4 0,0 1,2 1,2 2,6 2,2 2,1
Tubb6 4 0,0 0,5 1,2 2,6 5,0 2,3
Nme4 2 0,0 0,4 0,8 2,6 6,7 3,1
Adap1 2 0,0 1,1 1,7 2,6 2,4 1,5
Clip3 2 0,0 1,1 1,5 2,6 2,3 1,8
Asns 4 0,0 0,8 1,0 2,6 3,1 2,6
Gstt1 4 0,0 0,8 1,7 2,6 3,2 1,5
Ctla4 2 0,0 0,7 1,6 2,6 3,8 1,7
Slamf6 4 0,0 1,0 1,9 2,6 2,5 1,3
Tmem121 2 0,0 0,6 1,2 2,5 4,1 2,1
Batf 4 0,0 1,2 1,4 2,5 2,1 1,8
Pnpla3 2 0,0 0,4 1,6 2,5 5,6 1,5
Batf3 4 0,0 0,6 0,5 2,5 4,2 4,5
Sox12 4 0,0 0,6 0,9 2,5 4,4 2,6
Ctsl 4 0,0 0,7 0,9 2,4 3,4 2,8
Furin 4 0,0 1,1 1,3 2,4 2,2 1,8
Zfp827 4 0,0 1,2 1,7 2,4 2,1 1,4
Asb2 2 0,0 0,8 1,4 2,4 2,9 1,7
Zbtb18 2 0,0 1,6 1,2 2,4 1,5 2,0
Sptb 4 0,0 0,4 0,5 2,4 6,9 4,7
Eno2 4 0,0 0,5 1,0 2,4 4,9 2,4
Foxj1 4 0,0 0,5 0,5 2,3 5,1 4,6
Dbndd2 2 0,0 0,5 1,0 2,3 4,5 2,4
Otud5 2 0,0 0,9 1,6 2,3 2,6 1,4
Ceacam16 2 0,0 0,5 0,9 2,3 4,2 2,6
Gpr125 2 0,0 0,6 1,3 2,3 3,6 1,7
Ctsf 2 0,0 0,9 1,4 2,3 2,6 1,7
Slc15a3 4 0,0 0,5 0,7 2,2 4,2 3,4
Pfn2 2 0,0 0,7 1,0 2,2 3,1 2,1
Cd40lg 4 0,0 1,4 1,7 2,2 1,6 1,3
Spock2 2 0,0 0,7 1,0 2,2 3,1 2,2
RP24-113D21.1 4 0,0 1,0 1,1 2,1 2,2 2,0
Fah 2 0,0 1,1 1,0 2,1 1,9 2,1
Zc3h12d 2 0,0 1,0 1,5 2,1 2,2 1,4
Pik3c2b 2 0,0 0,8 1,5 2,1 2,7 1,4
Slc35f5 2 0,0 0,4 1,1 2,1 5,4 1,8
Gpr179 2 0,0 0,5 1,6 2,0 4,4 1,3
Trim71 4 0,0 1,2 0,5 2,0 1,7 4,0
Slc2a6 4 0,0 0,7 0,8 2,0 2,8 2,5
Hif3a 2 0,0 0,4 1,1 2,0 5,4 1,9
Mgrn1 2 0,0 0,7 0,8 2,0 2,7 2,5
Rab31 2 0,0 0,4 0,4 2,0 5,3 5,2
Zak 2 0,0 0,6 0,8 2,0 3,2 2,5
Ankrd34b 4 0,0 0,6 0,6 2,0 3,6 3,4
Irak3 2 0,0 0,9 0,7 2,0 2,1 2,7
Fam213a 2 0,0 0,5 1,4 2,0 3,8 1,4
Milr1 2 0,0 0,9 0,6 1,9 2,2 3,1
Gm7645 2 0,0 0,5 0,9 1,9 3,7 2,3
Abhd17c 4 0,0 1,1 1,0 1,9 1,7 1,8
Perp 4 0,0 0,5 0,6 1,9 3,5 3,0
Usp6nl 2 0,0 1,0 1,0 1,9 1,9 1,9
Tead1 4 0,0 1,2 0,5 1,9 1,6 3,9
Armcx2 2 0,0 0,7 1,0 1,9 2,6 1,9
Ltbp3 2 0,0 0,4 0,9 1,9 4,3 2,2
Ell2 4 0,0 1,0 1,2 1,9 1,8 1,6
Lama5 2 0,0 1,2 1,0 1,9 1,6 1,9
Gm15051 2 0,0 0,4 0,7 1,9 4,2 2,7
Tnp2 2 0,0 0,4 0,8 1,9 4,7 2,2
Gm13012 2 0,0 0,5 0,9 1,8 3,4 2,0
Tmsb15b1 2 0,0 0,9 1,0 1,8 2,0 1,8
Ikzf4 2 0,0 1,1 0,9 1,8 1,6 2,0
Gm20645 4 0,0 0,5 1,0 1,8 4,1 1,8
Gab2 2 0,0 1,0 0,7 1,8 1,8 2,5
Gm12699 4 0,0 0,5 0,8 1,8 4,0 2,4
Plscr1 4 0,0 0,4 1,3 1,8 5,0 1,5
Hrsp12 2 0,0 0,4 1,4 1,8 5,0 1,3
Ifnlr1 2 0,0 0,6 0,6 1,8 2,9 3,1
Slc37a2 4 0,0 0,5 0,9 1,8 3,5 2,1
Ccdc50 4 0,0 0,6 0,9 1,8 3,0 2,0
Fam46a 2 0,0 1,2 1,2 1,8 1,5 1,4
Itgb5 2 0,0 1,0 0,5 1,8 1,8 3,4
Tnfrsf25 2 0,0 0,7 1,2 1,8 2,5 1,4
Espn 2 0,0 0,6 0,8 1,8 2,7 2,3
H2-Eb1 2 0,0 0,6 0,6 1,7 2,8 3,1
Hk2 4 0,0 0,6 0,8 1,7 2,8 2,1
Ypel2 2 0,0 0,5 0,6 1,7 3,6 2,7
Rbpsuh-rs3 4 0,0 0,5 0,8 1,7 3,3 2,2
Abca1 4 0,0 0,6 0,9 1,7 2,8 1,9
Nfkbiz 4 0,0 1,1 0,9 1,7 1,5 2,0
Ccdc17 2 0,0 0,8 0,9 1,7 2,2 1,9
Ntng2 4 0,0 1,2 1,2 1,7 1,4 1,4
Ggn 2 0,0 0,6 1,0 1,7 3,1 1,7
Myb 2 0,0 0,5 1,3 1,7 3,3 1,3
Hip1r 2 0,0 0,9 0,9 1,7 1,8 1,8
Tnfsf8 4 0,0 0,9 0,8 1,7 2,0 2,0
Jdp2 2 0,0 0,7 1,3 1,7 2,5 1,3
Pde8a 2 0,0 0,8 0,8 1,6 2,1 1,9
Agpat4 4 0,0 0,7 0,8 1,6 2,2 2,0
Ksr1 4 0,0 0,5 1,1 1,6 3,3 1,4
Arhgef5 2 0,0 0,4 1,1 1,6 4,2 1,5
Cd72 2 0,0 0,4 0,6 1,6 4,1 2,8
Tcf7 2 0,0 0,8 0,9 1,6 2,1 1,8
Slc25a53 2 0,0 1,0 1,0 1,6 1,6 1,5
Stx11 4 0,0 0,6 1,1 1,6 2,6 1,5
Ston2 2 0,0 0,5 0,8 1,6 3,3 2,0
Hddc3 2 0,0 0,6 1,1 1,6 2,6 1,5
Rbpj 4 0,0 0,4 0,8 1,6 3,7 2,0
Bcl6 4 0,0 0,7 1,0 1,6 2,4 1,6
Tspan5 4 0,0 0,6 0,5 1,6 2,5 2,9
Fndc3a 2 0,0 0,8 0,7 1,6 2,0 2,2
Tcn2 2 0,0 0,8 1,0 1,6 1,9 1,5
Ldhb 2 0,0 0,4 1,0 1,6 3,8 1,6
Dynlt3 2 0,0 0,5 1,0 1,6 3,0 1,6
Gm12764 2 0,0 1,0 0,9 1,6 1,6 1,7
6720401G13Rik 2 0,0 0,5 0,9 1,6 3,4 1,7
Abhd4 2 0,0 0,6 0,9 1,6 2,6 1,7
Pla2g12a 4 0,0 0,5 0,7 1,6 2,9 2,1
Cd200 4 0,0 0,9 1,0 1,5 1,7 1,5
Mcam 2 0,0 0,5 0,6 1,5 2,9 2,5
Gm14680 2 0,0 0,5 0,6 1,5 3,3 2,7
Cxx1c 2 0,0 0,7 0,6 1,5 2,0 2,6
Slc39a13 2 0,0 0,5 0,7 1,5 3,3 2,0
Gm15473 2 0,0 0,6 1,0 1,5 2,4 1,4
Tmsb15l 2 0,0 0,9 0,9 1,5 1,7 1,6
Rundc3a 2 0,0 0,6 0,9 1,5 2,6 1,7
Mrpl45 2 0,0 0,4 1,1 1,5 3,4 1,3
Trerf1 2 0,0 0,5 1,0 1,5 3,0 1,4
Rragd 2 0,0 0,8 0,9 1,5 1,8 1,6
6530402F18Rik 4 0,0 1,1 0,9 1,4 1,3 1,6
Chic1 2 0,0 0,6 0,9 1,4 2,3 1,6
Cpt1c 2 0,0 0,5 0,6 1,4 2,9 2,6
Adam8 2 0,0 0,6 0,5 1,4 2,2 3,1
Fam46c 2 0,0 0,7 0,5 1,4 2,0 3,0
Zfp518b 2 0,0 0,5 0,9 1,4 2,8 1,6
Zc2hc1a 2 0,0 0,4 0,9 1,4 3,7 1,5
Lpxn 2 0,0 0,7 1,0 1,4 2,0 1,4
Plcb4 2 0,0 0,4 0,8 1,4 3,9 1,7
Hmgn3 2 0,0 0,6 0,9 1,4 2,3 1,6
Ndst1 2 0,0 0,6 0,8 1,4 2,4 1,8
Rapgef5 2 0,0 0,5 0,5 1,4 2,6 2,7
Plk2 4 0,0 0,8 0,6 1,4 1,6 2,2
Cldn12 2 0,0 0,5 0,9 1,4 2,8 1,5
Pecam1 2 0,0 0,8 0,6 1,4 1,8 2,1
Ccr4 2 0,0 0,9 1,0 1,4 1,6 1,3
Prrg4 4 0,0 0,6 0,9 1,3 2,3 1,5
Gstt2 2 0,0 0,4 0,9 1,3 3,6 1,5
Tmem198b 2 0,0 0,5 0,8 1,3 2,6 1,6
Gpr18 2 0,0 1,1 0,9 1,3 1,3 1,4
Armcx4 2 0,0 0,5 0,6 1,3 2,9 2,2
Ahr 4 0,0 0,8 0,9 1,3 1,6 1,5
Sdcbp2 2 0,0 0,6 1,0 1,3 2,3 1,3
Akr7a5 2 0,0 0,4 0,5 1,3 3,1 2,7
Ggt7 2 0,0 0,7 0,9 1,3 1,8 1,5
Zfp516 2 0,0 0,5 1,0 1,3 2,9 1,3
Cyp4v3 2 0,0 0,6 0,9 1,3 2,2 1,4
Tab2 2 0,0 0,9 1,0 1,3 1,4 1,3
Gucy1b3 2 0,0 0,8 1,0 1,3 1,7 1,3
Fam210b 2 0,0 0,4 1,0 1,2 3,3 1,3
Per2 4 0,0 0,4 0,4 1,2 2,9 2,8
Gls2 2 0,0 0,4 0,7 1,2 3,5 1,9
Pqlc1 2 0,0 0,5 0,9 1,2 2,4 1,4
Itfg3 2 0,0 0,4 0,7 1,2 2,8 1,8
Xk 2 0,0 0,4 0,6 1,2 2,9 2,2
Plxna1 4 0,0 0,5 0,7 1,2 2,5 1,7
Rybp 2 0,0 0,6 0,6 1,2 2,1 2,0
Ube2q2 4 0,0 0,5 0,5 1,2 2,2 2,3
Slc39a4 2 0,0 0,4 0,6 1,2 3,1 2,1
2310001H17Rik 2 0,0 0,5 0,7 1,2 2,2 1,7
Bcl2l2 2 0,0 0,5 0,9 1,2 2,2 1,3
Tmtc4 2 0,0 0,5 0,4 1,2 2,5 2,8
Gm20689 4 0,0 0,6 0,8 1,2 2,1 1,5
Gaa 2 0,0 0,4 0,6 1,2 2,7 1,9
Phyh 2 0,0 0,5 0,9 1,2 2,2 1,3
Lta 2 0,0 0,4 0,8 1,1 2,8 1,4
Tmbim1 4 0,0 0,4 0,6 1,1 3,1 2,0
Nabp1 2 0,0 0,6 0,8 1,1 1,9 1,3
Malt1 4 0,0 0,4 0,6 1,1 2,9 1,7
Cdc14b 2 0,0 0,4 0,5 1,1 2,8 2,2
Ube2f 2 0,0 0,7 0,8 1,1 1,5 1,3
Mink1 2 0,0 0,5 0,6 1,1 2,3 1,9
Map9 2 0,0 0,5 0,7 1,1 2,1 1,6
Hspa13 2 0,0 0,4 0,6 1,1 2,8 1,9
Slc4a7 4 0,0 0,6 0,5 1,1 1,9 1,9
Rrad 4 0,0 0,4 0,7 1,1 2,3 1,4
Acp6 2 0,0 0,6 0,8 1,1 1,8 1,3
Tspyl2 2 0,0 0,5 0,5 1,0 2,1 2,0
Atcay 2 0,0 0,4 0,7 1,0 2,4 1,6
Aldh7a1 2 0,0 0,6 0,7 1,0 1,7 1,5
Ocrl 2 0,0 0,4 0,6 1,0 2,5 1,6
Tcf4 2 0,0 0,6 0,5 1,0 1,7 2,0
Stat3 2 0,0 0,5 0,6 1,0 1,9 1,6
Fyttd1 2 0,0 0,5 0,5 1,0 2,2 2,0
Cited2 2 0,0 0,6 0,5 1,0 1,6 2,0
Ppt1 2 0,0 0,4 0,5 1,0 2,5 1,9
Cldn25 2 0,0 0,6 0,6 1,0 1,7 1,6
Cdkn1a 2 0,0 0,6 0,5 1,0 1,7 2,1
Hif1a 2 0,0 0,7 0,6 1,0 1,4 1,6
Gm5884 2 0,0 0,7 0,6 1,0 1,5 1,7
Pqbp1 2 0,0 0,4 0,6 1,0 2,4 1,6
Tspan3 2 0,0 0,5 0,6 0,9 1,8 1,5
Tes 2 0,0 0,5 0,7 0,9 1,8 1,4
Gnpnat1 2 0,0 0,4 0,5 0,9 2,2 2,0
Ddt 2 0,0 0,5 0,5 0,9 2,0 2,1
St3gal2 2 0,0 0,5 0,7 0,9 1,9 1,3
Plekha8 2 0,0 0,4 0,5 0,9 2,4 1,7
Ern1 2 0,0 0,6 0,5 0,9 1,5 1,8
Eml5 2 0,0 0,5 0,5 0,9 1,9 1,9
Tmem237 2 0,0 0,5 0,6 0,9 1,8 1,5
Grn 2 0,0 0,4 0,7 0,9 1,9 1,3
Slc25a36 2 0,0 0,5 0,6 0,9 1,7 1,4
Adam9 2 0,0 0,5 0,5 0,9 1,8 1,8
Usp33 2 0,0 0,4 0,6 0,8 1,9 1,4
Fam71b 2 0,0 0,4 0,5 0,8 1,9 1,6
Arhgef12 2 0,0 0,4 0,5 0,8 2,0 1,5
Sdf4 2 0,0 0,4 0,6 0,8 2,3 1,3
Tnfrsf14 2 0,0 0,4 0,6 0,8 2,2 1,5
Ccdc66 2 0,0 0,4 0,6 0,8 2,2 1,3
Tet2 4 0,0 0,5 0,5 0,8 1,7 1,6
Bmi1 2 0,0 0,4 0,5 0,8 2,3 1,7
Arrdc3 2 0,0 0,4 0,5 0,8 2,0 1,6
Ttc39c 2 0,0 0,4 0,5 0,8 1,9 1,5
Sqstm1 2 0,0 0,5 0,5 0,8 1,7 1,5
Tbrg1 2 0,0 0,4 0,6 0,8 1,9 1,3
Rab8b 4 0,0 0,4 0,4 0,8 2,1 1,7
Tmbim4 2 0,0 0,5 0,5 0,8 1,6 1,6
Plekhb2 2 0,0 0,4 0,5 0,7 1,9 1,3
Il12rb1 2 0,0 0,5 0,4 0,7 1,5 1,8
Arhgap26 2 0,0 0,4 0,4 0,7 1,7 1,8
Wsb2 4 0,0 0,5 0,4 0,7 1,3 1,7
Tmem30a 2 0,0 0,4 0,4 0,7 1,7 1,9
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Gm15987 4 0,0 3,4 1,3 5,5 1,6 4,3
Cebpd 4 0,0 1,2 0,7 5,5 4,4 7,5
Kit 4 0,0 2,0 1,9 5,0 2,5 2,6
Tnfrsf8 4 0,0 0,6 2,1 4,8 7,4 2,2
Tlr9 4 0,0 1,3 2,4 4,6 3,6 1,9
Gm14718 4 0,0 1,7 2,0 4,5 2,6 2,2
Zcchc18 4 0,0 2,6 2,7 4,4 1,7 1,6
Fam43a 4 0,0 0,8 1,2 4,4 5,5 3,7
Ebi3 4 0,0 1,0 3,3 4,1 4,3 1,3
Tox2 4 0,0 0,4 1,6 4,1 10,9 2,6
Ppic 4 0,0 1,8 1,4 4,0 2,3 2,9
Prickle1 4 0,0 2,2 1,1 3,9 1,8 3,6
Fcrl1 4 0,0 1,0 0,7 3,7 3,7 5,2
Icos 4 0,0 1,9 2,4 3,6 1,9 1,5
Mpzl1 4 0,0 1,1 0,9 3,5 3,2 3,7
Cpd 4 0,0 1,0 1,8 3,4 3,3 1,9
Lmna 4 0,0 0,4 1,6 3,3 9,5 2,1
RP24-312B12.1 4 0,0 2,2 2,0 3,2 1,5 1,7
Zc3h12c 4 0,0 0,4 0,9 3,2 8,8 3,5
Fam84a 4 0,0 0,7 1,2 3,2 4,4 2,6
Upp1 4 0,0 0,6 0,5 3,2 5,5 6,7
Gatm 4 0,0 0,6 1,4 3,1 5,0 2,3
Rhov 4 0,0 0,4 0,8 2,9 7,3 3,5
Tex15 4 0,0 1,0 1,0 2,8 2,9 2,8
Smox 4 0,0 1,1 1,3 2,7 2,4 2,2
Nfkbia 4 0,0 0,8 0,9 2,7 3,4 3,1
Rims3 2 0,0 1,2 1,1 2,7 2,2 2,4
Alcam 4 0,0 1,3 1,3 2,7 2,1 2,1
Marcks 4 0,0 0,5 0,9 2,7 5,8 3,1
Rilpl2 4 0,0 1,6 1,4 2,7 1,6 1,9
Pou2f2 4 0,0 2,0 1,8 2,7 1,3 1,5
Ankrd55 4 0,0 1,2 1,2 2,6 2,2 2,1
Tubb6 4 0,0 0,5 1,2 2,6 5,0 2,3
Nme4 2 0,0 0,4 0,8 2,6 6,7 3,1
Adap1 2 0,0 1,1 1,7 2,6 2,4 1,5
Clip3 2 0,0 1,1 1,5 2,6 2,3 1,8
Asns 4 0,0 0,8 1,0 2,6 3,1 2,6
Gstt1 4 0,0 0,8 1,7 2,6 3,2 1,5
Ctla4 2 0,0 0,7 1,6 2,6 3,8 1,7
Slamf6 4 0,0 1,0 1,9 2,6 2,5 1,3
Tmem121 2 0,0 0,6 1,2 2,5 4,1 2,1
Batf 4 0,0 1,2 1,4 2,5 2,1 1,8
Pnpla3 2 0,0 0,4 1,6 2,5 5,6 1,5
Batf3 4 0,0 0,6 0,5 2,5 4,2 4,5
Sox12 4 0,0 0,6 0,9 2,5 4,4 2,6
Ctsl 4 0,0 0,7 0,9 2,4 3,4 2,8
Furin 4 0,0 1,1 1,3 2,4 2,2 1,8
Zfp827 4 0,0 1,2 1,7 2,4 2,1 1,4
Asb2 2 0,0 0,8 1,4 2,4 2,9 1,7
Zbtb18 2 0,0 1,6 1,2 2,4 1,5 2,0
Sptb 4 0,0 0,4 0,5 2,4 6,9 4,7
Eno2 4 0,0 0,5 1,0 2,4 4,9 2,4
Foxj1 4 0,0 0,5 0,5 2,3 5,1 4,6
Dbndd2 2 0,0 0,5 1,0 2,3 4,5 2,4
Otud5 2 0,0 0,9 1,6 2,3 2,6 1,4
Ceacam16 2 0,0 0,5 0,9 2,3 4,2 2,6
Gpr125 2 0,0 0,6 1,3 2,3 3,6 1,7
Ctsf 2 0,0 0,9 1,4 2,3 2,6 1,7
Slc15a3 4 0,0 0,5 0,7 2,2 4,2 3,4
Pfn2 2 0,0 0,7 1,0 2,2 3,1 2,1
Cd40lg 4 0,0 1,4 1,7 2,2 1,6 1,3
Spock2 2 0,0 0,7 1,0 2,2 3,1 2,2
RP24-113D21.1 4 0,0 1,0 1,1 2,1 2,2 2,0
Fah 2 0,0 1,1 1,0 2,1 1,9 2,1
Zc3h12d 2 0,0 1,0 1,5 2,1 2,2 1,4
Pik3c2b 2 0,0 0,8 1,5 2,1 2,7 1,4
Slc35f5 2 0,0 0,4 1,1 2,1 5,4 1,8
Gpr179 2 0,0 0,5 1,6 2,0 4,4 1,3
Trim71 4 0,0 1,2 0,5 2,0 1,7 4,0
Slc2a6 4 0,0 0,7 0,8 2,0 2,8 2,5
Hif3a 2 0,0 0,4 1,1 2,0 5,4 1,9
Mgrn1 2 0,0 0,7 0,8 2,0 2,7 2,5
Rab31 2 0,0 0,4 0,4 2,0 5,3 5,2
Zak 2 0,0 0,6 0,8 2,0 3,2 2,5
Ankrd34b 4 0,0 0,6 0,6 2,0 3,6 3,4
Irak3 2 0,0 0,9 0,7 2,0 2,1 2,7
Fam213a 2 0,0 0,5 1,4 2,0 3,8 1,4
Milr1 2 0,0 0,9 0,6 1,9 2,2 3,1
Gm7645 2 0,0 0,5 0,9 1,9 3,7 2,3
Abhd17c 4 0,0 1,1 1,0 1,9 1,7 1,8
Perp 4 0,0 0,5 0,6 1,9 3,5 3,0
Usp6nl 2 0,0 1,0 1,0 1,9 1,9 1,9
Tead1 4 0,0 1,2 0,5 1,9 1,6 3,9
Armcx2 2 0,0 0,7 1,0 1,9 2,6 1,9
Ltbp3 2 0,0 0,4 0,9 1,9 4,3 2,2
Ell2 4 0,0 1,0 1,2 1,9 1,8 1,6
Lama5 2 0,0 1,2 1,0 1,9 1,6 1,9
Gm15051 2 0,0 0,4 0,7 1,9 4,2 2,7
Tnp2 2 0,0 0,4 0,8 1,9 4,7 2,2
Gm13012 2 0,0 0,5 0,9 1,8 3,4 2,0
Tmsb15b1 2 0,0 0,9 1,0 1,8 2,0 1,8
Ikzf4 2 0,0 1,1 0,9 1,8 1,6 2,0
Gm20645 4 0,0 0,5 1,0 1,8 4,1 1,8
Gab2 2 0,0 1,0 0,7 1,8 1,8 2,5
Gm12699 4 0,0 0,5 0,8 1,8 4,0 2,4
Plscr1 4 0,0 0,4 1,3 1,8 5,0 1,5
Hrsp12 2 0,0 0,4 1,4 1,8 5,0 1,3
Ifnlr1 2 0,0 0,6 0,6 1,8 2,9 3,1
Slc37a2 4 0,0 0,5 0,9 1,8 3,5 2,1
Ccdc50 4 0,0 0,6 0,9 1,8 3,0 2,0
Fam46a 2 0,0 1,2 1,2 1,8 1,5 1,4
Itgb5 2 0,0 1,0 0,5 1,8 1,8 3,4
Tnfrsf25 2 0,0 0,7 1,2 1,8 2,5 1,4
Espn 2 0,0 0,6 0,8 1,8 2,7 2,3
H2-Eb1 2 0,0 0,6 0,6 1,7 2,8 3,1
Hk2 4 0,0 0,6 0,8 1,7 2,8 2,1
Ypel2 2 0,0 0,5 0,6 1,7 3,6 2,7
Rbpsuh-rs3 4 0,0 0,5 0,8 1,7 3,3 2,2
Abca1 4 0,0 0,6 0,9 1,7 2,8 1,9
Nfkbiz 4 0,0 1,1 0,9 1,7 1,5 2,0
Ccdc17 2 0,0 0,8 0,9 1,7 2,2 1,9
Ntng2 4 0,0 1,2 1,2 1,7 1,4 1,4
Ggn 2 0,0 0,6 1,0 1,7 3,1 1,7
Myb 2 0,0 0,5 1,3 1,7 3,3 1,3
Hip1r 2 0,0 0,9 0,9 1,7 1,8 1,8
Tnfsf8 4 0,0 0,9 0,8 1,7 2,0 2,0
Jdp2 2 0,0 0,7 1,3 1,7 2,5 1,3
Pde8a 2 0,0 0,8 0,8 1,6 2,1 1,9
Agpat4 4 0,0 0,7 0,8 1,6 2,2 2,0
Ksr1 4 0,0 0,5 1,1 1,6 3,3 1,4
Arhgef5 2 0,0 0,4 1,1 1,6 4,2 1,5
Cd72 2 0,0 0,4 0,6 1,6 4,1 2,8
Tcf7 2 0,0 0,8 0,9 1,6 2,1 1,8
Slc25a53 2 0,0 1,0 1,0 1,6 1,6 1,5
Stx11 4 0,0 0,6 1,1 1,6 2,6 1,5
Ston2 2 0,0 0,5 0,8 1,6 3,3 2,0
Hddc3 2 0,0 0,6 1,1 1,6 2,6 1,5
Rbpj 4 0,0 0,4 0,8 1,6 3,7 2,0
Bcl6 4 0,0 0,7 1,0 1,6 2,4 1,6
Tspan5 4 0,0 0,6 0,5 1,6 2,5 2,9
Fndc3a 2 0,0 0,8 0,7 1,6 2,0 2,2
Tcn2 2 0,0 0,8 1,0 1,6 1,9 1,5
Ldhb 2 0,0 0,4 1,0 1,6 3,8 1,6
Dynlt3 2 0,0 0,5 1,0 1,6 3,0 1,6
Gm12764 2 0,0 1,0 0,9 1,6 1,6 1,7
6720401G13Rik 2 0,0 0,5 0,9 1,6 3,4 1,7
Abhd4 2 0,0 0,6 0,9 1,6 2,6 1,7
Pla2g12a 4 0,0 0,5 0,7 1,6 2,9 2,1
Cd200 4 0,0 0,9 1,0 1,5 1,7 1,5
Mcam 2 0,0 0,5 0,6 1,5 2,9 2,5
Gm14680 2 0,0 0,5 0,6 1,5 3,3 2,7
Cxx1c 2 0,0 0,7 0,6 1,5 2,0 2,6
Slc39a13 2 0,0 0,5 0,7 1,5 3,3 2,0
Gm15473 2 0,0 0,6 1,0 1,5 2,4 1,4
Tmsb15l 2 0,0 0,9 0,9 1,5 1,7 1,6
Rundc3a 2 0,0 0,6 0,9 1,5 2,6 1,7
Mrpl45 2 0,0 0,4 1,1 1,5 3,4 1,3
Trerf1 2 0,0 0,5 1,0 1,5 3,0 1,4
Rragd 2 0,0 0,8 0,9 1,5 1,8 1,6
6530402F18Rik 4 0,0 1,1 0,9 1,4 1,3 1,6
Chic1 2 0,0 0,6 0,9 1,4 2,3 1,6
Cpt1c 2 0,0 0,5 0,6 1,4 2,9 2,6
Adam8 2 0,0 0,6 0,5 1,4 2,2 3,1
Fam46c 2 0,0 0,7 0,5 1,4 2,0 3,0
Zfp518b 2 0,0 0,5 0,9 1,4 2,8 1,6
Zc2hc1a 2 0,0 0,4 0,9 1,4 3,7 1,5
Lpxn 2 0,0 0,7 1,0 1,4 2,0 1,4
Plcb4 2 0,0 0,4 0,8 1,4 3,9 1,7
Hmgn3 2 0,0 0,6 0,9 1,4 2,3 1,6
Ndst1 2 0,0 0,6 0,8 1,4 2,4 1,8
Rapgef5 2 0,0 0,5 0,5 1,4 2,6 2,7
Plk2 4 0,0 0,8 0,6 1,4 1,6 2,2
Cldn12 2 0,0 0,5 0,9 1,4 2,8 1,5
Pecam1 2 0,0 0,8 0,6 1,4 1,8 2,1
Ccr4 2 0,0 0,9 1,0 1,4 1,6 1,3
Prrg4 4 0,0 0,6 0,9 1,3 2,3 1,5
Gstt2 2 0,0 0,4 0,9 1,3 3,6 1,5
Tmem198b 2 0,0 0,5 0,8 1,3 2,6 1,6
Gpr18 2 0,0 1,1 0,9 1,3 1,3 1,4
Armcx4 2 0,0 0,5 0,6 1,3 2,9 2,2
Ahr 4 0,0 0,8 0,9 1,3 1,6 1,5
Sdcbp2 2 0,0 0,6 1,0 1,3 2,3 1,3
Akr7a5 2 0,0 0,4 0,5 1,3 3,1 2,7
Ggt7 2 0,0 0,7 0,9 1,3 1,8 1,5
Zfp516 2 0,0 0,5 1,0 1,3 2,9 1,3
Cyp4v3 2 0,0 0,6 0,9 1,3 2,2 1,4
Tab2 2 0,0 0,9 1,0 1,3 1,4 1,3
Gucy1b3 2 0,0 0,8 1,0 1,3 1,7 1,3
Fam210b 2 0,0 0,4 1,0 1,2 3,3 1,3
Per2 4 0,0 0,4 0,4 1,2 2,9 2,8
Gls2 2 0,0 0,4 0,7 1,2 3,5 1,9
Pqlc1 2 0,0 0,5 0,9 1,2 2,4 1,4
Itfg3 2 0,0 0,4 0,7 1,2 2,8 1,8
Xk 2 0,0 0,4 0,6 1,2 2,9 2,2
Plxna1 4 0,0 0,5 0,7 1,2 2,5 1,7
Rybp 2 0,0 0,6 0,6 1,2 2,1 2,0
Ube2q2 4 0,0 0,5 0,5 1,2 2,2 2,3
Slc39a4 2 0,0 0,4 0,6 1,2 3,1 2,1
2310001H17Rik 2 0,0 0,5 0,7 1,2 2,2 1,7
Bcl2l2 2 0,0 0,5 0,9 1,2 2,2 1,3
Tmtc4 2 0,0 0,5 0,4 1,2 2,5 2,8
Gm20689 4 0,0 0,6 0,8 1,2 2,1 1,5
Gaa 2 0,0 0,4 0,6 1,2 2,7 1,9
Phyh 2 0,0 0,5 0,9 1,2 2,2 1,3
Lta 2 0,0 0,4 0,8 1,1 2,8 1,4
Tmbim1 4 0,0 0,4 0,6 1,1 3,1 2,0
Nabp1 2 0,0 0,6 0,8 1,1 1,9 1,3
Malt1 4 0,0 0,4 0,6 1,1 2,9 1,7
Cdc14b 2 0,0 0,4 0,5 1,1 2,8 2,2
Ube2f 2 0,0 0,7 0,8 1,1 1,5 1,3
Mink1 2 0,0 0,5 0,6 1,1 2,3 1,9
Map9 2 0,0 0,5 0,7 1,1 2,1 1,6
Hspa13 2 0,0 0,4 0,6 1,1 2,8 1,9
Slc4a7 4 0,0 0,6 0,5 1,1 1,9 1,9
Rrad 4 0,0 0,4 0,7 1,1 2,3 1,4
Acp6 2 0,0 0,6 0,8 1,1 1,8 1,3
Tspyl2 2 0,0 0,5 0,5 1,0 2,1 2,0
Atcay 2 0,0 0,4 0,7 1,0 2,4 1,6
Aldh7a1 2 0,0 0,6 0,7 1,0 1,7 1,5
Ocrl 2 0,0 0,4 0,6 1,0 2,5 1,6
Tcf4 2 0,0 0,6 0,5 1,0 1,7 2,0
Stat3 2 0,0 0,5 0,6 1,0 1,9 1,6
Fyttd1 2 0,0 0,5 0,5 1,0 2,2 2,0
Cited2 2 0,0 0,6 0,5 1,0 1,6 2,0
Ppt1 2 0,0 0,4 0,5 1,0 2,5 1,9
Cldn25 2 0,0 0,6 0,6 1,0 1,7 1,6
Cdkn1a 2 0,0 0,6 0,5 1,0 1,7 2,1
Hif1a 2 0,0 0,7 0,6 1,0 1,4 1,6
Gm5884 2 0,0 0,7 0,6 1,0 1,5 1,7
Pqbp1 2 0,0 0,4 0,6 1,0 2,4 1,6
Tspan3 2 0,0 0,5 0,6 0,9 1,8 1,5
Tes 2 0,0 0,5 0,7 0,9 1,8 1,4
Gnpnat1 2 0,0 0,4 0,5 0,9 2,2 2,0
Ddt 2 0,0 0,5 0,5 0,9 2,0 2,1
St3gal2 2 0,0 0,5 0,7 0,9 1,9 1,3
Plekha8 2 0,0 0,4 0,5 0,9 2,4 1,7
Ern1 2 0,0 0,6 0,5 0,9 1,5 1,8
Eml5 2 0,0 0,5 0,5 0,9 1,9 1,9
Tmem237 2 0,0 0,5 0,6 0,9 1,8 1,5
Grn 2 0,0 0,4 0,7 0,9 1,9 1,3
Slc25a36 2 0,0 0,5 0,6 0,9 1,7 1,4
Adam9 2 0,0 0,5 0,5 0,9 1,8 1,8
Usp33 2 0,0 0,4 0,6 0,8 1,9 1,4
Fam71b 2 0,0 0,4 0,5 0,8 1,9 1,6
Arhgef12 2 0,0 0,4 0,5 0,8 2,0 1,5
Sdf4 2 0,0 0,4 0,6 0,8 2,3 1,3
Tnfrsf14 2 0,0 0,4 0,6 0,8 2,2 1,5
Ccdc66 2 0,0 0,4 0,6 0,8 2,2 1,3
Tet2 4 0,0 0,5 0,5 0,8 1,7 1,6
Bmi1 2 0,0 0,4 0,5 0,8 2,3 1,7
Arrdc3 2 0,0 0,4 0,5 0,8 2,0 1,6
Ttc39c 2 0,0 0,4 0,5 0,8 1,9 1,5
Sqstm1 2 0,0 0,5 0,5 0,8 1,7 1,5
Tbrg1 2 0,0 0,4 0,6 0,8 1,9 1,3
Rab8b 4 0,0 0,4 0,4 0,8 2,1 1,7
Tmbim4 2 0,0 0,5 0,5 0,8 1,6 1,6
Plekhb2 2 0,0 0,4 0,5 0,7 1,9 1,3
Il12rb1 2 0,0 0,5 0,4 0,7 1,5 1,8
Arhgap26 2 0,0 0,4 0,4 0,7 1,7 1,8
Wsb2 4 0,0 0,5 0,4 0,7 1,3 1,7
Tmem30a 2 0,0 0,4 0,4 0,7 1,7 1,9
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Ecm1 2 0,0 1,4 0,3 1,4 1,0 4,2
Arhgap5 2 0,0 1,1 0,2 0,9 0,8 5,1
Gbp2 2 0,0 1,1 0,2 0,6 0,5 2,9
Pld3 2 0,0 0,5 0,3 0,6 1,2 2,1
4632428N05Rik 2 0,0 0,6 0,3 0,5 0,9 2,0
Ptpn6 2 0,0 0,5 0,3 0,5 1,2 2,0
Hrh2 2 0,0 0,8 0,2 0,5 0,6 2,5
Zhx2 4 0,0 0,5 0,0 0,5 1,1 11,3
Helz2 2 0,0 0,5 0,2 0,5 0,9 2,1
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Appendix 6 ç Gene list of Roquin exclusive targets in cluster 2 and 4. 
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Tnfrsf4 4 0,0 0,3 1,7 2,1 6,8 1,2
Unc5b 2 0,0 -0,2 2,0 1,9 -9,1 0,9
Slc30a2 2 0,0 -0,1 1,5 1,8 -12,4 1,2
Ndst2 2 0,0 0,3 1,2 1,5 5,3 1,2
Fchsd2 2 0,0 0,2 1,2 1,5 6,3 1,2
Irf5 2 0,0 0,3 1,1 1,3 4,9 1,2
Atp13a2 2 0,0 0,2 1,1 1,3 8,4 1,2
2310015A10Rik 2 0,0 0,0 1,1 1,3 0,0 1,2
Cep85l 2 0,0 0,3 1,0 1,2 3,7 1,2
Zc4h2 2 0,0 0,1 1,0 1,2 11,4 1,2
Ptpn21 2 0,0 0,2 1,1 1,2 6,1 1,1
Zfp446 2 0,0 0,2 1,2 1,1 6,1 0,9
Wdr60 2 0,0 0,2 0,9 1,1 6,6 1,2
Mea1 2 0,0 0,3 1,0 1,1 3,3 1,1
Serpinb6b 4 0,0 -0,2 1,3 1,1 -5,1 0,8
Zfp219 2 0,0 0,3 0,9 1,1 3,6 1,2
Fuca2 2 0,0 0,1 0,9 1,1 11,9 1,2
Bcr 2 0,0 0,3 1,1 1,0 3,7 0,9
Gm11998 2 0,0 0,3 1,0 1,0 3,9 1,0
Junb 4 0,0 0,3 0,8 1,0 2,9 1,2
Gfi1 4 0,0 0,1 1,5 0,9 17,5 0,6
Tnfsf11 4 0,0 0,3 1,1 0,9 2,9 0,8
Med23 2 0,0 0,0 0,8 0,9 459,5 1,1
Wdr59 4 0,0 0,3 0,8 0,9 2,9 1,2
Kif3b 2 0,0 0,3 0,7 0,8 2,4 1,2
Cd84 4 0,0 0,3 0,8 0,8 2,8 1,0
2010111I01Rik 2 0,0 0,2 0,7 0,8 3,8 1,1
Fam129a 4 0,0 0,0 0,7 0,8 0,0 1,1
Sh3bgrl 2 0,0 0,3 0,6 0,8 2,6 1,2
Stx6 4 0,0 0,2 0,7 0,7 3,6 1,1
Tada1 2 0,0 0,0 0,7 0,7 0,0 1,0
Rnpep 2 0,0 0,2 0,6 0,7 4,0 1,2
Spg20 2 0,0 0,1 0,6 0,7 8,1 1,2
Eif2ak4 2 0,0 0,0 0,6 0,7 14,3 1,1
Wdfy2 2 0,0 0,2 0,7 0,7 3,1 0,9
Lime1 2 0,0 0,3 0,5 0,7 2,0 1,2
Ddx17 2 0,0 0,3 0,6 0,7 2,3 1,2
Wdr11 2 0,0 0,3 0,6 0,7 2,3 1,2
Ptgr2 2 0,0 0,1 0,7 0,7 5,7 1,0
Lpin2 2 0,0 0,0 0,8 0,7 0,0 0,8
Ezh2 2 0,0 0,1 0,6 0,6 5,6 1,1
Ccdc104 2 0,0 0,2 0,7 0,6 3,0 1,0
Braf 2 0,0 0,3 0,5 0,6 2,5 1,2
Chd9 2 0,0 0,2 0,5 0,6 2,8 1,2
Etaa1 2 0,0 0,0 0,6 0,6 0,0 1,1
Rnf2 2 0,0 0,3 0,5 0,6 1,8 1,2
Gpr174 4 0,0 0,3 0,9 0,6 2,1 0,7
Nfkb1 4 0,0 0,3 0,5 0,6 2,1 1,1
Clk1 2 0,0 0,3 0,6 0,6 2,1 1,1
Trabd 2 0,0 0,0 0,6 0,6 46,2 1,0
Mif4gd 2 0,0 0,2 0,5 0,6 3,0 1,2
Jmjd1c 2 0,0 0,2 0,6 0,6 3,6 0,9
Tfrc 2 0,0 0,2 0,6 0,6 2,7 1,1
Cd44 4 0,0 0,1 0,6 0,6 4,3 0,9
Ttpal 2 0,0 0,3 0,6 0,6 2,3 1,0
Paip2 2 0,0 0,3 0,5 0,6 1,7 1,2
Ncoa1 2 0,0 0,2 0,5 0,6 2,5 1,2
Zfp275 2 0,0 0,1 0,5 0,6 10,0 1,1
Reep3 4 0,0 0,3 0,7 0,6 2,2 0,8
Itgal 2 0,0 0,1 0,6 0,6 7,1 0,9
Map3k14 2 0,0 0,2 0,5 0,5 2,4 1,2
Slc43a3 2 0,0 0,1 0,5 0,5 3,7 1,1
Cog2 2 0,0 0,1 0,5 0,5 5,9 1,0
Elk3 2 0,0 0,1 0,5 0,5 7,3 1,1
Zc3h12a 4 0,0 0,3 1,7 0,5 1,6 0,3
Casp3 2 0,0 0,3 0,5 0,5 1,7 1,1
Secisbp2l 2 0,0 0,3 0,4 0,5 1,9 1,2
Zfp369 2 0,0 0,0 0,5 0,5 12,0 1,1
Tnrc6a 2 0,0 0,2 0,4 0,5 2,8 1,2
Cep170b 2 0,0 0,2 0,5 0,5 3,4 1,1
Dcaf12 2 0,0 0,2 0,4 0,5 3,0 1,1
Plxnc1 2 0,0 0,0 0,7 0,5 0,0 0,7
Brwd1 2 0,0 0,2 0,4 0,5 2,9 1,2
Paxbp1 2 0,0 0,3 0,4 0,5 1,9 1,2
Lmbrd1 2 0,0 0,3 0,4 0,5 1,7 1,2
Kdsr 2 0,0 0,2 0,4 0,5 2,5 1,2
Gramd1b 4 0,0 0,2 0,5 0,5 3,2 0,9
Heg1 2 0,0 0,0 0,6 0,5 0,0 0,8
Ak3 2 0,0 0,1 0,5 0,5 4,3 1,0
Rc3h2 2 0,0 0,2 0,4 0,5 2,0 1,2
Med13 2 0,0 0,1 0,5 0,4 3,7 1,0
Atp2c1 2 0,0 0,3 0,4 0,4 1,6 1,1
Prkcb 2 0,0 -0,1 0,6 0,4 -6,3 0,7
Rbm5 2 0,0 0,2 0,4 0,4 1,8 1,1
Inpp5b 2 0,0 0,3 0,4 0,4 1,7 1,1
Csnk1a1 2 0,0 0,1 0,4 0,4 3,7 1,1
Gpbp1l1 2 0,0 0,1 0,5 0,4 7,4 0,9
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Appendix 7 ç Gene list of redundant targets in cluster 2 and 4. 
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Tnfrsf4 4 0,0 0,3 1,7 2,1 6,8 1,2
Unc5b 2 0,0 -0,2 2,0 1,9 -9,1 0,9
Slc30a2 2 0,0 -0,1 1,5 1,8 -12,4 1,2
Ndst2 2 0,0 0,3 1,2 1,5 5,3 1,2
Fchsd2 2 0,0 0,2 1,2 1,5 6,3 1,2
Irf5 2 0,0 0,3 1,1 1,3 4,9 1,2
Atp13a2 2 0,0 0,2 1,1 1,3 8,4 1,2
2310015A10Rik 2 0,0 0,0 1,1 1,3 0,0 1,2
Cep85l 2 0,0 0,3 1,0 1,2 3,7 1,2
Zc4h2 2 0,0 0,1 1,0 1,2 11,4 1,2
Ptpn21 2 0,0 0,2 1,1 1,2 6,1 1,1
Zfp446 2 0,0 0,2 1,2 1,1 6,1 0,9
Wdr60 2 0,0 0,2 0,9 1,1 6,6 1,2
Mea1 2 0,0 0,3 1,0 1,1 3,3 1,1
Serpinb6b 4 0,0 -0,2 1,3 1,1 -5,1 0,8
Zfp219 2 0,0 0,3 0,9 1,1 3,6 1,2
Fuca2 2 0,0 0,1 0,9 1,1 11,9 1,2
Bcr 2 0,0 0,3 1,1 1,0 3,7 0,9
Gm11998 2 0,0 0,3 1,0 1,0 3,9 1,0
Junb 4 0,0 0,3 0,8 1,0 2,9 1,2
Gfi1 4 0,0 0,1 1,5 0,9 17,5 0,6
Tnfsf11 4 0,0 0,3 1,1 0,9 2,9 0,8
Med23 2 0,0 0,0 0,8 0,9 459,5 1,1
Wdr59 4 0,0 0,3 0,8 0,9 2,9 1,2
Kif3b 2 0,0 0,3 0,7 0,8 2,4 1,2
Cd84 4 0,0 0,3 0,8 0,8 2,8 1,0
2010111I01Rik 2 0,0 0,2 0,7 0,8 3,8 1,1
Fam129a 4 0,0 0,0 0,7 0,8 0,0 1,1
Sh3bgrl 2 0,0 0,3 0,6 0,8 2,6 1,2
Stx6 4 0,0 0,2 0,7 0,7 3,6 1,1
Tada1 2 0,0 0,0 0,7 0,7 0,0 1,0
Rnpep 2 0,0 0,2 0,6 0,7 4,0 1,2
Spg20 2 0,0 0,1 0,6 0,7 8,1 1,2
Eif2ak4 2 0,0 0,0 0,6 0,7 14,3 1,1
Wdfy2 2 0,0 0,2 0,7 0,7 3,1 0,9
Lime1 2 0,0 0,3 0,5 0,7 2,0 1,2
Ddx17 2 0,0 0,3 0,6 0,7 2,3 1,2
Wdr11 2 0,0 0,3 0,6 0,7 2,3 1,2
Ptgr2 2 0,0 0,1 0,7 0,7 5,7 1,0
Lpin2 2 0,0 0,0 0,8 0,7 0,0 0,8
Ezh2 2 0,0 0,1 0,6 0,6 5,6 1,1
Ccdc104 2 0,0 0,2 0,7 0,6 3,0 1,0
Braf 2 0,0 0,3 0,5 0,6 2,5 1,2
Chd9 2 0,0 0,2 0,5 0,6 2,8 1,2
Etaa1 2 0,0 0,0 0,6 0,6 0,0 1,1
Rnf2 2 0,0 0,3 0,5 0,6 1,8 1,2
Gpr174 4 0,0 0,3 0,9 0,6 2,1 0,7
Nfkb1 4 0,0 0,3 0,5 0,6 2,1 1,1
Clk1 2 0,0 0,3 0,6 0,6 2,1 1,1
Trabd 2 0,0 0,0 0,6 0,6 46,2 1,0
Mif4gd 2 0,0 0,2 0,5 0,6 3,0 1,2
Jmjd1c 2 0,0 0,2 0,6 0,6 3,6 0,9
Tfrc 2 0,0 0,2 0,6 0,6 2,7 1,1
Cd44 4 0,0 0,1 0,6 0,6 4,3 0,9
Ttpal 2 0,0 0,3 0,6 0,6 2,3 1,0
Paip2 2 0,0 0,3 0,5 0,6 1,7 1,2
Ncoa1 2 0,0 0,2 0,5 0,6 2,5 1,2
Zfp275 2 0,0 0,1 0,5 0,6 10,0 1,1
Reep3 4 0,0 0,3 0,7 0,6 2,2 0,8
Itgal 2 0,0 0,1 0,6 0,6 7,1 0,9
Map3k14 2 0,0 0,2 0,5 0,5 2,4 1,2
Slc43a3 2 0,0 0,1 0,5 0,5 3,7 1,1
Cog2 2 0,0 0,1 0,5 0,5 5,9 1,0
Elk3 2 0,0 0,1 0,5 0,5 7,3 1,1
Zc3h12a 4 0,0 0,3 1,7 0,5 1,6 0,3
Casp3 2 0,0 0,3 0,5 0,5 1,7 1,1
Secisbp2l 2 0,0 0,3 0,4 0,5 1,9 1,2
Zfp369 2 0,0 0,0 0,5 0,5 12,0 1,1
Tnrc6a 2 0,0 0,2 0,4 0,5 2,8 1,2
Cep170b 2 0,0 0,2 0,5 0,5 3,4 1,1
Dcaf12 2 0,0 0,2 0,4 0,5 3,0 1,1
Plxnc1 2 0,0 0,0 0,7 0,5 0,0 0,7
Brwd1 2 0,0 0,2 0,4 0,5 2,9 1,2
Paxbp1 2 0,0 0,3 0,4 0,5 1,9 1,2
Lmbrd1 2 0,0 0,3 0,4 0,5 1,7 1,2
Kdsr 2 0,0 0,2 0,4 0,5 2,5 1,2
Gramd1b 4 0,0 0,2 0,5 0,5 3,2 0,9
Heg1 2 0,0 0,0 0,6 0,5 0,0 0,8
Ak3 2 0,0 0,1 0,5 0,5 4,3 1,0
Rc3h2 2 0,0 0,2 0,4 0,5 2,0 1,2
Med13 2 0,0 0,1 0,5 0,4 3,7 1,0
Atp2c1 2 0,0 0,3 0,4 0,4 1,6 1,1
Prkcb 2 0,0 -0,1 0,6 0,4 -6,3 0,7
Rbm5 2 0,0 0,2 0,4 0,4 1,8 1,1
Inpp5b 2 0,0 0,3 0,4 0,4 1,7 1,1
Csnk1a1 2 0,0 0,1 0,4 0,4 3,7 1,1
Gpbp1l1 2 0,0 0,1 0,5 0,4 7,4 0,9
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Plcg2 2 0,00 0,28 0,31 2,19 7,80 7,16
Epha2 4 0,00 0,17 0,13 2,15 12,52 17,09
Tmem176a 2 0,00 0,20 0,32 2,11 10,39 6,57
Lrp4 2 0,00 0,02 0,21 1,97 98,50 9,62
8030451A03Rik 2 0,00 0,07 0,32 1,73 26,17 5,36
Arxes2 2 0,00 0,18 0,27 1,70 9,59 6,31
Coprs 2 0,00 0,15 0,33 1,55 10,64 4,66
Zfp703 4 0,00 0,12 0,29 1,46 12,00 5,10
BC018242 2 0,00 0,04 0,22 1,45 41,34 6,70
Mesdc1 2 0,00 0,34 0,29 1,44 4,28 5,02
D630003M21Rik 2 0,00 0,06 0,16 1,41 24,33 8,93
Bcat1 4 0,00 0,07 0,12 1,41 19,32 11,85
Cd320 4 0,00 0,33 0,20 1,41 4,33 6,90
Gsto1 4 0,00 0,21 0,28 1,22 5,87 4,36
Itsn1 2 0,00 0,34 0,27 1,17 3,45 4,35
Slc25a33 4 0,00 0,18 0,11 1,17 6,55 10,66
Gm9824 2 0,00 0,26 0,02 1,07 4,05 46,52
Tgif1 4 0,00 0,23 0,32 1,07 4,67 3,31
Prdm5 2 0,00 0,19 0,30 1,06 5,54 3,50
Purg 2 0,00 0,19 0,23 1,04 5,42 4,53
Ndrg3 2 0,0 0,3 0,3 1,0 2,8 2,8
Pdia6 2 0,00 0,20 0,14 0,96 4,80 6,92
Pebp1 2 0,00 0,26 0,29 0,95 3,70 3,25
March8 2 0,00 0,16 0,19 0,95 6,03 4,90
Lpcat3 2 0,00 0,22 0,15 0,93 4,28 6,23
Gm6166 2 0,00 0,20 0,11 0,92 4,60 8,72
Ralb 2 0,0 0,3 0,3 0,9 2,8 2,8
Nek6 4 0,00 0,20 0,11 0,91 4,66 8,08
Usp22 2 0,00 0,32 0,27 0,88 2,74 3,34
Mesdc2 2 0,00 0,24 0,34 0,87 3,61 2,57
Plbd2 2 0,00 0,05 0,19 0,86 19,11 4,48
Uhrf1bp1 2 0,00 0,18 0,29 0,86 4,73 2,97
Stat5a 4 0,00 0,18 0,30 0,85 4,74 2,85
Cd69 4 0,00 0,29 0,29 0,83 2,90 2,89
Ubfd1 2 0,00 0,31 0,27 0,83 2,73 3,13
Bhlhb9 2 0,00 0,21 0,27 0,80 3,86 2,94
Gm20458 2 0,00 0,28 0,28 0,80 2,92 2,86
Slc41a1 4 0,00 0,19 0,22 0,80 4,19 3,67
Coq9 2 0,00 0,34 0,28 0,80 2,34 2,82
Ssr2 2 0,00 0,25 0,07 0,79 3,16 11,17
Nip7 4 0,00 0,20 0,24 0,79 3,88 3,34
Sbno2 2 0,00 0,20 0,24 0,78 3,93 3,30
Creg1 2 0,00 0,14 0,13 0,77 5,69 5,91
Rictor 2 0,00 0,29 0,27 0,76 2,58 2,86
Naa30 2 0,00 0,23 0,09 0,75 3,22 8,04
Hspa5 4 0,00 0,15 0,05 0,73 4,82 13,57
Ptplad1 2 0,00 0,32 0,21 0,73 2,29 3,54
Iqcb1 2 0,00 0,15 0,30 0,73 5,03 2,42
Gm5560 2 0,00 0,29 0,07 0,73 2,49 10,11
Ube2e3 2 0,00 0,10 0,10 0,72 6,93 7,28
B230354K17Rik 2 0,00 0,25 0,27 0,72 2,87 2,69
Prkcsh 2 0,00 0,23 0,29 0,71 3,11 2,48
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